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1. Introduction
Based on its generally accessible I/II redox couple and bioavailability, copper plays a wide
variety of roles in nature that mostly involve electron transfer (ET), O2 binding, activation
and reduction, NO2− and N2O reduction and substrate activation. Copper sites that perform
ET are the mononuclear blue Cu site that has a highly covalent CuII-S(Cys) bond and the
binuclear CuA site that has a Cu2S(Cys)2 core with a Cu-Cu bond that keeps the site
delocalized (Cu(1.5)2) in its oxidized state. In contrast to inorganic Cu complexes, these
metalloprotein sites transfer electrons rapidly often over long distances, as has been
previously reviewed.1–4 Blue Cu and CuA sites will only be considered here in their relation
to intramolecular ET in multi-center enzymes. The focus of this review is on the Cu
enzymes (Figure 1). Many are involved in O2 activation and reduction, which has mostly
been thought to involve at least two electrons to overcome spin forbiddenness and the low
potential of the one electron reduction to superoxide (Figure 2).5,6 Since the Cu(III) redox
state has not been observed in biology, this requires either more than one Cu center or one
copper and an additional redox active organic cofactor. The latter is formed in a biogenesis
reaction of a residue (Tyr) that is also Cu catalyzed in the first turnover of the protein.
Recently, however, there have been a number of enzymes suggested to utilize one Cu to
activate O2 by 1e− reduction to form a Cu(II)-O2•− intermediate (an innersphere redox
process) and it is important to understand the active site requirements to drive this reaction.
The oxidases that catalyze the 4e−reduction of O2 to H2O are unique in that they effectively
perform this reaction in one step indicating that the free energy barrier for the second two-
electron reduction of the peroxide product of the first two-electron step is very low. In
nature this requires either a trinuclear Cu cluster (in the multicopper oxidases) or a Cu/Tyr/
Heme Fe cluster (in the cytochrome oxidases). The former accomplishes this with almost no
overpotential maximizing its ability to oxidize substrates and its utility in biofuel cells, while
the latter class of enzymes uses the excess energy to pump protons for ATP synthesis. In
bacterial denitrification, a mononuclear Cu center catalyzes the 1e- reduction of nitrite to
NO while a unique µ4S2−Cu4 cluster catalyzes the reduction of N2O to N2 and H2O, a 2e−
process yet requiring 4Cu’s. Finally there are now several classes of enzymes that utilize an
oxidized Cu(II) center to activate a covalently bound substrate to react with O2.
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This review presents in depth discussions of all these classes of Cu enzymes and the
correlations within and among these classes. For each class we review our present
understanding of the enzymology, kinetics, geometric structures, electronic structures and
the reaction mechanisms these have elucidated. While the emphasis here is on the
enzymology, model studies have significantly contributed to our understanding of O2
activation by a number of Cu enzymes and are included in appropriate subsections of this
review. In general we will consider how the covalency of a Cu(II)–substrate bond can
activate the substrate for its spin forbidden reaction with O2, how in binuclear Cu enzymes
the exchange coupling between Cu’s overcomes the spin forbiddenness of O2 binding and
controls electron transfer to O2 to direct catalysis either to perform two e− electrophilic
aromatic substitution or 1e− H-atom abstraction, the type of oxygen intermediate that is
required for H-atom abstraction from the strong C-H bond of methane (104 kcal/mol) and
how the trinuclear Cu cluster and the Cu/Tyr/Heme Fe cluster achieve their very low
barriers for the reductive cleavage of the O-O bond.
Much of the insight available into these mechanisms in Cu biochemistry has come from the
application of a wide range of spectroscopies and the correlation of spectroscopic results to
electronic structure calculations. Thus we start with a tutorial on the different spectroscopic
methods utilized to study mononuclear and multinuclear Cu enzymes and their correlations
to different levels of electronic structure calculations.
2. Electronic Structure and Spectroscopy
2.1 Cu(I) sites
Cuprous complexes have a closed shell, 3d10, configuration and thus must be studied by
methods involving either electron ionization or transitions into higher energy unoccupied
valence orbitals. The former methods include photoelectron spectroscopy where a valence or
core electron is ionized with a photon of known energy and the electron flux at a given
kinetic energy is directly recorded7 (not useful for metalloproteins due to the approximately
10 Å escape depth of the emitted electron) and K-β emission where a core 1s electron is
ionized and photon emission to fill the core hole is measured (see section 2.1.2). The latter
method is X-ray absorption spectroscopy (XAS) at the Cu(I) K-edge where a 1s electron is
excited into the Cu 4p levels. Since s→p transitions are electric dipole allowed, these
produce intense absorption features that are sensitive to the Cu(I) ligand environment. XAS
is commonly performed using synchrotron radiation emitted by electrons moving in an orbit
at relativistic speeds. This has a continuous range of energies, providing wavelengths in the
UV, soft X-ray, and hard X-ray regions and is polarized in the plane of the ring. Third
generation synchrotron sources produce extremely intense beams (many orders of
magnitude higher than conventional X-ray tubes, which only produce discrete energies).
This has made it possible to perform XAS on samples as dilute as ~0.1 mM.
2.1.1 Cu(I) K-edge X-Ray Absorption Spectroscopy (XAS)—The Cu 1s→4p
transition at approximately 8984 eV constitutes the lowest energy pre-edge region of the
Cu(I) K-edge with reasonable intensity. From spectroscopic studies on structurally defined
model complexes these transitions are sensitive to the coordination environment of the Cu(I)
center.8 As shown in (Figure 3 left) a linear two coordinate (2C) ligand environment raises
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the energy of the Cu 4pz orbital resulting in a low energy 1s→4px,y set of transitions at 8984
eV. Addition of a third ligand splits this degeneracy resulting in the double peaked spectrum
in (Figure 3 green). Thus both 2C and 3C Cu(I) sites have a low energy feature at 8984 eV
but the intensity in this lower energy feature is greatly decreased in 3C sites. For a four
coordinate approximately tetrahedral Cu(I) site, all three 4p levels interact with the ligand
field (LF) and are destabilized to higher energy. Thus a feature at ~8984 eV in Cu K-edge
XAS is characteristic of reduced Cu, its shape defines the coordination environment at the
Cu(I) site and its intensity can be used to quantify the amount of reduced copper in a
metalloprotein sample.
2.1.2 K-β emission—X-ray emission spectroscopy at the K-edge involves using the
synchrotron radiation to ionize a Cu 1s core electron and measuring the photon emission
associated with an electron filling the hole. The K-α region between 8030–8050 eV involves
a 2p→1s transition and is the most intense emission observed (dipole allowed) but it is not
very sensitive to the chemical environment of the Cu. Alternatively, K-β emission is
sensitive to oxidation state, spin state, ligand character, and coordination number. The K-β
region (Figure 4 left) consists of the main peaks (K-β1,3 and K-β') between 8900–8910 eV
involving a Cu 3p→1s transition and valence peaks (K-β" and K-β2,5) between 8960–8990
eV involving valence/ligand→1s transitions. Figure 4 right shows the K-β region of a 3d10
transition metal, Zn(II) (qualitatively similar to Cu(I) but at higher energy). The K-β' peak is
missing in the spectra of d10 systems but is present for Cu(II) complexes at ~10 eV lower
energy than the K-β1,3 emission and with less intensity.
The K-β1,3 is the second strongest feature observed in an emission spectrum and is roughly
1/8th as intense as the K-α peak. It is an electric dipole allowed 3p→1s transition where the
1,3 refers to the spin-orbit splitting of the 3p, which is not resolved in the lineshape. In
contrast to Cu(I) complexes, for Cu(II) complexes the hole in the 3d will exchange couple
with the hole in the 3p resulting in the K-β' feature when both holes have the same spin.9
The final state with opposite spins in the 3p and 3d orbitals gives rise to the main K-β1,3
peak. In Cu(II) there can also be a ligand to metal charge transfer (LMCT) process that
occurs due to the 3d relaxation associated with the increase in Zeff caused by the 1s core
hole, resulting in the transfer of a ligand electron in to the 3d orbital. This new 1sd10L
excited state is lower in energy than the 1sd9 excited state (the 1s and L are holes in the
orbitals indicated). The 3p→1s transition associated with this final state can also lead to a K-
β' feature, whereas the 3p→1s transition associated with the 1sd9 state leads to the main K-
β1,3 peak. In Cu(II) complexes, weaker final states can also arise on the lower energy side of
the K-β1,3 feature due to d electron excitations into the dx2-y2 hole (in the ground state). K-β
valence peaks lie higher in energy at 8960–8990 eV (Figure 5) than the main β1,3 peaks at
8900–8910 eV and are ~100 times weaker than the main peaks. These transitions involve
electrons from valence/ligand orbitals filling the metal 1s hole. The K-β valence region is
divided into the K-β" (the so called crossover peak) and the K-β2,5 lines. The crossover peak
is less intense and ~10–20 eV lower in energy than the K-β2,5 peak. The nomenclature of the
K-β region originated from the spectroscopy of high Z materials, such as uranium. K-β2 was
originally assigned to 4p→1s transitions and K-β5 to 3d→1s transitions. This nomenclature
has been transferred to transition metals where an understanding of the dominant
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interactions and transitions in this energy region has made the nomenclature lose its original
physical meaning. The K-β2,5 transitions are now known to originate from ligand np states
(where n=2, 3, etc. depending on ligand type) mixing with metal p character giving these
metal p→s electric dipole intensity. 9 The valence 3d→1s quadrupole allowed transitions are
also in the same energy range but carry very little intensity. The K-β" peak at 8955–8970 eV
are assigned as ligand ns (n=2, 3, etc.) to metal 1s transitions. The intensity of these
transitions is also thought to originate from mixing of metal p character into the ligand ns
orbital. The energies of these peaks correspond mainly to the ligand ns binding energies.
The absolute and relative energies of the K-β" peak shifts to lower energies relative to the K-
β2,5 peak with increase in ligand Zeff (from C to F) as shown for Zn complexes in Figure
6A.10 The intensity of these transitions depends on the number of ligands and the metal-
ligand distance 11, thus providing complementary information to EXAFS (extended X-ray
absorption fine structure). The K-β" crossover peaks are also sensitive to different
protonation states and can be used to distinguish H2O from a OH− ligation as shown again
for Zn complexes in Figure 6B.10 The energy positions of the crossover peak can thus give
valuable information about the ligand environment.
2.2 Mononuclear Cu(II) sites
2.2.1 Ligand Field Theory (LFT)—While there is now much interest in Density
Functional Theory (DFT) in modern physical-inorganic chemistry (see section 2.5) it must
be emphasized that LFT still provides the most accurate correlation to spectroscopic data
involving transitions of electrons between d-orbitals. In an octahedral LF, the five 3d
orbitals split into a three fold degenerate t2g and a two fold degenerate eg set at higher
energy. This splitting is given by 10Dq, the spectroscopic parameter of LFT (D relates to the
ligand electrostatic charge distribution and q the radial integral over the d-orbitals). Cu(II)
has a 3d9 configuration that results in a 2Eg ground state Figure 7A. This is orbitally
degenerate leading to a Jahn-Teller distortion that lowers the symmetry of the complex,
splits the orbital degeneracy and lowers the total energy of the system. Generally this leads
to a tetragonal distortion, i.e. elongation along z and contraction in the x,y plane, and a
limiting square planar structure. A key feature of LFT is that the energy splitting of the d-
orbitals is sensitive to the ligand environment at the metal center. For the square planar limit
this leads to the splitting pattern of Figure 7A center, where the highest energy half occupied
orbital is dx2-y2 as its lobes are oriented along the ligand-metal bonds and thus has the
largest repulsion (i.e. antibonding) interaction with the ligands. A structural coordinate that
has been important in Cu(II) (bio)inorganic chemistry is the distortion from square planar to
a D2d distorted tetrahedral structure.12 This involves raising two trans ligands above and two
trans ligands below the molecular plane. Note that in the tetrahedral limit (Figure 7A right)
the complex would have a 2T2 ground state which is again degenerate and unstable to a
Jahn-Teller distortion to the D2d structure. In the D2d distorted tetrahedral site the ground
state is still the half occupied dx2-y2 orbital (often referred to as dxy when the coordinate
system is oriented such that the x,y axes are along the perpendicular C2’s of the D2d
structure). Note from Figure 7A that the energy splitting of the d orbitals in the D2d structure
is much reduced relative to that of the square planar structure. This reflects the fact that
10Dq of an approximately tetrahedral structure is −4/9 the 10Dq of an octahedral (or related
square planar) structure. We finally note that in square planar structures the dz2 level is often
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lower in energy than predicted by LFT.13 This reflects the fact that the metal 4s mixes with
the 3dz2 level in planar structures, an interaction not directly included in LFT but present in
molecular orbital theory (section 2.5)
A second coordinate in Cu(II) (bio)inorganic chemistry should also be considered. Five
coordinate (5C) sites can be described as located along the square pyramidal to trigonal
bipyramidal coordinate in Figure 7B. This idealized C4v to D3h correlation can be achieved
either through a C2v distortion (top; i.e. the Berry pseudo-rotation) or a Cs distortion (Figure
7B bottom), the latter being relevant to square planar associative ligand displacement
reactions where a ligand binds axially and rotates into the plane to displace an equatorial
ligand.14 Note that the square pyramidal structure has a half occupied dx2-y2 orbital and
similar d orbital splittings as in the square planar structure but the fifth, axial ligand shifts
the Cu out of the equatorial plane. This increases the LF along the z axis (and decreases the
dz2/4s mixing) and decreases the LF in the equatorial plane. The net effect is that dz2 is no
longer the lowest energy level in the square pyramidal structure. Distortion to a trigonal
byparamidal structure changes the d orbital splitting and results in a new half occupied dz2
ground state. Note that this involves a change of coordinate system where the C3 z axis is
now perpendicular to the C4 z axis of the square pyramidal structure. (In the original
coordinate system the ground state is 3/4 dx2-y2 + 1/4 dz2). These ligand field energy
splittings of the d-orbitals determine the ground state and low lying LF excited state spectral
features of Cu(II) sites.
2.2.2 Cu(II) Ground States
2.2.2.1 Electron Paramagnetic Resonance (EPR) g and AM values: The unpaired electron
in the half occupied d orbital has STOT = ½, MS = ±1/2, thus a doublet ground state. This MS
= ±1/2 spin degeneracy splits in a magnetic field (H) by gβH (the Zeeman effect, β is the
Bohr magneton that converts an angular momentum into a magnetic moment), leading to the
EPR spectrum that gives the g value characteristic of the ground state.
In the EPR experiment (Figure 8) a fixed energy microwave source is used (X band ~ 9GHz)
and the magnetic field is varied until the resonance condition, gβH = hν (the microwave
energy), is satisfied and microwave photons are absorbed. Thus for a known source energy,
the magnetic field at which the microwaves are absorbed gives the experimental g value (g =
hν/βH = 0.71448hν(MHz)/H(Gauss)). The g values of a Cu(II) complex are generally
anisotropic, i.e. dependent on the orientation of the z axis of the complex relative to the
applied magnetic field. A frozen solution of a Cu(II) complex will have all orientations
relative to the fixed magnetic field direction, and the microwave absorption will spread from
H1 (Figure 9 top) for complexes with H parallel z to H2 (for H perpendicular z). Thus the
EPR absorption signal can spread over hundreds of Gauss with intensity increasing towards
H2 due to the greater number of molecules with z perpendicular to H. The EPR signal is
modulated to increase sensitivity leading to a first derivative spectrum (Figure 9 middle)
with features at the turning points, i.e. a peak at the magnetic field associated with g∥ (i.e.
the z axis of the complex parallel to H) and an intense derivative shaped feature at g⊥ (i.e.
the g value for the Zeeman splitting of the ground doublet with the z axis of the complex
perpendicular to the magnetic field). Finally, Cu has a nuclear spin (I) of 3/2 which couples
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to the electron spin to produce a hyperfine splitting of the spectrum into 2I+1 = 4 hyperfine
lines split by the metal hyperfine coupling constant AM, which can also be anisotropic (AM∥
for the z axis of the complex parallel to the magnetic field, AM⊥ for the z axis perpendicular
to the field). From Figure 9 bottom | AM∥| > | AM⊥| and the latter is often not resolved in the
EPR spectrum. Note that only the magnitude of AM is measured in the EPR spectrum;
generally A∥ is negative due to the physical origin of the hyperfine coupling (see below).
Thus we experimentally derive gi and  of a metal site by EPR spectroscopy
and interpret these experimental parameters in terms of LFT.
In contrast to organic radicals, metal complexes often have g values that deviate greatly
from the free electron value of 2.0023. This derives from the fact that transition metal ions
have large spin orbit coupling (SOC) constants; for Cu(II) λ3d = −830cm−1 while for N and
O radicals this value is approximately −70cm−1. This large SOC mixes the LF excited states
described in section 2.2.1 into the ground state and leads to the large deviations of the g
values from 2.00 observed experimentally. The expression describing the SO contribution to
the g values is15:
[1]
where ψ0 is the ground state, ψn’s the excited states at LF energies, En-E0, above the ground
state (section 2.2.1) and the values for the effects of the orbital angular momentum operator
Li (i = x,y,z directions of the molecule relative to the magnetic field) on electrons in the d-
orbitals are given in table 1. The  in equation 1 are the Steven’s orbital reduction
factors16 that account for the fact that the d-orbitals have ligand character due to covalent
bonding and this decreases the magnitude of the orbital angular momentum (and SOC) over
electrons in the d-orbitals. Thus k2 < 1 due to covalency and can be calculated from the
coefficients of molecular orbitals as described in reference 17. Note from equation 1, the
observed g values directly reflect the nature of the ground state thus ligand environment. For
a dx2-y2/dxy ground state (Figure 7B left) g∥>g⊥> 2.00 while for a dz2 ground state (Figure
7B right) g⊥>g∥=2.00.
The metal hyperfine couplings  are also dependent on the nature of the ground
state and its covalency. Those for a dx2-y2/dxy ground state are given in equation 2.18,19
[2]
The first term in equation 2 is the Fermi Contact interaction of the electron spin with the
nuclear spin at the nucleus. As only s orbitals can have electron spin density at the nucleus,
for electrons in d-orbitals this involves their spin polarization of electron pairs in the ns, n =
1,2,3 orbitals such that there is a net negative spin density at the nucleus. The Fermi Contact
term is isotropic, thus contributes equally in all directions. The second, spin dipolar, term
involves the dipole interaction of the electron spin, averaged over the shape of the half
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occupied d orbital, with the nucleus spin on the metal. For an electron spin in a dx2-y2
orbital, the A∥ spin dipolar term is also negative and large. It is purely anisotropic thus sums
to zero over the three molecular directions, (i.e. A⊥ = −1/2A∥). The third term involves the
magnetic dipole interaction of the orbital angular momentum, obtained from SOC to LF
excited states as described above, with the Cu nuclear spin and thus can be estimated from
the g value deviations from 2.00. Finally as the electron spin is delocalized onto the ligands
due to covalency, its interaction with the nuclear spin on the Cu decreases. In equation 2 this
is given by , the amount of metal character in the half occupied dx2-y2/dxy orbital which
decreases from 1.0 as the covalency increases, and the fact that experimental g values are
used in equation 2 which have  in equation 1 to account for covalency.
2.2.2.2 Superhyperfine coupling: As covalency delocalizes the electron spin onto the
ligands it can couple to the ligand nuclear spin IL and further split each hyperfine line in
Figure 9 bottom into 2IL+1 components. This superhyperfine splitting AiLi = x,y,z is
anisotropic and a direct measure of the amount of that ligand valence orbital contained in the
half occupied “d” orbital, i.e. the covalency of this bond. As shown in Figure 10 the covalent
mixing  of ligand i character into a half occupied d orbital delocalizes the electron spin
into a hybrid valence orbital on that ligand, where the hybrid has n s and  ligand
orbital character. The s character gives an isotropic Fermi contact contribution to the
superhyperfine coupling of the nuclear spin ILi to the electron spin, while the ligand p
character in the hybrid produces an anisotropic spin-dipolar contribution. The net effect of
these considerations gives the superhyperfine coupling in equation 3,
[3]
where the values for the Fermi contact and spin dipolar interactions of one electron spin in a
biologically relevant ligand valence orbital with the nuclear spin on that ligand is given in
table 2.20 Thus by experimentally measuring the superhyperfine coupling constants AiLi (i =
x,y,z) one can obtain the covalency of that ligand  and its hybridization (n2) involved
in bonding to the metal ion.
This superhyperfine coupling is generally very small and often not resolvable in the standard
EPR experiment at X-band. However it can be obtained by double resonance and pulsed
EPR experiments. In electron-nuclear double resonance (ENDOR) the EPR signal is used to
probe NMR transitions on directly coordinated ligand nuclei.21–23 Thus in addition to the
electron Zeeman effect, the ENDOR spectrum also involves the nuclear Zeeman effect
(gNβNH), the ligand hyperfine coupling to the electron spin and a quadrupole term if the
ligand nuclear spin is greater than or equal to 1. For protons, where the nuclear Zeeman is
large relative to the hyperfine coupling, as shown in Figure 11 left, two ENDOR peaks are
observed centered at the proton Larmor frequency (~14MHz in X band) split by the
hyperfine coupling; while for other nuclei (e.g. N) where the nuclear Zeeman is small,
transitions are centered at A/2 and split by twice the nuclear Zeeman effect (~1MHz for N at
X band) with a small additional splitting due to the quadrupole coupling (2P in Figure 11
right). Note that the ENDOR spectrum can be taken at different fields associated with
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different EPR g values, thus providing the anisotropic components of the ligand
superhyperfine coupling. Note also that the z axis of the superhyperfine is often not along
the molecular z axis but rather the z axis of the ligand p orbital involved in covalent bonding
to the half occupied d orbital in Figure 10.
Finally for very small superhyperfine couplings (as, for example, the non-coordinated N of a
Histidine ligand), electron spin echo envelope modulation (ESSEM) spectroscopy is
used.24–29 An intense microwave pulse sequence is applied to obtain an electron spin echo
whose decay is modulated by weak electron spin coupling to remote nuclear spins. The
Fourier Transformation (FT) of the modulation in Figure 12 top produces an ENDOR like
spectrum in the 0–5 MHz region in Figure 12 bottom. As shown in Figure 12 bottom for the
remote N of a His ligand to a Cu(II) site, two dominant features are observed in the FT of
the ESEEM spectrum (ν
−
 and ν+). For the remote N of a His ligand, the hyperfine coupling
is small enough that it just cancels the nuclear Zeeman splitting and the resultant signal
observed directly reflects the quadrupole splitting of the remote N nuclear spin (IN = 1)
caused by the electric field gradient of its chemical environment (equation. 4),
[4]
where e2Qq is the quadrupole coupling constant (Q the nuclear quadrupole moment, q the
electric field gradient) and η is the asymmetry parameter (i.e.for x≠y). Thus ESSEM
spectroscopy can provide chemical insight into weak interactions such as H-bonding or
deprotonation of a coordinated His ligand.
2.2.3 Ligand Field Excited States—Near IR/Visible photons excite d electrons into the
half occupied d orbital in the LF energy level diagrams in section 2.2.1 and Figure 7. These
transitions thus directly probe the ligand environment around the Cu(II) site. However these
d→d or LF transitions are parity forbidden, therefore weak in the absorption spectrum. This
intensity is given by the oscillator strength, f, associated with the electric dipole transition
moment between the ground and excited state (g and e, respectively in equation 5)
[5]
LF transitions generally have molar extinction coefficients ε < 100 M−1 cm−1 and can be
difficult to observe in metalloprotein absorption spectra. Alternatively due to different
selection rules, d→d transitions can be intense in Circular Dichroism (CD) and Low
Temperature Magnetic Circular Dichroism (MCD) spectra. The intensity in a CD spectrum
is given by the rotational strength, R, which is proportional to the projection of the electric
dipole transition moment between the ground and excited state into the magnetic dipole
moment (Mi, i = x,y,z) for this transition (equation 6).30
[6]
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Comparing equations 5 and 6, transitions that are intense in the CD spectrum relative to the
corresponding absorption spectrum are generally magnetic dipole allowed (and have a
nonzero projection into the electric dipole transition moment which can only occur in a
chiral environment). The magnetic dipole operator corresponds to a rotation of an electron
from one orbital to another, thus d→d transitions are generally magnetic dipole allowed and
relatively intense in CD spectra.
The “C-term” selection rule for low temperature MCD intensity of paramagnetic systems is
given by equation 7.31–35
[7]
Thus, two perpendicular electric dipole transition moments are required for a transition to a
given excited state to absorb circular polarized light in a longitudinal magnetic field. Active
sites in Cu(II) proteins are generally of low symmetry thus all electronic states are
nondegenerate and electronic transitions are uni-directional. Low temperature MCD
intensity thus requires SOC between excited states that are perpendicular in polarization. As
indicated above, the SOC of a transition metal ion is much larger than that of a ligand.
Therefore bands that are intense in the MCD relative to the corresponding absorption
spectrum (known as the C/D ratio) are metal centered LF transitions.36 As a rule for Cu(II)
sites, LF transitions have C/D > 0.1. It should be noted that SOC over all excited states leads
to the sum rule where the MCD intensity in left and right circular polarization tend to be
equal and sum to zero over spin orbit coupled excited states.37 Deviations from the sum rule
(i.e. dominant intensity in one circular polarization) reflects spin orbit coupling of a low
lying LF excited state into the ground state.
2.2.4 Charge Transfer Excited States—At higher energy than the LF transitions are
the LMCT transitions. These involve excitation of electrons from filled ligand valence
orbitals into the d hole on the Cu(II). Thus these transitions involve a large change in
electron density. These are electric dipole allowed and can be intense in the absorption
spectrum and provide a direct probe of the ligand valence orbitals involved in bonding. In
bioinorganic chemistry we are mostly interested in donor bonding interactions. All ligands
will have a lone pair available for σ donor bonding to the metal, and those that have
additional electron pairs available can also π donor bond to the metal center. Since σ donor
bonding is stronger than π donor bonding due to better directional overlap, the σ valence
orbital on the ligand will be at more negative energy than the π donor orbitals (Figure 13,
HM-L is the resonance integral of the molecular Hamiltonian over the metal and ligand
valence orbitals and thus proportional to their overlap). The intensity of a charge transfer
(CT) transition is proportional to the overlap of the donor and acceptor orbitals involved in
the CT excitation. Thus from Figure 13 the π CT will be at lower energy and relatively weak
in absorption, while the σ CT transition will produce a higher energy, intense feature in the
absorption spectrum. The stronger the donor bonding interaction of the ligand with the metal
the more intense the CT transition.
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From molecular orbital theory bonding is dominated by ligand and metal valence orbitals
that are close in energy and have good overlap. Thus ligands that produce low energy
intense CT absorption features form highly covalent bonds with the metal center.38 In
copper bioinorganic chemistry these are generally the oxygen intermediates, where as
described in section 3 their highly covalent bonding activates selective reactivity in
biological function. Other highly covalent L-M bonds in Cu biochemistry (i.e. active sites
that exhibit low energy, intense CT absorption features) are the sulfide bridge in nitrous
oxide reductase (N2OR) (Section 5.0), the cysteine crosslinked phenolate ligand radical in
Galactose Oxidase (Section 3.4), the phenolate ligand in pre-processed amine oxidase and
the thiolate ligand in blue Cu, CuA and in preprocessed Cu(II) Galactose Oxidase.
In Resonance Raman (rR) spectroscopy a Laser is tuned into an intense absorption band (i.e.
a CT transition) and vibrations associated with the chromophore (i.e. the active site in the
protein and the specific L-M bond associated with the charge transfer) become greatly
enhanced in Raman scattering intensity as illustrated from by the data in Figure 1439. In Cu
bioinorganic chemistry this generally involves an “Albright” A-term intensity enhancement
mechanism.40 A-term rR intensity reflects excited state distortions. The CT transition of
ligand L involves excitation of an electron from a L-M bonding donor orbital mostly on the
ligand into an L-M antibonding acceptor orbital mostly on the metal. Therefore the L-M
bond associated with the CT transition probed by rR spectroscopy will elongate and its
associated L-M stretching vibration will be greatly resonance enhanced. Other active site L-
M bonds can also be enhanced (but with less intensity) as the Cu d acceptor orbital is
generally antibonding to all equatorial ligands. Other intraligand and bending modes may
also be observed in rR spectroscopy dependent on how the bonding changes in the CT
excited state being probed by rR relative to the ground state.
2.2.5. XAS K-edge—An open shell Cu K-edge typically consists of two distinct
spectroscopic features—the pre-edge and the shakedown as shown in Figure 15. The lowest
energy pre-edge transition is the 1s→3d transition that can be used to distinguish between
Cu(II) and Cu(III) higher redox states. The Cu(II) pre-edge is around 8979 eV (Figure 15
inset). Cu(III) has a Zeff and contracted ligand field that results in a higher pre-edge energy
of approximately 8981 eV (Figure 15 inset). The edge is also shifted to higher energies in
Cu(III) compared to Cu(II). Thus the pre-edge position can be used to differentiate between
Cu(II)2 side-on peroxo and Cu(III)2 bis-µ-oxo complexes and quantitate the amount of each
component present.41,42
2.2.5.1 Pre-edge transition: The K-pre-edge 1s→3d transition has low intensity because it
is electric dipole forbidden. In centrosymmetric complexes, such as in D4h [CuCl4]2− that
have no 3d/4p mixing, the pre-edge transition (at 8979 eV) gains intensity mostly through
the electric quadrupole operator (Figure 16 left black).43 Blue Cu on the other hand has a
tetrahedrally distorted site, and a higher pre-edge intensity owing to some 4p mixing into the
3d orbital (Figure 16 left inset red). This 4p mixing into the 3d orbital while small has a
substantial impact on the intensity of the preedge because an electric dipole transition is ~2
orders of magnitude stronger than an electric quadrupole transition in this energy region.
From polarized single crystal XAS the origin of the pre-edge intensity in blue Cu has been
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shown to be from Cu 4px,y mixing into the 3dx2-y2 ground state as seen in the xy-polarized
K-edge (Figure 16 right).43 No pre-edge intensity is observed in the z-polarized spectrum
showing that the 4pz orbital does not mix into the 3dx2-y2 ground state in blue Cu. Thus, the
pre-edge intensity in an important spectroscopic probe of 3d-4p mixing that is allowed by
ligand field theory.
The 3d/4p mixing is indirect and occurs by overlap of both the 3d and 4p metal orbitals with
the same ligand based valence orbital.44 This mechanism of mixing can be described using
the configuration interaction (CI) model given below (equation 8):
[8]
The T1 and T2 terms give the bonding interaction between the ligand p and metal d and
between ligand p and metal p orbitals, respectively. Δ1 and Δ2 are the energy difference
between the ligand 3p and metal 3d configuration and between ligand 3p and metal 4p
configuration, respectively. Solving this determinant shows that there is some metal p
mixing into the ground state d wavefunction as both overlap the same ligand p orbital. The
K-pre-edge intensity thus provides a direct probe of the metal 3d-4p mixing and an indirect
probe of the metal-ligand bonding.
2.2.5.2 Shakedown transition: The K-edges of Cu(II) and Cu(III) systems commonly
contain a transition between 8986–8988 eV that is described as a shakedown transition
(Figure 15). In systems with more covalent interactions with the ligands, this feature appears
to the lower end of this range. The shakedown transition is a two electron process that
results from a 1s→4p electric dipole-allowed transition. The 1s core hole created results in
relaxation of the Cu valence orbitals to lower binding energies. For Cu this relaxation of the
3d orbitals is large enough to cause a transfer of a second electron from the ligand valence to
the metal 3d orbital (an LMCT process). The sudden approximation formalism can be used
to quantify the intensity of this shakedown (1s→4p + LMCT) feature as a percentage of the
total 1s→4p transition intensity.43 The main-to-shakedown peak intensity ratio (Im/Is) is
given by equation 9:
[9]
with tan 2θ′ = 2T/(Δ-Q) and tan 2θ = 2T/Δ, where T = <Ψ (3d9)|H|Ψ(3d10L)> is the
interaction matrix element between the configurations contributing to the ground state wave
functions, and Δ is the energy difference between the two configurations in the ground state
as shown in Figure 17A. Q accounts for the increase in the effective nuclear charge (Zeff)
felt by the 3d9 configuration upon creation of the c3d9 configuration (where c denotes a core
orbital hole) (Figure 17B). Thus, the change in wavefunction θ′ - θ upon creation of the 1s
core hole determines the main-to-shakedown peak intensity ratio. Using this configuration
interaction formalism, the shakedown transition intensity in a D2d [CuCl4]2− system was
calculated to be 59% of the total 1s→4p transition intensity, similar to that obtained from
fitting the z-polarized XAS spectrum (~60%) (Figure 18).
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2.2.6. XAS L-edge—The Cu L-edge spectrum results from a metal 2p→3d electric dipole-
allowed transition and consists of the L3 (2p3/2→3d) and L2 (2p1/2→3d) edges separated by
~20 eV due to 2p spin-orbit coupling. The L3 to L2 intensity ratio is ~2:1 due to the 4:2
degeneracy of the 2p3/2 and 2p1/2 states. For typical Cu(II) complexes, the L3-edge occurs at
~930 eV, whereas the L2-edge occurs at ~950 eV and is ~1.5 times broader from an
additional Coster-Kronig auger decay channel of this excited state. For Cu(III) complexes,
the L3- and the L2-edges are ~1.5–3 eV higher compared to those observed for Cu(II). The
2p→4s transition is Δl = −1 and is thus, ~20–30 times lower in intensity than the Δl = +1
(p→d) transition. Multiplet and shakeup effects, which usually lead to a redistribution of the
intensity of the L3 and L2 peaks do not contribute to the L-edge spectra of 3d9 complexes.
The total area under the L3- and L2-peaks reflects the extent of metal-ligand covalency. As
the unoccupied Cu 3d orbital mixes with filled ligand orbitals, the intensity of the L-edge
transition decreases because of the metal localized nature of the Cu 2p→ψ*β-LUMO
transition. The ground state wavefunction (ψ*β-LUMO) of a d9 Cu complex can be expressed
as equation 10:
[10]
where, 1 – β2 and β2 correspond to the Cu 3d and ligand np character, respectively. By
comparing the total area under the L-edge spectra to that of D4h [CuCl4]2− (a system that has
been studied by a wide energy range of spectroscopies, and found to have 61 ± 4% Cu
character in the ψ*β-LUMO), we can get a quantitative estimate of the amount of Cu character
in the ground state wavefunction of other Cu complexes.45 An important example of the use
of L-edge intensity to quantify covalency is for the blue Cu site in Figure 19. Its L3-edge has
0.67 times the intensity of square planar CuCl42−. D4h [CuCl4]2− has 61% Cu dx2-y2
character in its ground state. Thus, the blue Cu site in plastocyanin has only 41% Cu d
character reflecting a highly covalent ground state wavefunction, which is important in its
function of long-range electron transfer.
2.2.7. XMCD—X-ray magnetic circular dichroism (XMCD) combines L-edge XAS with
MCD. The XMCD signal is the difference in the L-edge spectra obtained with right and left
circularly polarized light in the presence of an external magnetic field. The low temperature
(<1 K) XMCD signal at the L-edge of plastocyanin (S = 1/2 mononuclear blue Cu center) is
shown in Figure 20A.46 The XMCD intensity at the L3 edge is seen to be negative. It is
interesting to compare the negative XMCD L3 intensity for the mononuclear blue Cu site
with the signal for the Cu in [(F8TPP)FeIII-O-CuII(TMPA)](ClO4) which is positive (Figure
20B).47 The binuclear complex (shown in Figure 20 C) has an Fe(III) (S = 5/2)
antiferromagnetically coupled to the Cu(II) (S = 1/2) to produce an S = 2 ground-state. This
S = 2 spin vector aligns with the magnetic field and thus produces a field of opposite sign at
the Cu due to the Cu(II) S = 1/2 antiferromagnetic coupling to the high spin S = 5/2 Fe(III).
The opposite sign of the XMCD signal confirms the antiferromagnetic coupling of the Cu to
the Fe and thus a powerful use of XMCD lies in studying ferro- and antiferromagnetic
coupling of Cu to other paramagnetic centers.
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2.3 Binuclear Copper Sites
2.3.1 Two Copper(II): Magnetic Coupling
2.3.1.1 Ground state Zero Field Splitting (ZFS) and Antiferromagnetic coupling: If two
Cu(II), each with S=1/2, are closer than ~ 6 Å apart their electron spins will dipole-dipole
couple. This produces an S=1 triplet EPR signal that has characteristic spectral features
(Figure 21). First there is a half field (or ΔMS = 2) transition at ~1500 Gauss (twice the g
value) in X-band. This however must be distinguished from “junk” Fe(III) generally present
in biological systems, and the ΔMS= 2 transition is often only observed at very low
temperature. Further the g ≈ 2.0 (ΔMS= 1) region will broaden or split into two dominant
spectral features (called fine structure). The splitting between these spectral features derives
from the Zero Field Splitting (ZFS) of the triplet. As shown in Figure 21 the magnetic field
splitting between these transitions (or better from simulation of the spectrum) gives the ZFS
parameter D which in turn gives the distance between the two Cu(II) centers (r in equation
11).48
[11]
If the two Cu(II)’s have a bridging ligand this can provide a superexchange pathway for
antiferromagnetic coupling between the two S=1/2’s to produce an STOT = 0 ground state.
The origin of this coupling is illustrated in Figure 22A left. The half occupied d orbital on
CuA overlaps a filled bridging ligand valence orbital. The electron pair in this ligand orbital
polarizes such that one electron spin dominantly pairs with the spin on CuA and the second
electron on the ligand polarizes towards the remote side of the filled ligand orbital. If
CuB(II) overlaps the same ligand orbital its electron pairs with this remote polarized spin
and the net effect is the antiferromagnetic coupling of the electron spins on the two Cu(II)
though the bridging ligand superexchange pathway. Note from Figure 22A right that if the
two Cu(II) overlap orthogonal orbitals on the bridging ligand, the two electron exchange
interaction between the second electron in each of the two orthogonal ligand orbitals will
lead to a parallel, ferromagnetic alignment of the electron spins on the two Cu(II) with an
STOT = 1 ground state. The molecular orbital version of this valence bond description is
shown in Figure 22B. From group theory one takes symmetric and antisymmetric
combinations of the half occupied d orbitals on the two coppers and allows for their bonding
interaction with the valence orbital on the bridging ligand. From Figure 22B, only the
antisymmetric combination (ϕ2) can have a non-zero overlap with the occupied pz orbital on
the bridging ligand. Thus, ϕ1 and ϕ2 split in energy and this leads to the spin paired
antiferromagnetic ground state.
This coupling of the spins on the two Cu(II) is described by the Heisenberg-Dirac-Van
Vleck Hamiltonian (equation 12)49:
[12]
which leads to an energy dependence on the total spin, STOT = SA +SB, SA + SB
−1,....,SA−SB = 1, 0 for 2 Cu(II) with S = ½. Thus, antiferromagnetic coupling (J negative)
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leads to an STOT = 0 ground state with the STOT = 1 at 2J, where J quantifies the exchange
coupling. An antiferromagnetic coupled Cu(II) dimer has an S = 0 ground state with no EPR
signal but can show a contribution to EPR, MCD and magnetic susceptibility if the STOT = 1
level becomes thermally populated.
In an exchange coupled dimer there is an additional contribution to the ZFS of the triplet
considered above (D in Figure 21). This is the pseudo-dipolar or anisotropic exchange
contribution.50–52 This derives from the second order SOC of a LF excited state into the
ground state of one Cu and the exchange interaction of this component with the ground state
of the second Cu(II). Since SOC is also responsible for the g values deviating from 2.00, the
anisotropic exchange contribution to the ZFS parameter D, Figure 21, for an exchange
coupled Cu(II) dimer can be related to the ground state g values as given in equation 13, for
a dx2-y2 ground state:
[13]
The problem with using this expression is that in addition to the ground state g values which
are obtained by EPR, it requires values from the magnetic exchange interaction between the
ground state on one Cu and the ligand field excited state on the second Cu(II) (Jx2-y2,xy and
Jx2-y2,xz,yz). These ground/excited state exchange couplings can, in principle, be observed in
LF excited states. However, this has only been investigated in one case (see ref 53).
Alternatively, if the sign and magnitude of D is measured experimentally, the electron spin
dipolar contribution to D is subtracted off using equation 11, and the first term in equation
13 is assumed to dominate, then Jx2-y2,xy can be obtained from the EPR experiment.
2.3.1.2 Excited States: Exchange coupling in bridged binuclear Cu(II) dimers can affect
both the LF and CT excited states. The effect on the d→d transitions is to split each into four
states where the splitting can provide the different ground to excited state and excited to
excited state exchange pathways associated with the bridging ligand. In practice this requires
very detailed spectroscopy on single crystals to resolve these effects (see ref 53) and
generally will not produce significant features in the LF region of low resolution spectra of
binuclear Cu(II) model complexes or protein sites. Alternatively, the CT transitions of a
bridging ligand can show large deviations relative to the CT transitions on Cu(II) monomers
(these are the “dimer bands” in the absorption spectra of binuclear model complexes), and
these deviations directly probe the superexchange pathway for the ground state
antiferromagnetic coupling.54
As shown in Figure 23, starting from the AF coupled ground state discussed above, the CT
transition of a bridging ligand to CuA leads to an unpaired electron directly on the ligand
which will have strong overlap thus AF coupling with the unpaired electron on CuB. This
produces a large excited state AF coupling, which greatly lowers the energy of the singlet
relative to the triplet CT excited state. Thus while bridging a ligand between two metal
centers will tend to stabilize the energy of the L donor orbital and increase the CT transition
energy of both the singlet and triplet, the large CT excited state AF coupling will greatly
lower the energy of the singlet CT relative to the triplet. The observed shift of the CT energy
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in a dimer relative to the corresponding monomer is then the net effect of these competing
contributions.
This excited state AF coupling in the LMCT transition of a bridging ligand propagates into
the ground state trough the covalency of the bridging ligand-metal bond. In valence bond
theory, covalency is introduced by the configuration interaction mixing of the CT excited
state into the ground state, which is known as the valence bond configuration interaction
(VBCI) model. Since the singlet and triplet CT states are greatly split in energy (due to the
excited state AF coupling in Figure 23 bottom) their configuration interaction with the
ground state splits the singlet and triplet ground state energies leading to the AF coupling
observed in the ground state of Cu(II) dimers. Thus the ground state AF coupling is given by
equation 14:
[14]
where c2 is the amount of bridging ligand character that is covalently mixed into the ground
state and JCT is the singlet/triplet splitting of the bridging ligand CT transition. Further
details of the VBCI model are given in reference 55, and it has been used in reference 54 to
estimate the ground state AF coupling in oxy hemocyanin which is too large to measure
experimentally using ground state methods (see Section 3.1.4).
2.3.2 Copper(II)Copper(I)—Mixed valent (MV) copper sites have been important in
biology in CuZ in N2OR56 and in the half Met derivatives57 of the coupled binuclear copper
proteins (also in the electron transfer site CuA 58,59). In a MV system, specifically a
binuclear site labeled CuA and CuB, the extra electron can be on CuA (ψ[CuA(I)CuB(II)]) or
on CuB (ψ[CuA(II)CuB(I)]) or partially to fully delocalized over the two coppers as given by
equation 15.
[15]
In the Robin and Day classification scheme,60 when α2 = 0, the system is a class I MV
complex, with the extra electron (or hole) localized on one Cu. For 0 < α2 < 0.5 the system
is class II MV and shows perturbed spectral features associated with interactions with the
second copper. In EPR there will be more than four copper hyperfine lines (four hyperfine
lines from CuB split by the hyperfine coupling constant of ACuB CuB that reflects the amount
of electron spin density on this copper, each again split into four hyperfine lines with a
hyperfine coupling, ACuA, reflecting the amount of electron spin density on CuA; this has
had a powerful application in multifrequencey EPR, particularly using S-band to resolve
overlapping hyperfine contributions)58 and in the absorption spectrum there will be an
intervalent transfer transition (IV) (vide infra). For α2 = 0.5 the system is a class III,
completely delocalized, MV site. This will exhibit 2NI+1=7 copper (N=2 equivalent Cu
with I=3/2) hyperfine lines split by a hyperfine coupling constant that is about half that of an
equivalent Cu(II) monomer, and a ψ→ψ* transition in its absorption spectrum (vide infra).
The origin of the electron delocalization between the two copper centers is the electronic
coupling matrix element, HAB, that, as shown in Figure 24 can reflect both direct d orbital
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overlap between the Cu’s and the effects of a superexchange pathway associated with
bridging ligands.
For two equivalent Cu’s this would lead to delocalization, however this electronic coupling
is opposed by vibronic trapping. As shown in Figure 25A, when the hole is on CuA the
ligands will contract to stabilize the hole on this Cu, while the opposite is the case for the
hole localized in CuB. This antisymmetric combination of these ligand breathing modes on
the two Cu’s is know as the Q
−
 vibrational mode in MV theory.61
Adding HAB to the vibronic trapping term leads to an interaction between the potential
energy surfaces as shown in Figure 24B. When HAB is small (HAB(i)) the two surfaces split
at the crossing point (Q
−
 = 0) but the minima are still localized (with some mixing into the
ground state from the second copper). This is the class II MV situation with some hyperfine
coupling from the second copper. As illustrated in Figure 24A, excitation from the ground
into the excited state transfers an electron from one Cu to the second Cu and is called an
intervalence (IV) transfer transition (at an energy λ). From the potential energy surfaces for
HAB(i) in Figure 25B the excited state distorts along the Q− mode and the rR spectrum will
exhibit resonance enhancement in this vibration. For the class III case (HAB(ii) in Figure
25B) the ground state minimum is at Q
−
 = 0, the complex is symmetric and both coppers
contribute equally to the ground state wavefunction. Thus seven hyperfine lines will be
observed in EPR, and excitation from the ground to the excited state involves a ψ→ψ*
transition in that an electron transfered from a bonding to an antibonding molecular orbital
between the coppers. From Figure 25B HAB(ii), this produces no distortion in the Q− mode
(the ψ and ψ* minima are both at Q
−
 = 0) but does lead to elongation and thus rR
enhancement in the Cu-Cu and bridging ligand vibrational modes, since it is a metal-metal
bonding to antibonding transition.62
It should finally be noted that HAB in MV systems can, through the VBCI model, be related
to the AF coupling between two Cu(II) described in section 2.3.1.1.55,63 This is given by
equation 16:
[16]
where U is the Coulomb repulsion between two electrons on the same copper (i.e. 2Cu(II)
→Cu(III)Cu(I)). This is important because the electronic coupling matrix element also plays
a key role in Marcus Theory of ET.64 Thus differences in J reflect differences in the rate of
electron transfer that can control the nature of intermediates required for different biological
functions65 (see Section 3.3.6)
2.4 Higher Nuclearity Sites: Spin Frustration and Antisymmetric exchange
The trinuclear copper cluster (TNC) active site in the multicopper oxidases (section 3.7.1)
requires additional consideration of the interactions among three Cu(II) S=1/2 centers. As
shown in Figure 26, the resting TNC site has a pair of Cu(II)’s (called Type 3, vide infra)
that can antiferromagnetically couple leading to an S’=1 triplet state at 2J above the S’=0
singlet ground state. Allowing for the presence of the third (Type 2) non-bridged S = ½
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Cu(II), the S’=0 couples to form an STOT = ½ ground state and the S’=1 couples to form an
STOT = ½ and 3/2 states, still at 2J, since there is no bridging interaction of the Type 2
Cu(II) with the Type 3 Cu(II) pair. The wavefunction for the S’=0 STOT =1/2 ground state
thus has the spin localized on the Type 2 Cu(II) and only exhibits paramagnetic properties of
this Cu(II) center. If all three Cu(II)’s are now allowed to have equivalent bridging,
therefore exchange interactions, the S’=1 STOT =1/2,3/2 split in energy leading to the
diagram in Figure 26 top right, with the quartet at 3J above the now orbitally degenerate 2E
ground state, where this degeneracy is associated with the S’=0 STOT =1/2 and S’=1
STOT=1/2 sublevels. The spin topology with three equivalent, exchange coupled S=1/2
Cu(II)’s is a spin frustrated system as all three pairs of S=1/2 Cu(II)’s cannot be
simultaneously AF coupled in a triangular bridged system.66
The spin frustrated 2E ground state will undergo a large ZFS (by amount  G in Figure 26
bottom) due to a phenomenon known as antisymmetric exchange. This derives from in state
SOC which can be large and mixes the S’=1,0 STOT=1/2 wavefunctions leading to an
equivalent spin distribution over the three Cu(II)’s. It also has a major effect on the Zeeman
splitting of the spin sublevels therefore the EPR spectrum of a spin frustrated system. In
particular, as shown in Figure 26 bottom, when the magnetic field is applied perpendicular
to the z (C3) axis of the Cu(II) trimer, there is a Zeeman interaction between the two ZFS
levels of the 2E. This leads to a non-linear dependence of the Zeeman splitting with
increasing magnetic field. Therefore higher fields, corresponding to very low g values, are
required to satisfy the resonance condition of the EPR experiment.
As with anisotropic exchange, this antisymmetric exchange derived ZFS is due to SOC of a
LF excited state into the ground state and thus can again be related to the ground state g
value deviation from 2.0050–52 (equation 17).
[17]
 involves both the ground state exchange interaction between dx2-y2 orbitals on
pairs of Cu(II)’s and the exchange coupling of the dxy LF excited state on one Cu(II) with
the dx2-y2 ground state on the second Cu(II). Therefore spin frustrated trinuclear Cu(II)
states with large antisymmetric exchange hence low g values (< 2.00, i.e. the native
intermediate in the multicopper oxidases (MCOs), see Section 3.7.1) require bridging
ligands between the three Cu(II)’s that provide good superexchange pathways for coupling
both the ground and excited state of each Cu(II) to the ground state of the adjacent Cu(II).
From model studies this can be accomplished both by a µ3 oxo and by three µ2-OH
bridges.66
2.5 Electronic Structure Calculations
Spectroscopy experimentally determines electronic structure and, therefore, it is important to
correlate spectroscopic data to the results of electronic structure calculations. New
developments in theoretical methods combined with the unprecedented computational
resources available have provided chemists with powerful new tools for the study of
electronic structure and reactivity of chemical systems. Thanks to the new advances in
Solomon et al. Page 17
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
supercomputing, is now possible to study with Quantum Mechanics relatively large systems
with multiple open shell metal centers and to further include, with the help of Molecular
Mechanics, the whole protein and the solvent molecules. The popularity of these methods is
reflected in the increasing number of electronic structure calculation software packages
available and their impact on research. It is not the aim of this section to provide a detailed
description of each theoretical method, but to present key essentials of the most popular
methods in the study of transition metal complexes, in general, and copper sites in particular.
We emphasize that different methods and basis sets give different results and it is critical to
evaluate calculations with spectroscopic data. Calculations validated by data can then be
used for insight into the transition states and frontier molecular orbitals, that are key to
reactivity.
2.5.1 Ab Initio Wave Function Methods—Hartree-Fock (HF) theory describes a many-
electron wave function Ψ as a linear combination of the products of independent one-
electron wavefunctions, χ molecular orbitals (MOs), which are linear combinations of
atomic orbitals ϕi and these, in turn, are linear combinations of the basis functions φa.67 The
time independent Schrödinger equation can then be solved using the Hartree-Fock Self
Consistent Field (HF-SCF) scheme
[18]
where the hamiltonian that operates over the trial wavefunction usually has the following
form,
[19]
The terms in the hamiltonian are the kinetic energy of the electrons i, the kinetic energy of
the nuclei k, the potential energy attraction between electrons and nuclei, the interelectronic
repulsion i,k and the internuclear repulsion k,l. This expression is solved through the
Hartree-Fock Self-Consistent Field approach, which is an iterative process to calculate the
best single-determinant solution for the time-independent Schrödinger equation.67 Fock
extended Hartree’s iterative process to Slater Determinant wave functions. The Fock
operator is defined for each electron i as:
[20]
where the first part of the operator is the one-electron core Hamiltonian, Ji is Coulomb
operator and Ki the exchange operator. It is the last part of the operator that leads to “four
center integrals”, which are the two electronic exchange and Coulomb interactions of the
form
[21]
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where ϕp,q,r,s are analytic functions on four different centers. Those integrals scale as N4
where N is the number of electrons of the system.
Basis functions are the set of mathematical functions from which the wavefunctions are
constructed. There are several mathematical functions that can be chosen to build the
wavefunction. Given the shape of the atomic orbitals, one must think in terms of Slater-type
functions are a logical choice, but the fact that the four center integrals corresponding to the
interelectronic repulsion in the hamiltonian have to be solved by numerical methods limits
their utility in medium to large size molecular systems. However, high quality Slater-type
orbital (STO) basis sets have been developed.68 Gaussian basis sets are the most widely
used, given that these functions solve the four index integrals in an analytical way.
Moreover, Gaussian basis sets can turn four center integrals into a finite sum of two center
integrals, and in the next step, to finite sums of one-center integrals, speeding up the
calculations by a factor of 4 to 5. The general functional form of a normalized Gaussian-
Type orbital (GTO) in atom-centered Cartesian coordinates is:
[22]
where α is an exponent controlling the width of GTO, and i, j, and k are non-negative
integers that dictate the nature of the orbital in the Cartesian notation.
There are a number of options in choosing a Gaussian basis set, depending on the balance
between accuracy and computing time. Ideally, the basis set should be as large as possible,
so the Hartree-Fock limit is achieved based on the Variational Principle. This can however
involve excessive computational cost. For systems that have transition metal centers, the
most common basis sets used in calculations are triple-ζ, which means three Gaussian
functions are used for each atomic orbital. Among the most popular basis sets of this type
are the split-valence basis set of Pople and coworkers, .69,70 the correlation-consistent
polarized core basis set from Dunning,71 and the triple-ζ basis set from Ahlrichs and
coworkers.72 In many cases it is necessary to include polarization functions on the metal
center as well as the donor atoms to improve the description of the bonding interaction and
add flexibility to the Gaussian basis set. Also diffuse functions often need to be included,
which are shallow Gaussian functions that allow for a better description of the “tail” of the
atomic orbital. The notation from the Pople group for a split valence basis set is usually of
the type X-YZW for a triple-ζ basis set, where X denotes the number of primitive Gaussians
(i.e., each of the Gaussian functions used to build up the orbital function) for each atomic
core orbital, and YZW indicate that the valence orbitals are made of three Gaussian
functions, the first a linear combination of Y primitive Gaussians, the second a linear
combination of Z primitive Gaussians, and so on. Polarization functions are usually denoted
by the symbol “*” and diffuse functions by the symbol “+”
Aside from the Gaussian basis sets, the other two main approaches are the use of Effective
Core Potentials (ECP, or pseudopotentials) and the use of plane waves. ECPs replace the
core electrons and the nucleus with an effective potential, allowing for a large reduction in
the size of the basis set and the number of electrons, speeding up the calculation. These also
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allow inclusion of relativistic effects in the calculation when dealing with heavy elements.
Plane waves are particularly useful in solid state calculations as these have translational
symmetry.
The HF-SCF wavefunction for the electronic ground state is then a single Slater determinant
build from occupied MOs.67 However, for a many electron system, the premise that the
motion of each electron can be described by assuming that it moves in a static field provided
by the nuclei and all the other electrons is an approximation. Electrons repel each other,
therefore, they will adjust to minimize their mutual repulsion, thus the electron motion is
correlated. As a result, HF theory overestimates the electron repulsion energy by an amount
called the correlation energy, which becomes important in describing the covalency and
calculating reaction energies and barriers. Thus the need for correlated ab initio methods.
Electron correlation is usually divided into dynamic and static correlation. The dynamic
correlation is the correlation of the movement of the electrons while the static correlation is
important for molecules in which the ground state cannot be described by a single
determinant. To improve the wave function use is made of the fact that after the SCF
optimization of the MO coefficients for all the occupied orbitals, the coefficients for the
virtual (i.e unoccupied) orbitals are also obtained. This allows one to construct additional
Slater determinants that account for different electronic excited configurations (single,
double, triple, etc, electron excitations into virtual orbitals).67 Mixing these additional
determinants with the ground state gives a more flexible wavefunction that includes static
electron correlation. When all the coefficients are optimized variationally for all possible
configurations within a set of occupied and unoccupied MOs, the method is called Full
Configuration Interaction (FCI). For biologically relevant systems, FCI is unaccessible, so a
truncation of the wavefunction is necessary. However, the truncation of the CI space leads to
the lost of size consistency (i.e., the energy of two noninteracting entities is different from
the sum of their individual energies). Given that the FCI is not accessible for large systems
other ways to achieve the inclusion of electron correlation in the wave function have been
developed.
2.5.1.1 Many Body Perturbation Theory: In a single configurational approach, the
electron correlation energy can be included using manybody perturbation theory (MBPT).
Møller and Plesset proposed operator expressions for these energy corrections. 73 The most
popular MBPT level calculation is Møller-Plesset second order perturbation theory (MP2)
with a HF determinant as the reference function. This allows an estimate of dynamic
electron correlation for species with an electronic ground state well represented by a single
Slater determinant. The increasing computational power available today allows for higher
order interactions, typically MP3,74,75 MP476 and MP5, 77 within this formalism.
2.5.1.2 Multiconfigurational Self-Consistent Field Method: As indicated above, a way to
improve the quality of the wave function is include additional possible determinants for
excited electron configurations in the ground state. By selecting only a limited number of
determinants from all possible, we can construct a multi-configurational wavefunction (ϕn
are many electron single determinants),
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[23]
for which the lowest energy its found by optimizing both the MO coefficients and the cn
configuration interaction coefficients. This MC-SCF wave function is able to retrieve the
static electron correlation energy for systems that can only be described with more than one
(nearly)-degenerate determinant. The most popular way to implement this is the Complete
Active Space (CAS) SCF method. For a given electronic state, the configurations with large
cn use only a limited set of molecular orbitals. Therefore, for an n-electron system, the MO
space can be split in three blocks. The inactive orbitals (those that are doubly occupied in all
the configurations, containing m electrons), the external orbitals (those that have zero
occupancy in all the configurations) and the active orbitals, which contain the active
electrons (n-2m). The wavefunction is defined as the Full Configuration Interaction of all the
possible configuration state functions (CSF) having the spatial and spin symmetry imposed
by the active electrons in the active orbitals.78,79 This method is convenient and overcomes
many problems of Hartree-Fock calculations on open shell systems. However, it is difficult
to recover a large portion of the dynamic correlation energy by expanding the active space.
A better way to include the dynamic correlation energy is using MP2 with a CASSCF
reference wavefunction (CASSCF/CASPT2).80
The obvious limitation of this method in biological relevant systems is the size of the active
space. To account for large systems, the Restricted Active Space (RAS) SCF method was
developed.81 In this method, the active space is further divided into three subspaces. In
parallel with CAS, RAS can account for dynamic correlation via MP2 in the RASSCF/
RASPT2 scheme.82
2.5.1.3 Coupled Cluster Methods: Coupled Cluster Methods (CC)83 are based on rewriting
the Full Configuration Interaction wave function as:
[24]
where the cluster operator Ti operates over all the n electrons and generates all the possible
determinants having i excitations from the reference wave function (ΨHF). In a sense, this
method is a full CI, but the advantage relies on the truncation of the T operator. Usually, the
T operator is approximated as T=T1+T2, defining the Coupled Cluster Singles and Doubles
(CCSD), and a Taylor expansion of this operator shows that the method accounts for size
consistency. This method is very computationally demanding, and inclusion of triple
excitations is non accessible for large molecules. Triple excitations are therefore included
via perturbation theory.84
2.5.2. Density Functional Methods—While CAS and CC wavefunction methods are
good when it comes to the inclusion of electron correlation, they are also very
computationally demanding, and have a problem of size limitation. Bioinorganic systems
usually involve large molecules that are often not accessible with these wavefunction
methods. An alternative approach to this problem is the use of Density Functional Theory
(DFT). Theoretically supported by the Hohenberg-Kohn85 theorems and within the Kohn-
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Sham (KS) DFT framework,86 the intractable many body problem of interacting electrons in
a static external potential is reduced to a tractable problem of non-interacting electrons
moving in an effective potential. This effective potential includes the external potential and
the effects of the Coulomb interactions between the electrons, therefore the exchange and
correlation interactions.
In many body electronic structure calculations, the nuclei of the molecules are assumed to be
fixed (the Born-Oppenheimer approximation), generating a static external potential V in
which the electrons move. A stationary electronic state can be described by a wavefunction
that satisfies the time independent Schrödinger equation for an n-electron system:
[25]
where H is the hamiltonian, T the kinetic energy, V the potential energy from the external
field due to the positive charges of the nuclei, and U is the electron-electron interaction
energy. While T and U are universal, V depends on the system, and this equation is not
separable into simpler single-particle equations because of U. This equation can be solved as
described above by expanding the wave function into Slater determinants, but DFT provides
an alternative method to deal with the electron-electron interaction. In DFT the key variable
is the particle density ρ(r ⃗), which for a normalized wave function is given by
[26]
where n is the number of electrons.
This relation can be reversed, this is, for a given ρ0(r⃗) it is possible to calculate the
corresponding ground state wavefunction Ψ0 (r⃗1, r⃗2,...., r⃗n. Ψ0 is a unique functional of ρ0,
and any ground-state expectation value of an observable is also a functional of ρ0. In
particular, the ground state energy is a functional of ρ0 as well as T, U and V. The electronic
density determines the potential and thus the Hamiltonian, which determines the wave
function.
[27]
In principle, this approach is exact, and minimization of the E(ρ) will give the exact E(ρ0)
and therefore all the other ground state properties.85 In practice, the exact functional is not
known and one still needs to approximate the small but important contribution to the single
particle potential energy term, called the exchange-correlation (XC) energy. Depending on
this approximation, the calculation will be more or less accurate. The present exchange-
correlation functionals are itemized below.87
2.5.2.1 Local Density Approximation (LDA): This is the simplest density functional,86
and has been widely used by the solid state community. In the LDA, the XC energy depends
only on the density at a point and is that of a uniform electron gas of that density. While the
exchange energy can be computed exactly, no analytical derivation of the correlation energy
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density has proven possible. Highly numerically accurate calculations of several different
densities allowed Vosko, Wilk and Nusair to design local functionals by subtracting the
analytical exchange density from the total calculated density in order to include the
correlation part. The authors proposed several fitting schemes for the correlation density, the
most popular being the VWN and VWN5 local exchange-correlation functionals.88
Unfortunately, LDA methods are not very accurate for molecular properties as the electron
density is not uniform.
2.5.2.2 Generalized Gradient Approximations (GGA): A way to improve the correlation
functional is to make it depend not only on the local value but on the gradient of the density.
Inclusion of the gradient correction defines the Generalized Gradient Approximation (GGA)
functionals. Originally labeled as “non local functionals”, GGAs correct the functional by
adding the gradient correction to the LDA functional, this is,
[28]
One of the most popular GGA exchange functionals was developed by Becke,89 which
includes a single empirical parameter, but other popular exchange functionals without
empirical parameters are BP86 and PBE. 89–91 For the correlation part, one of the most
popular correlation functionals, LYP, does not correct the LDA expression using the above
equation, but instead computes the total correlation energy.92 The GGA functionals are more
accurate than the LDAs, and reduce the error in bond dissociation energies and transition-
state barriers.
2.5.2.3 Meta-Generalized Gradient Approximations (MGGA): After the inclusion of the
gradient, the next step is to include the dependence of the electron density on the second
derivative, i.e. the Laplacian. This approach leads to the meta-GGA functionals, which in
addition to the gradient at each point also include the dependence of the KS kinetic energy
density. TPSS is an example of this kind of functional.93 Meta-GGA calculations are usually
as computationally expensive as the GGA and more accurate for pure functionals.
2.5.2.4 Hybrid Functionals: A hybrid functional includes a certain amount of the exact
Hartree-Fock exchange. By adding a fraction of exact exchange, one can often better
reproduce the effects of static correlation. Mixing exact exchange however is not free of
cost, because it is non-local, and depends both on the electron density and also the density
matrix. The most popular hybrid functional is the B3LYP, which includes an empirically
adjusted 20% of exact HF in the exchange part of the functional.94,95 Following this
approach, any functional can be turned into a hybrid functional by mixing some amount of
HF exchange.
2.5.2.5 Fully nonlocal functionals: These functionals require input from both the occupied
and unoccupied KS orbitals. These are the equivalent of including post HF methods in DFT.
Development of these functionals is still in progress and they are, in general,
computationally expensive.
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Due to the success of Density Functional methods, chemists have been trying to apply DFT
to problems with increasing complexity. This has resulted in the development of new
Density Functional methodologies aimed at overcoming the inherent limitations of “classic”
DFT methods. The double hybrid functionals96,97 include a certain amount of HF exchange
and a perturbational correlation correction. These functionals improve the calculation of
kinetic barriers and dispersion forces due to the inclusion of the perturbational term, and
have shown some success in the calculation of energy gaps between different spin states.98
However, the construction of the functional makes it more expensive than the usual DFT
methods. Constrained DFT methods have successfully been applied to systems with long-
range charge transfer states, which is of special interest when studying systems that involve
proton-coupled electron transfer processes.99,100 Also, major advances have been recently
made in the calculation of non-bonded interactions using dispersion corrected functionals,
that provides an accurate energy calculation for van der Waals interactions, a key factor for
the correct prediction of inter- and intramolecular noncovalent interactions.101,102
2.5.3. Quantum Mechanics-Molecular Mechanics (QM-MM) Methods—In order to
study chemical reactions at the active sites of enzymes, chemists usually simplify the system
by focusing on the metal center and its surrounding residues. To mimic the effects of the
enzyme and solvent, a dielectric continuum model (typically Polarized Continuum Model
(PCM) or COSMO (Conductor like screening model)) is usually used. The alternative is to
use a simplified model of the protein and solvent in the Quantum Mechanics-Molecular
Mechanics (QM-MM) method.103 This approach treats the active site at a high level of
theory (usually DFT, but wavefunction methods can also be used), and the protein
surroundings at a lower level, usually Molecular Mechanics. This allows the inclusion of
steric and electrostatic effects on the active site. In order to combine QM and MM one needs
a proper treatment of the boundary region. There are two basic groups of coupling schemes,
based on the treatment of electrostatic interactions.104
2.5.3.1 Electrostatic Embedding (EE): In this method, the QM calculation is performed in
the presence of the MM system by properly including terms that describe the electrostatic
interaction between the QM and the MM regions. This method accounts for the polarization
effect of the charge distribution of the MM region on the active site, which is key to the
electronic structure of the active site.
2.5.3.2 Mechanical Embedding (ME): Here, the QM calculation is performed in the
absence of the MM part, and all the interactions are treated at the MM level. The original
ONIOM (our own n-layered integrated Molecular Orbital and Molecular Mechanics)105
coupling scheme belongs to this group, although the most updated version of this coupling
scheme also allows for EE.
The connection of the QM and the MM region is a challenging problem. The two
approaches to do this are the link atom and the local orbital schemes. The first introduces an
extra hydrogen atom in order to saturate the QM-MM regions.106 The later uses localized
bond orbitals to connect the two regions. The treatment of the boundary region is still a work
in progress, where numerous and significant advances have been made in order to improve
the quality of QM-MM calculations.107
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2.5.4 Application to Cu sites—As presented above, there are a wide range of methods
to calculate electronic structures. Although the choice of method is highly influenced by the
size of the system and the goal of the calculation (i.e., geometry optimization, physical
properties, reaction profiles, etc), it is important to evaluate the predictive properties of these
methods as well as their ability to provide insight into the electronic structure of the studied
system. In order to do this, benchmark calculations and calibration protocols are required. In
the following sections, we present well-studied copper systems where spectroscopic data,
which provide the experimental electronic structure of the molecule, are used to evaluate
Density Functional Theory methods. Spectroscopically calibrated methods that reproduce
the experimental data provide insight into the frontier molecular orbitals that are key to
reactivity and a solid methodology to evaluate reaction coordinates.
2.5.4.1 Calibration of DFT methods using [CuCl4]2−: One of the early applications of
DFT in bioinorganic chemistry was the blue Cu site. However, this method had to first be
evaluated experimentally. This was done on the [CuCl4]2− complex, which has been studied
with spectroscopic methods extensively over ten orders of magnitude in photon
energy.108–110 The bridge between experimental data and theoretical calculations was done
within one of the earliest DFT methods, the Xα scattered wave (Xα-SW) code.86,111 The
results from these calculations were found to be too covalent relative to experiment,36,112
thus the atomic sphere radii were adjusted to fit the [CuCl4]2− experimental data. With
adjusted parameters, the ground-state description was in good agreement both for [CuCl4]2−
and for the blue Cu active site. Following this approach modern GGA functionals have been
evaluated using the [CuCl4]2− complex as a benchmark.113 A considerable amount of
ground and excited state data are available for both tetragonal (D4h) and flatted-tetrahedral
(D2d) [CuCl4]2− complexes.114,115 The spectroscopic data define the ground state spin
density of the Cu(II) ion in the D4h structure as 0.62 ± 0.02, which can be directly compared
with the results from electronic structure calculations, thus allowing experimental calibration
of GGA functionals. Spin density is a parameter directly related to the electronic structure of
the molecule, making it a better calibration guideline than bond distances or thermochemical
data.
Before discussing functional effects, it is important to consider the effect of the size of the
basis set on the calculated spin density. Both all electron and effective core potential basis
sets were tested with BP86 (GGA pure functional), B3LYP (hybrid with 20% HF) and
BHandHLYP (hybrid with 50% HF). The calculated spin density was found to be dependent
on the size of the basis set. From these calculations is was concluded that at least a triple-ζ
basis set with diffuse functions on the metal is required in order to achieve effective basis set
saturation. Lower quality basis sets give an incorrect spin density on the copper atom; larger
basis sets do not significantly improve the calculated spin density.
When the pure BP86 functional with a saturated basis set was used to calculate the
electronic structure of the [CuCl4]2− anion in a square planar geometry, the spin density on
the Cu atom was calculated to be 0.43 (± 0.02).113 This value indicated the presence of
excessive LMCT mixing into the ground state. In other words, the bonding description for
the ground state of [CuCl4]2− in D4h geometry with this functional is too covalent (Figure 27
left), and includes too much ligand character in the singly occupied HOMO (SOMO, the β-
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LUMO in spin unrestricted calculations). As a consequence of this, the ligand field
transitions are shifted too high energy while the LMCT transitions are found to be too low in
energy. Thus, a less covalent bonding description is required to increase the metal character
in the β-LUMO. This increases the spin density on the Cu center and shifts the ligand field
and charge transfer transitions to their correct range of energies based on experiment. This
requires destabilizing the copper d-manifold with respect to the ligand orbitals (Figure 27
right), through a more ionic description of the Cu-Cl bond.
This can be accomplished within the Density Functional Theory by adding exact Hartree-
Fock exchange into the exchange part of the functional by means of a hybrid functional.
Two functionals were explored, B3LYP and BH and HLYP, which mix 20% and 50%,
respectively, of HF exchange into the pure functional, at the basis set saturation limit. The
B3LYP functional significantly improves the ground and excited state properties of the
[CuCl4]2− in D4h geometry, but still gives a ground state that is too covalent, with a
calculated copper spin density of 0.52. On the other hand, the BHandHLYP functional gives
an overly ionic description, with a copper spin density of 0.67. Therefore the optimal
amount of HF exchange was determined by systematically varying the local and non-local
exchange and correlation functionals (Figure 28). Among the different combinations, 38%
of the total Density Functional exchange (both local and non-local) was replaced with HF
exchange to match the experimental spin density keeping the correlation part unchanged.
This calibration was done for the BP86 functional, but the amount of HF is transferable to
other pure functionals such as BLYP. This B(38HF)P86 hybrid functional, adjusted to the
ground state, is also able to calculate the ligand field and charge transfer transition energies
with reasonable agreement with respect to experiment. Although all the functionals
overestimate the Cu-Cl bond length relative to crystallographic data, it is worth noting that
the spectroscopically calibrated B(38HF)P86 functional is the one that gives the best
agreement with the experimental value.113
Both solvent and crystal lattice effects on the calculated spin density have been evaluated
and lead to small variations of less than 2%. However, the solvent has a larger effect on
energy related parameters and bond dissociation energies, as expected for a negative charged
molecule. Also the crystal lattice (H-bonding from the counterions) stabilizes the square
planar geometry, preventing the distortion towards the D2d geometry observed in the gas
phase calculations.
Comparison with higher levels of theory has also been performed. The electron density has
been generated for the selected methods in Table 3. MP4 converges to a reasonable bonding
description, and only Quadratic Configuration Interaction Singles and Doubles (QCISD)
method with a saturated basis set is able to reproduce the experimental value. Coupled
Cluster methods give a too ionic bonding description due to the lack of triple excitations.
The good description of the ground state and the electronic excitation energies obtained with
the B(38HF)P86 functional make it suitable to study biologically important Cu(II) systems.
However, as discussed in the next section, environment effects on the HOMO and the
presence of stronger covalent bonds require a detailed analysis of each class of copper
complexes.
Solomon et al. Page 26
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
2.5.4.2 Blue Cu site: The first crystallographic determination of plastocyanin was
accomplished in 1978 by Freeman and coworkers.116 The geometric structure of the
copper(II) active site, distorted tetrahedral, raised the issue of the protein’s role in
determining the geometric structure of the active site. The copper coordination sphere in
plastocyanin also has two chemically interesting ligands: a thiolate sulfur of a Cys residue
with a short bond length (~2.1Å) and a long thioether sulfur-Cu bond of a Met (~2.9Å). The
coordination sphere is completed by two His ligands at normal bond distances (Figure
29A). 116
The unusual geometry and ligation are responsible of the unique spectral features of the blue
Cu site.2,117 Blue Cu has an intense absorption band at 16000cm−1 (ε= 5000 M−1 cm−1)36,
and a ground state EPR signal with a hyperfine coupling (|A∥| = 53×10−4 cm−1)118 of the
electron spin to the nuclear spin on the copper, reduced by more than a factor of two with
respect to normal copper complexes. These spectral features reflect a novel ground state
wave function that plays a key role in the biological ET function of this protein. From single
crystal EPR studies43 the ground state has an unpaired electron in a dx2-y2 orbital (SOMO, β-
LUMO), and the electronic z-axis of this site was found to be tilted only 5° with respect to
the long thioeter Cu-S bond. This axis orientates the dx2-y2 orbital to be within 15° of the
plane defined by the three strong ligands (Cys and two His). Initially the low Cu hyperfine
coupling value was attributed to the distorted tetrahedral coordination site. It was thought
that this distortion would allow the Cu 4pz orbital to mix into the dx2-y2 orbital, which would
lower A∥ due to the spin dipolar contribution to hyperfine coupling. However, Cu K-edge
(Section 2.2.5) experiments clearly showed that only Cu 4px,y mixes into this orbital. These
data led to the alternative explanation for the small hyperfine coupling of a highly covalent
site. In fact, the experimental values for the ground state wave function through Cu L-edge
(Section 2.2.6) and S K-edge XAS spectroscopies are 0.41 Cu-d and 0.38 S-p character
respectively.43
As with [CuCl4]2−, Xα-SW calculations gave ground state description that was too covalent,
and it was necessary to adjust the parameters of the calculation. This resulted in good
agreement with the spectroscopic data on the blue Cu ground state showing a highly
covalent site mostly delocalized between the π orbital of the Cys-S and the dx2-y2 orbital of
the Cu (Figure 29B).112 When a small model for the active site including only the first
coordination sphere was used with modern DFT calculations, the same qualitative
description of the ground state was obtained. However, as with Xα-SW this was
quantitatively too covalent and the adjusted functional, B(38HF)P86, was required to reduce
the covalency through inclusion of significant Hartree-Fock exchange. However, for the
blue Cu site when the model used for the calculations was expanded to include second
sphere interactions, the H-bond of a nearby amide with the thiolate (which has been studied
in detail for iron-sulfur proteins)119 and the protein dipoles, less HF exchange (the 20% of
B3LYP) was required in the functional to reproduce experiment (Table 4). This has been
experimentally evaluated for the blue Cu site in azurin.120
It is important to observe that the protein effects on blue Cu site differs from than the
inclusion of the crystal lattice effects in [CuCl4]2−. In the [CuCl4]2−, the counterions also
interact through H-bonds to the chlorides, but while this stabilizes the square planar
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geometry it has essentially no effect on the covalency and the Cu-Cl bonds. In the case of
blue Cu, however, the site is more covalent and second sphere interactions do effect the
covalency of the Cu-S bond. Therefore less HF exchange is required in the hybrid functional
to reproduce the experimental nature of the bond.
In summary, correlation to experiments on the blue Cu site show that one must be careful in
choosing a computational approach. Although the spectroscopically calibrated B(38HF)P86
functional is in excellent agreement for inorganic Cu(II) complexes, for the highly covalent
blue Cu site second sphere interactions affect the covalency of the Cu-ligand bond and result
in the need for less HF mixing into the ground state (but still the 20% HF in B3LYP for the
blue Cu center).
2.5.4.3 CuO2 species: There are two structural types in this class of oxy-Cu species: end-on
and side-on bound O2. For the latter, two limiting electronic structure descriptions are
observed. From L-edge XAS and rR spectroscopies the side-on CuO2 complex with the
trispyrazolyl borate ligand is a superoxo-Cu(II) species,121 while for the β-diketiminate
ligand the side-on CuO2 complex has a peroxo-Cu(III) electronic structure.122 For all end-on
CuO2 complexes, the electronic structure description is that of a superoxo-Cu(II) species.123
Both side-on structures are ground state singlets while the end-on structures are triplets. It is
important to evaluate how well the different types of DFT calculations (i.e., pure functionals
and hybrids) do in correlating to experiment in order to use DFT calculations in evaluating
possible reaction coordinates. Both the details of the spectroscopic elucidation of the
electronic structures of these complexes and the evaluation of possible reaction coordinates
are presented in section 3.3.
For the end-on CuO2 complexes, both pure (BP86) and hybrid (B3LYP and B(38HF)P86)
functional calculations give the experimentally observed triplet ground state. In correlating
to the crystallographically defined [TMG3trenCuO2]+ complex (Table 5),123,124 the hybrids
give the best agreement with respect to the CuO2 bonding. These appear to be appropriate
for reaction coordinate calculations for the end-on CuO2 structure observed in the non-
coupled binuclear Cu site in peptidylglycine α-hydroxylating monooxygenase (see section
3.3).125 The origin of the triplet ground state can be seen from Figure 30A. For the end-on
bound case, the π*σ orbital of the O2•− overlaps with a lobe of the dz2 orbital (highest energy
d orbital) of the Cu(II) leading to a σ bonding/antibonding interaction. This raises the energy
of the dz2 orbital while leaving the second O2•− orbital, the π*v, non-bonding and on the Cu.
If their splitting, Δ, is not large, both the dz2 and the π*v will be half occupied predicting the
triplet ground state observed experimentally.123
In going to the side-on CuO2 structure, the highest energy molecular orbital is now the
dx2-y2 orbital and it undergoes a stronger bonding/antibonding interaction with the O2•− π*σ
due to the greater overlap in the side-on geometry (two Cu-O bonds). This leads to a larger
value for Δ. When this is large enough, one gets a spin paired singlet ground state. This is
the case for the trispyrazolyl borate CuO2 complex, from SQUID magnetic susceptibility
measurements.121 Correlations to DFT calculations (Table 6) show that only a pure
functional (BP86) is capable of reproducing the singlet ground state. B3LYP gives a side-on
triplet at 8.25 kcal/mol below the antiferromagnetic coupled singlet. It is interesting to
Solomon et al. Page 28
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
compare the contours of these two calculations (Figure 31). For the B3LYP calculation, both
the triplet and antiferromagnetic coupled singlet have a dx2-y2 and a π*v orbital half
occupied as their splitting Δ is not large enough to spin pair. For the BP86 singlet, the α and
β unoccupied orbitals have similar spatial distributions hence little spin polarization. Thus
for the pure functional, Δ in Figure 30B is large enough to overcome electron-electron
repulsion and spin pair, and the direct covalent interaction between the π*σ and dx2-y2
orbitals is large enough to lead to little spin polarization.123
From this correlation to experiment, it appears that when the metal-ligand bond gets very
strong (i.e, covalent), there is less need for HF mixing in the functional as this tends to
decrease the covalency. Finally from L-edge XAS, the appropriate energy diagram for the β-
diketiminate complex is that shown in the Figure 30C where the strong β-diketiminate donor
ligand raises the energy of the d orbital and limits the amount of charge donation from the
O22− to the Cu.122,126 This leads to the peroxo-Cu(III) electronic structure description with a
singlet ground state. DFT calculations with a pure functional reproduce this, however when
HF is included for this strong donor, β-diketiminate ligand the calculations predict a triplet
ground state, while from experiments it is a singlet.126
Therefore, it is clear that the nature of the copper oxygen bond (i.e, the covalency)
determines the functional required to correlate electronic structure calculations to
experimental data. End-on CuO2 systems are less covalent, thus HF exchange mixing is
needed, and the B3LYP functional correctly reproduces the covalency of the bond and the
S=1 ground state. Alternatively, side-on CuO2 systems are more covalent, thus requiring
less HF exchange. As a consequence, the correct bonding description and S=0 ground state
are well described by the pure functional BP86.
These correlations between different functionals and experiment for CuO2 and those
presented above for [CuCl4]2− and Blue Cu suggest that the amount of HF mixing in the
functional can vary, decreasing with increasing covalency of the bond, and the amount
required is best established by correlation to experiment on the system being studied
2.5.4.4 Cu2O2 species: Several enzymes involved in O2 activation for the oxidation of
organic substrates function with a coupled binuclear Cu active site. Much effort has been
focused on their structure, spectroscopy and reactivity both in the metalloproteins and in
model complexes aimed at understanding the nature of the copper-oxygen bond and the
characterization of possible intermediates to provide mechanistic insights into reaction
coordinates. These are described in Section 3.2. For some model systems, two types of
isomers can be found in equilibrium,127 which are the µ-η2: η2 side-on peroxo128 and the
bis-µ-oxo species129 (Figure 32). The interconversion and reactivities of these species will
be discussed later. Here, we focus on their electronic structures.
The µ-η2:η2 side-on peroxo128 species has been spectroscopically characterized by K-edge
XAS, which shows a pre-edge peak at 8979 eV characteristic of Cu(II) (Section 2.2.5).
Resonance Raman spectroscopy indicates that this species contains a peroxide moiety with a
relatively weak O-O bond (νO-O ranging between 720 and 760 cm−1). SQUID magnetic
susceptibility measurements show it has a singlet ground state. The most direct experimental
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probe into the [Cu2(O2)]2+ bonding interaction is L-edge XAS (Section 2.2.6) that shows
52±4% Cu d character in the LUMO.130 To reproduce this experimental covalency, a hybrid
functional containing 10–20% HF exchange is needed. B3LYP (20% HF exchange) gives a
ground state wavefunction with 56.6% Cu d character. With BP86 the Cu covalency is
underestimated to be 45.3%. Importantly, this difference in HF exchange produces
fundamentally different electronic structure descriptions. The pure functional gives
delocalized α and β spin orbitals, thus no spin polarization (Figure 33 Left), whereas,
B3LYP gives opposite spins localized on each CuII leading to an antiferromagnetically
coupled ground state (Figure 33 Right). Thus, hybrid functionals with 10–20% HF exchange
better capture the experimental covalency and lead to a different description of the ground
state wavefunction compared to the pure functional BP86.
K-edge XAS performed on the bis-µ-oxo41 isomer shows a pre-edge at ~8981 eV that is
characteristic of Cu(III). Magnetic susceptibility measurements have characterized this
isomer as a singlet (S=0). L-edge XAS has again been used to quantitate Cu-O bonding
giving 40±4% Cu d character per hole in the ground state wavefunction. This experimental
covalency can only be reproduced with a hybrid functional containing 20–40% HF exchange
(BP86 and B3LYP give 32.9% and 35.4% Cu covalency, respectively).
Thus, the experimental electronic structure of both the µ-η2: η2 side-on peroxo and the bis-µ-
oxo species are best reproduced using significant HF exchange. One might thus expect this
spectroscopically calibrated hybrid functional to give the best thermodynamic description
for the µ-η2:η2 side-on peroxo to bis-µ-oxo equilibrium. However, the literature has
indicated that pure functionals (e.g. BP86) seem to correctly estimate the experimentally
observed Gibbs free energy of ~0–1 kcal/mol that is associated with the isomer equilibrium
for several ligand systems where both species are observed. B3LYP seems to overstabilize
the µ-η2:η2 peroxo isomer by ~18 kcal/mol.131 These calculations, however, do not include
relativistic and dispersion corrections, both of which have been shown to significantly affect
the total free energy.132 The inclusion of these effects are reported to modify the absolute
energies of the Cu2O2 systems by significant amounts that range from 10 kcal/mol for the
bis-µ-oxo to 30 kcal/mol for the for µ-η2:η2 peroxo isomer, the relativity correction being
the dominant contribution to the total energy. Thus, significant changes are expected when
calculating the thermodynamics of this equilibrium, which seems to indicate that hybrid
functionals with HF exchange are in fact needed to best reproduce the experimental
electronic structure and to provide good agreement to thermodynamic quantities when
dispersion and relativistic corrections are included.
3. Copper Active Sites that Activate Dioxygen
3.1 Reversible O2 Binding: Overcoming the Spin Forbiddenness
3.1.1. Enzymology—Hemocyanin (Hc) is an extra-cellular oxygen transport protein that
makes up the major component of the circulatory fluid (hemolymph) in arthropods and
molluscs. Deoxy-Hc contains a pair of Cu(I) atoms which bind dioxygen yielding two Cu(II)
centers that lack an EPR signal.133 The antiferromagnetic coupling that is responsible for
this observation is a defining feature that classifies Hc as a coupled binuclear copper protein
and distinguishes it from other binuclear copper proteins that lack magnetic interactions
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between the copper centers (Section 3.3). Oxy-Hc also has a unique absorption spectrum
(Section 3.1.4) that imparts a blue color to the hemolymph, in contrast to the red blood of
organisms that utilize hemoglobin for oxygen transport. However, Hc does not contain the
heme prosthetic group of hemoglobin. While the spectral features and protein derived
ligands of the binuclear copper site are highly conserved, the protein structure of Hc in
molluscs and arthropods is unique.
Hc’s from both organisms have quaternary structure that contains a significant number of
binding sites as required for cooperative O2 binding. Mollusc Hc subunits are ~400 kDa and
contain eight functional units that each contain a single binuclear copper site (labeled a-h
beginning from the amino terminus). The quaternary structure is a decamer of eight subunits
or a dimer of decamers arranged as hollow cylinders that are roughly 18 nm high by 35 nm
in diameter (Figure 34A).134–136 Within the cylinder, the individual peptides are arranged in
an antiparallel fashion forming a major and minor groove. The structure of the wall is highly
conserved and contains three tiers made up of functional units a-f (the ordering of the
functional units in the decamer of Keyhole Limpet Hc134 is shown in Figure 34A). At one
end of the cylinder, functional unit g and h make up the collar, which contains more
structural variability across various organisms. Functional unit g (shown in light blue, Figure
34A right) forms dimers to make up the arc portion of the collar located on the inside of the
cylinder while functional unit h (shown in gold, Figure 34A right) makes up the slab. In
some cephalopods (octopus, squid, and cuttlefish), functional unit g is absent and the arc is
symmetrically arranged. In other organisms, one of the g functional units in each dimer is
shifted towards the slab reducing the overall symmetry of the decamer.135,136 These
decamers can also dimerize at their open face, which occurs in organisms such as keyhole
limpet.134 These structures have also been found to contain a diverse array of carbohydrate
structures,137–141 however the physiological significance is not well understood. A variety
of mollusc Hcs have been clinically used to fight carcinomas due to the antigenic potency
from these unique glycosylation patterns.142
Arthropod Hc subunits are ~75 kDa and contain one oxygen binding site. The quaternary
structure is characterized by one, two, four, six, or eight hexamers depending on the species.
Each individual hexamer is comprised of a heterogeneous mixture of bean shaped subunits
arranged as two trimers in D3 symmetry (a representative structure of P. interruptus143 is
shown in Figure 34B). The two trimers are connected by two types of dimer interface; a
tight dimer interface (between the blue and yellow subunits in Figure 34B) and a loose
dimer interface (between the blue and green subunits). This hexameric structure also forms
the building blocks for the oligohexamers in a variety of different conformations. While
arthropod Hc is also a glycoprotein, the carbohydrate content is a smaller fraction of the
protein weight and less chemical diversity has been observed across different arthropod
species.144–146
While the presence of Hc in chelicerata and crustacean (two subphyla of arthropods) are
well known, it was believed that the tracheal system was sufficient for oxygen transport in
centipedes, millipedes, and insects which belong to the subphyla myriapoda and hexapod.
These organisms, though, contain hexamerins, which are evolutionary related to the
arthropod Hc.147,148 The insect hexamerins lost their copper binding domains and hence
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oxygen binding capacity and instead function as amino acid storage proteins. Recently, Hc
proteins that bind oxygen have been identified in myriapods149,150 and hexapods151. While
little is known about the O2 binding properties of these Hc’s, Hc from myriapods have high
oxygen affinity coupled with low cooperatively which is consistent with a primary function
of oxygen storage rather than transport.150 However, higher cooperativity has been observed
in a hexapod Hc suggesting a possible role in O2 transport.151 Little is know about the
evolutionary causes for the loss or retention of Hc oxygen transport in myriapoda and
hexapod.
The evolutionary divergence of arthropod and mollusc Hc from a common copper
dependent oxygen binding protein is believed to have happened approximately 550–600
million years ago (MYA)152,153 and 700–800 MYA154, respectively. This divergence
occurred early within the evolution of the phyla and is believed to have proceeded gene
duplication that is responsible for the unique quaternary structure.155 While it is likely that
Hc evolved from a primordial oxygen binding protein that preceded aerobic respiration, the
identity of the common ancestral copper protein is currently disputed. Due to sequence and
structural similarity at only one copper-binding site, some have proposed that the ancestral
protein contained a mononuclear copper site.156,157 However, sequence similarity with
tyrosinase (Ty) and catechol oxidase (CO) (vide intra) have lead others to speculate that the
common ancestor was a binuclear copper protein and that differences in the second copper-
binding site are a result of divergent evolution.153,158
3.1.2. Thermodynamics and Kinetics—Hc is one of three oxygen transport proteins
found in biology (a binuclear iron protein hemerythrin and the heme containing protein
hemoglobin are the other two). While cooperativity is limited in hemerythrin,159 this feature
is essential for the function of hemoglobin and Hc. In the absence of cooperativity, oxygen
binds to isolated sites producing a hyperbolic saturation curve (shown in blue in Figure
35A). In the presence of molecular interactions between active sites, the binding of oxygen
to one site can increase the affinity of the other active sites producing a sigmoidal binding
curve (shown in red in Figure 35 A) described by the following equation
[29]
where θ is the fraction of bound sites, PO2 is the pressure of O2, P1/2 is the pressure where
the concentration of oxy and deoxy sites are equal, and n (the Hill coefficient) is related to
the strength of the interaction between the sites. For a hexamer, n can range from perfectly
cooperative (n = 6) to completely isolated (n = 1). In Hc, the values of P1/2 have been shown
to vary greatly with environmental factors such as ionic composition, pH, and the presence
of organic molecules (vide infra). As a result, oxygen affinities (P1/2) between species have
been compared for various organisms measured in whole blood or in physiological saline
and pH (Table 7). The average oxygen affinity of Hc in these organisms is 14 and 18 torr for
arthropods and molluscs, respectively, which is only slightly higher than the oxygen affinity
of adult hemoglobin (27 torr). While these organisms all have similar affinities despite
living in different climates, organisms that live in extreme ocean environments such as
hydrothermal vents (B. thermydron160) or the oxygen minimum layer (G. ingens161) have
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very high O2 affinity, similar to other organisms that live in these environments for which
the physiological hemolymph pH has not been determined.162
However, the high affinity of Hc is not the only feature of these proteins that allow them to
reversibly bind O2. In vivo, the presence of sigmoidal oxygen binding behavior is essential
to efficiently transfer oxygen from the gills to the extremities. In the case of the crab Cancer
magister, hemocyanin in the hemolymph is characterized by a P1/2 of 20 torr and a Hill
coefficient of 3 (Figure 35A).167 In vivo, the O2 pressure in the gills and extremities is 105
and 24 torr, respectively. For the physiological sigmoidal curve, the oxygen saturation
changes from 99% to 63%, delivering 36% of the O2 capacity of the protein. However, a
hypothetical non-cooperative O2 carrier with the same affinity would only deliver 29% of
the O2. The difference between the cooperative and non-cooperative binding is greatly
increased during exercise where the in vivo pressures drop to 89 and 10 torr in the gills and
extremities, respectively. During this time of metabolic demand, a cooperative oxygen
transport protein is much more efficient (88% delivery) than the non-cooperative one (48%
delivery), which binds less oxygen at the gills and releases less at the extremities.
This cooperative behavior has been shown to dependent on the multimeric quaternary
structure of Hc,197–199 including molluscs that contain seven or eight functional units per
protein.188,200,201 From equation 29, the magnitude of this cooperativity is quantified by the
Hill coefficient. The largest measured Hill coefficients are 9.3202 and 8.6203 for arthropods
and mollusc, respectively. While these large Hill coefficients assist with O2 binding, they
are much smaller than the number of active sites in each enzyme (24 and 160). These results
indicate that the primary function of these large molecular assemblies is not to extend the
cooperative unit throughout the quaternary structure. Rather the large molecular weight is
believed to increase the number of O2 binding sites in an extracellular protein without
drastically increasing the osmotic pressure.204 Experimentally, the Hill coefficient is
frequently determined from the linearization of the oxygen binding plots (Figure 35B),
called a Hill plot. Here, the  is plotted as a function of the log(PO2) and the
slope determines the Hill coefficient (n) while the intercept is the log(P1/2). In the case of
non-cooperative oxygen binding, the slope is unity since n = 1 (shown in blue squares in
Figure 35B). For cooperative binding, three distinct regions of the Hill plot can be identified
(shown in red dots in Figure 35B). At high and low oxygen pressures, the slope is one while
the slope between these extremes is greater than one.
Physical insight to these regions can be provided by the Monod, Wyman, Changeux (MWC)
two-state model.205 In this model, oxygen binding is characterized by two quaternary
confirmations of the enzyme, a low affinity tense state (the T-state) and a high affinity
relaxed state (the R-state) related by the equilibrium constant L where L=[T]/[R]. At low
and high O2 pressures, oxygen binds to only the T-state and R-state, respectively, resulting
in a slope of one. At intermediate oxygenation, an increased number of deoxy sites are in the
high affinity R-state, resulting in slopes greater than unity. From these plots, three important
parameters can be determined. The affinity for the T and R states can be determined from
non-linear fitting of the MWC two-state model or by extrapolation of the linear region of the
Hill plot (Figure 35B), where the intercepts correspond to the P1/2 of the T and R states.
Solomon et al. Page 33
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Additionally, the site-site interaction, δ(ΔG), can be determined from the difference in the
Gibbs free energy of the T and R states and is related to their respective equilibrium
constants where
[30]
This site-site interaction represents the thermodynamic change that resulted from the
structural re-arrangement from the tense to the relaxed state. In hemocyanin, the average
δ(ΔG) is significantly larger in arthropods (−2.5 kcal/mol) than mollusc (−1.4 kcal/mol)
suggesting that the hexameric quaternary structure found in arthropods allows for a larger
driving force (Table 8) for O2 binding.
Yet only cooperative oxygen binding is generally not sufficient to efficiently function as an
oxygen transport protein especially in organisms that live in dynamic aquatic environments.
In many organisms, the modulation of oxygen affinity in response to environmental factors
such as temperature changes and temporary hypoxia is essential to survival. The effect of
temperature changes on Hc O2 affinity can be curtailed by minimizing the magnitude of ΔH
since
[31]
However the value of ΔH for Hc has been frequently calculated incorrectly in the literature.
Numerous reports have utilized an integrated form of the van’t Hoff equation in the
following form
[32]
The use of P1/2 rather than the equilibrium constant does not account for the temperature
dependence of the solubility of O2, resulting in ΔH values that are significantly smaller due
to the decreased solubility of O2 at higher temperatures.220 As a result, thermodynamic
parameters have been re-determined from the temperature dependence of P1/2 values by
accounting for the solubility of oxygen at the experimental salinity221 from the temperature
dependence of Henry’s law parameterized for O2 solubility in sea water.222 Determining
values for the themodynamic parameters in this manner (Table 9) indicates that on average,
O2 binding by Hc is slightly exothermic (−4.5 and −8.2 kcal mol−1 for arthropods and
mollusc, respectively) and ΔS is slightly positive (6 and 5 cal mol−1 K−1), however, large
variability in ΔH and ΔS is observed. Some of the most exothermic binding energies exist in
organisms (G. antarcticus177 and A. monachus223) that live in cold environments that have
little to no change in temperature. Similarly, organisms that live near hydrothermal vents
have small or slightly positive values for ΔH, which is believed to be an advantageous
adaptation as a direct result of an environment where temperatures change
rapidly.160,161,224–246 However, physiological responses to temperature changes complicate
the direct interpretation of thermodynamic data. For example, the oxygen affinity of blue
crab (C. sapidus) Hc at low temperatures is very high (less than 4 torr), however the animals
respond to this environmental condition by entering into a semi-hibernative state.165
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Further insight into thermodynamic parameters can be determined from the T and R states of
Hc. Since these parameters have only been determined for a smaller number of organisms
(Table 10), general trends are difficult to define. For P. interruptus199 and H. pomatia227,
both ΔH and ΔS are more positive in the high affinity R-state than the low affinity T-state.
However, the opposite trend is observed for L. hierosolima.228 One important difference
between L. hierosolima and P. interruptus is the affinity of the monomer. In L. hierosolima,
monomeric Hc has identical thermodynamic parameters to the R-state,228 while the
monomer in P. interruptus is that of the T-state199 (the affinity of the monomer in H.
pomatia is unknown). This difference would necessitate differential subunit interactions to
induce cooperativity and could explain the different trends in the thermodynamic
parameters.
The effect of the protein on the thermodynamics can be determined from a comparison to
the oxygenation of Cu(I) salts of binucleating and mononucleating synthetic ligands which
form binuclear, side-on bridged copper peroxide complexes. For these model compounds,
ΔH ranges from −28 to −7.7 kcal mol−1 and ΔS ranges from −65 to −21 cal mol−1 K−1
(Table 11). These ranges are a result of the coordinating ligand, the flexability of the linker
in the binucleating ligands, coordinating molecules in the Cu(I) complex, and the solvent.
And while the rates of oxygenation for the binucleating ligands are faster due to their
intermolecular nature, both the mononucleating and binucleating ligands have similar
thermodynamic parameters. This is likely due to large geometric changes in the binucleating
ligands since the Cu•••Cu separation in the Cu(I) salts is much longer (7.0 to 8.9 Å for the
structurally characterized models250–252) than after O2 binding (Cu•••Cu of ~3.6 Å). A
comparison to monomeric Hc199,228 (ΔH ranges from −10.1 to −7.5 kcal mol−1 and ΔS
ranges from −12.6 to −1.7 cal mol−1 K−1) indicates that the protein environment causes the
reaction to be more thermoneutral and decreases the entropic cost of binding dioxygen. A
further comparison to thermodynamic parameters determined from cooperative O2 binding
in Hc indicates that on average, ΔH is more thermoneutral and ΔS is slightly positive. Given
an identical binuclear copper core, these results suggest that the protein environment
functions to preorganize the active site for O2 binding and indicate that changes in the
protein tertiary and quaternary structure overcome the intrinsic entropic cost of O2 binding.
However, it is important to recognize that data determined from Hc also includes other
factors such as the interactions of protein with ions or protons.
Of these various factors, Hc is generally most sensitive to changes in pH. For oxygen
transport proteins (Hc and hemoglobin) a decrease in pH generally causes a decrease in O2
affinity, referred to as the normal Bohr effect.258 During metabolic demand, the
concentration of CO2 (which acidifies the blood via conversion to carbonate) and acidic
metabolic products such as L-lactate decrease the hemolymph pH.171,247,259–263 The normal
Bohr effect causes a decrease in Hc O2 affinity delivering more oxygen under these
conditions. The magnitude of this effect is quantified by the Bohr coefficient (Δlog(P1/2)/
ΔpH). Bohr coefficients for arthropods and molluscs can be as large as −2.7225 and −2.2223,
respectively. However, some Hcs exhibit a reverse Bohr effect where decreases in pH
increase O2 affinity. While some of the measured reverse Bohr effects only occur at extreme
pH values,228,237,248 snails,191–194,94,231,247,248,264–267 horseshoe crabs,268,269 and a species
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of chiton184 and a crayfish240 have reverse Bohr effects within a physiologically relevant pH
window. For some snails191,192,270,271, the pH of the blood is around 8.0 where the Bohr
effect is very small. For horseshoe crabs272 and some snails193,194,247, the physiological pH
falls within the range of the reverse Bohr effect. However, more pronounced blood
acidification results from large environmental changes such as decreased temperature or
environmental hypoxia.191,192,248,265,266 This increased affinity allows for O2 transport
under environmentally imposed O2 limiting conditions and is believed to be an adaptive
feature of Hc in these organisms since both snails and horseshoe crabs enter into periods of
extended hypoxia during their life cycle.
Within the framework of the MWC two-state model205, external effectors, such as pH, that
modulate Hc affinity are referred to as heterotropic allosteric effectors in contrast to O2,
which is a homotropic allosteric effector. Within the framework of this model, heterotropic
allosteric effectors affect O2 affinity by preferentially stabilizing either the T or R state
changing the value of the equilibrium constant L. However, some experimental data in the
presence of allosteric effectors, such as protons, cannot be fit to this model. As a result,
different modifications of the MWC model have been employed. One modification is to
allow the affinities of the T and R state to change as a function of pH.188,203,206,208,264 For
Hc’s with a normal Bohr effect, the affinity of both the T and R state decreases with
increasing pH. Another strategy that has been employed is the addition of other states to the
MWC two-state model. In the three-state MWC model, a third allosteric state is invoked that
has an O2 affinity intermediate between the T and R state.273 Another model employs nested
interactions.274 In this model, a smaller allosteric unit (likely a hexamer in arthropod Hc) is
affected by a larger allosteric unit (an example being a dimer of hexamers). Each of these
structural units has a T and R state resulting in four states, tR, tT, rR, and rT, where the
lowercase letter denotes the affinity of the smaller allosteric unit and the capital letter is that
of the larger one. The fitting of these models to Hc O2 affinity for species with a normal
Bohr effect indicates that protons stabilize the lower affinity states.212,214 In the case of
organisms with a reverse Bohr effect such as snails, the application of a pH dependent
MWC two-state model indicates that protons increase the affinity of either the T-state in H.
pomatia264 or the R-state in L. stagnalis203. Data for the horseshoe crab L. polyphemus
indicate that in the region of the reverse Bohr effect, protons stabilize the high affinity state
decreasing the values of L in a nested model.275
While both temperature and pH independently affect Hc O2 affinity, a decrease in
temperature also results in an increase in hemolymph pH.272,276,277 For most Hc’s, the
negative ΔH and the normal Bohr effect both increase the O2 affinity of the protein. To
minimize the change in Hc O2 affinity, some have hypothesized that the temperature
sensitivity of Hc is inversely related to the Bohr effect.231 A large compilation of
thermodynamic parameters and Bohr effects (Table 9) indicates that these two parameters
are only weakly coupled (the Pearson product-moment correlation coefficient for the
compiled arthropods and mollusc in Table 9 is −0.38 and −0.19, respectively, where 1 is a
positive correlation, −1 is a negative correlation, and 0 is no correlation.).
For most hemocyanins, temperature and pH have the largest effect on O2 affinity. However,
numerous other heterotropic allosteric effectors are known including inorganic ions,
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products of anaerobic respiration, and neuro-transmitters. In some mollusc Hc, cooperativity
has been shown to depend on the presence of divalent cations such as calcium and
magnesium.188,201,218,228,267,278 However, this behavior results from a lack of quaternary
structure in the absence of these ions. In species where the Hc quaternary structure does not
depend on divalent ions, cooperative oxygen binding is observed in their absence.210,279 The
majority of Hc have an increased affinity and cooperativity in the presence of increasing
concentrations of calcium188,198,203,206,215,280 and magnesium resulting from an increased
affinity of the R-state.206 A second calcium binding site has also been observed that causes a
decrease in O2 affinity.218,281,282 However, the high concentrations of calcium required to
bind in this second site are not observed in hemolymph under normal environmental
conditions.259,283–285 Interestingly, at low concentrations calcium has been shown to
decrease the affinity of horseshoe crab275 and snail218,228,264,278 Hc while increasing
cooperativity resulting from changes to the affinity of both the T and R state,218 however
exceptions are known.203
Similar effects have also been observed with chloride. Most species188,215,286, including
horseshoe crabs,287 show an increased affinity and cooperativity in the presence of
increasing chloride ions, however snail203 Hc experiences a decreased affinity and an
increased cooperativity. While these properties of snail and horseshoe crab Hc are generally
conserved within their species, the cause or adaptive function of these properties is not well
understood. Unlike pH, there is currently no evidence that in vivo ionic environments are
utilized to effect Hc O2 affinity. Instead, changes in salinity in organisms that move between
different environments must be combated. In general, organisms seem to utilize three
strategies to modulate changes in oxygen affinity. Some organisms regulate the ionic
concentration of their hemolymph.183,288 Other organisms possess Hc that is not greatly
modulated by changes in ionic concentrations289 and some arthropods adapt to changing
salinities by regulating Hc protein expression, which changes the ratio of the different
subunits making up the hexameric quaternary structure.290,291
In contrast, organic heterotropic allosteric effectors are utilized to modulate Hc in response
to changing environments. These organic effectors can be grouped into two broad
categories; products of anaerobic metabolism (urate and L-lactate) and neurotransmitters
(dopamine). Both the concentration of urate and L-lactate increase in the hemolymph when
organisms are maintained in hypoxic environments,283,292–294 while significant increases in
L-lactate and not urate occur during exercise.260,295,296 Generally, both urate212,297,298 and
L-lactate206,207,216,297 increase the O2 affinity of Hc, however exceptions are known.234 It is
believed that the primary adaptive function of these effectors is to increase O2 affinity
during hypoxia. During exercise, it is believed that Llactate functions to moderate the Bohr
effect. Interestingly, land based arthropods are less sensitive to L-lactate which likely results
from these organisms infrequently encountering hypoxic environments.299 The
concentration of neurotransmitters in the hemolymph has also been shown to increase during
exercise.300 However, its effect on Hc is less well understood since it has only been studied
in a small number of species with mixed results. While the O2 affinity of Hc from the crab
C. magister increases in the presence of dopamine,207 other Hc are insensitive to changes in
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dopamine levels.170,301 However, the physiological concentration of dopamine in the
hemolymph is very low300,302 suggesting that this effect is moderate in vivo.
Further molecular insight can be gained from exploring the kinetics of O2 binding. In
general oxygen-binding rates (kon) range from 1.3 to 44 µM−1 s−1 and dissociation rates
(koff) range from 9 to 2750 s−1 (Table 11) These results indicate that changes in affinity
result from changing only the dissociative rate. This change accounts for the difference in
affinity between the R and T199,303 as well as in the cooperative state203,268 as pH203,215 or
temperature199 is perturbed. However, Hirota and coworkers have proposed that changes in
kon and not koff are responsible for the observed changes in O2 affinity.304 However, in
these experiments koff values were measured by laser flash photolysis while values of koff in
Table 11 were determined from temperature jump or stopped flow measurements. The
differences in technique are likely the cause of these different results with the temperature
jump and stopped flow measurements being more reflective of the O2 dissociation caused by
O2 depletion in vivo.
An extensive collection of various molecular properties (P1/2, thermodynamic parameters,
responces to heterotropic effectors, etc.) on a large variety of species allows us to draw some
general conclusions about the thermodyanic and kinetic properties of Hc. Most essential to
its function, is the low O2 affinity coupled to high cooperativity. This allows Hc to transport
oxygen in organisms that live in diverse ecosystems, some that have very low O2
concentrations. While the protein functions to minimize the entropic cost of O2 binding,
organisms in environments that are susceptible to rapid changes in temperature have adapted
to minimize the magnitude of ΔH. In general, a decrease in the hemolymph pH is
accompanied by a decrease in O2 affinity (normal Bohr effect), which assists in delivering
O2 to the extremities during exercise-induced hypoxia. Yet some species of molluscs that
experience extended periods of environmentally induced hypoxia have a reverse Bohr
effects in response to lower O2 concentrations. Similarly, divalent cations, chloride, and a
number of small molecues that are the byproducts of metabolism have also been shown to be
heterotropic allosteric effectors. Yet the concentration of ions is generally kept constant
(either in the environment or via regulatory mechanisms) and the concentrations of
metabolic products are generally low except in cases of extended environmental hypoxia.
From kinetic measurements, changes in the equilibrium constant are attributed to changes in
the off rate while the on rate generally remains constant. Yet, less is understood about how
various conditions such as changes in temperature or pH affect the tense and relaxed states
of Hcs. This is especially true when comparing organisms that have very different responses
to the same effector, such as the reverse Bohr effect. This lack of knowledge hinders the
development of more molecular models for these properties and a more thorough
understanding of the difference properties of Hc among different species.
3.1.3. Structure—The tertiary structures of Hc from both arthropods and molluscs
hemocyanins consist of three distinct domains. In arthropod Hc (a representative structure of
L. polyphemus306 is shown in Figure 36A) domains one and two (in yellow and red,
respectively) are mainly α-helical and the third domain is a β-barrel (in blue). While domain
one shields the binuclear copper site contained in domain two, the third domain is believed
to be the evolutionary remnant of a copper chaperone.307 This domain is structurally similar
Solomon et al. Page 38
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
to cupredoxins and a bacterial CopC protein (an evolutionary link between copper-
trafficking proteins and cupredoxins308). However, the lack of a copperbinding site in
domain three suggests that this function has been lost over time. Domain two contains the
active site, which is located in a four-helix bundle.309 The tertiary structure of the mollusc
Hc functional units a-g contain only two domains (the oxy structure of subunit g from E.
dofleini is shown in Figure 36B); an α-helical domain one that contains the active site (in
red) and a six-stranded β-sandwich (domain two in blue) that shields the active site.157
While the structure of these two domains area similar in all mollusc functional units,
functional unit h contains an extra C-terminal domain that is structurally similar to domain
three in arthropods and the copper chaperone CopC.307
The central domain contains the copper active site, which is coordinated by three His
residues per copper. Two copper centers are distinguished by their relative location where
CuA is ligated by residues closer to the N-terminus than CuB. While the structure of the CuB
site in both arthropod and mollusc Hc is conserved, the structure of CuA is rather unique
(Figure 37). In arthropods, the four α-helicies that contain the six His ligands are arranged in
pseudo-two fold symmetry.143,306,309 However, in molluscs this symmetry is absent and one
CuA ligand (His2562 in E. dofleini, Figure 37C) is located on a loop instead of an α-
helix.157,310 However, this His is covalently tethered to a highly conserved Cys residue
(2560 in E. dofleini, Figure 37C) at the ε1 carbon. From a structural standpoint, it is believed
that this covalent linkage is critical to stabilizing His2562 in the active site yet any definitive
role in O2 binding is unknown. The binuclear active site in both arthropods and molluscs is
surrounded by two highly conserved Phe residues (Phe200 and Phe360 in arthropods and
Phe2569 and Phe2698 in molluscs Figure 37), which form a conserved Phe-X-X-X-His
sequence pattern that makes up the coordination environment of both CuA and CuB in all
known Hc. A steric interaction between these Phe residues and the copper coordinating His
residues and hydrogen bonds from peptide carbonyl oxygens or waters to the histidine Nδ
orients these residues for copper binding. Another highly conserved hydrophobic residue is
also found in the vicinity of the active site that links two protein domains. In arthropods,
domain one is linked to domain two by a single residue, Phe49 (shown in yellow in figure
37B).309 In molluscs, Leu2830 (shown in blue in figure 37C) connects domain two to the
active site in domain one.157 Both residues are believed to be essential for allosteric
regulation (vide infra).
A variety of atomic resolution structures from both arthropods and molluscs have been
determined (Table 12) In deoxy-Hc, the Cu(I) is coordinated in a distorted trigonal
environment (Figure 37A and Table 13).309 Dioxygen binds to the Cu(I) site and is reduced
by two electrons to peroxide which binds in an µ-η2:η2 coordination mode (Figure 37B–
C);157,306 a structural motif that was originally characterized in a tris(pyrazolyl)borate
model complex.311 In L. polyphemus, peroxide binding results in a square planer
coordination environment with two trans axial histidines (His204 and His328, Figure 37B)
with bond lengths of 2.3 Å.306 In oxy-Hc from E. dofleini (Figure 37C), the His nitrogens
adopt a staggered, trigonal, coordination environment and have similar Cu-N bond
distances.157 In oxy-Hc, the Cu•••Cu distance is 3.5–3.6 Å, similar to the average Cu•••Cu
distance in model complexes (3.51 Å).312 While the crystal structures do not have sufficient
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resolution to accurately determine the O-O bond length, binuclear Cu peroxo model
complexes indicate that average O-O and Cu-O bond are 1.42 and 1.92 Å, respectively.312
A comparison between the oxy and deoxy structure of L. polyphemus reveals that the
binding of O2 shortens the distance between the two copper atoms from 4.6 to 3.6 Å.306
Despite this large structural change at the active site, the rest of the protein structure is
mainly unperturbed. However, a larger geometric change between the two arthropod deoxy-
Hc structures provides a clue to the molecular mechanism of cooperative oxygen
binding.143,309 The Cu(I) coordination distorts from a trigonal planer environment in L.
polyphemus to a more pyramidal environment in P. interruptus changing the Cu•••Cu
distance from 4.6 to 2.9 Å (Table 13). This change in Cu•••Cu distance is accompanied by a
rotation of domain one from a closed conformation in L. polyphemus to an open one in P.
interruptus. This rotation of approximately 8° places a steric constraint on the active site via
Phe49 in the closed position (found in P. interruptus), which increases the Cu•••Cu distance.
The movement of Phe49 (Figure 37A) has also been proposed to gate an O2 diffusion tunnel
assisting in cooperativity.306,310 Dioxygen affinity in the crystallization buffer indicates that
the deoxy-Hc structure of L. polyphemus is in the T-state while deoxy-Hc from P.
interruptus has no O2 affinity.309 Despite the lack of a crystal structure of deoxy-Hc in the
R-state, it is hypothesized that the domain rotation, which results in an increased Cu•••Cu
separation, is responsible for the major mechanism of allosterism. A binding site for the
allosteric regulator, chloride, is located between domain one and two,306 which stabilizes the
closed conformation decreasing oxygen affinity for isolated subunits of L. polyphemus.313
However, the native quaternary structure has an increased affinity for O2 in the presence of
chloride;287 an observation that currently has no molecular explanation.
In arthropod Hc, the rotation of domain one is proposed to be translated to the hexameric
quarternary structure through the tight dimer interface (i.e. between the blue and yellow
subunits in Figure 34B).309 The two trimers then rotate with respect to one another along the
three-fold symmetry axis. The loose dimer interface (i.e. between the blue and green
subunits) assist in the geometric rotation since this contact is located in a plane horizontal to
the axis of rotation and is comprised of a small number of residue interactions. In molluscs,
the effect of the domain rotation on the molecular structure is less well understood.
Molecular modeling combined with electron microscopy suggest the major allosteric unit is
located in the wall between the major and minor groove due to an increased number of inter-
subunit contacts.134,135 This model suggests that the interfaces contain numerous histidine
residues and salt bridges, which has been offered as an explanation for the observed effect
protons have on cooperative oxygen binding.
These structures are consistent with a model where cooperative O2 binding is modulated by
the Cu•••Cu separation. In the low affinity state, the separation is larger (4.6 Å in the
arthropod L. polyphemus) than the high affinity state. The high affinity state is formed by a
domain rotation that shortens the Cu•••Cu by placing a steric constraint on the active site via
a conserved Phe in arthropods. This rotation can affect other active sites in the hexameric
quaternary structure leading to cooperative oxygen binding. A similar model has been
proposed for mollusc Hc due to the multidomain structure and a conserved Leu linking the
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second domain to the active site. However, no direct structural evidence of this rotation has
been observed in arthropod Hc.
3.1.4. Electronic Structure—Deoxy-Hc, owing to its closed shell, diamagnetic binuclear
Cu(I) state, is spectroscopically silent to most methods. Nonetheless, the oxidation state of
the Cu was firmly established as +1 based on its diagnostic 1s → 4p pre-edge transition at
8984 eV (Figure 38).304,314 From the Cu(I) K-edge XAS analysis presented in Section 2.1.1
the intense pre-edge reflects a site composed of a pair of three coordinate Cu(I) ions,
consistent with that observed via crystallography.
Upon coordination of O2 to the deoxy-site to form oxy-Hc, a change in the Cu K-edge pre-
edge spectrum is observed (Figure 38) indicating that both Cu(I) ions are oxidized to the +2
oxidation state.315,316 Oxy-Hc has an intense absorption band at ~350 nm (ε: ~20 mM−1
cm−1) with an associated resonance enhanced Raman vibration at 749 cm−1 that shifts to 708
cm−1 in the 18O2 isotopologue.317,318 The observation of this band indicates that when the
two Cu(I) ions are oxidized (to +2) the O2 is reduced by two electrons to the peroxide level
and the 350 nm absorption feature can be assigned as a peroxide → Cu(II) CT transition. For
peroxide end-on bound to a single Cu(II) (Figure 39) there is a CT transition at ~10,000
cm−1 lower energy and with approximately one fourth the intensity of oxy-Hc.319 From the
resonance enhanced Raman spectrum νO—O is 803 cm−1; 50 cm−1 higher that that of oxy-
Hc. Moreover, oxy-Hc has no EPR signal, and from SQUID magnetic susceptibility the two
Cu(II)s are strongly antiferromagnetically coupled (-2J > 600 cm-1).320 From Section
2.3.1.1, this reflects the peroxide bridge between the two Cu(II) ions in oxy-Hc providing a
superexchange pathway for the strong antiferromagnetic coupling (through the peroxide π*σ
orbital, vide infra). For an end-on peroxide bridged binuclear Cu(II) complex, the peroxide
to Cu(II) CT transition intensity goes up by a factor of two and νO—O increases by 30 cm−1
relative to the end-on peroxide bound mononuclear Cu(II) site (Figure 39B vs A). The CT
intensity quantifies the donor strength of the peroxide to the Cu(II) and the two fold increase
in intensity reflects the peroxo donor interactions with the two Cu(II) ions in the end-on
bridged structure. This removes electron density from the HOMO of the peroxide that is a π*
orbital (antibonding with respect to the O—O bond) and νO—O increases from 803 cm−1 to
832 cm−1. Thus the unique high energy and intensity of the peroxide to Cu(II) CT transition,
and low νO—O in Figure 39C, reflect a unique electronic structure associated with the
geometric structure of oxy-Hc.
From an early model study of Kitajima321 and from the protein crystallography (Section
3.1.3), oxy-Hc has the peroxide bound side-on and bridged between the two Cu(II)s (Figure
39C). This results in the unique electronic structure of oxy-Hc shown in Figure 40.128 The
O22− π* HOMO set is doubly degenerate but split in energy upon binding to the Cu(II). The
π*σ orbital is oriented along the Cu–O (peroxide) bonds and is strongly σ bonding with the
LUMO, the symmetric combination of dx2-y2 orbitals on the two Cu(II)s. The second
peroxide π* orbital (the π*v, v = vertical) is perpendicular to the Cu–O bond and only
weakly interacting with the Cu(II) ions. The π*σ donor dominates the bonding and is
responsible for the intense 350 nm CT absorption band in oxy-Hc. As shown by the contour
of the LUMO in Figure 40, the side-on peroxo bridge has four donor interactions (two with
each Cu(II)) which stabilizes the π*σ donor orbital energy and results in the high energy and,
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in particular, the high intensity of the peroxide π*σ → Cu(II) LUMO CT of oxy-Hc (the 350
nm band). This strong donor interaction removes electron density from the peroxide π*
orbital and νO—O would be expected to increase to well above the 830 cm−1 of the end-on
peroxide bridge structure in Figure 39B. However, the νO—O decreases to 750 cm−1. This
reflects the second important contribution to the bonding. The LUMO of peroxide is its σ*
orbital. In the side-on bridged structure this undergoes a bonding interaction with the
HOMO (antisymmetric contribution of the dx2-y2 orbitals in the Cu(II)). This shifts a limited
amount of electron density from the Cu(II) ions into the σ* orbital on the peroxide (a
backbonding interaction) which is strongly O—O antibonding resulting in the low νO—O.
Finally, these π*σ donor bonding/σ* backbonding contributions produce a large HOMO/
LUMO splitting and result in the strong antiferromagnetic coupling of oxy-Hc (see section
2.3.1.1).322
A detailed description of the bond strengths and definitive assignments of the vibrational
features of the side-on Cu2O2 peroxo core was obtained from a force field based on the
resonance Raman data and the IR spectrum of the [{(Tp)Cu}2-(µ-η2:η2-O2-2)] model
complex (Tp = trispyrazoyl borate).128 These data are shown in Figure 41 with the normal
mode assignment in Figure 42 as obtained from a Urey-Bradley normal coordinate analysis
(NCA) (Table 14). In order of increasing energy, the dominant feature in the resonance
Raman spectrum associated with the 350 nm absorption is the 284 cm−1 vibration. This has
no 18O2 isotope dependence and is assigned as the totally symmetric (Ag in D2h with Cu-Cu
along x and z perpendicular to the Cu2O2 plane) Cu•••Cu stretch (vCu•••Cu) which reflects
the dominant excited state distortion in this CT transition. In the same energy region in
Figure 41 are weaker Cu–N stretches of the ligand environment that varies among species
and likely has new information yet to be uncovered. At 331 cm−1 in the IR spectrum of the
model is the B2u Cu–O stretch (Figure 42) that shifts to 321 cm−1 in the 18O2 isotopologue.
In the proteins (but not in the more symmetric model complex) a weak resonance Raman
feature is present at 572 cm−1, which shifts to 549 cm−1 with 18O2 and is assigned as the B3u
or B1g Cu-O stretch, both possibilities having been considered in the NCA. Neither mode is
totally symmetric and therefore not allowed in resonance Raman but would gain some
intensity in the distorted protein site. At 763 cm−1 is the νO—O that is totally symmetric and
allowed by resonance Raman and reflects a shortening of the O—O bond in the CT excited
state. Finally the feature at 1144 cm−1 shifts to 1098 cm−1 with 18O2 and is assigned as the
first overtone of the 572 cm−1 vibration. While the fundamental is not totally symmetric and
therefore does not contribute to the resonance Raman spectrum in the model complex, the
overtone of a non-totally symmetric vibration is symmetric and resonance Raman allowed.
The NCA of oxy-Hc gives the kO—O of 2.4 mDyn/Å. For the end-on peroxo model (Figure
39A) and end-on peroxo bridged dimer (Figure 39B), the kO—O are 2.9 mDyn/Å and 3.1
mDyn/Å respectively. The NCA eliminates mechanical coupling and mode mixing and
demonstrates that the O—O bond of oxy-Hc is indeed weak due to the σ* backbonding
discussed above.
We now consider in more detail the electronic absorption spectrum of oxy-Hc. Figure 43A
shows the low temp absorption and RT CD spectra of oxy-Hc.323 Also included is the low-
temp absorption of met-Hc which has two Cu(II) ions that are antiferromagnetically coupled
Solomon et al. Page 42
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
but with the peroxide replaced by a water derived ligand (likely a bridging OH− ligand).
This allows the absorption and CD features of oxy-Hc at ~700 nm (~14,000 cm−1) to be
assigned as the LF transitions of the two Cu(II) ions. In addition to this and the intense 350
nm peroxo → Cu(II) CT transitions there is a weaker absorption band at ~600 nm (~16,700
cm−1) and a CD feature at ~480 nm (~21,000 cm−1). Neither are present in met-Hc. The
excitation dependence of the resonance Raman (Figure 43B) shows that in the low energy
(600 nm) absorption band, the νO—O is enhanced while in the ~350 band, the Cu•••Cu
stretch at 280 cm−1, which reflects Cu–O distortion (vide supra), is dominantly enhanced.
Thus, the low-energy absorption is assigned as the O22− π*v → Cu(II) CT transition with the
low intensity reflecting the limited overlap of the dx2-y2 acceptor orbital with the peroxide
π*v donor. The enhancement of νO—O by excitation into this band reflects the relative
donation of the peroxide π*v being less than that of the π*σ. Thus, CT excitation out of the
π*v leads to a greater distortion of the νO—O bond, while CT from the π*σ leads to dominant
distortion in the Cu-O bond. The enhancement of the νO—O band also profiles the CD
feature at 480 nm; therefore, it is a second component of the π*v CT. In a series of
binucleating model complexes where the Cu•••Cu distance was constrained by the length of
the organic linker, a fourth CT band is present on the low energy side of the 350 nm
absorption which increases in intensity and decreases in energy as the Cu•••Cu distance
decreases (Figure 44).324 The Cu2O2 butterflies as the linker is shortened and the new
absorption feature was assigned as a second component of the O22− π*σ to Cu(II) CT
transition from the resonance Raman profile that shows enhancement of the 280 cm−1
Cu•••Cu vibration in this new absorption feature.
These spectral features of oxy-Hc and related model complexes can be explained based on a
transition dipole vector coupling model (TDVC),323 which is a relative of exciton theory.316
Each peroxide π* orbital makes CT transitions to each of the two Cu(II) ions in the peroxide
bridged site. In zeroth order, these transitions are degenerate. However, in a dimer their
transition dipole moments, which are vectors along the change in electron density in the CT
process, couple into symmetric and antisymmetric combinations. These coupled excited
states thus split into two transitions for each of the π*σ and π*v CT processes. Considering
only the planar Cu2O2 D2h structure (with z perpendicular to the plane and x along the Cu-
Cu vector) the O2−2 π*v and π*σ transform as b3g and b1g respectively, and the symmetric
and antisymmetric combinations of the dx2-y2 Cu orbitals transform as b1g and b2u
respectively. Thus, the π*v transitions split into a B1u (z) component that is electric dipole
allowed and corresponds to the 600 nm absorption band and the B2g (Ry) that is electric
dipole forbidden but magnetic dipole allowed. From section 2.2.3, the B2g component
should contribute to the CD but not the absorption spectrum and thus is assigned to the 480
nm CD feature in Figure 43A. The π*σ CT also splits into two components (Ag and B3u),
only one of which (the B3u (x)) is electric dipole allowed and can be assigned to the 350 nm
absorption band of oxy-Hc. The butterfly distortion of the Cu2O2 core lowers the symmetry
to C2v. In C2v symmetry, the two components of the π*σ become A1 (z) and B1 (x). Thus
both are now electric dipole allowed wherein the A1 gains intensity in the out of plane
direction due to the butterfly distortion. Thus, π*σ makes a CT transition to each Cu center
and these transition dipole moment vectors couple. In the planar D2h structure, in one
combination (B3u) the transition dipole vectors add giving intensity polarized along the
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Cu•••Cu and in the other combination, these cancel and there is no intensity (Ag). In the
butterfly distortion, the vectors shift out of the xy plane. Now the antisymmetric (A1)
combination of transition dipoles gives a non-zero net dipole that is polarized along z
(Figure 44).
The TDVC model correlates the intensity of the A1 and B1 CT transitions in the Cu(II)-
peroxo model complexes with the magnitude of the bending of the Cu2O2 core. This gives
the intensity ratio as a function of the angle (Θ) between the two transition dipole vectors
(μ):
[33]
From equation 33, it is evident that as the core distorts away from planar (i.e. the “butterfly”
bending distortion), the intensity of the B1 component decreases concomitant with an
increase in the intensity of the A1 component.324 This is just what has been observed in the
spectra in Figure 44 and may be relevant in the CT absorption and CD spectra of the two
phyla of hemocyanins.325 In Figure 45A comparing the mollusc Busycon with the arthropod
Cancer Hc, the latter shows increased absorption intensity in both π*v peaks and a
moderately intense low energy shoulder is at 400 nm. The EXAFS of oxy-Hc is rather
unique showing an intense outer shell feature at ~3.7 Å corresponding to the Cu•••Cu
interaction with a low Debye-Waller factor (arrows in Figure 45B and C). In going from
mollusc to arthropod Hc, the Cu•••Cu distance decreases from ~3.7 to ~3.6 Å, an
observation consistent with some butterfly distortion of the Cu2O2 core in arthropod
hemocyanin.315 This structural difference in arthropod compared to mollusc may be relevant
to reactivity, as catalase activity is only observed in mollusc hemocyanins.326
As described in Section 2.3.1.2, CT transitions of bridging ligands in metal dimers provide
the superexchange pathway for antiferromagnetic coupling in the ground state.327 Here we
consider the correlation of the unique CT absorption spectrum of oxy-Hc in Figure 43A to
the strong ground state antiferromagnetic coupling (−2JGS > 600 cm−1). In the next section
we explore how changes in this superexchange pathway overcome the spin-forbidden
process of triplet dioxygen bonding to singlet deoxy-Hc to produce ox-Hc, an
antiferromagnetically coupled singlet.
From Figure 46, the electron pair in the π*σ orbital of the peroxide provides the
superexchange pathway for the strong antiferromagnetic coupling between the two Cu(II)
ions. As indicated at the top of Figure 46, a CT transition from the π*σ of the bridging
peroxide ligand to CuA leaves net electron spin in the π*σ orbital which directly overlaps the
electron spin on CuB and will have a very strong antiferromagnetic coupling as there is
direct orbital overlap. This CT antiferromagnetism greatly lowers the energy of the singlet
CT states of bridging ligands (by −2JCT) and it is the mixing of this CT antiferromagnetic
coupling into ground state that is responsible for −2JGS. The high intensity of the O22− π*σ
→ Cu(II) (dx2-y2) CT reflects significant overlap of the π*σ with the dx2-y2 orbitals. Thus,
both a large −2JCT and a significant CT mixing into the ground state contribute to a large
−2JGS.
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A VBCI model was developed to describe this correlation of the bridging ligand CT excited
states to the superexchange pathway of the ground state (i.e. the coupling of the CT
absorption spectrum to the ground state magnetism).55,328 This is presented in Figure 47.
The GS configuration has spins of ½ on CuA and CuB and forms 1Γ+ and 3Γ− states at zero
energy in the absence of CI (+/− refer to symmetric and antisymmetric with respect to the
two halves of the dimer). The bridging ligand to metal CT generates four
states: 1Γ+, 1Γ−, 3Γ+, 3Γ− given the electron can be excited to CuA or CuB, at an energy Δ
above the ground configuration. States of the same symmetry and spin can undergo a
configuration interaction due to the covalent ligand-metal overlap given by hdπ that
correlates to the intensity of the LMCT transition. As shown in Figure 47, singlet (left) and
triplet (right) energy diagrams labeled CI GS-CT, the interaction between the singlet (triplet)
ground state and CT state of the same symmetry splits the singlet (right) CT transition by
ΔEHL, the energy splitting deriving from covalent overlap (hdπ) and can be related to the
HOMO/LUMO splitting in a MO diagram. Importantly, at this level of CI the singlet and
triplet GS are at the same energy (i.e. no antiferromagnetic coupling). However, these do
split in energy upon inclusion of two more configurations: 1) the metal to metal charge
transfer (MMCT) at an energy U above the ground state where U is the the Mott-Hubbard
Columb potential of charge transfer insulators that is the repulsion of two electrons in the
same Cu d orbital (~6.5eV for Cu), and 2) the double CT (DCT) where the two electrons on
the bridging ligand orbital have been transferred to the two Cu(II) ions. The energy of DCT
transitions are much higher than U and can generally be neglected. Importantly, the MMCT
and DCT transitions only produce singlet excited states and at energies above the LMCT
states. These singlet excited states will mix and lower the energy of the singlet CT states
relative to the triplet CT states through CI, an effect which propagates to the singlet ground
state. As shown in Figure 47 it is the MMCT singlet mixing with the bridging singlet CT
state that leads to the CT excited state antiferromagnetic coupling, −2JCT, which in turn
yields the ground state antiferromagnetism −2JGS observed experimentally. The energy
matrices describing this CI are given by:
[34]
[35]
and the ground state antiferromagnetic coupling can be related to the excited state
antiferromagnetic coupling by −2JGS = λ2(-2JCT), where λ2 is the amount of CT mixing into
the ground state due to covalency. Given that λ2 ~10%, the excited state antiferromagnetic
coupling will be an order of magnitude larger then the ground state antiferromagnetic
coupling. Application of the VBCI model to the absorption spectrum of oxy-Hc gives
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~25000 cm−1 for −2JCT suggesting that the 350 nm band is significantly lowered in energy
relative to its one electron orbital transition energy (high due to the high Zeff of the side-on
peroxide as it has strong donation to the two Cu(II)) leading to a −2JGS of 2500 cm−1.54 This
value is consistent with the originally reported lower limit of > 600 cm−1 obtained by
SQUID magnetometry320 and reflects the only experimentally based estimate of the ground
state exchange coupling; but more importantly demonstrates that the CT absorption
spectrum is a distinct probe of the superexchange pathway for exchange coupling between
the two Cu(II) ions.
A number of derivatives of Hc have been prepared as probes of the protein environment and
the mechanism of O2 binding. One particular derivative of oxy-Hc, metazide, results from
the associative displacement of peroxide by azide in the active site while the oxidation state
of both Cu ions is still +2.325 Met-azide Hc is EPR silent, which suggests that the azide
(possibly along with a µ-OH) bridges the metals creating an overall antiferromagnetically
coupled ground state. This is verified by the observation of three intense N3− → Cu(II) CT
transitions in the absorption spectrum (Figure 48), whereas only two are possible with an
azide bound to a single Cu(II) ion.325 These transitions are πnbσ and πnbv analogs of the
peroxide π* CT transitions described above but where the HOMOs of N3− are non-bonding.
The splitting and intensity of these transitions of the N3− binding reflect the TDVC of CT
transitions to two Cu(II) as described above for oxy-Hc and are quite dependent on the
phylum, indicating structural distortions.
A second derivative of Hc is the “half-met” state generated by reacting deoxy with NO. Two
initial equivalents of NO yield met-Hc and N2O, which is then reduced by a third equivalent
of NO to yield the half-met NO2− derivative. The NO2− binds tightly but can be displaced
using excess N3−, which can in turn be displaced by other anions.57 Half-met Hc is an EPR
active mixed-valence Cu(I)Cu(II) state with an overall spin of S = ½. The binding of a
variety of monoanionic ligands to half-met Hc has been surveyed including N3–, F–, Cl–,
Br–, I–, SCN–, CN–, NO2–, OCN–, CH3CO2–.329–331 The binding of these anions can be
classified into two groups. The first group is composed of CH3CO2–, OCN–, SCN–, NO2–,
F–, and CN– and result in a localized class I mixed-valence electronic structure. The second
group is composed of the halides (not including F–) and azide. Coordination of these anions
results in a class II mixed-valence electronic structure as a result of N3– and halides bridging
the Cu centers. These second class of anions result in two particularly diagnostic spectral
signatures as a result of delocalization of the unpaired spin over the two coppers. The first is
the appearance of a broad intervalence-transfer (IT) transition (λmax = 1570 nm, ε = 1200
M−1 cm−1 when L = N3−) in the UV/Vis spectrum 0 (Figure 49A), a feature that requires a
bridging coordination mode. This was the first proof that the ligands (including O2) bridge
the two Cu(II) ions of Hc. The energy and intensity of this IT band are inversely related,
with both the intensity and energy proportional to the efficiency of the bridge as an ET
pathway. The second diagnostic spectral feature is the dramatic change in shape of the EPR
spectrum (Figure 49B), which is a result of the delocalization of the unpaired spin. The
unique EPR spectrum of azide bound half-met Hc was used for structural insight into
cooperativity in dioxygen binding to Hc in the “spectral probe” studies described in the next
section.
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3.1.5. Mechanism—The binding of dioxygen to deoxy-Hc requires the transfer of two
electrons from the Cu(I) ions to dioxygen to form the bridged peroxide. Additionally, the
triplet ground state of dioxygen must be converted to the antiferromagnetically coupled
singlet of oxy-Hc; a formally spin forbidden process. DFT calculations have been performed
to obtain insight to the manner in which the active site overcomes this spin
forbiddenness.332 Throughout the reaction coordinate, the coordination mode of the
dioxygen adjusts to maximize metal-ligand overlap. When the center of dioxygen is distant
from that of the coppers (Figure 50 right), the bonding interaction of the O2 is weak and the
π* orbitals are not spilt in energy maintaining the triplet ground state, which minimizes
electron-electron repulsion. As dioxygen more strongly interacts with the coppers, the
coordination mode is converted to a bridging, butterflied µ-η2:η2 one. This results in
productive overlap of the Cu orbitals with dioxygen and the transfer of charge from the
coppers to dioxygen, each copper interacting with a different π* orbital of dioxygen
(becoming a peroxide bridge) producing orthogonal magnetic orbitals, which are
ferromagnetic (Figure 22A middle) maintaining the triplet ground state. Importantly at this
point, the two unpaired electrons are on the two coppers and the electron, electron repulsion
is greatly reduced thus the singlet potential energy surface (PES; Figure 50 blue) is now
close in energy to the triplet PES (red). Flattening of the butterfly distortion along the O2
binding coordinate leads to the overlap of both metal centered magnetic orbitals with one
superexchange pathway (the π*σ orbital on peroxide), resulting in strong antiferromagnetic
coupling to produce the singlet state (Figure 50 left in blue). Analysis of the Mulliken
charges along this O2 binding coordinate indicates that the two electrons from the two
coppers reduce dioxygen simultaneously, (in the bridged structure), and thus overcome the
unfavorable one electron reduction of dioxygen. Thus the strong exchange coupling
associated with the bridging peroxide that forms along the O2 binding reaction coordinate
overcomes the “spin forbiddenness” of this binding reaction and results in a concerted, 2-
electron process.
Further insight to the mechanism of O2 binding has come from a comparison to the coupled
binuclear Type 3 (T3) site in the multi-copper oxidases (see Section 3.7.1).333 The O2
binding site of the multi-copper oxidases (MCOs) contains a tri-nuclear copper cluster in its
native form. Removal of the Type 2 (T2) copper (see Section 3.7.1.2) results in the isolation
of a binuclear T3 copper site that is structurally similar to Hc (2 Cu ions each coordinated by
3 His ligands). The oxidized form of this site also lacks an EPR signal due to
antiferromagnetic coupling and the reduced form binds small molecules such as CO but
importantly does not react with oxygen in the absence of the T2 copper.8,334 A comparison
between the XAS spectra of the deoxy forms of both enzymes indicates a substantial
difference in their spectral features (Figure 51).333 The binuclear T3 copper in the MCO has
a more intense pre-edge feature at 8983 cm−1 corresponding to the Cu 1s → Cu 4pz
transition due to a more planar coordination environment. In contrast, both arthropod and
mollusc Hc have a lower intensity Cu 1s → Cu 4pz transition and lower energy and higher
intensity Cu 1s → Cu 4px,y transitions due to a more trigonal pyramidal coordination
environment.
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The implications of the different coordination environments of Hc and the binuclear T3
copper site in the MCO on their respective O2 reactivity have been computationally
evaluated.333 Models for both sites were constructed that contained the six His ligands from
representative crystal structures with frozen α carbon atoms on each of the ligands.
Optimization of the deoxy-structures indicated that deoxy-Hc was 6.9 kcal/mol higher in
energy than the deoxy form of the T3 site. Importantly, the geometry optimized deoxy sites
also had different Cu•••Cu distances (4.2 and 6.5 Å for Hc and the binuclear T3 center in the
MCOs, respectively) and a larger trigonal pyramidal distortion of the Cu(I) centers in Hc,
consistent with the XAS spectra in Figure 51. While the binding of O2 to the Hc model to
form oxy-Hc is exothermic (ΔH = −2.9 kcal/mol), the binding of dioxygen, as peroxide in a
side-on configuration to the binuclear Cu(I) site in the MCO is endothermic by 5.6 kcal/mol.
This difference in binding energy mostly reflects the protein constraints on the reduced sites.
The origin of the energy difference observed in the deoxy structures was determined by
comparing an unconstrained potential energy surface (open symbols in Figure 52) along the
Cu•••Cu vector to one where the α-carbons were frozen by the protein constrains (filled
symbols in Figure 52). The slopes of the two unconstrained potential energy surfaces are
very similar, indicating similar electrostatic repulsion in the two protein environments. The
energy difference between a Cu•••Cu separation of 6.5 Å (the optimized Cu•••Cu distance in
the constrained T3 model) and 4.2 Å (the optimized Cu•••Cu distance of the constrained Hc
model) for the unconstrained T3 site is ≈5.8 kcal/mol, which accounts for most of the
energy difference between deoxy-Hc and deoxy-T3 MCO. This indicates that the larger
electrostatic repulsion between the two Cu(I) atoms in deoxy-Hc is critical for its ability to
bind dioxygen.
This electrostatic repulsion in Hc results from the protein constraint on the Cu•••Cu distance
due to interactions between two α-helicies that contain a His ligand for each Cu (His204 and
364 in Figure 53). In the absence of this electrostatic repulsion that destabilizes the deoxy
site, as observed in the binuclear T3 copper site in the MCO, O2 binding is lost. This protein
derived constraint, due to the presence of salt bridges and π-π interactions between these
two α-helicies, results in an electrostatic repulsion between the Cu ions that functions as an
“entatic” or “rack” state in Hc.333 Cooperativity between active sites can effect this
electrostatic repulsion by modulating the Cu•••Cu distance in the deoxy site. In a structural
model of the relaxed deoxy state (Figure 53 in orange and light blue), Phe49 is distant from
CuB and the Cu•••Cu separation is short (2.9 Å) increasing electrostatic repulsion.143 In the
tense deoxy state (red and yellow in Figure 53), the rotation of domain 1 to the closed
conformation (with Phe49 close to the copper site) results in a π-π stack between Phe49 and
His328 causing the Cu•••Cu distance to increase to 4.6 Å, decreasing electrostatic
repulsion.309 Dioxygen binding in a bridging mode shortens the Cu•••Cu distance, breaking
this π-π interaction, which favors the open confirmation. This leads to a domain rotation that
can be transmitted to other subunits via a variety of interdomain contacts.
Direct evidence for active site structural perturbations arising from O2 binding to adjacent
functional units has come from the preparation of a Hc derivative denoted the “spectral
probe”, where a small fraction of the active sites in the quaternary structure have been
converted to the EPR active half-met state.335 When the adjacent sites are oxygenated, the
EPR spectrum of the half-met spectral probe in both arthropod and mollusc Hc is similar to
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the half-met monomer in the presence of excess azide (Figure 54). Upon deoxygenation, the
spectral probe converts to a class II mixed-valent state, resembling the nonexcess azide
spectra (Figure 54 deoxy, compare to Figure 49B red), which converts back to the excess
azide spectra upon re-oxygenation. The changes in the spectral features of the half-met sites
in the spectral probe indicate that when O2 binds to a binuclear Cu+ site, the quaternary
structure shifts (from T to R), which affects the O2 binding through a change in the Cu•••Cu
distance.
3.2 Oxygen Activation by Coupled Binuclear Active Sites: Polyphenol Oxidases and
Phenol Oxygenases
3.2.1. Enzymology—Coupled binuclear polyphenol oxidases (CB-PPOs) contain a
magnetically coupled binuclear copper active site336 that activates dioxygen to catalyze the
production of quinones in a diverse range of organisms. While the term “polyphenol
oxidases” has been used to describe the multi-copper oxidase, Laccase (Section 3.7.1),
laccase performs one-electron oxidations of phenols, in contrast to the two-electron
oxidation of o-diphenols by the coupled binuclear copper protein family. CB-PPOs can be
further divided into two subsets of enzymes with differing reactivity: tyrosinase (Ty), also
called monophenol monoxygenase, internal monooxygenase, or a mixed function oxidase,
(EC 1.14.18.1) and catechol oxidase (CaOx) (EC 1.10.3.1). While both Ty and CaOx
perform the two-electron oxidation of o-diphenols to quinones (referred to as two-electron
oxidase or catecholase activity), only Ty can catalyze the conversion of phenols to o-
diphenols (referred to as monooxygenase, phenolase, or cresolase activity). Ty catalyzes the
conversion of the amino acid, L-tyrosine to 3,4-dihydroxy-L-phenylalanine (L-DOPA) and
the subsequent oxidation of L-DOPA to L-DOPAquinone (3-(3,4-dioxocyclohexa-1,5-
dien-1-yl)-L-alanine) (Figure 55). Early oxygen labeling studies by Mason indicated that the
oxygen atom incorporated into L-DOPAquinone originates from dioxygen.337 This, in
combination with Hayaishi’s studies on a non-heme iron containing intradiol
dioxygenase,338 demonstrated the presence of oxygenases in biology (monooxygenase for
Ty and dioxygenase for pyrocatechase).
The enzymatic production of L-DOPAquninone by the CB-PPOs provides the monomers
that nonenzymatically polymerize, forming eumelanin via the Mason-Raper pathway.339–341
First, L-DOPAquinone forms cycloDOPA via an intramolecular Michael addition (Figure
56).342,343 CycloDOPA is then oxidized by another molecule of LDOPAquinone forming
DOPAchrome, regenerating a molecule of DOPA. DOPAchrome decomposes preferentially
into 5,6-dihydroxyindole (DHI) via decarboxylation but can also form 5,6-
dihydroxyindole-2-carboxylic acid (DHICA) via a tautomerization.344 These two
dihydroxyindoles are then oxidized enzymatically by Ty or CaOx or nonenzymatically by L-
DOPAquinone before auto-polymerizing, forming eumelanin.345,346 While eumelanin
makes up the major component of melanin found in nature, pheomelanin can also be present
(usually <25% of the total melanin polymer).347–349 Pheomelanin forms from the
intermolecular addition of L-cysteine to L-DOPAquinone, forming 5-S-Cysteinyldopa
(Figure 56) or 2-S-Cysteinyldopa (not shown).341,350 Similar to the Mason-Raper pathway,
the cysteinyldopa will be oxidized by L-DOPAquinone before cyclizing to a 1,4-
benzothiazine intermediate that autopolymerizes to pheomelanin. While the chemical
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formation of both the benzothiazine and dihydroxyindoles has been extensively studied, the
molecular structures of both the eumelanin and phenomelanin polymer are less well
understood.
Overall sequence similarity suggests that the CB-PPOs in arthropods are closely related to
arthropod Hc (and hexamerins, see Section 3.1.1)351,352 while fungal, bacterial, plant, and
vertebrate Ty is more closely related to mollusc Hc.351 One defining structural difference
between arthropod and mollusc Hc is the presence, only in the later, of a highly conserved
His ligand on CuA (the Cu atom that is coordinated by residues closer to the N-terminus)
that has been cross-linked to a Cys residue (Section 3.1.3). However sequence
similarity,353,354 protein sequencing,355,356 and protein crystallography (vida infra) indicate
that plant and fungal CB-PPOs contain a Cys-His crosslink that is absent in bacterial Ty.
While not conclusive, this structural feature suggests that the coupled binuclear copper
proteins evolved from a common binuclear protein and that the observed differences are a
result of divergent evolution. However, the function of this divergence is not well
understood.
A variety of intra and extra cellular CB-PPOs have been characterized in fungi, gram-
positive, and gram-negative bacteria. The production of melanin in these organisms has been
correlated to the resistance to radiation, toxic metals, oxidants, free radicals, extreme
temperatures, and fungal tissue damage.357–359 Melanin is also believed to increase
virulence in pathogenic fungi and bacteria through a variety of mechanisms including
protection from enzymatic lysis and hydrolysis, antimicrobial compounds, and phagocytosis
(the process of cellular entrapment in a membrane vesicle).359,360 In soil bacteria, CB-PPOs
polymerize otherwise toxic mono and o-diphenols into a variety of polymers such as
melanin, and humic acids.357 These physiological functions rely upon the presence of a
copper chaperone that ensures the proper transportation and copper loading of Ty. The
chaperone MelC1, in the genus Streptomyces, is critical for copper loading361,362 and
transports the enzyme through the twin-arginine translocation (Tat) pathway363,364 by
forming a dimer with apo Ty.365 A copper chaperone (PpoB1) has also been identified in
Marinomonas,366 however a CB-PPOs copper chaperone has not been reported in fungi.
In plants, CB-PPOs polymerize a variety of o-diphenols (catechin, chlorogenic acid,
dopamine, and caffeic acid are common in vivo substrates). While the majority of known
COs are found in plants and fungi, some of these enzymes also possess monooxygenase
activity.367–375 CB-PPOs are nuclear encoded proteins that are directed to the thylakoid
lumen by a N-terminal signaling peptide via multiple pathways including the Tat
pathway.376,377 While little is known about the function of the enzyme in the thylakoid
lumen, it has been hypothesized that the CB-PPOs are involved in the reduction of dioxygen
produced from photosynthesis.378,379 Yet most of the enzyme in the lumen is inactive due to
the presence of the C-terminal domain (similar to mollusc Hc). In vivo, this latent form can
be activated by free fatty acids380 or proteolytic cleavage between the two domains.381
Upon tissue damage, phenols are released from the vacuole and the CBPPOs are activated
resulting in the browning of plant tissue.382–385 CB-PPOs are also localized in the
trichromes of plants and are critical for the entrapment of insects.282,386 Expression levels
have also been correlated to defense mechanisms against insects, pathogens, and
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herbivores.383,387–389 The plant signaling molecule methyl jasmonate has been shown to
increase the expression levels of CB-PPO genes and corresponding protein product in many
plants.384,390 A number of CB-PPOs also participate in synthesis of various natural products
in plants. Ty related proteins possessing monooxygeanse activity participate in the
production of plant pigments such as aurone391 and betalin392 as well as antioxidants such
as creosote bush 8–8' linked lignans.393
In arthropods (most notably insects, crustaceans, and arachnids), the CB-PPO (sometimes
called phenoloxidase or prophenoloxidase for the active and inactive forms, respectively) is
mostly produced by hemocytes, an immune cell found in the hemolymph, and participates in
clotting, encapsulation of parasites, and sclerotization of the cuticle.394,395 Similar to plants,
arthropod CB-PPOs are transcribed in an inactive form that is activated by a cascade of
serine proteases.394,395 However, some arthropods, such as the horseshoe crab, lack a CB-
PPOs gene.395 Instead, it is believed that the immune system utilizes a clotting enzyme that
induces CaOx activity in horseshoe crab Hc.396,397 A similar activity in Hc has been
accomplished in vitro with protein denaturants398,399 such as SDS400–403 or urea404 and by
proteolytic cleavage;405,406 however, a more general physiological function of this activity
in Hc has not been established.
In animals, the most common CB-PPOs is Ty, which is responsible for melanin formation.
However, some specialized functions in animals have been characterized, such as the
formation of ink in molluscs including octopus.407–409 Present in vertebrates are two Ty
related proteins (Trps) that are believed to have formed from gene duplication.410 While
other organisms, notably plants, contain multiple isoforms of CB-PPO, the Trps
enzymatically control the polymerization of L-DOPAquinone creating a more diverse
melanin polymer.347 One of the Trps, DOPAchrome tautomerase (Dct or Trp2), contains a
zinc cofactor and catalyzes the tautomerization of DOPAchrome to DHICA (Figure 57).411
In the absence of enzymatic control, the ratio of DHICA to DHI is 1:70 at neutral pH.344
While the metal cofactor of Trp1 is still unknown,412 it is believed to be an isozyme of Ty
given that mouse Trp1 has low monooxygenase and CaOx activity.413,414 However, the
reactivity of Trp1 towards DHICA is less clear. In mice, only Trp1, and not Ty, has two-
electron oxidase activity for DHICA415,416 while in humans, only Ty has this activity.417
Besides catalytic activity, Trp1 also has a structural function in stabilizing Ty.418,419
The regulation of Ty expression levels in vertebrates is induced by environmental factors,
such as UV light, which is translated to numerous signaling molecules including cyclic
AMP.420 The majority of these signals lead to the production of the Microphthalmia
associated transcription factor (MITF) causing the upregulation of Ty, Trps, and numerous
other proteins that assist in the cellular processing of Ty.420,421 Ty, once synthesized in the
cytosol, is processed in the endoplasmic reticulum (ER) and the Golgi apparatus, and is
stabilized by both Trp1 and 2.418,419 In the ER, the N-terminal signaling sequence is cleaved
and Ty is glycosylated, and folded with the assistance of multiple chaperones.422 Ty is then
transported to the Golgi where the glycans are further modified before being exported to the
melanosomal membrane that is spanned by a C-terminal domain (only in vertebrates).
Copper is loaded by the metal chaperone ATP7A once Ty reaches the melanosome.423
There are numerous mutations in the signaling pathway, in Ty, or in related processing
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proteins that are responsible for various pigmentation disorders in humans.424 Hundreds of
specific mutations of the Ty gene are known that range from point mutations to frame shift
mutations cause Type I oculocutaneous albinism causing hypopigmentation and impaired
vision with varying severity.424–426 Diminishing melanosome formation in hair follicle is
believed to be one cause of hair graying with age.427 While numerous mechanisms have
been proposed to account for these observations, recent evidence suggests that high
hydrogen peroxide levels coupled to low expression of methionine sulfoxide reductase also
cause grey hair by inactivating Ty via methionine oxidation.427,428 Some have also
postulated that another function of Ty is the formation of neuromelanin in the brain,429–431
however others have proposed that phenols, such as dopamine, polymerize non-
enzymatically.432 Even the presence and expression levels of Ty in neuronal cells are
disputed.429,430,432,433 While little is known about the formation of neuromelanin, the
cellular production of neuromelanin increases the likelihood of cell death in patients with
Parkinson’s disease.434
Recently, a new, fourth sub-class of the coupled binuclear copper enzyme family has been
discovered (in addition to Hc, CaOx, and Ty) that converts o-aminophenols to
nitrosophenols (hydroxyanilinase activity, Figure 57).435 In S. murayamaensis, a
hydroxyanilinase (NspF) performs the terminal step of the biosynthesis of 4-hydroxy-3-
nitrosobenzamide. A similar enzyme from S. griseus (GriF) has also been shown to possess
hydroxyanilinase activity in vitro on specific p-substituted phenols (vide infra).435 In vivo,
GriF performs the two-electron oxidation (oxidoreductase activity) of 3-amino-4-
hydroxybenzaldehyde to the corresponding o-iminoquinone in the biosynthesis of grixazone
A and B, a yellow pigment and parasiticide (Figure 57).436 Hydroxyanilinases have also
been shown to possess CaOx and monophenolase activity indicating that these enzymes
possess all of the Ty functions as well as the additional hydroxyanilinase function.435 With
o-aminophenols as substrates, Ty only performs a two-electron oxidation to produce o-
iminoquinones.435,437
3.2.2. Kinetics—While a number of CB-PPOs have been characterized with various
substrate specificities, Ty is the most prevalent and best characterized member. To convert
phenols such as tyrosine to L-DOPAquinone, Ty binds dioxygen with a measured
equilibrium binding constant of 16.5 – 46.6 µM,438,439 falling within the range of oxygen
affinities found in mollusc Hc (Section 3.1.2). The rate of O2 binding to deoxy-Ty (19–23
µM−1 s−1)438,440 is also similar to mollusc Hc (5–30 µM−1 s−1).203,303,305 During catalysis,
three states of Ty (and CaOx) have been characterized; deoxy ([Cu(I)2]2+), oxy
([Cu(II)2O2]2+), and met-Ty (two Cu(II)’s bridged and antiferromagnetically coupled by a
hydroxide ligand) (Figure 58 and 59). Unlike in Hc where almost all of the active sites are
oxygenated under air-saturated conditions, purified Ty contains approximately 85% met and
15% oxy-Ty.441,442 This can be converted to mostly oxy by a peroxide shunt reaction441 or
reduction to deoxy followed by exposure to oxygen. While oxy-Ty is able to convert both
phenols443 and o-diphenols to quinones,444 met-Ty is only able to oxidize o-diphenols to
quinones (Figure 58 and 59). Despite similarities at the active site between oxy-Hc and oxy-
Ty, the differential reactivity has been shown to result in part from differential access to the
active site. Addition of small molecule ligands, such as azide, displace the peroxide from the
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oxy site four orders of magnitude faster in Ty than in Hc.325,445 Additionally, a substrate
analogue and competitive inhibitor, mimosine, readily displaces peroxide from oxy-Ty (k =
162 h−1) but not from oxy-Hc (k << 10−4 h−1).445 Yet, similar rates of O2 binding to deoxy-
Ty and Hc suggest that the active sites have similar access for dioxygen, potentially due to
the presence of an O2 tunnel, which in Hc is believed to close after oxygen binding (Section
3.1.3).
3.2.2.1 Catechol Oxidase Activity: While the enzymatic control of the oxidation of o-
diphenols is essential in vivo, the oxidation of o-diphenol can occur in vitro by a variety of
oxidants including dioxygen (k = 2.0 × 10−5 s−1, pH = 7.6)446 and is catalyzed by copper
chloride (the rate of oxidation more than doubles with 1.0 mM CuCL2).447 While the
oxidation of L-DOPA (E0’ = 0.54 V vs SHE, pH = 6.75, n = 2)448 is required to form
melanin, L-DOPA also functions as the in vivo reducing agent for met-Ty (E0’ = 0.60 V vs
SHE, pH = 7.0, n = 2)336 regenerating deoxy-Ty (Figure 58). Under steady state turnover
conditions, mushroom Ty oxidizes L-DOPA with a kcat of ~150 s−1 (seven orders of
magnitude faster than the uncatalyzed reaction) and a Km value of ~450 µM.449–451 The Km
for dioxygen varies with the chemical structure of the substrate,449,452 suggesting that the
binding of o-diphenols and oxygen is not ordered,14, however kinetic modeling can account
for this observation assuming oxygen binds first.453 Thermodynamic parameters for CaOx
activity have also been determined from kcat giving ΔG≠ ~ 13–17 kcal/mol (25° C)
depending on the substrate (ΔG≠ = 14.5 kcal/mol for L-DOPA).449,454
The CB-PPOs, especially the CaOx from different plant sources, have varied substrate
specificity with respect to substituted o-diphenols such as 4-methylcatechol, catechin,
pyrogallol, and caffeic acid.455–460 Ty also exhibits stereospecificity with respect to L-
DOPA (  for mushroom Ty).450 In vitro, the specific activity of
CaOx maximizes around neutral pH.449,461 A decrease in Km from pH 4–7 corresponds to a
pKa of 4.9 – 6.0 depending on the substrate.449 However, the molecular identity of this pKa
or the cause of the substrate dependence is unknown. In vivo, the pH of human melanosomes
(~ 3.5)462 has been shown to affect pigmentation levels due to the pH dependence of Ty.463
Increased melanin production in individuals with darker skin results in part of a more neutral
melanosome, increasing Ty activity.464 The substrate dependence of catalysis has also been
used as a mechanistic probe of mushroom tyrosinase indicating that substrates with similar
redox potentials have kcat values that differ by an order of magnitude.438 However,
substrates with no substituents such as pyrogallol (kcat = 1263 ± 63 s−1) are oxidized more
rapidly than substrates with large, polar substitutents such as L-DOPA (kcat = 109 ± 9.1 s−1)
consistent with the hypothesis that the rate-limiting step in the oxidase catalysis is affected
by a steric interaction and not the redox couple of the diphenol.438
To determine the rate-determining step, kinetic modeling coupled with transient phase
kinetics have determined that the reaction of 4-tert-butylcatechol with oxy-Ty is 20 times
slower than its reaction with met-Ty.438 This model is also consistent with the observation
of a steady state concentration of oxy-Ty.438 Additionally, a solvent deuterium isotope effect
of 1.67 ± 0.1 on kcat during the oxidation of L-DOPA suggests the rate-limiting step
includes a proton transfer.465,466 The observation of a linear free energy relationship
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between the Hammett parameter and Km and kcat indicates that the resonance delocalization
of a negative charge affects both the binding and the rate-limiting step (ρ = −1.0 and −2.5 for
Km and kcat, respectively).449 Assuming that the different enzyme sources and substrate
substituents do not change the rate-determining step, these data indicate the slowest step in
catalysis is the reaction of the oxy form with the diphenol. The solvent KIE and substrate
dependence suggest that within this reaction, the rate-determining step is a structural
rearrangement that is effected by the size of the substrate concurrent with the transfer of a
proton. This proton transfer is then followed by a two-electron oxidation of the diphenol,
which is not rate-determining.
3.2.2.2 Monooxygenase Activity: In mushroom Ty, the kinetics of the reaction with L-
tyrosine is characterized by a ten-fold decrease in kcat (~10 s−1) compared to the conversion
of L-DOPA (~ 150 s−1), while Km is similar (~300 µM) for both reactions.453,467 In steady
state turnover, the slowest elementary kinetic step of the monooxygenase and CaOx steps
(kMO = 103 s−1, kCO=107 s−1) have been estimated from comparing kinetic simulations to
turnover frequency.468 During turnover with a non-native reductant, the o-diphenol can be
trapped by borate,469 indicating that the o-diphenol is an intermediate in the catalytic cycle
(Figure 59). Ty also exhibits preferential binding of L-tyrosine (Km = 0.270 mM) over D-
tyrosine (Km = 1.870 mM).450 Similarly, Ty exhibits regiospecificity, reacting preferentially
(lower Km and higher kcat) with p-phenols over m-phenols and is unreactive towards o-
phenols such as o-fluorophenol.470 The temperature dependence of kcat in an aqueous,
organic solvent mixture gives a free energy barrier of 16.1 kcal/mol (25 °C),454 which is in
excellent agreement with the turnover number measured in aqueous solution (kcat = 10 s−1 at
25° C predicts ΔG‡ = 16 kcal/mol). The hydroxylation of monophenols proceeds most
favorably at neutral pH.461 Over a pH range of 5–9, a decreased in KM corresponds to a pKa
of 7.85,461 however the molecular origin of this protonation is currently unknown.
Unique to the reaction of Ty with monophenols is the presence of a lag period before steady
state turnover is established.471 This lag phase depends on substrate
concentration,449,472–474 enzyme concentration,471–474 and the presence of native (o-
diphenols) 449,461,471,475,476 and non-native473 reductants. The lag phase has been attributed
to the presence of met-Ty in the resting form of the enzyme, which is unreactive towards
monophenols.14,442 As a result, met-Ty must be converted to deoxy-Ty before the system
reaches steady state turnover.14,442 Absent any initial reductant to reduce met-Ty, it (~85%
of resting Ty441) does not participate in turnover until o-diphenols such as L-DOPA are
generated non-enzymatically from L-DOPAquinone (Figure 56).14,442,477 L-DOPA can then
react with met-Ty forming deoxy-Ty to eventually achieve steady state turnover.14,442
Additionally, the lag phase has been shown to increase with increased substrate
concentration.449,472–474 This has been attributed to phenols binding to met-Ty forming an
off pathway complex,14 consistent with the observed substrate inhibition (Figure 59 bottom
left).
To determine the mechanism and the rate-limiting step during turnover, substrate specificity
and isotope effects have been measured. Steady state turnover of para-substituted
monophenols has been shown to vary with respect to electron withdrawing
substituents.469,478 A Hammett relationship between σ+ and kcat has a negative slope (ρ =
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−2.4 and −1.7 for A. bisporus469 and A. oryzae,478 respectively) indicating that a positive
charge is created in the rate-determining step. The magnitude of ρ compared to binuclear
copper model systems253,479 has been further used to support a mechanism of electrophilic
aromatic substitution (EAS) (vide infra). Incorporation of deuterium at the ortho-carbon
produces an inverse isotope effect (kHcat/kDcat = 0.9) supporting a mechanism of EAS where
the hydroxylation is rate limiting.478 However a tritium isotope effect of 1.2 has also been
measured on Ty from a different source that was originally proposed to support a
mechanism of EAS where the proton transfer from the ortho-carbon was rate limiting.480
Yet others have reported being unable to kinetically distinguish between protium and
deuterium or tritium.469,481 A large solvent deuterium isotope effect that is linear with
respect to the concentration of D2O has been measured for various substrates (3.45 ± 0.3 for
L-tyrosine).465 The strength of the isotope effect was correlated to chemical shift of the C1
carbon of the substituted phenol, consistent with the rate-limiting step being the transfer of
the phenolic proton to a base upon coordination to the Cu.465 However, this interpretation is
inconsistent with the Hammett relationship since this mechanism should produce a positive
ρ value due to the creation of negative charge.
To probe the effect of second sphere residues on substrate binding, kinetic parameters of
mutatated varients have been determined. Most intriguing is a series of varients have a
differential effect on the oxidase and oxygenase reactivity of Ty indicating that
monophenols and o-diphenols have different interactions with the protein pocket. For
example, the sterospecific recognition of L-DOPA in mouse Ty has been attributed to
His389, which is adjacent to His390, a ligand for the Cu atom closest to the C-terminus
(CuB) (See Section 3.2.3).482 Interestingly, the H389L variant affects the relative Km for L
and D-DOPA (  for WT and 1.3 for H389L) without affecting the
sterospecific recognition of L-tyrosine.482 A comparison between the kinetics of L-DOPA
and dopamine suggest that His389 forms a hydrogen bond to the carboxylic group in L-
DOPA. Another variant in mouse Ty (H378Q), which is also in the vicinity of CuB, affects
the substrate Km for the CaOx activity while the Km of the monooxygenase activity is
unaffected (Table 15).482 A similar improvement in the oxygenase/oxidase activity has also
been observed in the CuB variant (R209H) of bacterial Ty from B. megaterium, which
increases the kcat for the Ty activity while decreasing the CaOx activity (Table 15).483
Interestingly, a variant of human Ty (A206T located near CuA) that is responsible for type 1
oculocutaneous albinism484 increases the oxygenase activity 204% while decreasing the
oxidase activity to 15% of WT.485 These results have been interpreted to support a
mechanism where phenols bind to CuA while o-diphenols bind at CuB.
Numerous inhibitors of the CB-PPOs have also been studied for various applications in
medicine and agriculture.486–489 Correlations of inhibitor structure to function have
generated insight into the nature of the active site pocket. Carboxylic acids have been shown
to be competitive inhibitors of L-tyrosinse and L-dopa.449 Binding kinetics for various
carboxylic acids indicate that aromatic acids (such as benzoic acid) have larger binding
constants (Keq = 800 M−1) than aliphatic acids (such as acetic acid Keq = 180 M−1).14 This
is due to an order of magnitude change in binding rate (kon = 17 and 4 M−1h−1 for benzoic
acid and acetic acid, respectively) while the dissociation rates are comparable (~1000 h−1).14
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This kinetic difference, combined with spectroscopic studies (vide infra), suggests a
favorable interaction between the aromatic inhibitor and the protein pocket. These results are
also consistent with the weak competitive inhibition of the monooxygeanse activity in Ty by
toluene (Ki = 23 mM while the Ki of benzoic acid is 0.018 mM).490 The large ΔS° of
binding of toluene (54 cal mol−1 K−1) is also consistent with a hydrophobic interaction
between toluene and the protein pocket.490
To further probe the mechanism of binding to the active site, the pH dependence of various
inhibitors has been determined. P-nitrophenol, a slow substrate and competitive inhibitor of
L-tyrosine, is a better inhibitor at low pH with a pKa of 6.82 measured from the formation
constant during L-tyrosine turnover.490 This pKa is similar to the pKa of the phenolic proton
of p-nitrophenol under the same conditions, consistent with the protonated phenol inhibiting
turnover.490 A similar experiment with the inhibitor benzoic acid indicated that the
protonated form inhibits Ty.490 A proton inventory, which measured change in the
formation constant with respect to the fraction of D2O in the solvent, is linear indicating that
a single proton is transferred in the rate-determining step of inhibition.490 This result
excludes protonated groups such as water or hydroxide as the proton acceptor since they
would involve multiple protons and would give a non-linear relationship.490 From the slope
of this plot, a product fractionation factor, which is the enrichment of deturium in the
product relative to the solvent concentration, was determined to be 0.64 ± 0.02.490 This
fractionation factor is unique since amino acid residues generally have fractionation factors
of one except cysteine which has a fractionation factor of 0.40 – 0.46.491 As a result,
Strothkamp and coworkers propose that the identity of the base during inhibition could be
the peroxide bridge and hypothesize that the peroxide could also function as a general base
in catalysis.490 However, results from model complexes argue against this hypothesis since
side-on copper peroxides are not basic.492–494 Additionally, low fractionation factors have
been observed with amino acid residues other than cysteine due to the presence of low-
barrier hydrogen bonds.495 These low-barrier hydrogen bonds occur when there are short
heavy-atom, heavy-atom distances and similar pKa’s of the two groups involved.
These results indicate that the reaction of oxy-Ty with a monophenol is slower than the
subsequent reaction of the intermediate diphenol with met-Ty. Data suggest that the
monophenol first binds CuA resulting in the formation of a π-protein interaction.
Subsequently, attack at the ortho-carbon in an EAS mechanism generates the diphenolic
intermediate. However, the rate-determining step of this reaction is currently disputed. Some
have argued that the deprotonation of the substrate upon coordination to CuA is rate limiting
while others have argued that the EAS (either the attack on the ring or the deprotonation of
the σ complex) is rate limiting. A similar controversy exists over the identity of the base that
deprotonates the monophenol. While the pH dependence of inhibitors binding has resulted in
a model where the bridging peroxide acts as the base, second sphere residues within the
vicinity of the active site (vide infra) have also been suggested.
3.2.2.3 Activated Hc: While Hc has a primary function as a dioxygen tranport protein,
native Hc has been shown to have weak CaOx activity.496 Significant enhancement of CaOx
activity in both arthropod and mollusc Hc has been accomplished with protein
denaturants398,399 such as SDS400–403 or urea,404 proteolytic cleavage,405,406 or via protein/
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protein interactions.396,397 These results further support early kinetic studies that suggest the
functional difference between Ty and Hc is due in part to substrate access to the binuclear
active site.325,445 A more limited number of both arthropod and mollusc Hc has been shown
to have inducible monooxygenase activity.398,400,404–406 For example, tarantula Hc has been
shown to convert L-tyrosine to DOPA quinone, however kinetic parameters were not
determined.405 The monooxygenase activity of mushroom Ty and subunit g of O. vulgaris
Hc have been measured for a series of p-substituted phenols (Figure 60).404 The kinetic
parameters indicate that activated Hc is an inefficient tyrosinase with a Km that is two to
three orders of magnitude larger in Hc (~10 mM) than in Ty (~ 0.010 mM) and a kcat that is
three orders of magnitude smaller (0.099 vs 120 for the reaction of Ty and Hc with 4-
methyphenol, respectively).404,469 Given that Ty and Hc have identical oxy sites, these
results indicate that second sphere residues in Ty both bind substrate more tightly and lower
the activation barrier for hydroxylation more efficiently than in Hc. Yet, the Hammett plot
(Figure 60) of kcat for activated Hc is suggestive that both Ty and Hc operate via a similar
mechanism (ρ = −1.6 and −2.4 for Hc and Ty, respectively).404,469 Incorporation of
deuterium into the ortho positions of the substrate yields in an inverse deuterium isotope
effect in subunit g of O. vulgaris Hc, which is suggestive of EAS where the hydroxylation of
phenol is the rate-determining step.404
3.2.2.4 Hydroxyanilinase Activity: The best-characterized hydroxyanilinase, NspF, has a
kcat and Km of 260 s−1 and 0.72 mM, respectively, for its native substrate, 3-amino-4-
hydroxybenzamide (Figure 57).435 Substitution of the functional group para to the o-
aminophenol results in a decrease in kcat for the hydroxyanlinilase activity and for some
substrates, such as the unsubstituted o-aminophenol, no hydroxyanilinase activity is
observed. For this substrate, NspF instead performs the two-electron oxidation to form the
corresponding o-iminiquinone (Figure 57). Interestingly, Ty only performs the two-electron
oxidation of o-aminophenols.435,437 Turnover rates for the two-electron oxidase activity of
S. murayamaensis NspF435 and N. crassa Ty437 with the same substrate are of the same
order of magnitude indicating that the difference in selectivity between these two enzymes
originates from a difference in kcat for the hydroxyanilinase activity. From the magnitude of
the rates, the ΔΔG‡ for this activity in NspF relaive to Ty is expected to be greater than 4
kcal mol−1.497
3.2.3. Structure—High-resolution crystal structures of the CB-PPOs can be divided into
four categories, plant CaOx (I. batatas498 and V. vinifera499), bacterial Ty (S.
castaneoglobisporus500 and B. megaterium501), fungal Ty (A. bisporus502) and insect Ty
(M. Sexta503) (Table 16). While the plant CaOx and bacterial and fungal Ty structures are
evolutionarily and structurally similar to mollusc Hc,351 the structure of insect Ty is similar
to arthropod Hc.351,352 All of the structures contain a central, globular domain that is mainly
α-helical. This domain contains a 4 α-helix bundle that is highly conserved in all known
CB-PPOs and Hc. In the plant498,499 and bacteria500,501 CB-PPOs, a highly conserved His-
X(n)-His-X(8)-His sequence coordinates CuA while a His-X(3)-His-X(n)-His motif
coordinates CuB. While in insect Ty503 (and arthropod Hc), the ligands have a His-X(3)-His-
X(n)-His motif for both Cu atoms. Unique to plant CaOx377 and insect503 and
vertebrate354,504,505 Ty is the presence of multiple domains that shield the active site.
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Plant377 and vertebrate505 CB-PPOs also contain an N-terminal signaling peptide that
directs transport of the protein to the thylakoid lumen and endoplasmic reticulum,
respectively. While plant CB-PPOs are associated with the thylakoid memebrane, only
vertebrate CB-PPOs contain a transmembrane fragment found at the C-terminus.354,504
However, the structures of these domains are unknown since the plant CaOx structures are
of the processed form that lacks this domain498,499 and no vertebrate structures have been
reported.
Crystal structures of four different forms of the binuclear copper active site in the CB-PPOs
have been obtained; apo, deoxy, oxy, and met. The similarity between apo and deoxy Ty
indicate that the His residues are pre-aligned for Cu binding.500 In the deoxy form, the
copper coordination environment is characterized as a distorted tetrahedron with a fourth,
bridging water derived ligand that is absent in the deoxy structures of Hc.500 Despite the
presence of a bridging solvent ligand, the Cu(I) coordination environment is mostly planer
resulting in a Cu•••Cu separation greater than 4.0 Å,500 similar to the T-state of deoxy Hc
(Table 13 and Table 17). Oxygen binds the deoxy site as peroxide in an µ-η2:η2 coordination
mode, decreasing the distance between the two copper atoms (3.8 Å and 3.4 Å in oxy-CaOx
determined from EXAFS in I. batatas498 and oxy-Ty determined from crystallography in S.
castaneoglobisporus500, respectively). (Figure 61A). The shorter Cu•••Cu distance in oxy-
Ty from S. castaneoglobisporus is potentially influenced by the presence of a caddy protein
required for crystallization.500 A caddy protein residue (Tyr98) forms a hydrogen bond with
the peroxide (OTyr98-Operoxide = 3.0 Å) causing the core to butterfly, decreasing the Cu•••Cu
distance.500 The coordination environment of Cu(II) with respect to the three His ligands in
oxy-Ty from S. castaneoglobisporus is staggered trigonal (Cu-NHis bond lengths range from
2.1–2.2 Å),500 similar to oxy-Hc from E. dofleini157. Also relevant to the catalytic cycle is
the active site structure of met CaOx and Ty (Figure 61B and Table 17). A variety of
different crystal structures of met-CB-PPOs contain two Cu(II) atoms bridged by zero, one,
or two solvent derived ligands. In these structures, the distance between the coppers is
extremely flexible with Cu•••Cu distances ranging form 4.9 – 2.9 Å. However, two solvent
derived bridges can only be accommodated by Cu•••Cu distances that are 3.1 Å or shorter
due to steric repulsion between the two single atom bridges.250 A single bridge can
accommodate Cu•••Cu distances up to 4.0 Å due to a Cu-O distance of ~2.0 Å. Yet, the
inherent flexibility in the Cu•••Cu distance within these different structures assists with
oxygen binding (Section 3.1.5) and the shorter Cu•••Cu distances suggest that other copper
dioxygen isomers, such as a bis-µ-oxo (Cu•••Cu ≈ 2.8 Å in model complexes312), would not
be structurally restrained by the protein environment. However, this isomer has not been
observed in any member of this enzyme family.
Due to their evolutionary relationship, the overall fold and Cu His ligands of bacterial and
fungal Ty, plant CaOx, and mollusc Hc are very similar. While all of these structures have a
CuA His ligand that is located on a flexable loop, a conserved Cys (92 in I. batats498 CaOx
and 83 in A. bisporus500) is crosslinked to a CuA His ligand (109 in CaOx and 85 in fungal
Ty) (Figure 61B). The amino acid sequence of two other fungal Ty355,356 and sequence
similarity353,354 indicates that the Cys-His crosslink is conserved in fungal Ty. In both
fungal Ty502 and mollusc Hc157, the Cys-His crosslink occurs within a conserved Cys-X-X-
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His motif while this crosslink is found in a His-X(4)-Cys motif in plant CB-PPOs.498,499
However, the Cys in plant CB-PPOs is not crosslinked to the adjacent His but rather a
different CuA His ligand (I. batatas, His88-X(4)-Cys92 forms the motif while Cys92 is
crosslinked to His109).498 While this covalent linkage is absent in bacterial Ty (Figure 61),
the presence of this structural motif in vertebrate Ty cannot be determined due to the
presence of three Cys rich regions that have no sequence similarity to the structurally
characterized CB-PPOs enzymes.354 Intriguingly, computational modeling of a human Ty
structure predicts five Cys residues located on flexible loops that are unlikely to form
disulfide bonds.506 While these regions are known to be essential for protein function,504 no
direct evidence for this crosslink in vertebrate Ty has been reported. The formation of this
crosslink has been shown to occur in vitro upon loading Cu(II).356 The formation of a
disulfide linkage leads to the reduction of the coppers allowing oxygen to bind, forming
oxy-Ty that is then reduced to met upon the formation of the crosslink.356 Mutation of this
crosslinked Cys was also found to decrease kcat for L-tyrosine (59 s−1 vs 1.8 s−1 in wt vs
enzyme varient) but does not completely abolish enzymatic function.356 Structural data
indicate that this covalent linkage restricts active site flexibility since crystal structures of
bacterial Ty, which lack the crosslink, have larger disorder (B factors) at CuA.500 Yet, how
this flexibility impacts catalysis is not well understood.
The second sphere residues of all structurally determined bacterial Ty and CaOx contain a
structurally conserved Glu (236 in I. batatas498 and 182 in S. castaneoglobisporus500) that
can act as an important acid/base residue during catalysis498 (Figure 61A). While Glu 236 is
highly conserved in CaOx, the presence of a variable length, flexible loop in bacterial Ty has
likely obscured the observation of this residue based on sequence comparisons.498 While
three crystal structures of Ty (from S. castaneoglobisporus,500 B. megaterium,501 and A.
bisporus502) have a Glu in the vicinity in the active site, some have suggested that a His
ligand could also act as a proton acceptor if it is displaced by substrate binding.500 However,
NMR studies on a slow substrate, p-nitrophenol, indicate that all six His ligands remain
coordinated to Cu(II) when this substrate binds to met-Ty bridged by a single chloride
ion.507 Additionally, the Cys/His crosslink in fungal Ty would greatly restrict the
conformational flexibility of this CuA His ligand making it unlikely to act as a base in these
organisms.
Unique to CaOx is a large hydrophobic residue (Phe261 in I. batatas CaOx) that shields
substrate access to the CuA site (Figure 61B).498 This residue is conserved in all plant CaOx
except for two, which have a Leu at this positon.381 In Ty, a smaller hydrophobic residue
can be found at this position (Gly 204, Val 218, or Val 283 in S. castaneoglobisporus,500 B.
megaterium501 Ty, and A. bisporus,502 respectively), which increases access to the CuA site
(Figure 61A). This structural difference in CuA substrate access is consistent with the kinetic
results from various Ty variants (Section 3.2.2). A structure of a variant with mutation to a
residue in the vicinity of CuB (R209H varient in B. megaterium Ty) has also been
determined.501 This residue is located one residue after a CuB His ligand and the wt
structure with the inhibitor bound (Figure 62B vide infra) shows the position of Arg209.
Kinetic characterization of this variant shows an increase in the oxygenase/oxidase activity
ratio. The two different confirmations of Arg present in the wt structure suggest that this
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residue is more flexible than His209. Hence, His209 is believed to restrict access of
diphenols to CuB supporting the hypothesis that monophenols bind CuA while o-diphenols
bind CuB.
Three structures with inhibitors bound have also been determined. Phenylthiourea (PTU)
(Figure 62) binds the two Cu atoms in CaOx from I. batatas via a bridging sulfur atom of
the thiocarbamide while the nitrogen interacts with CuB (Figure 62A).498 The binding of
PTU increases the Cu•••Cu separation to 4.2 Å,causes a slight rotation of Phe261, and a
movement of His244 ligand to form a π-stack. The direct coordination of sulfur to the Cu in
the crystal is also consistent with the observation of a sulfur to copper CT transition at 625
nm.508 Molecular modeling of o-diphenols in this orientation favors monodentate
coordination of the substrate to CuB.498 Additionally, two inhibitors that both contain an α-
hydroxyketone, kojic acid (KA), and tropolone (TP), have been soaked in crystals of B.
megaterium501 (Figure 62B) and A. bisporus502 (Figure 62C) Ty, respectively. However,
neither inhibitor interacts directly with the Cu active site, although a direct interaction with
the metal centers is observed in solution with a similar inhibitor, mimosine (Figure 63), due
to the observation of mimosine to Cu CT transition at 425nm.509 Kojic acid binds to met-Ty
crystals from B. megaterium with the hydroxymethyl ~ 7 Å from the active site, forming
interactions with Phe197, Pro201, Asn205, and Arg209 (Figure 62B).501 Tropolone binds to
met-Ty510 from A. bisporus in a similar hydrophobic pocket 3.0–3.5 Å from the Cu active
site forming interactions with Val283, His263, and Phe264 (Figure 62C).502 However, the
presence of a pre-binding site is consistent with kinetic measurements that indicate that both
kojic acid and tropolone are slow-binding inhibitors.511,512 The most common mechanism
that results in slow-binding inhibition involves the formation of a lower affinity enzyme-
inhibitor complex that converts to a second, more stable complex.513 For these inhibitors,
the structural characterized interaction is likely the non-convalent enzyme-inhibitor complex
and the second binding site involves direct coordination to copper.
While the majority of CB-PPOs are structurally related to mollusc Hc, the crystal structure
from an insect (M. sexta) has also been determined (Figure 64).503 The tertiary structure of
insect Ty is different from either the bacteria Ty or the plant CaOx but is similar to the
structure of arthropod Hc (RMSD 1.27 Å with 41.4 % amino acid identity to L.
polyphemus309). Unique to insect Ty (relative to other CB-PPOs) is the presence of three
domains and a hetero dimer interface (between two isozymes, PPO1 and PPO2),503 similar
to the three domains in arthropod Hc and the tight dimer interface that makes up the
hexameric quaternary structure (Figure 34).309 Domain one shields the active site via Phe88
in PPO2 (Figure 64),503 which is in a similar location as the aromatic ring of PTU bound to
CaOx in I. batatas498 (Figure 62A). To activate insect Ty, PPO activating protease cleaves
within domain one of Ty at Arg51514,515 exposing a negatively charged surface, which is
believed to dimerize with the clip domain of an auxiliary factor, the serine protease
homolog.503 This interaction is hypothesized to cause a rearrangement of the tertiary
structure of insect Ty, removing Phe88 from the active site,503 however the structure of this
active form is unknown. Also within the vicinity of the active site in PPO2 is a basic residue
(Glu395), similar to Glu236 in I. batatas CaOx (shown in Figure 61B).503 However, the
structurally equivalent residues in L. polyphemus Hc309 and PPO1503 are Thr351 and
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Ser393, respectively. Kinetic studies suggest that Glu395 in PPO2 may assist in the two-
electron oxidase activity of insect Ty since Vmax for PPO2 is approximately five times larger
that PPO1.516 Yet, similar tyrosinase activity is measured in the presence of small amounts
of L-DOPA.
Interestingly, the proteolytic activation of plant and fungal CB-PPO occurs via a different
mechanism than in insect Ty. Instead of cleaving within the shielding domain, the
proteolytic cleavage of plant and fungal PPO occurs between the two domains.381 While the
structures of the two domains in plant, fungal, and mollusc Hc are predicted to be similar
from homology modeling,381,517 the two domains are believed to be connected by different
secondary structure.381 In mollusc Hc, these two domains are connected by a 24 residue α-
helix,157 while the corresponding sequence in plant and fungal CB-PPOs is predicted to be
disordered which is believed to favor proteolytic cleavage.381 Thus while both cleavage and
a tertiary structure rearrangement are necessary to activate insect Ty, the shielding domain is
directly removed by proteolytic cleavage in plant and fungal CBPPO. 381 A similar
structural rearrangement has been proposed for the detergent induced oxidase activity in
Hc.518 Molecular models from cryo-electron microscopy (8.0 Å resolution) suggest that
domain one in arthropod Hc rotates in the presence of SDS, exposing the active site to allow
substrate access.518
3.2.4. Electronic Structure—Crystallography of Hc, CaOx, and Ty reveals a common
binuclear copper active site. This common molecular structure leads to identical
spectroscopic features for both oxy and deoxy states. The spectral features of oxy and deoxy-
Hc were described in Section 3.1.4. To summarize, the spectroscopic signature of deoxy is
an intense Cu(I) preedge feature at 8984 eV in the XAS. The spectroscopic signatures of oxy
are the O22− → Cu(II) CT transitions at ~345 nm (ε ~ 20,000 M−1 cm−1) and ~580 nm (ε ~
1,000 M−1cm−1) which upon excitation with laser light leads to a low intraperoxide stretch
at 755 cm−1 that downshifts to 714 cm−1 in the 18O2 isotopologue, and a “νCu•••Cu” at 274
cm−1 in the resonance Raman spectrum, consistent with a µ-η2:η2 binuclear copper peroxo
core (Figure 65).519 Both oxy and deoxy are EPR silent. As presented above, a third EPR
silent state found during catalysis for Ty and CaOx that is not functionally relevant in Hc is
called the met or fully oxidized bicupric state.
Met-Ty and CaOx have been crystallographically characterized, and contain a water derived
bridging ligand between the Cu centers (Figure 62B and 64). XAS of met-Ty indicates the
Cu ions are in the 2+ oxidation state.520 However, met-Ty is EPR silent, indicating the
Cu(II) ions are strongly antiferromagnetically coupled. Given the coupling, the water-
derived bridge is likely a hydroxide anion, which would be a far more efficient
superexchange pathway than a water bridge and the pKa of the proton to form a µ-hydroxo
bridge is estimated to be < 5. A hydroxide anion bridge is supported by EXAFS on the met
form which indicates a 1.8 Å scatterer on Cu.508 Met-Ty does not absorb strongly in the
visible region. A ligand field band is observed at 680 nm in the absorption spectrum, and a
moderatly intense feature at ~325 nm (ε: 3500 M−1cm−1) is observed and assigned as the
OH− → Cu(II) CT transition. This feature is also present in the CD spectrum.445
Solomon et al. Page 61
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Despite the similarity between the active sites of Hc, CaOx, and Ty, substrate access to the
sites is very different as described in Section 3.2.2. Access to the site is not the only issue, as
the substrate interaction with the protein pocket at the active site of Ty and CaOx is also
essential. From Section 3.2.3, crystallographic characterization of Ty with inhibitors bound
display the inhibitor bound to the Cu directly or near the site in a secondary binding site.
The structure of CaOx solved with the inhibitor phenylthiourea bound to the active-site in a
bridging configuration between the Cu ions (Figure 62A). All other information regarding
the interaction of the active-site with substrate and substrate analogs comes from
spectroscopy. In a key experiment, the substrate analog mimosine was used as a probe of
substrate binding in met-Ty. Upon addition of mimosine, an absorption feature was observed
at 425 nm, which was assigned as a mimosine → Cu(II) charge transfer transition (Figure
66).509 The detection of a CT transition is significant, as it requires orbital overlap between
the donor phenolate and the acceptor Cu, indicating that mimosine is bound directly to Cu.
Further information comes from the EXAFS, wherein a slight increase in intensity of the
dipole forbidden 1s → 3d transition was observed upon binding mimosine. This increase is
consistent with a distortion of the tetragonal environment of the Cu.520
As a detailed spectral probe of mimosine binding to the active site of Ty, a half-met
derivitive was created in an analogous manner to that for Hc (See Section 3.1.4). The half-
met derivative consists of a Cu(I)Cu(II) mixed-valent site with an overall S = ½ ground
state. EPR spectroscopy of half-met Ty reveals a localized mixed-valent state, displaying a
normal Cu(II) type spectrum. Upon addition of mimosine to half-met Ty, significant changes
occur in the EPR spectrum (Figure 67).509 Specifically, the EPR spectrum becomes more
rhombic with a splitting of g⊥, the hyperfine coupling at gz decreases, and a large hyperfine
coupling is observed on gx (gz = 2.290, gx = 2.115, gy = 2.023, Az = 111.3 × 10−4 cm−1, Ax =
15.0 × 10−4 cm−1, and Ay = 72.0 × 10−4 cm−1). Taken together, these spectral changes
require a substantial amount of dz2 mixing into the dx2-y2 ground state. This mixing would
occur if a trigonal bipyramidal structural perturbation accompanies the binding of mimosine
to copper (Figure 7B).
In a similar manner, the binding of aliphatic and aromatic carboxylates was also investigated
with the half-met Ty derivative.14 Whereas binding of aliphatic carboxylates produced no
significant change in the EPR spectrum, binding of aryl carboxylates that are competitive
inhibitors results in EPR spectral changes that are analogous to those observed in the
mimosine adduct (Figure 67), which indicate a similar trigonal bipyramidal distortion. The
carboxylate binding is also accompanied by the appearance of a positive CD transition at
10,000 cm−1, the origin of which is a ligand field transition that gains intensity and lowers in
energy further supporting a distortion of the Cu towards a trigonal bipyramidal geometry.
Thus, substrate analogs bind directly to Cu, and when these contain aromatic substituents
there is an additional interaction with the protein pocket that stabilizes a trigonal
bipyramidal distortion of the site along the reaction coordinate. From the differences in
binding constants (150 M−1 for alkyl versus 1000 M−1 for aryl substrates) the interaction
with the pocket is worth −1.3 kcal/mol. Two candidates for the origin of this stabilization
are: 1) π-π interaction with a copper bound histidine or 2) interaction with the strictly
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conserved Asn205 (Figure 62). However, significant efforts are required to develop an
understanding of this protein pocket effect.
3.2.5. Mechanism
3.2.5.1 Diphenolase: The mechanism of Ty is described by two interpenetrating catalytic
cycles that comprise monophenolase and diphenolase activity (Figure 68). The diphenolase
cycle (the outer cycle in Figure 68) has a reductive and an oxidative phase and requires two
substrates and one dioxygen for each turnover. In the reductive phase, the 1,2-catechol binds
to met to generate met-D. The catechol substrate reduces the Cu(II) ions to Cu(I)
concomitant with release of the quinone to generate deoxy. In the oxidative phase, dioxygen
binds to deoxy to generate oxy, which subsequently reacts with 1,2-catechol to generate oxy-
D, finally releasing quinone and water to generate met. In essence, the enzyme is catalyzing
the four-electron reduction of dioxygen to water in discrete 2 electron steps using the
substrate catechol as a two electron donor without the release of hydrogen peroxide.
The structural requirements for diphenolase activity are less than those required for the
monophenolase activity, as catechol oxidases are unable to perform monophenolase
reactions. Nonetheless, information regarding the structural requirements of the diphenolase
cycle is emerging. In the oxidative phase, oxy-D state has traditionally been drawn with
catechol bridging the two Cu centers. However, in oxy, the Cu ions are efficiently
antiferromagnetically coupled through the peroxide bridge, and thus the twoelectron
oxidation of the catechol could proceed via coordination to a single copper. Support for this
possibility comes from mechanistic studies on Ty variants (see Table 15), which
distinguished effects associated with residues near the individual Cu ions. In these studies,
mutations in the vicinity of CuA resulted in no effect on the catechol oxidase activity,
whereas mutations to residues around CuB affected this activity. Taken together, these
mutational studies suggest that the protein pocket is exerting some influence on the
diphenolase reaction, and that binding to a single metal site should be considered.
3.2.5.2 Monophenolase: The monophenolase cycle (inner cycle of Figure 68) requires one
phenol substrate and one dioxygen per turnover, and generates one quinone product and one
water. The cycle begins with the addition of dioxygen to deoxy to generate oxy. Next,
reaction of oxy with a phenol is believed to generate the enzyme-oxygen-phenol ternary
complex oxy-T, which is the key intermediate in the catalytic cycle, although this has not yet
been observed.521 Interpretations of mutagenesis studies favor coordination of the phenol to
CuA since mutations of residues in the vicinity of CuA had an effect on the Ty activity (see
Section 3.2.2). It is generally understood that the phenol substrates coordinate directly to a
copper, rather then docking into the protein in the vicinity of the Cu2O2 core (as found for
example in cytochrome P450)522 based on the spectral features observed upon addition of
substrate analogs (Section 3.2.4) to met and half-met Ty. These spectral features require that
the phenol-analogs coordinate directly to the Cu. Nonetheless, direct coordination of phenol
to Cu in oxy-Tyr has not been demonstrated and model studies of Karlin and coworkers
(vide infra) show that monoxygenation can occur without direct substrate coordination.
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The intimate details of the attack of oxygen on the ring subsequent to oxy-T has been the
subject of intense research efforts that have spanned decades. The consensus overall
mechanism of the hydroxylation of the phenol ring is via EAS based on: 1) the negative
slope of the Hammet parameter (ρ), which indicates positive charge buildup in the
intermediate (Section 3.2.2), 2) correlation to the EAS mechanism of monoxygenation of
phenols by cleaved mollusc Hc that proceeds with a similar Hammet parameter and an
inverse 2H isotope effect, and 3) correlation to functional model studies (vide infra) which
have been conclusively demonstrated to proceed via EAS. The remaining issue pertains to
the nature of the Cu2O2 core in the ternary complex oxy-T, an issue raised based on
observations in model studies.
Tolman and coworkers discovered that the reaction of dioxygen with certain Cu(I) model
complexes resulted in a product wherein the O—O bond was broken to generate a bis-µ-oxo
Cu2(O)2 core (Figure 69).127 X-ray diffraction studies demonstrated a long O•••O (2.287 Å)
and a short Cu•••Cu distance (2.794 Å). This bis-µ-oxo core was in equilibrium with the
“side-on” peroxo Cu2(µ-η2:η2-O2) isomer, an equilibrium that was sensitive to
environmental factors including solvent and anions, indicating that these two species were
necessarily close in relative free energy for the ligand systems studied. The isomerization
from side-on peroxo to bis-µ-oxo is accompanied by significant spectral changes (Figure
70), which have facilitated an in depth study of the electronic structure change associated
with this isomerization. An essential detail is that the pre-edge feature at 8979 eV in the
side-on peroxo species that is characteristic of Cu(II) (see Section 2.2.5) shifts up in energy
by 1.9 eV indicating that the oxidation state of the Cu has increased from Cu(II) to Cu(III).
Thus, two electrons from Cu break the peroxo bond. The process can be understood from the
correlation of the molecular orbitals upon isomerization (Figure 71).129 As described in
Section 3.1.4, the side-on bridged peroxide species on the left has a peroxo group in which
its σ* is accepting electron density from Cu dx2-y2 HOMO (i.e. backbonding). As the O—O
bond is lengthened from 1.4 Å to 2.8 Å, the σ* of the peroxo is decreased in energy and
charge flows from the Cu(II) into this σ* orbital to cleave the O—O bond. In the bis-µ-oxo
species on the right of Figure 69, complete transfer of a pair of electrons (one from each
Cu(II)) has taken place leaving two µ-oxo groups and two Cu(III). This change in electronic
structure leads to two additional diagnostic spectral changes. A new intense charge transfer
transition appears at lower energy (400 nm in the bis-µ-oxo compared to 350 nm in the side-
on peroxo) corresponding to an oxo → Cu(III) CT transition to the new LUMO on the
Cu(III)s. Laser excitation into this band leads to a different resonance Raman spectrum,
where the O—O stretch of the side-on peroxide is replaced by an intense peak at ~600 cm−1,
assigned as the symmetric Cu2O2 core expansion (Figure 70 bottom). These side-on
peroxide and bis-µ-oxo structures provide distinct frontier molecular orbitals (FMOs), which
are low lying unoccupied orbitals with significant oxygen character for good overlap with
substrate, for electrophilic attack on the π density of the substrate ring. In a side-on peroxo
case, the LUMO is Cu(II) based with significant O22− π*σ character and in the bis-µ-oxo
case, the Cu(III) LUMO has significant (O2−)2 σ* character (Figure 71). The existence of
this equilibrium in model studies raises the possibility of a bis-µ-oxo participating in Ty
chemistry upon substrate coordination to the Cu in oxy-T in Figure 68.
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Indeed, chemical precedence for this hypothesis has been generated by Stack and coworkers
using the dbed (N,N-di-tert-butylethylenediamine) ligand framework (Figure 72).479 From
resonance Raman spectra, the precursor complex is a µ-η2:η2 peroxo [dbedCuIII]2(O2) (vo-o
= 730 cm−1); reaction with phenolate at cryogenic temperatures (−120°C) results in
phenolate binding which drives the formation of a discrete intermediate {[dbedCuOPh]-
(O)2-[dbedCu]}, wherein the O—O bond is cleaved, resulting in a bis-µ-oxo core, based on
the loss of the 730 cm−1 O—O feature of the side-on peroxide with concomitant growth of
the 600 cm−1 feature of a bis-µ-oxo core (Figure 72 left). Upon warming, the phenol is
hydroxylated; a process that has been attributed as an EAS mechanism based on its inverse
isotope dependence (kH/kD = 0.9) and phenol substituent effects (σ+ correlation, ρ = 1.4).
Monitoring this process by resonance Raman spectroscopy indicates the loss of bis-µ-oxo at
600 cm−1 and the growth of the carbonyl stretch of the oxygenated product, demonstrating
that the bis-µ-oxo is directly responsible for oxygenation of the ring (Figure 72 right).
DFT calculations correlated to the spectral data have been performed to quantitatively assess
the reaction coordinate.523 The phenolate binds axially to the side-on peroxo core, and
undergoes a rotation into the equatorial plane, which drives the formation of the bis-µ-oxo
isomer. This orientation is suitable for proximal attack on the ortho position of the ring.
Inspection of this process reveals that the frontier molecular orbital (the LUMO) that is
available for EAS in bis-µ-oxo complexes is the antisymmetric combination of the Cu
3dx2-y2 orbital which contains the oxo σ* character (Figure 73 left). Two electrons from the
ring are transferred to reduce the Cu(III) to Cu(II), forming the EAS sigma complex (Figure
74). Finally, the reaction trajectory is completed by deprotonation of the ring to yield a
bidentate bridged catecholate species. Taken together, these studies demonstrate that it is
feasible for a bis-µ-oxo to be the reactive intermediate during tyrosinase catalysis, formed by
coordination of phenolate to the Cu with substrate rotation into the equatorial plane.
Earlier, Karlin and coworkers demonstrated that Cu-peroxo adducts were also competent for
EAS to yield phenols.524–526 They synthesized a scaffold based on a m-xylyl bridge to
generate the µ-η2:η2 peroxo complex [Cu2(NO2-XYL)O2]+ (Figure 75). This complex, upon
warming, hydroxylates the xylyl tether. The rate of oxidation is dependent on the
substituents on the tether, which correlates to the Hammett σ+ parameter with a ρ value of ~
2.1. When the reactive ring carbon position is methylated, an NIH shift was observed.525
These observations strongly indicate an EAS mechanism. The reaction has been monitored
spectroscopically by resonance Raman (a 750 cm−1 O—O stretch is observed in this µ-η2:η2
peroxo; no 600 cm−1 stretch of a bis-µ-oxo is present, therefore there is no evidence for
involvement of this species along the reaction), and as shown in Figure 76, the
disappearance of the peroxo structure was coupled to the growth of C-O stretch of the
phenolate product. These studies indicated that the µ-η2:η2 peroxo core is also competent for
EAS of exogenous substrates. Calculations were performed on this model system to evaluate
the reaction coordinate. The side-on peroxo attacks the ring to generate an sp3 hybridized
carbon, followed by electron transfer from the ring directly in the peroxo. Importantly, the
transfer of the electrons proceeds without intermediacy of a bis-µ-oxo along the reaction
coordinate.
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Given these two model systems that demonstrate both bis-µ-oxo and side-on peroxo cores
are competent for the EAS of phenols, the timely question is which does Nature utilize as
the active oxidant in Ty and what are the factors that control this selection. The lack of a
trapped intermediate state with phenol bound to the oxy core has motivated theoretical
investigation into the likelihood of the peroxo/bis-µ-oxo equilibrium in Ty. DFT studies
deemed the bis-µ-oxo to be prohibitively uphill from the µ-η2:η2, and thus an unlikely
intermediate.131,527,528 However, different functionals suggest this possibility is feasible. It
is useful to consider the structural factors required to direct the core towards peroxo or bis-µ-
oxo descriptions, and the impact of the protein pocket on structure. One factor that derived
from the studies on the binuclear copper complexes in Figure 74 is the rotation of the
phenolate donor ligand into the equatorial plane as being essential for bis-µ-oxo formation.
It could be envisioned that the protein pocket controls the orientation of the phenol relative
to the Cu2O2 core. In this context, two observations provide insight. First, in the binding of
aliphatic versus aromatic carboxylates to met-Ty it was found that substrate binding is
favorable in the aromatic case by an additional ~1.5 kcal/mol due to interactions of the
phenol ring with the active site pocket. Second, the EPR spectrum of mimosine bound half-
met Ty (Figure 67) showed a significant trigonal bipyramidal distortion about the copper,
indicative of the active-site influence on the orientation of the phenol. These observations
suggest that the pocket influences the orientation of the phenol prior to and during
electrophilic attack and the key issue is whether a major rearrangement of the substrate
occurs before the transition state of the EAS.
To complete the monophenolase catalytic cycle, the face of the phenol ring rotates towards
the oxygen of the core to orient the ortho carbon into position for electrophillic attack.
During the attack, the electrons are transferred to the dioxygen (or to the Cu’s directly in the
case of a bis-µ-oxo oxidant) and the C—O bond is formed in a sigma complex. The proton is
removed from the ring to the distal O to yield an orthodiphenolate that bridges the Cu(II)
ions, perhaps asymmetrically as in Figure 74. Further protonation of the resulting µ-OH to
H2O leads to the reduction of the Cu ions and a release of quinone, thus reforming the deoxy
state.
A final observation of the hydroxylation of phenols by synthetic complexes is that the
hydroxylation occurs when phenolate,479,529 rather then phenol,530,531 is reacted with the
Cu2O2 cores. Reaction of the synthetic copper dimers with phenol does not result in the
hydroxylation product, but instead results in the radical coupling products, suggestive of H•
abstraction competency of Cu2O2 cores in addition to EAS.531 The relevance of this
synthetic observation for tyrosinase catalysis is unclear but suggests an intimate relationship
between protons and mechanism in Ty catalysis. The identity of the associated active site
base has been the subject of investigation, with three possible candidates emerging. First, it
has been proposed that the bridging peroxo itself is basic, a hypothesis that is contradicted
by model studies wherein side-on peroxo adducts have been shown to be electrophilic,
rather then nucleophilic. Second, it has been proposed that a Cu bound His could dissociate
and be the destination of the proton. However it is noteworthy that the His believed to be
involved is in fact crosslinked to a nearby Cys residue in nearly a third of the Ty homologs,
and a crosslink would be expected to rigidify this residue. In addition, the dissociation of His
from the Cu is expected to be a thermodynamically uphill process. Finally, a third possible
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base that is somewhat underexplored in the literature is a conserved glutamate in close
proximity to the Cu2O2 core (see Section 3.2.3). Regardless of the identity of the base, the
issue of proton movement is important, based on the observation of a solvent 2H isotope
effect (Section 3.2.2).
3.2.5.3 Hydroxyanilinase: Reaction of o-aminophenol with Ty and CaOx yields the two
electron oxidation product, o-iminoquinone, in a reaction analogous to diphenol oxidation
by CaOx. Recently it was found that a fourth member of the coupled binuclear copper
family (NspF) catalyzes an alternative reaction, the oxygenation of o-aminophenol to
nitrosophenol, reactivity coined hydroxyanilinase activity. Comparison of the
hydroxyanilinase versus CaOx activities in NspF versus a close homolog GriF and Ty
revealed that the difference in selectivity leading to the oxygenated nitrosophenol product
was a result of differences in the oxygenase (hydroxyanilinase) activity rather than
differences in the oxidase (CaOx) activity (see Section 3.2.2).497 This observation was
suggestive of protein secondary coordination impacts on the reaction landscape rather than
intrinsic differences in the reactivity of the Cu2O2 cores, which appear indistinguishable
spectroscopically. The reaction trajectories were evaluated by DFT and further supported
this secondary coordination environment control hypothesis, in that the structural
requirements for the hydroxyanilinase reaction differed from that of either oxygenation of
monophenols or oxidation of diphenols (Figure 77). Specifically, the transition state for
oxygenation of o-aminophenols by an electrophilic attack mechanism required a six member
ring, whereas oxygenation of monophenols requires a five member ring. Thus, the substrate
orientation is significantly different in the transition state, which would be expected to be a
major factor in controlling the selectivity of the reaction as the protein pocket must
accommodate this different in substrate orientation. Details regarding which specific
residues direct the reaction landscape require a crystal structure of NspF, but the coupled
binuclear Cu family of enzymes provide an important series where the protein pocket
different types of reactivity utilizing equivalent Cu2O2 active sites.
3.3 O2 Activation for H-atom abstraction: Non-coupled Binuclear Copper Enzymes (role of
exchange coupling in reactivity)
3.3.1 Enzymology—In addition to the coupled binuclear copper enzymes Tyrosinase,
Catechol Oxidase and NspF, there exists another class of binuclear copper proteins where
the coppers are at a distance of ~11 Å with no bridging ligands such that they do not
electronically couple. These enzymes, the non-coupled binuclear copper enzymes,
accomplish activated C-H bond hydroxylation for the synthesis of physiologically important
neurotransmitters and hormones.532 Three enzymes comprise this class: the well studied
eukaryotic proteins dopamine β-monooxygenase (DβM; EC 1.14.17.1) and peptidylglycine
α-hydroxylating monooxygenase (PHM; EC 1.14.17.3) and the recently identified insect
tyramine β-monooxygenase (TβM).533,534
The non-coupled binuclear copper enzymes catalyze the regio- and stereospecific
hydroxylation of secondary C-H bonds (Figure 78). This hydroxylation is a two-electron
oxidation, which is coupled to the reduction of dioxygen to yield one H2O and the
incorporation of the second oxygen into the substrate therefore these enzymes are classified
Solomon et al. Page 67
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
as monooxygenases. Two electrons come from the substrate and the second two electrons
come from the oxidation of two equivalents of ascorbate to semidehydroascorbate.535–537
These enzymes have two coppers per subunit. On the basis of structural538 and
spectroscopic539 studies (vide infra), the coppers have different coordination environments,
either CuH (or CuA) and CuM (or CuB). CuM is the site where dioxygen is activated and
substrate binding occurs while CuH serves as an electron transfer site.540
DβM, a glycoprotein found in mammalian neurosecretory vesicles of the adrenal gland,
carries out the catalytic conversation of dopamine to norepinephrine (Figure 78) in the
catecholamine biosynthetic pathway.541 DβM activity is physiologically critical for the
regulation of dopamine and epinephrine. DβM genetic deficiency in humans results in
patients being unable to synthesize norepinephrine and epinephrine resulting in severe
hypotension.542 Additionally, in mouse studies it has been found that knocking out the DβM
gene results in fetal death in utero, verifying that DβM is also essential for fetal
development.543 Inhibitors have been developed for DβM as antihypertensive agents in
effort to limit the production of norepenephrine. The first compound to reach clinical testing
was fusaric acid, 544 but most modern inhibitors are based on an imidazole-2-thione scaffold
and are significantly more potent.545 DβM is also capable of carrying out hydroxylation
chemistry on a series of phenylethylamine compounds similar to dopamine.546 Interestingly,
the presence or absence of the phenol –OH group does not impact turnover suggesting that
aryl alcohol group does not constructively interact with the protein (Figure 78).547 DβM is
also capable of catalyzing various non-native oxidation reactions including sulfoxidation,548
selenoxidation549 and epoxidation550 of olefins. The protein has been isolated from a
number of mammalian sources, most studied of which are bovine551 and rat552. The protein
exists in both soluble553 and membrane-bound554 forms. Soluble DβM can be either a dimer
or tetramer consisting of two and four identical 73-kDa monomeric subunits,
respectively.555 The membranebound enzyme is exclusively a tetramer and is composed of
two soluble-like subunits of 73-kDa and two other distinct 77-kDa subunits. It is thought
that this protein exists in equilibrium between the membrane-bound and soluble forms
where the soluble form is released into the blood and cerebrospinal fluid.555
TβM catalyses the hydroxylation of tyramine to octopamine (Figure 78), a crucial
neurotransmitter that is responsible for a wide variety of physiological functions including
neuromuscular transmission, behavioral development and ovulation556,557. TβM is a
homologue of DβM exhibiting 39% and 55% sequence identity and similarity,
respectively.558 It has been isolated from Lobster559, Moth560 and Drosophila561, but little
is understood about the enzyme in vivo. Recombinant TβM (rTβM), from Drosophila, has
been expressed and used in site-directed mutagenesis studies (vide infra). rTβM exists in
solution primarily as a ~69 kDa monomer with small amounts of dimer.561
PHM exhibits 32% sequence identity with DβM and is one component in the bifunctional
membrane-bound enzyme peptidylglycine α-amidating monooxygenase (PAM), which
facilitates hydrolytic amidation of peptide hormones.562,563 PAM is capable of carrying out
alternative monooxygenase reactions including sulphoxidation, amine N-dealkylation and O-
dealkylation.564 Peptide amidation occurs in two steps. The first is accomplished by PHM
that hydroxylates the α-carbon of a C-terminal glycine-extended peptide (Figure 78). This is
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followed by hydrolytic amidation of the geminal aminoalcohol by peptidyl-α-
hydroxylglycine-α-amidating lyase (PAL) yielding the activated N-terminal peptide
hormone. This process is crucial in the activation of hormones since over half of all peptide
hormones must be α-amidated to be bioactive.565 PAM has been isolated from a number of
mammalian sources including bovine563, mouse566 and rat567 and is found in Drosophila568.
Deletion of the PAM gene in Drosophila results in the absence of amidated peptides and
leads to late embryo or early larva death.569 Additionally, PAM knockout mice died
midgestation consistent with the amidated peptides being crucial for fetal development.570
Rat PAM (~120 kDa) undergos endoproteolytic cleavage to give a soluble PHM domain of
45 kDa and a membrane-associated (70 kDa) or soluble (50 kDa) PAL domain where each
domain was catalytically active in their respective reactions.571 This recombinant form has
been used in site-directed mutagenesis experiments (vide infra). An important development
in the study of this enzyme came from the development of a recombinant form of PAM from
rat. A 35 kDa protein was isolated, exhibiting only PHM activity, denoted as the PHM
catalytic core (PHMcc).572 This is the predominant form used in kinetic, crystallographic
and spectroscopic studies (vide infra).
As stated above, these proteins contain two copper ions per subunit in different coordination
environments, which are suggested to have different roles in catalysis. Blackburn has
succeeded in producing a ‘half-apo’ form of PHM.573 This was accomplished by using CN−
to remove Cu from the protein with CO bound selectively to CuM (vide infra). For DβM the
tetrameric form can exist as either an 8 Cu or 4 Cu form, where the 4 Cu form is thought to
contain only CuM.574 Whether this form is catalytically active has been the subject of
debate. Another human protein was found to exhibit high sequence similarity to these
enzymes and classified as a member of this family. Named monooxygenase-X (MOX), this
enzyme is the least well-understood member as its chemistry and function are still unknown.
MOX is not secreted, as is DβM, but membrane bound in the endoplasmic reticulum of both
endocrine and non-endrocrine cells and highly expressed in the salivary gland and
ovaries. 575
Together, these enzymes exhibit distinct physiological functions but are complimentary in
their stereospecific hydroxylation chemistry. The following sections deal with the
similarities and differences in reactivity of these proteins and how they relate to the
mechanism of substrate hydroxylation and dioxygen activation by the non-coupled binuclear
copper sites. We then correlate their reactivity to that of the coupled binuclear Cu enzymes
and consider the role of exchange coupling in determining reactivity.
3.3.2 Kinetics—The enzymes in this group exhibit similar kinetics and therefore
equivalent mechanisms.532 Generally, two molecules of ascorbate reduce the coppers of the
fully oxidized resting state in a ping-pong mechanism576 (vide infra)–giving the reduced
enzyme and two molecules of semidehydroascorbate. Substrate and dioxygen then bind to
the reduced enzyme yielding a ternary complex577 from which dioxygen activation and
substrate hydroxylation occur to give product and oxidized enzyme.
3.3.2.1 Steady State Kinetics: Extensive steady-state kinetic studies533, including isotope
effects, have been performed on all three of the enzymes in this group. Under conditions of
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excess ascorbate where the reduction of the enzyme is facile, the two steady-state
parameters are the catalytic efficiency (kcat/Km), which accounts for all reversible steps
leading to the first irreversible step (i.e., the C-H abstraction step) and turnover number
(kcat), which includes all steps after the first irreversible step leading to product and resting
enzyme.532 The perturbation of these kinetic parameters is important for the discussion of
isotope effects later in this section.
These proteins turnover in the presence of substrate, ascorbate and dioxygen. Dioxygen
dependent steady-state kinetics for these enzymes are comparable where all enzymes exhibit
Km(O2) ~ 50–500 µM.534,580,581 The dependencies on substrate will be discussed in terms
of the most studied substrates of the respective enzymes. The substrate dependent steady-
state parameters are enumerated in Table 18. It is found that these enzymes have comparable
kcat and Km values. It should be noted that hippuric acid is the smallest substrate and most
versatile for isotope substitution for PHM (vide infra), however, many glycine terminal
peptides are found to be catalytic for PHM (e.g., Tyr-Val-Gly).581 These extended peptides
bind tighter to PHM (Km ~ 10 µM), which may be due to constructive protein-substrate
interactions absent in hippuric acid. Additionally, the substrate dependence on enzyme
activity is found to exhibit Michalis-Menton steady-state kinetics for DβM and PHM, while
TβM is inhibited (Ki = 3.5 mM) by substrate at tyramine concentrations greater than 250
µM.534 It is suggested for this enzyme that tyramine binds to the oxidized state since enzyme
inhibition diminishes with increasing ascorbate, generating more reduced enzyme. This is
also supported by an increase in inhibition with additional dioxygen, generating more
oxidized enzyme.534
These enzymes exhibit similar Km values for ascorbate and a ping-pong mechanism for
enzyme reduction. PHM exhibits an apparent ascorbate Km(asc) = 0.25 mM, where
increasing the ascorbate concentration leads to an increase in both kcat and Km for substrate
(Tyr-Val-Gly).582 Therefore, the rate of enzyme reduction increases the rate of substrate
turnover. Interestingly, no ascorbate is found to be bound in the reported crystal structures
for PHM, where reductant is in significant excess (vide infra)125,583,584. In contrast to PHM,
DβM turnover velocities decrease with increasing ascorbate fitting to negative cooperatively
with a Hill coefficient in the range of 0.15 – 0.30.585 This is reflected in the increase of
apparent Km(asc) of 0.05 – 0.10 mM at high ascorbate concentration to > 10 mM under
limiting reductant concentration. Due to the substrate inhibition of TβM, only an estimated
Km(asc) ≥ 16 mM was obtained.534 Additionally, it was found that kcat/Km(asc) decreases
with added tyramine, which is not observed in the other two enzymes. These results, along
with the substrate inhibition, indicate that tyramine competes with ascorbate for binding to
the oxidized enzyme. Therefore, an ascorbate binding site can be invoked for TβM where no
such a binding site has been found for PHM and DβM.
Significant mechanistic insight has come from the substrate primary isotope effect on kcat
and Vmax/Km, (Table 19). The isotopic perturbations do not significantly alter kcat indicating
that C-H activation is not rate limiting.534,586,587 Furthermore, dioxygen 18O kinetic isotope
effects on kcat/Km values (table 20) values are consistent with dioxygen reduction also not
being rate limiting since they are below the maximum equilibrium isotope effect for the
formation of a superoxo (1.0339). 588 Interestingly, with deuteron-substrate, the
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measured 18O isotope effect for both PHM and DβM increases implying that changes in the
dioxygen bond order are coupled reversibly to the C-H activation step.578,587 If dioxygen
activation were irreversible, the magnitude of the 18O isotope effect would be independent
of substrate deuteration. In other words, O-O bond cleavage can only occur after H-atom
abstraction (vide infra).
Since the isotope perturbations do not significantly impact turnover, in contrast to the
expected behavior for an enzymatic process where C-H and/or O-O activation would be rate
limiting, dissociation of product has been proposed as the likely rate determining process in
catalysis. This is consistent with the fact that enzyme reduction and reoxidation can be ruled
out as rate determining based on single turnover studies, where the latter process includes
the intramolecular electron transfer step (vide infra). 540,576
3.3.2.2 Dioxygen and Substrate Order: To determine the order of the reaction of substrate
and dioxygen in catalysis, two general methods were employed. The first comes from the
interpretation of the intercepts of reciprocal (1/v versus 1/[O2]) plots where varying amounts
of reactants change the intercepts depending on the formation of the ternary complex589.
The other, developed by Klinman measured the substrate primary isotope effect on kcat/
Km(substrate) as a function of dioxygen concentration.590 Since this parameter contains all
rates up to the first irreversible step (k5 in Figure 79), which is the step that exhibits the
isotope effect, the effect of varying dioxygen on the isotope effect will reflect the binding of
dioxygen to the ternary complex relative to the labeled substrate.591
For PHM, the substrate and dioxygen binding order was found to indicate an equilibrium
ordered mechanism (Figure 79 top).578 The intercepts of the initial velocity measurements in
the plot of 1/v versus 1/[O2] showed no variance with substrate consistent with a mechanism
where dioxygen binds to the enzyme after substrate. The isotope effect on kcat/Km(hippuric
acid) was invariant with respect to dioxygen (and kcat/Km(O2) showed no variation with
hippuric acid). This was also consistent with an equilibrium ordered mechanism where the
dissociation of substrate (k2) is faster than that of dioxygen binding (k3[O2]). 578
Alternatively, the mechanism was found to be random for DβM and TβM (Figure 79
bottom). 534,577 For both proteins, the plots of 1/v versus 1/[O2] intercept change with
varying substrate concentrations all to the left of the 1/v axis, consistent with either substrate
or dioxygen having the ability to bind first to the reduced enzyme Additionally, the isotope
effect on kcat/Km(substrate) (2H for tyramine with TβM and 3H for dopamine with DβM)
varies with dioxygen concentration and remains above 1.0 at maximal O2 concentration.590
Since the isotope effect remains above 1.0, it is implied that both dioxygen and substrate are
capable of dissociating from the ternary complex, consistent with a random mechanism.
3.3.2.3 C-H hydroxylation: As mentioned above, the primary isotope effect on kcat is
minimal and implies that C-H hydroxylation is not rate limiting in catalysis. However, it is
still possible to obtain the ‘intrinsic’ kinetic isotope (Dk) effect for this step in a method
developed by Northrop using the tritium and deuterium isotope effects on V/K under
identical conditions (equation 36) 591,593
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[36]
The intrinsic isotope effects for PHM and DβM (table 21) are remarkably similar and imply
that the complex for C-H activation is identical in both enzymes. Using this intrinsic primary
isotope effect, the microscopic rate for C-H activation can be modeled and the values for
both enzymes are comparable. The intrinsic secondary deutero α-isotope effects are also
found to be essentially identical.533 Additionally, using the temperature dependence on the
intrinsic isotope effect (Dk) in PHM afforded an estimation of the ΔH‡ for C-H cleavage to
be ~ 13 kcal/mol and a ΔG‡ can be calculated from transition state theory for C-H cleavage
to be ~ 14 kcal/mol.594 Using kcat for these overall reaction conditions, an activation free
energy of ~ 17 kcal/mol for the overall rate determining process (likely product release).
3.3.2.4 Dioxygen and Substrate Coupling: The kinetic relationship between substrate
oxidation and dioxygen reduction came from a study on DβM where substrates with a ~103
fold range of kcat/Km all showed ~1.0 dioxygen consumption per product formed.595 This
establishes that dioxygen and substrate are ‘tightly coupled’ in catalysis and suggests that no
partially reduced dioxygen species (e.g., hydrogen peroxide) are ‘leaked’ during turnover,
which would result in values < 1.0. It was argued on this basis that a Cu-hydroperoxo
species is unlikely the primary oxidant in catalysis. This is strongly supported by electronic
characterization of a Cu-hydroperoxo model complex where the results clearly indicate that
this species is not activated towards C-H abstraction (vide infra).596,597
3.3.2.5 Single Turnover: Further insight concerning the mechanism of these enzymes came
from single turnover experiments on DβM.540,576 Kinetics on the reduction of the copper
sites in DβM came from EPR freeze quench studies. Reduction of DβM fit to a first order
rate of 250 s−1. Steady state measurements at these conditions (16 s−1), and those noted
previously are an order of magnitude slower and therefore enzyme reduction is not rate
limiting in catalysis.576
In order to examine the kinetics of enzyme reoxidation, DβM was stoichiometrically
reduced with ascorbate and then combined with tyramine substrate. It is noted that pre-
reduced enzyme does reoxidize in air, but on the minute time scale.540 It was measured by
EPR that in the presence of substrate the enzyme reoxidizes at a maximal rate of 82 s−1.540
This confirms two aspects of the oxidation of the enzyme and substrate hydroxylation: (1) in
the absence of substrate the enzyme reacts with dioxygen nearly 1000-fold slower
confirming that substrate accelerates dioxygen reduction, and (2) that enzyme reoxidation is
also not rate limiting in catalysis (Table 18).
3.3.2.6 Possible Cu-O2 species: The species responsible for C-H abstraction has been a
debated topic for many years. To this end, the aforementioned kinetics studies are able to
eliminate a few possibilities. The first intermediate proposed to perform this reaction was a
Cu(II)-hydroperoxo species.540,580 From the kinetics on dioxygen-substrate coupling, the
argument that no decoupling of dioxygen reduction and product formation has provided
evidence that a Cu(II)-hydroperoxo is likely not the primary oxidant.595 Furthermore, a
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Cu(II)-hydroperoxo species has been studied experimentally in a model complex and is not
activated towards C-H abstraction.596 Another relevant intermediate discussed recently is a
[Cu-O]+ oxyl species.598,599 From O-O cleavage bond energetics, it is expected that the
formation of this is very energetically unfavorable and likely catalytically inaccessible.
Furthermore, the 18O isotope effects increase with deutro-substrate indicating that dioxygen
reduction is coupled to C-H activation.578,587 Therefore, the O-O bond cannot be cleaved
prior to C-H activation. The intermediate that best fits the kinetic and experimental models
(vide infra) is a Cu-superoxo species.533,597
In summary, kinetic studies mostly by Klinman533 have been paramount in the development
of the mechanism of the non-coupled binuclear copper enzymes. Overall, the kinetics
derived mechanism (Figure 80) of these enzymes involves initial reduction (kred) of the
resting enzyme by ascorbate to give the reduced state. This then binds substrate and
dioxygen, random in DβM and TβM and equilibrium ordered in PHM, to give the ternary
complex. From here the dioxygen bond is activated to form a putative Cu(II)-O2·− (vide
infra) and is coupled to the abstraction of a hydrogen atom from substrate (kC-H).595,600 The
following step is either (pathway 1) hydroxyl transfer to form product (i.e. O-O bond
homolysis) followed by electron transfer from CuH to CuM (ket) (vide infra) or (pathway 2)
electron transfer that occurs with protonation and heterolytic O-O cleavage followed by
substrate radical coupling to a Cu-O. radical species. The pathway for the electron transfer
has yet to be determined and has been subject of debate (vide infra). Both mechanistic
pathways yield the oxidized enzyme with substrate still bound, to CuM in pathway 2 versus
protein bound in pathway 1. The dissociation from the enzyme (koff) is suggested to be the
rate determining process in catalysis. This mechanism will be further elaborated with
information from spectroscopic and electronic structure studies (section 3.3.4 and 3.3.5).
From a physiological standpoint, a rate determining product release implies that these
proteins function not only to produce their respective biological products but also in product
regulation.
3.3.3 Structure—Important advances in the understanding of these enzymes came with
the determination of various crystal structures of PHMcc by Amzel and coworkers and are
summarized in Table 22. Due to the high sequence identity among these enzymes, the
structure of PHMcc has been interpreted generally for all of the proteins in this class.
The overall structure of PHMcc has two domains consisting of about 150 residues each.538
The protein secondary structure is mostly composed of β-strands (Figure 81 top) with one
copper cofactor per domain. The two coppers are separated at a distance ~ 11 Å, which is
consistent with the spectral features indicating no magnetic coupling (Figure 81 bottom).
Interestingly, both coppers are solvent exposed where a water filled cleft separates the metal
sites and provides easy access for substrate to the active site. The coppers are differentiated
on the basis of their protein derived coordinating ligands. CuH is bound by three histidines
(107, 108 and 172) while the other copper, CuM, is bound by two histidines (242 and 244)
and one methionine (314) (Figure 81 bottom). Both oxidized538 and reduced584 forms of
PHMcc have been crystallized and show changes at the copper centers. In the oxidized form,
CuM is also coordinated by a solvent derived aquo ligand, presumably hydroxo, which is
absent in the reduced form. CuH also has an aquo derived ligand in the oxidized state based
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on spectroscopic studies539 (vide infra); this ligand is not observed in the reduced structure,
which has a trigonal planar geometry. The overall protein structure does not change
considerably between the reduced and oxidized forms. Interestingly, the reduced structure,
obtained with high ascorbate concentration, shows no evidence for ascorbate bound to the
protein. The structure of these sites will be further refined by spectroscopic studies in the
following section.
Another series of crystal structures have described the nature of substrate interaction with
the protein.584 Oxidized PHMcc was crystallized in the presence of a substrate, N-α-
acetyl-3,5,-diiodotyrosylglycine (Ac-DiI-YG, IYG). The resulting crystal structure (PDB
code 1OPM) shows the substrate bound near the CuM, which supports the idea that this
copper is the site of substrate hydroxylation. More recently, the crystal structure of a pre-
catalytic complex (Figure 82A) was solved at a resolution of 1.85 Å (PDB code 1SDW)
with the slow substrate N-acetyl-diiodotyrosyl-D-threonine (IYT) bound near CuM.125
Interestingly, a dioxygen derived moiety is observed bound to CuM in an end-on mode
(Figure 82 B, O-O of 1.23 Å). The IYT substrate is anchored to the protein via a salt bridge
to Arg240, a hydrogen bond to nearby Tyr318 and a hydrogen bond from the side chain
amide of Asn316 (Figure 82C). Although the Cu(I) oxidation state was thought to be
appropriate as the crystal structure was under reducing conditions, since the crystal was
exposed to molecular oxygen, the oxidation state of the copper and dioxygen derived moiety
are ambiguous. Additionally, the dioxygen moiety is poised, upon rotation by 110° of its
distal oxygen, at a distance of ~ 2.2 Å to abstract the Pro-S hydrogen of the glycine residue
(Figure 82D). The findings in this structure support the idea that an end-on Cu(II)-superoxo
activated species is formed at CuM and is oriented such that it can abstract the relevant H-
atom in catalysis.
Recent investigations have lead to crystal structures of PHMcc with small molecules bound
to CuM.601 Crystals of PHMcc were soaked with excess NO2−, N3− and CO (3 atm), and
show the exogenous ligands only bound to CuM. These results are consistent with FTIR
studies of CO binding to the reduced enzyme, where CO only binds to CuM.574 It is
suggested that, since CuH functions to transfer electrons to CuM, CuH must maintain its
redox potential in a narrow range and therefore does not bind exogenous ligands. However,
these results are not consistent with the spectroscopic findings from solution samples that
show both N3− and NO2− bind to both the CuM and CuH sites.539 This likely reflects the
higher concentration of exogenous ligands used in the spectroscopic studies and/or the
difference in sample preparation between the spectroscopic studies and the crystallization.
These crystal structures have provided (1) the identity of the endogenous ligands that bind
the copper centers, (2) insight into the distance between the two coppers, (3) the substrate
binding mode, and (4) the possibility of having an activated Cu/O2 intermediate poised to
perform H-atom abstraction in catalysis. The next section reviews the electronic structure of
these sites and possible reactive Cu/O2 intermediates as candidates in the enzyme
mechanism.
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3.3.4 Electronic Structure and Spectroscopy
3.3.4.1 Enzyme Spectroscopy: First, the spectroscopy of the reduced Cu(I) state will be
considered. As mentioned in section 2, this is limited to only a few methods (XAS, XES and
FTIR of carbon monoxide binding). EXAFS on reduced DβM indicates that the protein has
two coppers with an average of ~ 2–3 histidines at ~ 1.93 Å with one Cu bound to a
methionine at 2.25 Å and ~ 1–2 aquo derived ligands.602 These results are analogous to
those observed for PHM603 and TβM.604 Additionally, copper pre-edge and EXAFS data on
the reduced M314I variant in PHM indicate the loss of a copper, likely CuM.605 This implies
that the methionine ligand is essential for stabilization of the reduced CuM site. This is
consistent with the observation of no activity of the M314I varient. Carbon monoxide (CO)
binds the Cu(I) ions in both PHM and DβM with a Cu:CO stoichiometry of 1:0.5, indicating
that CO only binds to one copper.574 EXAFS of this form shows that CO binds to CuM. The
enzyme-CO complexes exhibit analogous C-O stretches at ν(CO) = 2089 cm−1 and 2093
cm−1 for DβM and PHM, respectively, which show only limited backbonding from Cu into
the CO.574,603 A reduced half-apo derivative of DβM has also been characterized (prepared
by dialysis of the CO bound form in the presence of CN−). EXAFS on this derivative shows
one copper with 2 histidines at 1.99 Å, one methionine at 2.25 Å and a solvent derived
ligand weakly bound at 2.53 Å. The presence of the methionine ligand indicates that the
copper remaining is CuM.574 EXAFS on this form also shows that CO binding displaces the
weakly bound ligand, and the FTIR spectrum shows a C-O stretch at ν (CO) = 2089 cm−1,
which is identical to the fully metalated enzyme.574 These results confirm that CO binds to
CuM, the dioxygen binding site. Using the XAS data and DFT calculations based on the
crystal structures, reduced Cu(I) resting state geometries were obtained.539 The resulting
CuM structure is tetrahedral with two histidines, an axial methionine and a water ligand
(Figure 83A). CuH is in a trigonal planar geometry ligated by three protein derived histidines
and no solvent ligand (Figure 83B).
The oxidized state of these enzymes contains two Cu(II) ions and is accessible to a larger
range of spectroscopic studies (Section 2.2). EXAFS on the oxidized state of DβM exhibits
an average of ~ 2–3 histidines at 1.99 Å and ~ 1–2 solvent derived O ligands per copper at
1.94 Å.602 Interestingly, there is no observed methionine bound to copper, implying that the
Cu-SMet bond has elongated or been broken upon oxidation. Ligand field (LF) transitions
(i.e., d→d transitions) are essential in describing the geometry of Cu(II) sites. The LF region
of the CD and MCD spectra of resting PHMcc gives two transitions at 12,200 cm−1 and
16,700 cm−1 that form a pseudo-A term (derivative shape) in the MCD spectrum (Figure
84A).539 These transitions do not shift upon binding of substrate (acetyl-Tyr-Val-Gly,
AcYVG) implying that substrate binding does not perturb the copper ions, consistent with
the EXAFS of substrate bound to DβM and the IYG bound crystal structure. The EPR
spectrum of oxidized PHMcc exhibits only one resolvable signal (gz = 2.288; Az = 157 ×
10−4 cm−1 (Figure 84B)) that integrates to 2 Cu(II) ions and exhibits gz > gx,y > 2.0,
confirming that both coppers have dx2-y2 ground states. In attempt to differentiate the Cu
centers, nitrite (NO2−) and azide (N3−) were bound to the Cu(II) sites.539 Azide binding
slightly shifts the two LF transitions (Figure 84C) and new transitions are observed in the
charge transfer (CT) region at 21,000 cm−1 to 30,000 cm−1 (Figure 85). Azide bound to a
single copper can only exhibit two CT features from the highest occupied πnbv and πnbσ
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MOs of azide. Since the CT spectrum resolves into three bands (29,600 cm−1, 25,550 cm−1
and 21,950 cm−1), azides must bind to both coppers. The 29,600 cm−1 and 25,550 cm−1
features are assigned to πnbσ (the non-bonding MO of the azide that σ-bonds to the copper)
to Cu(II) CT transitions for CuM and CuH, respectively (since CuM has a higher coordination
number and therefore higher energy Cu d orbitals then CuH). The third transition at 21,950
cm−1 is of lower intensity and can be assigned to a πnbv (where the v indicates the azide
orbital perpendicular to the Cu-azide plane) CT to one of the Cu(II) sites due to the limited
orbital overlap. Thus the absorption/CD/MCD spectra show that azides are bound to both Cu
centers. The X-band EPR spectrum of azide bound PHMcc (Figure 84D) shows only one
tetragonal Cu(II) EPR signal with a smaller gz = 2.246. NO2− binding results in significant
perturbation of the MCD spectrum (Figure 84E). Six transitions were observed in the LF
region and since a single Cu(II) can only have 4 d→d transitions, this confirms that NO2−
binding leads to different geometric and electronic structures for both CuM and CuH. This
observation is consistent with changes in the EPR spectrum. Addition of NO2− to the PHM
enzyme leads to the resolution of two EPR signals with gz = 2.265 and 2.298 (Figure 84F).
Neither corresponds to that of the resting oxidized state and indicate that both two copper
sites have bound nitrite. This change in the EPR indicates different binding modes for nitrite
to CuM and CuH, presumably due to differences in the exchangeable coordination positions
for each copper. Over all, these spectroscopic findings show that azide and nitrite bind to
both the CuH and CuM sites in solution.
With insight from spectroscopy539 and crystallography538,601, structures of the oxidized
Cu(II) sites were obtained from DFT calculations (Figure 83C and D). The CuM site is in a
distorted square pyramidal geometry ligated by a long axial methionine, two histidines and
two aquo derived ligands, one hydroxo and one water (Figure 83C). Oxidized CuH is in a
D2d distorted square planar geometry ligated by three histidines and one aquo ligand (Figure
83D).539
It is interesting to consider how these very structurally different resting Cu(II) sites exhibit
practically identical EPR and LF spectroscopic features. This was explained with geometric/
electronic structural correlations between CuH and CuM (Figure 86). The square pyramidal
CuM structure has a LF with the dx2-y2 orbital highest in energy and dxy, dz2, and dxz/dyz in
decreasing order (Figure 86, right). The LF of the CuH D2d distorted square planar structure
has dx2-y2 highest in energy with dxy, dxz/dyz, and dz2 in decreasing order (Figure 86, left).
Removing the axial methionine of CuM shifts the dx2-y2 and dxy orbitals up in energy while
the dz2 orbital shifts down. Replacing a hydroxo ligand with a histidine significantly
stabilizes the dx2-y2 and dz2 due to the stronger donation of the hydroxo relative to histidine.
Distortion (D2d) of the ligands from square planar destabilizes the dx2-y2 orbital while the
dxy is stabilized resulting in the CuH site. Its LF is similar to that of CuM where the only
significant difference is the energy of the dz2 orbital, which is higher in the latter case due to
bonding with the methionine. Therefore, the square pyramidal distortion and the axial
methionine oppose the effects of the strong hydroxo ligand yielding an electronic structure
that produces analogous spectral features for CuM and CuH. 539
3.3.4.2 Cu/O2 Model Complexes: Thus far, no dioxygen intermediates have been
spectroscopically characterized for these enzymes in solution leading to much speculation
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about their nature. Alternatively, synthetic model chemistry has produced a series of
structurally defined and, in some cases, reactive mononuclear Cu-oxygen complexes,
including Cu(II)-superoxo, Cu(III)-peroxo and Cu(II)-hydroperoxo species that have been
used to evaluate the plausibility of each intermediate in this reaction.
Early kinetics investigations of DβM and PHM proposed that a Cu(II)-hydroperoxo was the
likely candidate for the intermediate responsible for H-atom abstraction. 540,580 This
prompted the spectroscopic study of Fujisawa’s tris(pyrazolyl)borate Cu(II) hydroperoxo
model complex (Figure 87), in addition to analogous alkylperoxo complexes, in effort to
evaluate its electronic structure and potency for H-atom abstraction.596 The EPR spectrum
of this complex has g∥ = 2.380, g⊥= 2.090 consistent with a dx2-y2 ground state where the
small hyperfine splitting |A∥| ~ 40 × 10−4 cm−1 is consistent with a ground state with ~ 62%
Cu character (note from equation 2 the high g// value brings down the A// value). Absorption
and MCD spectra (Figure 88) exhibit LF transitions at < 13,000 cm−1 and two CT transitions
at ~ 16,500 cm −1 and ~ 18,000 cm−1 associated with the hydroperoxo π*v and π*σ peroxo
orbitals respectively, where v and σ indicate that the π* orbitals are perpendicular to and
within the Cu-O-O plane, respectively. The former transition is more intense than the latter,
indicating that the dominant bonding interaction is between the dx2-y2 and the π*v
hydroperoxo orbitals. This complex exhibits a resonance Raman (rR) enhanced O-O stretch
at 843 cm−1, which shifts to 799 cm−1 upon 18O substitution, and a Cu-O stretch at 624
cm−1, which shifts to 607 with 18O substitution (Figure 89). The high O-O stretch frequency
for the peroxo is indicative of a strong O-O bond due to polarization of the hydroperoxo by
the proton, which mixes the π*v and π*σ orbitals. Extending this hydroperoxide intermediate
to the CuM active site of PHM produces a half occupied FMO mostly on the Cu site with a
dx2-y2 - π*σ ground state of 61% Cu and only 2% distal O character (Figure 90 right). This
electronic structure will be considered with respect to its relevance in the reaction
mechanism in the next section.
As presented in the kinetics and structure sections, further research on these enzymes led to
the postulation that a Cu(II)-superoxo intermediate is responsible for C-H abstraction.595,600
In efforts to understand this intermediate, a number of synthetic complexes have been
reported as reported (Table 23) along with their Cu-O and O-O vibrational frequencies. The
first such structurally and spectroscopically defined side-on bound (η2) Cu(II)-O2•− model
complex was synthesized by Fujisawa and coworkers (Figure 91).121 Resonance Raman
spectra of the complex exhibited a diagnostic O-O vibration of a superoxo at 1043 cm−1
accompanied by the symmetric Cu-O vibration at 554 cm−1 (Figure 92). The presence of a
pre-edge feature at ~8979 eV in the K-edge XAS confirmed that the copper oxidation state
was Cu(II).126 This complex exhibits no effective magnetic moment (µeff) from SQUID
magnetic susceptibility below 150 K indicating an S = 0 ground state (Figure 93) (consistent
with its lack of an EPR signal). As the temperature is increased, µeff increases consistent
with Boltzmann populating a low-lying S = 1 excited state, fit to ~1500 cm−1 above the
ground state. The absorption spectrum reveals four weak (< 400 M−1cm−1) d → d transitions
at 10,200 cm−1, 14,300 cm−1, 22,100 cm−1 and 26,100 cm−1, consistent with a square
pyramidal Cu(II) LF. The onset of an intense band occurs at an energy of > 30,000 cm−1
was assigned to a dimeric Cu2O2 component in the CuO2 complex while no LMCT
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transition from the superoxo Cu(II) is observed (Figure 94A). The O-O vibration in the
resonance Raman spectrum profiles the 22,100 cm−1 feature implicating d → d transition
mixed with the superoxo π* → Cu CT and therefore is assigned as dyz → dxy since the dyz is
the only orbital with the correct symmetry to mix with the superoxo π* orbital. The Cu dxy
is the highest energy metal orbital in square pyramidal complexes while the two highest
occupied superoxo MOs (in the singlet side-on copper complex) are the π*σ and π*v
orbitals. Thus, two LMCT transitions would be expected from the π* orbitals to the Cu dxy
orbital. The π*σ orbital is located in the CuO2 plane and has considerable overlap with the
dxy, which would lead to an intense CT feature at high energy. Since no CT feature is
observed experimentally (Figure 94A), this transition must be higher than the spectral cutoff
(i.e. > 32,500 cm−1). DFT calculations predicted a low-lying singlet excited state would
produce a low energy LMCT transition and, indeed, this was observed at low temperature at
4,200 cm−1 (~ 200 M−1cm−1 at 10 K, Figure 94B). This CT arises from the superoxo π*v
orbital, which is oriented out of the CuO2 plane and minimally overlaps the dxy orbital
leading to its weak intensity. The (xy)1(π*v)1 CT excited configuration associated with this
singlet would lead to a triplet excited state at lower energy. This can be assigned to the
paramagnetic excited state that is experimentally observed by SQUID magnetic
susceptibility (Figure 93) at ~1500 cm−1 above the singlet ground state. Consequently, the
singlet ground state must derive from a different electronic configuration compared to the
lowest energy triplet state.
Correlation of these data to DFT calculations of the singlet ground state and the triplet
excited state provides further insight into the electronic structure of this complex. The
singlet ground state MO diagram consists of a pair of opposite spin electrons delocalized
over the Cu dxy and the π*σ antibonding orbitals (Figure 95). The calculated spin
distributions have very little polarization (small net spin densities) on the Cu and superoxo
moieties due to the highly covalent spin delocalized nature of the ground state. The
computed triplet excited state is comprised of the two orthogonal β-LUMO orbitals: the
superoxo π*v and the Cu dxy-π*σ. These two states reflect different configurations where the
singlet ground state is highly covalent with no spin polarization and the triplet excited state
involves excitation of one e− from the π*v into the dxy/π*σ orbital.121
The high covalency between the copper and superoxo of the ground state of this Cu(II)-
superoxo species is significant. When a side-on superoxo is modeled into the active site for
PHM, an α, β unoccupied FMO is obtained that is delocalized over the superoxo and the Cu
(Figure 96). Due to this high oxygen character in the FMO, this intermediate is more
activated for H-atom abstraction than the Cu(II)-hydroperoxo therefore strongly implying
the relevancy of the CuII-superoxide for reactivity.600
Elucidation of the PHMcc crystal structure showing dioxygen bound to CuM125 in an end-on
fashion focused interest on end-on bound Cu(II)-superoxo complexes. Although end-on
bound species are observed as transient intermediates in the formation of binuclear copper
trans-peroxo complexes, eight stabilized end-on bound mononuclear Cu(II)-superoxo model
complexes have been reported (Table 23). The first and only structurally characterized
complex is end-on Cu(II)-superoxo, [TMG3trenCuO2]+ (where TMG3tren is 1,1,1-tris[2-
[N2-(1,1,3,3-tetramethylguanidino)]ethyl]-amine), of Sundermeyer and Schindler (Figure
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97).124,614 This complex has been subjected to rigorous spectroscopic study. According to
the NMR, the model complex is paramagnetic.615 Variable temperature, variable field
(VTVH) MCD shows that this complex has a triplet ground state.123 The complex exhibits
one intense absorption band at 22,500 cm−1 (3,500 M−1 cm−1) attributed to a LMCT (π*σ of
the superoxo to the dz2 of the copper; note the trigonal bipyramidal geometry of TMG3tren
leads to a dz2 ground state) based on its low MCD to absorption intensity (Figure 98A and
B). Three bands at 10,100 cm−1, 11,670 cm−1 and 14,820 cm−1 exhibit intense MCD signals
but limited absorption intensity and thus were assigned as d→d transitions. There is also a
weak transition at ~13,000 cm−1 with no MCD intensity but is apparent from the rR
excitation profile (Figure 98C). The rR spectrum exhibits resonance enhancement of both
the Cu-O stretching mode at 435 cm−1 and O-O stretching mode at 1120 cm−1 consistent
with a superoxo-level species. The rR profiles of these two vibrations are significantly
enhanced over the aforementioned CT transition while only the O-O stretch is enhanced
within the envelope of the low energy transitions (Figure 98C). The former is consistent
with the assignment of a superoxo to Cu(II) CT, but the second is unique. The profile
reaches a maximum corresponding to the weak absorption feature at 13,000 cm−1 implying
considerable distortion of the O-O, with little distortion of the Cu-O bond, in the excited
state associated with this transition. From analysis of possible excited state distortions using
TD-DFT calculations, the 13,000 cm−1 was assigned as a superoxo intraligand (IL)
transition from the π*σ to the π*v orbital (Figure 99), the first observed for any superoxo
bound metal complex.
From the above discussion, side-on superoxo Cu(II) complexes are singlets while end-on
superoxo-Cu(II) complexes are triplets.123 The separation of the π*v and the dz2 orbitals (Δ
in Figure 99) is the significant contributor in determining the ground state of these
complexes. For the triplet to be the ground state, Δ must be smaller than the electron spin
pairing energy. In going from end-on to side-on the binding of the superoxo with the Cu(II),
the d-π*σ/π*v splitting (Δ) increases due to the strong σ bonding in the side-on case causing
the spins to pair (Figure 100). From the experimentally observed π*σ to π*v (IL) and
superoxo π*σ to copper dz2 (LMCT) transitions in the end-on [TMG3trenCuO2]+ complex,
an upper limit of Δ in the end-on structure can be established (Figure 99) to be 9,500 cm−1,
which is ~ 1/2 of the energy required for spin pairing. A calculated end-on structure from
CuM in PHM also has a triplet ground state with two orthogonal half occupied orbitals: the
Cu dx2-y2 - π*σ and the superoxo based π*v. Importantly, the half occupied π*v orbital is at
low energy (Figure 100) with near 100% character on the superoxo (Figure 101; it would
therefore be an optimal FMO for H-atom abstraction by a metal bound superoxo species.597
3.3.5 Molecular Mechanism
3.3.5.1 Dioxygen Intermediates: Initial mechanistic hypothesis for the non-coupled
binuclear Cu enzymes suggested that H-atom abstraction is accomplished by a CuM(II) -
hydroperoxo intermediate. 540,580 The electronic structure of this species was characterized
in the aforementioned spectroscopic study of the tris-pyrazolyl borate Cu(II)-hydroperoxo
complex.596 Computationally, an end-on bound hydroperoxo was modeled into the active
site of CuM (Figure 90) where the electronic structure consists of a singly occupied FMO
that has essentially no character on the distal oxygen of the hydroperoxo (~ 2%).600 This
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FMO is not activated for H-atom abstraction since it lacks oxygen orbital character to
overlap with the substrate H-atom donor orbital. Consistent with this, there is a high
computed activation barrier for H-abstraction by a Cu(II)-OOH intermediate (~ 40 kcal/mol)
(Figure 102, left in blue). Therefore, a Cu(II)M-hydroperoxo is not suitable for H-atom
abstraction in catalysis.597
Spectroscopic123, kinetic595 and crystallographic125 studies have alternatively suggested that
the key reaction intermediate for H-atom abstraction is a Cu(II)-superoxo species. Modeling
a side-on Cu(II)-superoxo at the active site of CuM results in an electronic structure with an
α, β unoccupied FMO that is non-polarized and covalently delocalized over the Cu and πσ*
with considerable oxygen character (Figure 96). Therefore, this FMO is more activated
towards H-atom abstraction than the Cu(II)-hydroperoxo model.600 However, the PHMcc
pre-catalytic crystal structure exhibits an end-on bound dioxygen. Building on the results
from the spectroscopically and structurally defined end-on superoxo model complex
[TMG3trenCuO2]+, which has a triplet ground state, an end-on superoxo species was
modeled at the CuM active site.597 This computed intermediate also has a triplet ground state
with two half-occupied orthogonal magnetic orbitals: one being the Cu dx2-y2 that is
antibonding with the πσ* and the other is the πv* orbital with little Cu d character (Figure
101). The latter orbital is highly activated for H-atom abstraction due to its low energy and
considerable oxygen character. Extending this one-electron reduced end-on triplet Cu(II)M-
superoxo species into the PHM active site, a Gibbs free energy activation barrier for H-atom
abstraction is calculated to be 19.7 kcal/mol, which is much lower than that for the Cu(II)-
hydroperoxo model and is in reasonable agreement with the experimental value of ~ 14 kcal/
mol. Thus, the one-electron reduced Cu(II)-superoxo species is a viable intermediate in the
non-coupled binuclear copper enzymes.597
Other reactive dioxygen intermediates have been proposed based on calculations as the
primary oxidant in these enzymes. Yoshizawa and coworkers modeled the homology of the
PHM crystal structure to construct a three-dimensional structure of DβM.598 QM-MM
calculations were then used to generate reaction coordinates. The H-atom abstraction by a
Cu(II)-superoxo species (modeled as an antiferromagnetic coupled singlet state) was
calculated to have a barrier of 16.9 kcal/mol; while a Cu(III)-oxo species was shown to
accomplish H-atom abstraction with a barrier of +3.8 kcal/mol (modeled as a triplet state).
The Cu(III)-oxo intermediate is actually a Cu(II)-oxyl with a triplet ground state from DFT
calculations.600 However, this intermediate is not feasible due to the thermodynamic cost of
forming this strong oxidant (~ 37 kcal/mol from Cu(II)-OOH homolytic cleavage). Another
QM-MM calculation by Crespo and coworkers invokes the formation of the Cu(II)-
hydroperoxo species but predicted that it will spontaneously form a [Cu(IV)O]2+
intermediate upon protonation where this high valent species would be responsible for H-
atom abstraction.599 This reaction parallels that of P450 mechanism where compound I
(formally a Fe(V)=O species) forms via protonation and heterolytic cleavage of a Fe(III)-
hydroperoxo intermediate.522 This is also unreasonable as the energy required to form this
intermediate is thermodynamically inaccessible. The spontaneous cleavage of the O-O bond
upon protonation of the Cu(II)-OOH was performed by adding a proton to the system
without compensating the for the energy of removing the proton from solution (~260 kcal/
mol). Additionally, both of these proposals are inconsistent with the kinetics result of
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Klinman and coworkers where the dioxygen 18O2 kinetic isotope effect was found to
increase with substrate deuteration establishing that the O-O bond must be intact prior to H-
atom abstraction (vide supra).533
Synthetic model complexe experiments have also supported a Cu(II)-superoxo species in H-
atom abstraction. Two end-on Cu(II)-superoxo model complexes have been shown to
activate C-H bonds. Karlin et al. have synthesized an end-on Cu(II)-superoxo species, from
the reaction of the Cu(I) complex with dioxygen at −125 °C, that is competent towards C-H
activation via H-atom abstraction from N-Benzyl-1,4-dihydronicotinamide (BNAD).606 This
reaction is first order in both Cu(II)-superoxo complex and the substrate, and exhibits a
primary KIE of 12.1, consistent with enzyme kinetic data. Additionally, Itoh and coworkers
have synthesized a mononuclear compound that is spectroscopically characterized to be an
end-on Cu(II)-superoxo, in the ligand system LX (LX =1-(2-p-X-phenethyl)-5-(2-pyridin-2-
ylethyl)-1,5-diazacyclooctane; X=-OCH3, -H, -NO2).609 Upon first-order decomposition, it
is found that the benzyl C-H bond of the ligand has been hydroxylated in ~ 30% yield where
an 18O substitution experiment confirms that the origin of the hydroxyl is from molecular
oxygen. The Sundermeyer end-on Cu(II)-superoxo [TMG3trenCuO2]+ has also been found
to perform H-atom abstraction from TEMPO-H and phenols producing a Cu(II)-
hydroperoxo species that is proposed to go on to hydroxylate a ligand methyl group.616
Calculations investigating this hydroxylation found the barrier to abstract the H-atom by the
Cu(II)-hydroperoxo species to be 23.5 kcal/mol. This barrier is much lower than that
calculated for a Cu(II)-hydroperoxo species in the enzyme system (~ 40 kcal/mol) and
appears to reflect an incorrect transition state.600
Finally, the significant issue remaining in the research on this mechanism is the lack of
definition of the oxygen intermediates in the enzymes. The PHMcc pre-catalytic crystal
structure has defined an end-on oxygen bound species whose electronic structure is unclear
and requires experimental definition.
3.3.5.2 Electron Transfer (ET): One puzzling aspect of the mechanism of these enzymes is
the process by which the electron is transferred from CuH to CuM. As observed in the crystal
structure of PHMcc, the coppers are separated at a distance of 11 Å through a water filled
cleft.538 It has been suggested that inter-domain motion may help to diminish the distance
between the coppers, but this is considered unlikely due to the fact that PHM in the crystal
phase, where conformational rearrangement is limited, is catalytically active.584 An ET
pathway provided by the substrate and protein residues has also been proposed for the
enzyme-substrate complex. Interestingly, in the IYT bound form of the pre-catalytic
complex of the PHMcc, the enzyme shows a ~ 20 Å pathway, which has been considered
viable for ET.584 This pathway consists of H108 bound to CuH that is hydrogen bonded to
Gln170 where the electron would be delivered to substrate via a water mediated hydrogen
bond (Figure 82A). It is important to note that this electron transfer would be to the glycyl
α-carbon, which is conserved for all substrates. This is supported by molecular dynamics
calculations by Moliner.617 However, a mutational study by Eipper and coworkers showed
that mutation of Gln170 to Ala or Asn resulted in no change in enzymatic activity
suggesting that this residue does not play an important role in ET.618 These findings have
been evaluated by the previously mentioned calculations, which do not agree as they predict
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significant loss of activity for the Asn variant. Klinman has also studied the effects of
peptide substrates of different lengths on turnover.619 The kcat was found to be higher (~ 2
times) for the shorter substrate. This implies the electron transfer step is independent of
substrate length where the difference in rate was attributed to a difference in product
dissociation from the enzyme (vide supra). This is presented as evidence for a water-
mediated pathway and against a through protein-substrate ET pathway.
3.3.5.3 Completion of the Reaction Coordinate: After the hydrogen atom from the
substrate has been abstracted, the resulting intermediate is proposed to be a Cu(II)-
hydroperoxo species and a substrate radical.595,597,600 Two mechanisms, a rebound
mechanism and a heterolytic cleavage mechanism, have been suggested as shown in Figure
80. Calculations suggested a mechanism of hydroxyl rebound to the substrate radical to
yield a Cu(II)-oxyl species. Proton coupled electron transfer from CuH to this then results in
the fully oxidized form with a hydroxo bound to CuM, which can be reduced to react with
dioxygen (Figure 102 green). Klinman and coworkers proposed an alternative hydroxylation
mechanism where electron transfer from CuH is coupled to the hydroperoxo cleavage to
form a Cu(II)-oxyl species, which then recombines with the substrate radical to give a
copper bound hydroxylated product complex. The relative energetics of these and other
possibilities are presently being evaluated.
3.3.6 Exchange Coupling Contribution to Reactivity—The key electronic difference
between the “coupled” and “non-coupled” binuclear copper enzymes is the different
magnetic interactions between the Cu(II)’s that leads to consideration of the impact of
exchange coupling on determining the individual reaction mechanisms. The exchange
coupling term J of binuclear cupric sites can be related to the electronic coupling matrix
element for electron transfer (HAB) between a Cu(I) and Cu(II) in Marcus Theory via
equation 16 in Section 2.3.2, where U is the repulsion between two electrons on the same
copper.55 For the coupled binuclear copper sites (sections 3.1 and 3.2) this exchange
coupling, therefore HAB, is large and results in the simultaneous two electron reduction of
dioxygen to peroxide, where the resulting [Cu2O2]2+complex has an electronic structure
(i.e., an FMO) capable of 2 e− electrophilic aromatic substitution (section 3.2).65 This
contrasts the non-coupled binuclear enzymes where the exchange coupling is immeasurably
weak and thus HAB is small. This would allow for initial single electron reduction of
dioxygen (as opposed to two electron reduction) at CuM to form a superoxo species with the
appropriate electronic structure (π* FMO in Figure 101) for 1 e− H-atom abstraction.
Electron transfer from CuH would then occur at a later stage in the reaction where an
intermediate is formed with a large driving force to allow for ET even at low HAB (e.g., the
Cu-oxyl species that would form upon substrate oxygenation (Figure 102, right green).
3.4 O2 activation by a mononuclear Cu site: cofactor biogenesis in Galactose Oxidase
The enzymes Galactose Oxidase and Amine Oxidase catalyze the two-electron oxidation of
substrates with a single copper center. This is accomplished with an additional covalently
bound redox active cofactor present at the active site. The formation of this cofactor (known
as a biogenesis reaction) involves the post-translational modification of a Tyrosine residue at
the active site. In this section we consider the cofactor biogenesis reaction of Galactose
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Oxidase, with Cu(I) and Cu(II), with the former being more efficient and potentially relevant
to the reduction of O2 by Cu(I) in the non-coupled binuclear copper enzymes discussed in
the last section.
3.4.1. Enzymology—The active form of Galactose Oxidase (D-Galactose Oxidase EC
1.1.3.9, GO) has a radical containing copper site that catalyzes the stereospecific oxidation
of primary alcohol substrates into aldehydes, coupled to the two electron reduction of one
dioxygen molecule to hydrogen peroxide (Figure 103 top).620,621 Although the natural
substrate for the enzyme is D-Galactose, GO accepts a broad range of substrates, from
sugars to aromatic alcohols. Alcohol oxidation is strictly regioselective and no secondary
alcohols are oxidized. The enzyme can also oxidize aldehydes to carboxylates, but at a much
slower rate (Figure 103 bottom).622,623
GO is a secretory fungal enzyme that has been isolated from Dactylium dendroides,
Gibberella fujikuroi and Fusarium graminearum. Mature GO is a monomer of 68 kDa
molecular mass, containing one copper center per protein. The protein has three distinct
domains, and the active site is located on the surface of the second domain, which is the
largest. It has been reported that the mature protein contains a small amount of carbohydrate
(less than 10% of the total mass), although this has not been observed in the crystal
structures. 624
The GO oxidation reaction (Figure 103 top) makes this enzyme ideal for bioanalytical
applications, due to the stoichiometric relation between substrate oxidation and oxygen
reduction. The highly clinically important determination of galactose uses this type of
chemistry.625 GO is also used in synthetic chemistry to generate complex aldehydes and
carboxylic acids from compounds with a single primary alcohol as a functional group. In
addition, GO has recently been used because of its selectivity towards galactose, among
other hexoses, to modify D-galactose-β[1,3]-N-acetylgalactosamine, an important tumor
marker. The presence of this disaccharide is strongly correlated with colon cancer, and GO
provides a rapid method for its early detection.626
The two-electron reduction of dioxygen to hydrogen peroxide involves the two-electron
oxidation of the substrate by a site that contains only one copper center. Therefore, nature
has evolved an additional cofactor at the active site, a Cys-Tyr covalently linked radical
center bound through the phenoxyl oxygen and antiferromagnetically coupled (J < −100
cm−1 for H = −2J•S1•S2) to the copper(II) center. The redox potential for this cysteinated-
tyrosine ligand has been measured to be 0.45 V, and is thus stabilized relative to a free
tyrosine radical (0.95 V) through the covalent linkage with the cysteine residue in the ortho
position and through π-π stacking with a nearby tryptophan residue (W290). Among the
variants that have been developed for this enzyme, those that involve W290 (W290G,
W290H and W290F), show profound effects on the galactose binding constant and the
catalytic rate of the enzyme, suggesting an additional role of W290 residue in substrate
binding and activation. 627
The catalytic mechanism of GO has been studied with a range of approaches, including
enzyme model studies and calculations.628–633 The kinetics of GO are complex due to the
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coexistence of three oxidation states of the enzyme and the possibility of reversible
activation/inactivation by the interconversion of these states (section 3.4.5). The overall
reaction consists of separate reduction and oxidation steps, i.e. a ping-pong mechanism
(Figure 104).634 While kred has a broad range of values depending on the substrate (0.8–
2.7×104 M−1s−1), the kox is more or less constant (0.98–1.02×107 M−1s−1). Steady state
kinetics gives a Km of 82 mM for D-Galactose substrate at saturated O2 concentrations,635
that varies a little depending on the organism from which the enzyme is obtained. This large
kox value might reflect an enzyme strategy for broad substrate specificity.
There is no crystal structure of the active site with the D-galactose bound, but the fact that
the open coordination site of Cu(II) in the crystal structures is usually occupied by water or
an anion of the crystallization buffer indicates that the galactose coordinates to replace the
labile equatorial ligand (see section 3.4.3).636 The proposed mechanism involves the
deprotonation of the OH group of the sugar by an axial tyrosine (Y495) upon coordination to
the Cu(II), a stereospecific pro-S hydrogen atom abstraction by the Cys-Tyr radical cofactor,
an inner sphere electron transfer by the substrate radical reducing Cu(II) to Cu(I) and finally
the dissociation of the aldehyde product (Figure 105).622
Glyoxal oxidase (GLOX) is a related enzyme that performs the oxidation of aldehydes to
carboxylic acids coupled to a two electron reduction of O2 to H2O2. This enzyme is found in
the fungus Phanerochaete chrysosporium, an organism extensively studied for its lignin-
degrading ability. GLOX shares many properties with GO despite lacking obvious sequence
identity (less than 20%). No crystal structure has been solved yet for GLOX, but the
spectroscopic data on the active site (mostly EPR and rR) indicate that the active site is very
similar to that of GO.637 Although these two enzymes are related in many ways (including
similar molecular weights), the redox potentials for the radical cofactors are different (0.66
V in GLOX vs. the 0.45 V in GO, both relative to NHE). The biological function of GLOX
is clearly the generation of H2O2. The enzyme only works under ligninolytic conditions,
when lignin peroxidase and manganese peroxidase are also produced, and both of these
enzymes require hydrogen peroxide to function. The fact that the main biochemical role of
GLOX is the generation of H2O2 has raised the issue of as to whether this might also be the
in vivo role of Galactose Oxidase.
In order to be fully active, Galactose Oxidase has to go through a series of post-translational
modifications that results in three protein forms. The pre-sequence form has 680 amino
acids and a molecular weight of 70.2 kDa. The first cleavage removes the 24 amino acid
pre-sequence leader peptide in the secretory pathway, and seems to be copper independent,
because fungi can produce both cleaved and pre-sequence forms of GO under metal
deprivation stress.627 A second cleavage that is dependent on the Cu(II) cuts the C-terminus
at an arginine and removes 17 amino acids to generate the preprocessed form of the enzyme
(without the Cys-Tyr crosslink), with 639 amino acids and 68 kD molecular weight. Finally,
the biogenesis reaction takes place, generating the processed Cu(II)-Tyr-Cys radical
antiferromagnetically coupled active site. In copper-limited conditions, heterologous
expression of galactose oxidase results in the three forms of the protein, identifiable as
distinct bands on SDS/PAGE.638 The other enzymes that use a metal catalyzed biogenesis
reaction to modify a tyrosine residue (cytochrome c oxidase, with a histidine ligand
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covalently linked to a tyrosine residue, and Amine Oxidase) use the modified Tyr along with
the copper to react with O2. Here we focus on the biogenesis reaction to form the radical
cofactor in GO, which involves dioxygen activation by a single copper center without the
involvement of an additional redox cofactor.
3.4.2 Kinetics—Preprocessed GO from Pichia pastoris can be expressed without the
crosslink between Cys228 and Tyr272, allowing for kinetic studies of the biogenesis
reaction. This can be accomplished by following the formation of the radical cofactor, which
has been studied using both redox states of copper (Cu(I) and Cu(II)) and under both aerobic
and anaerobic conditions. Studies of copper(I) biogenesis are more challenging as this d10
metal ion is spectroscopically silent (section 2.1)
Cu(I) performs the biogenesis reaction about 104 times faster than Cu(II),639 with a t1/2 of
3.9 s compared with a t1/2 of 5.1 h for Cu(II). The Cu(I) reaction (studied at low copper
loading) uses 1.8eq of O2 consistent with the generation of two molecules of H2O2 per
active site formed. For Cu(I), three reactions are observed depending on pH. Reaction 1
(Figure 106) dominates at the biologically relevant pH (pH ~7.0). Stopped-flow kinetic
experiments monitoring the reaction of Cu(I) GO with O2 leads to the formation of the
characteristic bands of the fully oxidized form, with the crosslink between Tyr272 and
Cys228, at 445 nm and 850 nm (see section 3.4.4) with a k1 = 1.78×10−1 s−1, which is well
described by a single exponential. This rate constant increases with increasing pH to k2 =
4.15×10−1 s−1 at pH = 8.35, at which point reaction 2 (Figure 106) dominates. The increase
in rate constant with pH is interpreted as the deprotonation of the mechanistically important
Cys228 proton (section 3.4.5). The increased rate at pH 8.35 can also be described using a
single exponential. The spectral features observed at pH < 7.0 are different from the ones
observed at pH ≥ 7.0 (Reactions 1 and 2 in Figure 106), lacking the 850 nm band and
showing a blue shift of the 445 nm band (a phenolate to Cu(II) charge transfer band, see
section 3.4.5). Reaction 3 proceeds in two steps, in which the GO-Cu(I) first reacts with O2
in the presence of a proton with k3 = 4.47×10−2 s−1 to oxidize the metal and release HO2.
The GO-Cu(II) then turns into a species (k4 = 1.8×10−5s−1) that has spectral features similar
to those of GO anaerobically loaded with Cu(II) and lacking the Tyr272 and Cys228
crosslink (406 nm band, see section 3.4.4), suggesting a possible Cu(II)-Cys bond. Further
characterization of this species is yet to be reported. The solvent kinetic isotope effect
(SKIE) has been studied for this reaction over a broad range of pH, showing a maximum
kH2O/kD2O of 1.51 at pH 7.00 that drops to 1.00 at pH 8.35. The pH dependence of the
kinetic constants and the SKIE between 6.5 ≤ pH ≤ 8.5 show the same behavior, implying
that the trend observed in both is due to the ionization of an unique proton that plays a
mechanistically important role in the biogenesis reaction (see section 3.4.5).
While the Cu(I) biogenesis reaction is much faster, there has been discussion as to whether a
Cu(II) might be involved in forming the crosslink in vivo, possibly in the absence of O2 to
avoid premature cell deterioration due to radical reactions and is thought to be viable in the
formation of the thioether crosslink in the trans-Golgi network.636 To study the possible role
of Cu(II) in biogenesis, both aerobic and anaerobic loading experiments have been done
with preprocessed GO and Cu(II).
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When 0.8eq of Cu(II) and O2 are added simultaneously to preprocessed GO, the biogenesis
reaction takes place with a kinetic constant of k = 3.8×10−5 s−1 (Figure 107a), which
increases by two orders of magnitude to k = 3.5×10−3 ± 5×10−4 s−1 when 3.5 fold excess
Cu(II) is added, indicating a copper concentration dependence.640,641 Under excess copper
conditions, densitometry measurements on stained gels from samples taken during the
reaction gave a rate constant for the formation of the Cys228-Tyr272 bond of k = 5×10−3 ±
8.3×10−4 s−1, which is comparable to the biogenesis rate under the same copper
concentration conditions. These results suggest that the rate limiting step for the formation
of the fully oxidized mature GO is the formation of the thioether crosslink. This reaction
consumes 1.5 equivalents of O2, determined by the concomitant formation of H2O2.
When Cu(II) is added anaerobically to preprocessed GO, a three phase process is observed
(Figure 107b). The first occurs upon addition of 0.8eq of Cu(II) to preprocessed GO. Based
on EPR data, the copper(II) loads completely in seconds into the active site, showing one
very weak absorption band at 600 nm.639 Anaerobic incubation of this species leads to the
formation of a second species with an intense absorption feature at 406 nm. The kinetics for
the formation of this absorption band can be fit with a single exponential to give a k406 =
3.2×10−4 s−1. Longer incubation times (up to 24 h) leads to a third bleached species
indicating reduction to Cu(I). Crystallographic data and SDS-PAGE analysis show that this
species contains the covalent bond between the Cys228 and the Tyr272, indicating that
Cu(II) is able to crosslink these two residues in the absence of O2. The decay of the 406 nm
band gives k406(decay) = 5×10−5s−1 ± 5×10−6 s−1, which is comparable to the aerobic rate of
formation of the mature form of the enzyme when stoichiometric Cu(II) is added (vide
supra). This may indicate that the rate-determining step is the anaerobic formation of the
thioeter crosslink by the single Cu(II) center.
There is also an anaerobic Cu(II) concentration dependence on the kinetic constants as
addition of a 3.5eq excess Cu(II) leads to the immediate formation of the 406 nm species,
followed by its rapid decay to the bleached species (k406(decay) = 4.08×10−3s−1 ±
3.66×10−4 s−1). SDS-PAGE analysis shows that this species contains the thioether crosslink.
Interestingly it has also been detected that the excess copper does not act as the additional
electron acceptor required in the formation of the crosslinked, bleached species. The nature
of the extra electron acceptor remains unclear (section 3.4.5)
The effect of anaerobic Cu(I) addition was also studied and the amount of thioether bond
formed quantified by SDS-PAGE analysis. The rate of thioether bond formation with Cu(I)
was estimated to be kCu(I) = 7.8×10−5 s−1, which is on the same order as the kinetic constant
of the anaerobic crosslink formation with stoichiometric copper(II). From the experimental
data it remains unclear if the similar rate is because both Cu(I) and Cu(II) can perform the
anaerobic crosslink or their similar rates simply reflect a faster conversion of Cu(I) to Cu(II).
When the second species (406 nm) is mixed with oxygenated buffer, the crosslinked radical
site is generated with a k406,O2 = 3.9×10−5 s−1 for stoichiometric Cu(II) loading This rate is
very similar to the rate reported for biogenesis by the addition of Cu(II) in oxygenated
buffer, and is in the same order of magnitude as the kinetic constant k406,O2 for the
anaerobic decay of the 406 nm species to the bleached one. These rates suggest that the 406
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nm species is the reactive species that forms the crosslink anaerobically in vivo, and that the
rate-determining step is the formation of the thioether bond.
From the above rates is can be concluded that the Cu(I) performs the aerobic biogenesis
reaction most rapidly with a rate dependent on the protonation state of the nearby cysteine
residue, while Cu(II) can also generate the crosslink in a slow, but O2 independent reaction.
3.4.3 Structure—X-ray crystal structures for GO have been reported from a variety of
organisms, including Dactylium dentroides, Aspergillus nidulans and Fusarium
Graminearum. Most of the crystal structures are on processed forms of the enzyme (i.e.,
with the thioether crosslink or with the radical cofactor present); little crystallographic data
are available for the preprocessed enzyme (Table 24).
Processed Galactose Oxidase (with the radical cofactor) is a monomer with one copper
center per protein, three distinct domains and a total molecular weight of 68 kD with 639
aminoacids (Figure 108). The three domains are composed mostly of beta sheets, with
almost no turns. The N-terminal domain (domain 1, red in Figure 108) contains the first 155
amino acids, and forms a globular unit with eight strands of antiparallel β-sheets folded into
a sandwich. This domain contains a metal binding site that is not the active site. It is formed
by Asp32, Asn34, Thr37, Glu142 and the peptide carbonyls of the Lys29 and Ala141. These
amino acids define a pseudo octahedral coordination site that contains a Na+ cation from the
crystallization buffer (PIPES). However, based on its −2 negative charge, the natural metal
might be a divalent cation (e.g. Ca2+). In addition, this domain contains a carbohydrate
binding site that may function in targeting extracellular carbohydrates. A hydrophobic patch
connects domain 1 with domain 2. The second domain is the largest (residues 156 to 532,
yellow in Figure 108) and contains the copper active site. This domain is formed by groups
of four-stranded antiparallel β-sheets in pseudo sevenfold symmetry (Figure 108B). This
second domain contains three of the four metal ligands of the active site Tyr272 from the
Cys-Tyr radical cofactor, Tyr495 and His496. Domain 2 contains a large hole along the
sevenfold axis, which is filled by two β-strands of the third domain and a number of water
molecules, one of this β-strands, belonging to the third domain, contains the fourth copper
ligand (His581).644 The third domain (residues 533 to 639, blue in Figure 108) lies behind
the second domain, and is formed by a pack of seven, mostly antiparallel, β-strands
surrounding a hydrophobic core.
The active site of the enzyme is located in the second domain, and the copper center is
located on the solvent accessible surface of this domain, close to the pseudo-sevenfold axis.
The copper ion has a square pyramidal geometry, with Tyr495 in the axial position and the
rest of the ligands in the equatorial plane, including the crosslinking cofactor formed by the
Tyr272 and Cys228. The open equatorial coordination position is usually filled by a water
molecule or a negative counterion from the crystallization buffer. Once the cofactor is
formed, a Tryptophan residue from domain 2 interacts with the crosslinked Cys-Tyr residue
through a π-π stacking interaction (Figure 109). This interaction has been shown to provide
structural and electronic stability to the active site of GO through the effects on the catalytic
reaction of a series of Trp290 variants. 641
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Dooley and coworkers have reported the only crystal structure of apo-preprocessed
Galactose Oxidase. The structure largely resembles the mature GO, with the exception of the
active site region. The thioether bond is not present, and the Tyr272 is disordered and
modeled in two conformations. Trp290 is also not found in its stacking position (Figure
110A). The authors were also able to obtain crystallographic data on a 3 minute Cu(II)
soaked apo crystal (Figure 110B). The electronic density suggests that the copper binds to
His496 and His592, and that Cys228 rotates around its carbon-carbon bond to coordinate to
the copper. The later observation is based on a negative density peak from the Cys228 sulfur
and a positive peak adjacent to the copper. The Cu-S bond is estimated to be 2.2 Å and the
copper(II) is in a very unusual three coordinate T-shaped geometry. After 24 h, the
anaerobic Cu(II) soaked crystals show that the Cu-S bond is broken, the thioether crosslink
is formed, and Tyr272 is coordinated to the Cu(II) in the equatorial plane (Figure 110C). 636
Given the important role that Cu(I) seems to play in the biogenesis reaction, it would be
highly desirable to have structural information on its coordination environment in the
preprocessed enzyme. However, no crystallographic or XAS information on this species is
currently available.
3.4.4 Electronic structure—Preprocessed copper bound GO, is an important target for
spectroscopic studies that would provide insight into the metal ion activation for the
biogenesis reaction. As indicated in section 3.4.2, this reaction is performed by both Cu(I)
and Cu(II), and it is clear that the cofactor biogenesis is 104 times faster with Cu(I). As
shown in section 2.1, Cu(I) is unaccesible to most spectroscopic techniques, and requires the
use of X-ray absorption and emission spectroscopy at the Cu K-edge and crystallographic
studies. However such studies have not yet been reported.
From section 3.4.2, when Cu(II) is loaded anaerobically into preprocessed GO, a series of
three species is observed. The first species appears almost immediately after anaerobic
Cu(II) loading. This species has a characteristic EPR signal (g∥ = 2.21, g⊥= 2.05, 
Gauss, Figure 111A black), indicative of coordination of the Cu(II) to the protein, and shows
a weak absorption feature at 600 nm (ε600 = 200 M−1cm−1, Figure 111B, first spectrum) that
likely reflects ligand-field transitions. After a few hours of incubation, the spectral signature
of the second species is fully formed, although it is important to note that the 600 nm
absorption band does not decay. This second species has been studied with several
spectroscopic methods. Its EPR spectrum shows basically the same features as the short time
species (g∥ = 2.225, g⊥ = 2.005,  Gauss, Figure 111A blue and red), which are
characteristic of an axial Cu(II) site) and lacks a detectable free radical feature. Its most
distinctive feature is its yellow color, which reflects the intense ligand to metal charge
transfer (LMCT) at 406 nm (ε406 = 3790 M−1cm−1, Figure 111B). The CD spectrum of the
406 nm species shows features at 434 nm and 748 nm (both bands positive, Figure 111C).
The 406 nm absorption band was used to resonance enhance the Cu-ligand Raman
vibrations associated with this feature. The rR spectrum shows vibrational features at 257
and 343 cm−1, assigned to Cu-S stretches (Figure 111D).645,646 Based on these vibrations
and the lack of Tyr ring modes, the 406 nm band has been assigned as a Cys to Cu(II)
charge transfer transition. At longer incubation times (24 h), the bleached species is formed.
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This third species has the thioether crosslink, and from the lack of an absorption and EPR
features is likely reduced. Thus, from spectroscopy, a Cu(II)-thiolate complex forms and this
then decays to form the crosslink between Tyrosine and Cysteine. The crosslink involves a
two-electron oxidation. The first electron is accepted by the Cu, while the acceptor of the
second electron is not clear. Experiments with 3.5 excess Cu(II) shows the rapid formation
of the 406 nm feature and a broad and weak band at 625 nm. The band at 625 nm has
tentatively been assigned to aqueous Cu(II), and does not decay with time. With 3.5 fold
excess Cu(II), the 406 band decays to a species with absorbance at 435 nm and lower
intensity.
The reaction of anaerobic processed reduced GO with O2 generates mature GO. Mature GO
has some distinctive spectral features not observed in any other copper metalloenzyme,
reflecting the Cys-Tyr radical and its interaction with the Cu(II). The fully oxidized form
shows no EPR signal, due to antiferromagnetic coupling between the Cu(II) and the Cys-Tyr
crosslink radical cofactor (J < −100cm−1 for H = −2J•S1•S2). A small sharp signal around
the free electron value corresponds to a small (~0.1 spins/protein) fraction of crosslinked
apoenzyme in the sample that is able to form a stable free radical (Figure 112, upper
right).634 In addition to the lack of EPR signal, the holo enzyme has distinctive features in
its absorption spectrum. This is dominated by two intense bands: one centered at 445 nm
(ε445 = 5500 M−1cm−1) the second is very broad and centered at 850 nm (ε850 = 3400
M−1cm−1) (Figure 112, upper left). The CD spectrum resolves these bands into at least 8
different transitions (Figure 112, left). rR experiments with excitations at 659 nm and 875
nm on the 850nm band show vibrations that correspond to ring mode frequencies (Figure
112 lower right). The peaks at 1382, 1487, 1479, 1595 and 1185 cm−1 are assigned to the
tyrosyl radical, while the peaks at 1170, 1246, 1499 and 1603 cm−1 are assigned to the
tyrosinate ligand. From these the 445 nm band has been assigned as a LMCT from the Cys-
Tyr radical cofactor to the Cu(II). Based on absorption and MCD data, The 850 nm band is
assigned as a ligand to ligand charge transfer (LLCT) between the axial tyrosinate and the
equatorial Tyr-Cys ligand radical mediated by the dxy orbital of the Cu(II). TD-DFT
calculations disagree with this assignment and suggest an intraligand transition of the
cysteinated Tyrosine with no contribution from Tyr495. 634,647,648
3.4.5 Mechanism—In contrast to the biogenesis mechanism for the formation of TPQ in
Amine Oxidase (see section 4.2), very little is known about the cofactor biogenesis
mechanism in GO. The ortho covalent linking of the cysteine sulfur to the tyrosine is
indicative of oxidative radical coupling reactions and would be consistent with the
nucleophilic addition of a thiol to a phenoxyl radical or the addition of a phenol to a thiyl
radical. The proposed mechanisms for the radical cofactor biogenesis are often based on the
product and involve a high degree of speculation. For the more efficient Cu(I) aerobic
mechanism the radical would have to be generated by reaction with O2, while for the less
efficient but anaerobically viable mechanism the radical would be generated by ligand
coordination to the Cu(II). This ligand could either be the Tyr272 or the Cys228, and the
radical character in the Cu-ligand is thus thought to reflect a resonance contribution to the
ground state.
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Dooley and coworkers have proposed two possible pathways for the cofactor biogenesis
with copper(II), one for aerobic and another for anaerobic conditions. The aerobic proposal
(Figure 113) invokes the copper(II) coordination to the Tyr272 in the active site, and some
radical character in the ground state, very similar to a proposal for the first step in the
biogenesis reaction of Amine Oxidase (section 4.2). This tyrosyl radical character would
react with O2, generating a peroxo-bridged quinone species. The thiolate would then attack
at the ortho position with the loss of H2O2. The loss of the ortho hydrogen atom as H+
recovers the aromaticity of the ring and a second oxidation with another O2 molecule
generates the final Cu(II)-Tyr(•) cofactor with the concomitant formation of a another H2O2
molecule. Firbanks, Dooley and coworkers have outlined an alternate aerobic mechanism,
which involves the monooxygenation of the Cys228 to a sulfenate group. 638
Both Firbank and Dooley have also proposed a possible route for the anaerobic copper(II)
dependent biogenesis.636,638 This mechanism (Figure 114) uses the rR data that show a
copper-thiolate bond (i.e. the absorption band at 406 nm, Figure 111B). The authors propose
that under anaerobic conditions, the copper(II) binds to the cysteine (and not the tyrosine),
generating a copper(II)-thiolate species which has a resonance form in which one electron is
transferred from the sulfur atom to the copper(II) to generate a Cu(I)-thiyl radical species.
The thiyl radical would attack the phenol ring, and with the loss of an electron (acceptor
unknown) generate a carbonium ion intermediate. Proton loss would then lead to the final
species in which the thioether bond has been formed (i.e. the Cu(I) containing bleached
species in Figure 114). 636
These mechanisms, although consistent with the formation of a crosslinked product, have
issues. In the aerobic route, the proposed resonance contribution of the radical form to the
ground state complex will be very small, because it corresponds to a charge transfer excited
state of the phenolate-copper(II) complex (see section 4), and the EPR data show no
contribution from a radical. In the anaerobic route also no radical is observed and the final
electron acceptor is unknown.
Finally, as indicated above, the biogenesis reaction with copper(I) is orders of magnitude
faster than with copper(II). Whittaker and coworkers have proposed a mechanism for the
copper(I) aerobic biogenesis reaction (Figure 115). The copper(I) coordinates to His496,
His581 and Tyr272, and reacts with O2 to generate a superoxide radical via one electron
transfer from copper to dioxygen. This would parallel the discussion in Section 3.3
concerning the non-coupled binuclear Cu enzymes and would likely involve end-on triplet
CuO2 species.
This bound radical is thought to perform hydrogen atom abstraction from the Cys228 to
form a thiyl radical, reducing the superoxide to hydrogen peroxide. The next step would be
an electrophilic addition of the thiyl radical to the Tyr272 ring and the formation of the
thioether bond. Loss of the ortho proton with concomitant lost of an H2O2 molecule would
then lead to a reduction of the copper(II) to copper(I). Addition of another equivalent of O2
generates the final Cu(II)-Tyr(•) species (Figure 115). Within this model the measured rate
constant at high pH (8.5, see section 3.5.2) is associated with the deprotonation of the
Cys228. The thiolate group has a lower reduction potential (E0(RS•/RS−) = 0.80 V vs.
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E0(RSH•/RSH) = 1.37 V both vs. NHE) and would react more rapidly (via electron transfer)
to generate a thiyl radical and a coordinated peroxide. Exchange of the cysteine sulfhydryl
group in D2O would also account for the observed SKIE. However, this mechanism does not
deal with the spin along the biogenesis reaction, particularly as end-on Cu(II)-O2(−)
complexes are triplets while formation of the crosslinked product results in a singlet. Also
the one electron reduction of O2 is energetically unfavorable and for this to occur the
potential of the Cu(I) preprocessed site needs to be tuned down and the resultant superoxide-
Cu(II) bond needs to be strong.
In summary, a lot is known about the catalytic reaction of GO, but less is known about the
biogenesis reaction to form the unique Cys-Tyr radical cofactor. Although the in vitro
biogenesis reaction with Cu(I) is four orders of magnitude faster than with Cu(II), there is
still a debate as to which copper redox state is involved in the biogenesis reaction in vivo.
Both processes clearly involve different mechanisms as O2 is the oxidant with Cu(I) in the
aerobic route while the Cu(II) would be the oxidant in the anaerobic mechanism. Also, the
aerobic reaction appears to involve coordination of a Tyr to the Cu(I) while the anaerobic
reaction appears to involve activation of the Cys by coordination to the Cu(II). Clearly,
interesting chemistry needs to be understood in the formation of this unusual covalent
crosslinked-Cu site.
3.5 Particulate methane monooxygenase and related systems: H-atom abstraction from
methane
3.5.1 Enzymology—Methane monooxygenases (MMOs) present in methanotrophic
bacteria accomplish a formidable task in nature: oxidation of the inert C-H bond of methane
(bond dissociation energy of ~104 kcal/mol). It is this capacity which constitutes the
enzyme’s functional significance and application. Methane gas is an underutilized source of
global energy; understanding the mechanism of methane oxidation by MMOs can greatly
advance the molecular design and synthesis of functional catalysts with the ability to carry
out the methane to methanol conversion at ambient temperature and pressure. This would
allow for the efficient storage and use of methane as an independent source of carbon-
derived energy.649 This is attractive as current methods which perform the methane to
methanol conversion involve high temperatures and pressures and are not energy efficient.
In industry, the first step in methanol synthesis from methane gas is steam-methane
reformation (SMR) (CH4 + H2O → CO + 3H2O) over a nickel catalyst, which is highly
endothermic. The products of this reaction are referred to as synthesis gas (syngas). Syngas
is further reacted over a different catalyst (Cu/ZnO/AL2O3), also at high temperature and
pressure, to form methanol (CO + 2H2 → CH3OH). Methane is also a major contributing
greenhouse gas.650 In this respect, overall methane reduction in the atmosphere is important
and could be facilitated by MMOs.650–652 Also important from the standpoint of
bioremediation is the ability of MMOs to oxidize other alkanes and alkenes, including
chlorinated compounds.653,654
There are two types of MMOs, a soluble (sMMO)655 and particulate (pMMO),656–658
membrane bound form. Methane oxidation in sMMO occurs at a binuclear non-heme iron
site, while for pMMO this has been controversial but appears to occur at a binuclear copper
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site (vide infra, 3.5.3).659 It should be noted that the only other enzyme currently known to
oxidize methane is ammonia monooxygenase (AMO) and is found in ammonia oxidizing
bacteria.660,661 These bacteria are obligate chemo-lithoautotrophs which oxidize ammonia
to nitrite in two steps. NH3 is oxidized to NH2OH by AMO and NH2OH is oxidized to
NO2− by hydroxylamine oxidoreductase (HAO). Like pMMO, AMO is membrane bound
and has three subunits (Section 3.5.3). Unfortunately, the structure and metal content of
AMO remain unknown due to the lack of pure active enzyme , which retains activity.
Evidence exists that supports either a copper662,663 or iron664 or copper/iron665 metal
containing cofactor in AMO.
Methanotrophic bacteria currently constitute 13 genera, all of which are within α and γ
proteobacteria.666 These bacteria thrive in diverse, and sometimes extreme, aerobic
environments,667 which consist of sediments, soils, peat bogs, freshwater, seawater, and
hotsprings. Methane, utilized as a sole source of carbon and energy in these bacteria, is
oxidized in the first step of their metabolic pathway (Figure 116). Proceeding methane
oxidation is the oxidation of methanol to formaldehyde by methanol dehydrogenase,
formaldehyde oxidation to formate by formaldehyde dehydrogenase (FalDH), and, finally,
the pathway completes with formate oxidation to CO2 by formate dehydrogenase. Carbon
utilized for biosynthesis of cellular material is assimilated at the level of formaldehyde.
Further oxidation of formaldehyde to CO2 is dissimilatory, generating metabolic reducing
equivalents. The division of these bacteria into types is based upon their mode or pathway of
formaldehyde assimilation. Type I (genera Methylomicrobium, Methylomonas,
Methylosphaera, Methylocaldum, and Methylobacter) methanotrophs use the ribulose
monophosphate (RuMP) pathway and type II (genera Methylosinus, Methylocella, and
Methylocystis) use the serine pathway. Type X (e.g. Methylococcus) utilizes the RuMP
pathway, while also containing enzymes involved in the serine pathway. Type X also grow
at higher temperatures than Types I and II. Researchers within the bioinorganic community
largely study MMOs derived from the organisms Methylococcus capsulatus (Bath) (Type X)
and Methylosinus trichosporium OB3b (Type II).
Apart from the genus Methylocella, all types of methanotrophs produce particulate forms of
MMO (pMMO), which are housed in intracytoplasmic membranes.668–670 The genus
Methylocella utilizes only sMMO.671 However, both types II and X are capable of
expressing either pMMO or a cytoplasmic, sMMO. Which MMO is expressed is dependent
upon the growth media, with sMMO being expressed under copper starvation conditions.
When copper is present in sufficient concentrations the ‘copper switch’ is thrown, a
currently unknown mechanism, and pMMO is expressed.668–670,672
Given the importance of copper concentration in MMO expression, an efficient mechanism
for copper uptake and acquisition is essential. Recent progress has been made concerning
this subject. The main player has been identified as methanobactin (mb),673–677 originally
coined, more generally, as copper binding compounds (CBCs) or copper binding ligands
(CBLs), although the latter compounds were previously poorly identified and of variable
sizes. Recently, mb has been isolated678,679 and more thoroughly characterized using
XAS,680 XPS,681 and EPR,680,682 and is compared to the iron siderophores, the iron-binding
compounds responsible for the cellular uptake of iron. Interestingly, copper bound mb is
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reduced (Cu(I)) upon either Cu(I) or Cu(II) loading.678–680,682,683 The source of the
reducing equivalent has yet to be determined. Cu(I) and Cu(II) binding to mb have been
proposed to take place via different pathways. Cu(II) binding is proposed to proceed through
multiple steps, which may involve dimeric and tetrameric forms,679 while Cu(I) binding
appears to take place through a monomer species. Affinity for Cu(II) has been reported for
various Cu:mb ratios, and can be as high as 3.25 × 1034 ± 3.0 × 1011 M−1 for Cu:mb ratios
between 0.07 and 0.2.679 A value of >8 × 1018 M−1 was reported upon fitting the isothermal
titration calorimetry data.679 The affinity of mb for Cu(I) has been reported to be (6–7) ×
1020 M−1.684
pMMO and sMMO, although performing the same function, show large differences in their
structural features. sMMO contains three components: a hydroxylase (MMOH), a regulatory
protein termed B (MMOB), and a reductase (MMOR). All of these components must be
present for methane oxidation. pMMO is trimeric; each monomer is composed of three
polypeptide subunits, α (pmoB), β (pmoA), and γ (pmoC), ~47, ~24, and ~22 kDa,
respectively, in an α3β3γ3 polypeptide arrangement. This differs from MMOH of sMMO.
MMOH is a heart-shaped dimer; the protomers are each made up of three subunits, and form
an overall α2β2γ2 structure. X-ray crystallographic studies (Section 3.5.3) indicate that the
pmoB subunit is made up of two cupredoxin-like β-barrels, which constitute the soluble
domain, and two transmembrane helices.685 The pmoA and pmoC subunits constitute the
majority of membrane-spanning region. Although the metal content and the location and
nature of the active site for methane oxidation have been highly controversial, X-ray
crystallography, in combination with a reactivity study involving site-directed mutagenesis
has recently allowed for significant headway. It is now considered that the pmoB subunit
contains the active site for methane oxidation and consists of a binuclear copper center
ligated by highly conserved residues.659 Furthermore, in the Bath enzyme, the pmoB subunit
also contains a mononuclear copper site, but this site is not conserved across all pMMOs and
is not observed in the crystal structure of the OB3b enzyme. The pmoC subunit houses
another metal binding site. In M. capsulatus Bath it is occupied by zinc from the
crystallization buffer, but houses copper in the OB3b enzyme. The function of the
mononuclear metal sites is not currently understood. A more detailed discussion of the
structure of pMMO is presented in Section 3.5.3.
3.5.2 Kinetics—Unlike the well-studied sMMO, only limited kinetic data exist for
pMMO. Data that are currently available show a high degree of variability depending on
preparation and purification procedure. The variations across different preparations have
been previously discussed and tabulated.656,686 While sMMO is capable of oxidizing a wide
range of substrates including n-alkanes, n-alkenes, aromatic and alicyclic compounds,
pMMO is far less promiscuous and only shows the capability of oxidizing short alkane and
alkene chains up to five carbons in length.687–690 Additionally, pMMO has been shown to
hydroxylate n-butane and n-pentane enantioselectively to (R)-2-butanol and (R)-2-
pentanol,691 respectively. Both pMMO and sMMO can oxidize chlorinated substrates.692
The activity of pMMO samples is typically determined using the propylene epoxidation
assay either with NADH (used for membrane bound pMMO) or duroquinol (used for
solubilized pMMO) as a reductant. As mentioned, values obtained from these assays show a
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high degree of variation. Nevertheless, specific activities of ~10–200 nmol propylene oxide
(mg protein · min)−1 have been reported for the membrane bound form of M. capsulatus
(Bath), while values of ~2–126 nmol propylene oxide (mg protein · min)−1 have been
reported for purified preparations.656,693 Purified M. trichosporium OB3b pMMO had a
reported activity of ~3–4 nmol propylene oxide (mg protein · min)−1. A more confusing
aside is that, in one report, when pMMO was isolated under anaerobic conditions, a specific
activity of 290 nmol propylene oxide (mg protein · min)−1 was measured, the highest yet
observed.670 This is inconsistent with another report that anaerobic purification yields an
enzyme with little to no activity.694
Although it is typical to use NADH or duroquinol (only quinols can reduce solubilized
pMMO)675,694–69 in determining the enzymatic activity, the in vivo electron donor is
unknown. Some data exist that suggest various possible physiological electron donors for
pMMO. pMMO activity is inhibited by diphenyliodonium (DPI). DPI is known to inhibit
type 2 NADH:quinine oxidoreductase (NDH-2), which is proposed to catalyze the reduction
of pMMO through the reduction of a pool of endogenous quinones. These reducing
equivalents may arise from oxidation of formaldehyde and formate during metabolism
(Figure 116). Alternatively, methanol dehydrogenase and the cytochrome bc1 complex have
also been implicated as having possible involvement in the electron transfer process. The
former proposal is based on the observation of increased pMMO activity when copurified
with 63 and 8 kDa polypeptides, where the 63 kDa polypeptide may be methanol
dehydrogenase. The cytochrome bc1 complex may reduce pMMO through ubiquinone 8, a
hypothesis based on the copper induced coexpression of pMMO and the cytochrome b-
linked FalDH. A putative docking site for electron transfer agents, which consists of several
negatively charged residues, has been observed by X-ray crystallography (Section 3.5.3).685
pMMO from M. trichosporium OB3b is inhibited by the aerobic addition of H2O2.691 This
was determined by the observation that the addition of catalase to pMMO reduced with
duroquinol increased the activity of pMMO. H2O2 inhibition could also be reversed by the
subsequent addition of catalase.
Studies of sMMO have benefited from a large body of kinetics data using radical clock type
probes; however, little data of this type have been accumulated for pMMO. Furthermore,
single-turnover reactivity has yet to be addressed for pMMO, and therefore little is known
about the catalytic cycle. Using chiral ethanes and butanes,697 Chan and coworkers have
observed complete retention of stereochemistry upon hydroxylation and a kH/kD kinetic
isotope effect of 5.2–5.5 at 30 °C.698 Further study indicated that, for multicarbon alkane
chains, pMMO preferentially oxidizes at the C-2 position.699 Also, no
intermolecular 12C/13C kinetic isotope effect was observed for pMMO initiated propane
hydroxylation at the secondary carbon (no 12C/13C isotope effect was found for sMMO
either), which was interpreted as indicating that there is very little transition state structural
change at the carbon center involved in the oxidation.700 Alkene epoxidation of cis- and
trans-but-2-ene by pMMO yielded only the meso and d,l-2,3-dimethyloxirane products,
which led the authors to favor an electrophilic syn addition across the double bond.699 With
these data, Chan and coworkers argue that methane oxidation by pMMO occurs via a
concerted, direct O-atom (or oxene) insertion mechanism (vide infra, Section 3.5.5).700,701
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In order to unravel the mechanism of pMMO, further single turnover kinetics data,
activation energies, and trapping intermediates will be important.
3.5.3 Structure—X-ray crystal structures of pMMO have been reported for both the M.
capsulatus (Bath)685 and M. trichosporium OB3b658 enzymes at resolutions of 2.8 and 3.9
Å, respectively. We first address the Bath structure and then highlight important differences
between the M. capsulatus Bath and M. trichosporium OB3b structures. pMMO is found to
crystallize as a trimer, as mentioned above, consisting of three copies each of the pmoB,
pmoA, and pmoC subunits, which together form an α3β3;3 polypeptide arrangement (Figure
117). The trimer is ~105 Å in length and ~90 Å in diameter with a large hole at its center.
The three pmoB subunits form the soluble region, which consists of six β-barrels, two from
each protomer, and extends ~45 Å from the membrane region (Figure 117). The pmoA and
pmoC subunits comprise the majority of the membrane region, which is spanned by 42
transmembrane helices, 14 from each protomer. The hole is ~11 Å in diameter in the soluble
region and expands to ~22 Å on its way through the intramembrane space. Hydrophilic
residues (e.g., glutamic and aspartic acid and arginine) line the inside of the hole in the
soluble region while hydrophobic residues line the hole in the membrane region. The
hydrophilic residues are not conserved, however.
A single protomer is shown in Figure 118a. It contains one copy each of pmoA, pmoB, and
pmoC. A single subunit of pmoB, shown in Figure 118b, consists of two anti-parallel β-
barrels (one seven stranded, the other eight) located at both the N-terminus and C-terminus.
These β-barrels are roughly perpendicular to one another and are separated by a β-hairpin
and two transmembrane helices. pmoA and pmoC are shown in Figure 118c and Figure
118d, respectively. pmoA is made up of seven transmembrane helices, which pack against
the two from pmoB. Some of these helices are parallel to the membrane while others are
tilted. The five transmembrane helices of pmoC are parallel to the membrane.
pmoB was found to contain two distinct metal sites: one mononuclear copper center and one
binuclear copper site. The mononuclear copper center is located ~25 Å above the membrane
near the N-terminal β-barrel surface (Figure 118a and b) and is coordinated via δ-N atoms of
His48 and His72 in a close to linear fashion (Figure 119A). Another residue, Gln404, is
within 3 Å of copper. No solvent ligands could be discerned at 2.8 Å resolution. Neither
His48 nor Gln404 are conserved across all pmoB subunits, and this results in different metal
contents across pMMOs (vide infra). Also contained within the pmoB subunit is a binuclear
copper site (Figure 119B), found to be ~10 Å from the lipid bilayer interface (arrow, Figure
118a). The Cu-Cu distance was refined to ~2.6 Å, in good agreement with EXAFS
experiments (vide infra, Section 3.5.4). One copper is coordinated by both the δ-N and N-
terminal amino nitrogen of the N-terminus His33 residue (the first 32 residues have been
proposed to be part of a leader sequence) while the other copper is coordinated by both the
δ-N and ε-N of His137 and His139, respectively–two highly conserved residues in various
pMMOs. pmoC contains the third metal binding site in the crystal structure. This site, ~19 Å
from the binuclear copper site, contains zinc (Figure 118a, just beneath arrow). The Zn2+
coordination environment is represented by a distorted tetrahedron made up of by the
conserved residues Asp156, His160, and His173 from pmoC and Glu195 from pmoA
(Figure 119c). The authors contribute the presence of zinc in this site to zinc acetate derived
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from the crystallization buffer because of the virtual absence of zinc measured by
inductively coupled plasma atomic emission spectroscopy (ICP-AES) before crystallization.
The possibility of other metal binding sites was not fully ruled out. Chan et al have used the
crystal structure to model a trinuclear copper cluster in a site ~13 Å from the ‘zinc site’,
termed ‘Site D’ (Figure 120).702 The presence of this cluster was considered on the basis of
metal stoichiometry and spectral data (vide infra, Section 3.5.4). This putative metal binding
site is composed of a number of hydrophilic residues from the pmoA subunit (His38, Met42,
Met45, Asp47, Trp48, Asp49, and Glu100) and one from the pmoC subunit (Glu154). Chan
et al proposed that the lack of metals in this site in the crystal structure was due to loss of
copper during purification. In summary, the X-ray crystallographic results for M. capsulatus
(Bath) pMMO show that the enzyme contains both a mononuclear and a binuclear copper
site located within the soluble pmoB (spmoB) subunit, a possible third metal binding site in
pmoC, and a hydrophilic pocket that may house other metals.
The X-ray crystal structure of M. trichosporium OB3b shows interesting correlations to that
of M. capsulatus (Bath). There was also a Cu-Cu interaction in this structure (~2.52 Å);
however, the mononuclear copper site which was present in M. capsulatus (Bath) (in the
pmoB subunit) is not found in pMMO from M. trichosporium OB3b as the ligands of this
metal site are not conserved. The third metal binding site (zinc site) present in M. capsulatus
(Bath) was found to be occupied by copper in M. trichosporium OB3b. Here, copper is
coordinated by the same ligands found for the ‘zinc site’ in M. capsulatus (Bath) (ligands
are conserved). Lastly, similar to the Bath enzyme, no copper was found in site D.
Recently, a 2.68 Å X-ray crystal structure of Methylocystis species strain M (type II) has
appeared and is the highest quality structure yet determined.703 It shows structural
similarities to both M. capsulatus (Bath) and M. trichosporium OB3b in that it contains a
binuclear copper site (although not all pmoB subunits bind two copper ions, but instead
contain only one (vide infra)), a ‘zinc site’ (pmoC), and no mononuclear site (pmoB subunit)
(Figure 121A). Furthermore, the overall trimeric structure is maintained; however this
structure has led to revised models of the pmoA and pmoC subunits and the coordination
geometry of the ‘zinc site’ in the M. capsulatus (Bath) structure. The pmoB subunit structure
in Methylocystis species strain M is very similar to other pMMOs; however, two of the three
binuclear active sites of the trimer were modeled as containing one copper ion. The lack of
the second copper ion in these sites was proposed to be due to the increased lability of
copper. The structure also revealed that part of pmoA in the Bath enzyme structure was
actually from pmoC. An overlay of pmoA from the Methylocystis species strain M and the
original M. capsulatus (Bath) structures are shown in Figure 121B. A difference was
observed at Thr196 (Thr191 in M. capsulatus (Bath) pmoB), which is labeled in Figure
121B, where it extends along the membrane (on the periplasmic side) and is connected to a
transmembrane helix (residues 217–244) and terminates at residue 252 (on the cytoplasmic
side of the membrane). This is different from the structure from Bath, in which Thr191 is
modeled as continuing through the membrane to the cytoplasmic side and winds up toward
the periplasmic side (overlaid with residues 217–244 of Methylocystis species strain M).
This difference in traces indicated that residues 195–215 in the M. capsulatus (Bath)
structure belonged to pmoC, which now makes them residues 178–197 of Methylocystis
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species strain M pmoC. Furthermore, the residues 225–252 of pmoC from Methylocystis
species strain M (Figure 121C) were proposed to derive from a yet to be identified
polypeptide. Because the extra helix is not observed in the Bath enzyme (Type X) and is
also observed in the OB3b enzyme, it was suggested that it may be related to type II
methanotrophs. The M. capsulatus (Bath) structure was resolved using this model as a
starting point and resulted in a higher quality fit. Also, instead of Asp156, His160, and
His173 from pmoC and Glu195 (M. capsulatus (Bath) numbering) from pmoA being bound
to zinc, this structure showed that zinc was bound by only Asp129, His133, and H146 from
pmoC. Glu200 (Methylocystis species strain M numbering) from pmoA is H-bonded to
pmoB residues. A fourth ligand was modeled as water, but possible partial occupation of
this ligand binding site by a disordered side chain was not ruled out because of the poor
electron density in this region and the fact that residues 197–225 could not be modeled. This
structure shows that the ‘zinc site’ is now exposed and resides along the wall of the hole in
the center of the trimer.
The hydrophobicity of a protein pocket adjacent to the binuclear site has led to the
suggestion that it may support methane binding.691 This pocket is lined with hydrophobic
residues (Pro94 from pmoB and Leu78, Ile163, and Val164 from pmoC). Other aspects of
the protein structure have been used to make observations concerning putative electron
donors. As mentioned in Section 3.5.2, the in vivo electron donor is not known for pMMO.
It was noted previously that there was a section of non-protein derived, strong electron
density found close to the interface of the pmoB β-barrels (Figure 122, Left).685 This density
was overlaid with the structure of a duroquinol molecule, and it was suggested that quinols
derived from exogenous quinones could bind in this region. Also, Figure 122, Right shows a
surface representation of the electrostatic potential of a pMMO protomer. A negative (red)
patch made up of acidic residues from both the pmoB and pmoC subunits is located in the
soluble region. This patch of density is near the binuclear copper site in the pmoB subunit
and was compared to the proposed cytochrome c docking site in cytochrome c oxidase.704
It is also interesting to compare the binuclear copper site found in pMMO to those observed
for the other coupled binuclear copper sites in hemocyanin and tyrosinase (Section 3.1 and
3.2), as well as the T3 site in the MCOs (Section 3.7.1). In pMMO, the protein only provides
two nitrogen-based ligands to each copper, whereas three histidine-derived ligands to each
copper are present in the other binuclear copper sites. Furthermore, the Cu-Cu distance in
pMMO is very short (~2.6 Å) relative to hemocyanin (~4 Å), tyrosinase (~3.5 Å), and the
T3 site in the MCOs (~6 Å) in their deoxy states. The function of protein constraints on the
ligand field geometry of the coppers and the initial Cu-Cu separation has already been
shown to play a functional role in the differences in O2 activation (or reversible binding)
across these related active sites (e.g. the close Cu(I)-Cu(I) distance in hemocyanin relative to
the T3 site provides the driving force for O2 binding in the former). Some experimental data
concerning O2 (and/or H2O2) activation at the binuclear site in pMMO exist and are
summarized in Section 3.5.4.
As mentioned in Section 3.5.1, copper uptake and acquisition is accomplished by mb.
Despite being difficult to isolate and purify, several different types of mbs have been
identified, although only a couple have been fully structurally and chemically characterized.
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The 0.92 Å resolution X-ray crystal structure of mb from M. trichosporium OB3b is shown
in Figure 123.684 The exact mass has been determined from mass spectrometry to be
1215.1781, with the molecular structure of 1-(N-[mercapto-{5-oxo-2-(3-
methylbutanoyl)oxazol-(Z)-4-ylidene}methyl]-Gly1-L-Ser2-L-Cys3-L-Tyr4)-pyrrolidin-2-yl-
(mercapto-[5-oxo-oxazol-(Z)-4-ylidene]methyl)-L-Ser5-L-Cys6-L-Met7
(C45H56N10O16S5Cu−).678,681 Other forms of fully structurally characterized mbs vary
slightly.683 Cu(I) is bound in a distorted tetrahedron by two nitrogen (~2.0 Å) and two sulfur
ligands (~2.4 Å) provided by the two non-amino acid moieties (oxozolone rings), which
each contribute one nitrogen and one sulfur ligand (Figure 123). The sulfur ligands are
modeled as thionyl groups (C=S-Cu) as opposed to thiolates (C-S-Cu).
3.5.4 Electronic Structure—In this section, we first briefly review the spectral features
of mb, then focus on the spectral data of pMMO. Because of the controversial nature of the
active site and its rationalizations based on the reported spectroscopy, we briefly summarize
these spectral data and the proposed structures, but focus more on the data that directly
relate to the M. capsulatus (Bath) and M. trichosporium OB3b crystal structures (Section
3.5.3).
To date, absorption data for apo-mb have been reported for M. trichosporium OB3b from
various preparations with only subtle differences.678,679,683,684,705,706 They show several
features in the 200–400 nm region. From low to high energy, these features have been
assigned to the oxazolone rings and the thionyl functionalities. Small contributions in the
higher energy region (<300 nm) may also occur from the disulfide linkage as well as the
phenolic group of the tyrosine residue.679 The absorption spectra do show variability with
addition of Cu(II), pH, and UV light exposure.678 Fluorescence data at various wavelengths
have been reported as well, and have been shown to be quenched upon addition of
Cu(II).678,706 As mentioned in Section 3.5.1, Cu(I) is bound in mb, despite Cu(II) loading.
The source of the reducing electron is not currently known, but structural, analytical, and
spectroscopic methods have been able to rule out the S(Cys) residues or disulfide linkages of
the copper binding molecule or a ‘sacrificial’ pool of mb molecules which form disulfide
linkages.679,680,684 In addition, the origin of high binding affinity for Cu has not been
determined and no electronic structure calculations have appeared. A bonding analysis for
copper mb would be important in determining the origin of the high affinity for copper and,
possibly, whether or not the ligand donates the reducing equivalent upon Cu(II) binding.678
mb can also bind other metals, but with a reduced affinity relative to Cu.707
As opposed to sMMO, the study of pMMO has not benefited from a large body of
spectroscopic data on different forms of the enzyme, and no catalytic intermediates have yet
been observed. This is due mostly to the difficulties associated with handling and purifying
pMMO, which has led to a number of different preparation protocols to be implemented and
reported in the literature. Not surprisingly, the metal contents and stoichiometries of these
preparations vary considerably. Tabulations provide a summary of these various
preparations and the resultant metal analyses.656,686 Some spectroscopic data do exist on
these different samples, and they have been used to generate hypotheses of the active site
structure of pMMO. Chan and coworkers, with samples containing 13.6 Cu per 100 kDa,
observed a broad, isotropic EPR signal at g ~2.1. This signal was superimposed with a type
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2 EPR signal (g∥ = 2.24 and g⊥ = 2.059), which exhibited hyperfine coupling (190 × 10−4
cm−1). The g ~2.1 signal was assigned to a ferromagnetically coupled trinuclear Cu
cluster,708 while the type 2 signal was proposed to arise from a separate trinuclear Cu(II)
cluster containing two antiferromanetically coupled Cu(II)’s.709 When combined with the
Cu stoichiometry, Chan and coworkers proposed pMMO housed five trinuclear Cu clusters:
3 E-clusters, which function as ET conduits, and two catalytic C-clusters.689 Note that the
appearance of the X-ray crystallographic data led to the revision of this original assignment
to a single catalytic trinuclear Cu center, which was modeled into the M. Capsulatus (Bath)
crystal structure (vide supra, Section 3.5.3)702 (Chan and coworkers also pointed out that the
other C-cluster could also be mononuclear or binuclear copper). Other groups have not been
successful in reproducing the broad, isotropic g ~2.1 signal, but do observe the type 2 EPR
signal.670,675,694,695,710 Alternative interpretations of the g ~2.1 EPR signal have been
suggested.675,694,711,712 Other propositions for the active site structure in pMMO include a
Cu/Fe site,675 a binuclear iron site,713 or a binuclear copper site.685,695 The Cu/Fe
proposition by DiSpirito and coworkers was due to the observation that pMMO activity
increased upon addition of Fe(III) to M. trichosporium OB3b membrane preparations
isolated from cells grown at low iron concentrations. Mössbauer data indicated the presence
of a binuclear Fe(III) center, which was observed to be diamagnetic and thus
antiferromagnetically coupled. The binuclear iron site was proposed to reside in the
crystallographic ‘zinc site’ in M. Capsulatus (Bath).
Before the crystal structure in 2005, Rosenzweig et al suggested pMMO from M.
Capsulatus (Bath) contained both a mononuclear copper site and a copper containing
cluster.695 In that study, the XANES exhibited features indicative of both Cu(I) and Cu(II)
in as-isolated pMMO (pMMOiso). The Q-band EPR data for purified and membrane bound
pMMO are given in Figure 124, Left. The spin Hamiltonian parameters were reported to be
g∥ = 2.24, g⊥ = 2.05, A∥ = 177 × 10−4 cm−1. Integration of the X-band EPR signal indicated
that this species accounted for 40–50% of the total copper present (Note a variety of
methanotrophs display this type 2 EPR signal). The intensity of this EPR feature did not
increase upon ferricyaninde addition, but did go away entirely upon addition of dithionite.
The EXAFS data indicated a Cu-metal interaction, which was best fit to a 2.57 Å Cu-Cu
interaction. Another study has provided more information on the nature and oxidation state
of the metal sites in purified pMMO.714 Again, the XANES indicated the presence of both
Cu(I) and Cu(II) in the as-isolated sample (Figure 124, Middle; note that the 8984 eV
feature is characterstic of Cu(I) (see Section 2.1). The intensity of the Cu(I) feature
increased upon reduction and decreased slightly with the addition of H2O2, although it did
not disappear entirely. EPR spin quantitation indicated that ~40 % of copper in pMMOiso
and oxidized (pMMOox) was EPR active. As observed before, this type 2 signal went away
upon reduction. It also did not increase in intensity upon H2O2 addition. EXAFS data for
pMMOox, pMMOiso, and pMMOred are given in Figure 124, Right. Single first shell fits to
these data gave Cu-O/N bond lengths of 1.95, 1.97, and 2.11 Å for pMMOox, pMMOiso, and
pMMOred, respectively. Addition of a split first shell Cu-O/N ligand environment improved
the fits. The bond distances for pMMOred and pMMOox were within the range of 1.93–2.11
Å. However, the Cu-O/N ligand environment in pMMOiso was best fit with inclusion of a
bond at 2.22 Å in addition to 1.97 Å. Fits were further improved when scattering
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interactions at >2.5 Å were included. This resulted in a Cu-Cu bond length of 2.51 Å (a
refinement of the previously reported 2.57 Å) for pMMOiso and pMMOox. This increased to
2.65 Å in pMMOred. Furthermore, the Fe EXAFS data reported in this study did not yield an
iron-metal scattering in the 2.5–2.65 Å range, which ruled out a Cu/Fe site. The very low
intensity (~3 % of the Cu edge) observed in the Zn fluorescence region was used to rule out
the presence of zinc in the ‘zinc site’ observed in crystallography, which indicated that this
site was loaded with either copper or another metal. The EPR data (Q-band, 2K) also
indicated that the iron present in these samples corresponded to high-spin ferric heme
impurities (g⊥ = 6.00 and a g∥ feature that could not be observed due to overlap with the
copper-based signals).
Spectral data relative to the OB3b enzyme crystal structure have been reported (i.e. purified
M. trichosporium OB3b, three Cu/protomer and no iron or zinc).658 The X-Band EPR
spectra are given in Figure 125, Left. These contained contributions from two species: a
major component (g∥ = 2.247, g⊥ = 2.052, A∥Cu = 196 × 10−4 cm−1) and a minor component
(g∥ = 2.225 and g⊥ = 2.060 with an A∥Cu very similar to the major component). The relative
amount of the two components was not determined, but it was estimated that the major
component made up at least 80% of the total copper present. Cu XANES data are given in
Figure 125, Middle, and showed that purified M. trichosporium OB3b contained a mixture
of Cu(I) and Cu(II). EXAFS data (Figure 125, right) were best-fit with a Cu-O/N ligand
environment with 1.97 Å bond lengths and a Cu-Cu distance of 2.52 Å.
A limited set of spectroscopic data do exist on variants (obtained by site-directed
mutantagenesis) available in pMMO from a heterologous expression system in E. coli (vide
infra, Section 3.5.5).659 These are given in Figure 126, Left. Fits to the EXAFS data for
spmoB (Figure 126, Left, A and B) yielded a Cu-O/N environment with bond lengths of
1.95 Å and a Cu-Cu interaction at 2.53 Å. The XAS edge data on spmoB (Figure 126, Right)
indicate that all copper is present in the reduced state, despite loading Cu(II). The source of
the electron was not determined, nor was the possibility of photoreduction ruled out. The
Cu-Cu interaction at 2.53 Å in spmoB is shorter than that found in pMMOred (2.65 Å).
Some spectral data exist for the enzyme variants spmoB_H48N and spmoB_H137,139A
(Figure 126, Left, (C,D) and (E,F) and Figure 126, Right, (B,C)). The former was designed
to eliminate the mononuclear copper site (this is the copper site that is not present in the
OB3b enzyme, but is present in the Bath enzyme) and the latter to eliminate the binuclear
copper center (vide infra, Section 3.5.5). The XAS data on the these variants indicate that
copper is present as a mixture of Cu(I) and Cu(II) (Figure 126, Right). The EXAFS data for
spmoB_H48N were best fit with a Cu-O/N ligand environment of 1.96 Å and a Cu-Cu
distance of 2.52 Å. The presence of a binuclear copper site in spmoB_H137,139A was ruled
out by the fact that, upon including a second shell, the fits were best when carbon was used
as a scatterer rather than copper.
Thus, the current, most favored situation for the oxidation states of the metal ions in
pMMOiso from the combination of the X-ray crystallography and spectroscopy is that the
binuclear copper site is in a localized mixed-valence Cu(I)Cu(II) state.657 Since reduction
eliminates the type 2 EPR signal and the Cu-Cu distance increases from 2.51 to 2.65 Å, this
signal is thought to be associated with the mixed-valent binuclear copper site. Thus, the
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binuclear copper site would be in a Cu(I)Cu(I) state in the fully reduced enzyme, which is
important for further development of the mechanism of methane oxidation (vide infra,
Section 3.5.5). The copper bound in the mononuclear and ‘zinc site’ would then be either
Cu(I) or Cu(II). Note that the assignment of the Cu(II)Cu(I) site as localized mixed-valent
(vide supra) is difficult to rationalize due to the short Cu-Cu distance (2.51 Å). This short
distance leads to a direct overlap of the Cu 3d orbitals and will strongly favor a delocalized
Cu(1.5)Cu(1.5) site. It is also interesting to note that the assignment as localized mixed-
valent comes from the lack of the observation of a seven-line hyperfine pattern. An
analogous situation occurs in CuA, which is a fully delocalized mixed-valent Cu(1.5)Cu(1.5)
site (vide infra, Sections 3.7.2 and 5.2), where upon lowering the pH from 7 to 5 the seven-
line hyperfine pattern collapses into a four-line pattern.59,715 Originally, this was thought to
reflect a transition from a delocalized to a localized mixed-valent state; however, in CuA,
lowering the pH from 7 to 5 resulted in the loss of a His ligand due to protonation and
allowed a small amount of 4s mixing on one of the coppers.716 This mixing is responsible
for the change in the EPR spectrum, but the site remains fully delocalized (from ENDOR
and rR spectroscopy) due to the strong Cu-Cu interaction. If the binuclear site in pMMO is
mixed-valent, a possibility such as this has yet to be ruled out. Further spectroscopic study
of pMMO in various oxidation states should further elucidate the nature of the metal sites in
pMMO.
Some spectroscopic data suggest H2O2 and/or O2 may bind at the binuclear copper site.717
Anaerobic reaction of reduced pMMO (solubilized) with H2O2 (incubated overnight at room
temperature) resulted in the formation of an absorption band at 345 nm (ε not reported)
(Figure 127 (left)). This absorption band does not form using O2 instead of H2O2. The same
experiments were carried out in spmoB and the spmoB_H48N, spmoB_H137,139A, and
spmoB_H48N_H137,138A variants. For reduced spmoB, addition of O2 and H2O2 both
result in the formation of 345 nm absorption feature (ε ~10 000 M−1cm−1) (Figure 127
(middle)). Titration data indicated binding of two molecules of H2O2 per spmoB. Only the
spmoB_H48N variant was capable of forming the 345 nm band with O2 and H2O2 (Figure
127 (right)). Furthermore, incubation of CH4 and the spmoB samples in which the 345 nm
band was formed (1h and 45 °C) resulted in a loss of absorption intensity, which was
proposed to indicate that the 345 nm species is involved in the CH4 oxidation pathway.
However, it should be noted that protein degradation occurred during this process and
inhibited the monitoring of the absorption feature with time. The results of a similar
experiment without CH4 were not reported. The absorption band energy and ε of these Cu2-
H2O2/O2 derived species are all consistent with the formation of the following: 1) µ-η2-η2-
peroxo-Cu(II)2; 2) met-Cu(II)2; and 3) hydroxo-bridged Cu(II)2 type 3 site. These results
support the fact that Cux/Oy species can be formed at the binuclear copper site in both
solubilized pMMO and spmoB. Further studies are needed to determine whether they are
involved in catalysis. Lastly, also interesting are possible comparisons between the results
presented here and those for the O2 activation of Cu-ZSM-5, the only binuclear copper
model capable of methane oxidation, where a µ-η2-η2-peroxo-Cu(II)2 is the precursor to a
mono-(µ-oxo) dicopper(II) reactive intermediate (vide infra, Section 3.5.5).718
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3.5.5 Mechanism
3.5.5.1 Methane Oxidation by pMMO: Recently, a study by Rosenzweig and coworkers
has addressed the location and nature of the active site for CH4 oxidation in pMMO, and
builds on this group’s report of the 2.8 Å X-ray crystal structure of pMMO from M.
capsulatus (Bath) (vide supra, 3.5.3).659 Using a series of variants from site-directed
mutants, the authors showed that methane oxidation occurs at the binuclear copper site in the
soluble domain of the pmoB subunit.
Specifically, the as-isolated pMMO sample in membranes had a specific activity of 50–200
nmol propylene oxide mg−1 min−1.659 Cyanide treatment to remove metal ions eliminated
all activity in the propylene epoxidation assay. Reconstitution of apo pMMO with 2–3
equivalents of copper/100 kDa pMMO protomer restored ~70 % of the propylene
epoxidation activity. The ability for these samples to oxidize methane was also investigated.
The as-isolated pMMO samples had a specific activity of 22.9 ± 6.1 nmol methane mg−1
min−1. Reconstitution with copper after cyanide treatment restores ~90 % of the activity
(21.7 ± 3.5 nmol methane mg−1 min−1). Addition of iron under either aerobic or anaerobic
conditions to the apo pMMO, however, does not form an active enzyme. This was taken as
evidence that copper, not iron, is contained in the active site of pMMO.659
With the knowledge that copper is the metal in the active site, the authors showed that the
location of the active site is in the spmoB subunit, specifically, spmoBd1 (the amino (N)-
terminal cupredoxin domain; residues 33 – 172, contains both the binuclear and
mononuclear copper sites).659 The soluble domains of the pmoB subunit were expressed in
E. coli. spmoB, spmoBd1, and spmoBd2 (the carboxy (C)-terminal cupredoxin domain;
residues 265 – 414) load copper in quantities of 2.84 ± 0.66, 1.59 ± 0.84, 0.24 ± 0.09,
respectively. spmoB loads 0.17 ± 0.1 iron ions per protein. (The low copper loading value of
1.59 ± 0.84 for spmoBd1 is attributed to protein instability due to loss of stabilizing contacts
(i.e., H-bonds and hydrophobic contacts) between spmoBd1 and spmoBd2). Both propylene
epoxidation and methane oxidation activity were measured for these samples. The results are
summarized in Figure 128, in which activity is given as the percentage of activity as
compared to the activity of as-isolated, membrane-bound M. capsulatus (Bath) pMMO. The
specific activity for propylene epoxidation by spmoB was reported to be 30.2 ± 10.5 nmol
propylene oxide µmol−1 min−1 (note change in units), while the same assay under similar
conditions for as-isolated pMMO yielded 51.1 ± 11.3 nmol propylene oxide µmol−1 min−1.
For methane oxidation, spmoB yielded 203.1 ± 20.2 nmol methanol µmol−1 min−1, and the
as-isolated pMMO yielded 325.1 nmol methanol µmol−1 min−1. spmoBd1, which houses
both the mononuclear and binuclear copper sites, showed activity in both assays: 8.1 ± 3.7
nmol propylene oxide µmol−1 min−1 and 19.3 ± 4.7 nmol methanol µmol−1 min−1. Neither
the spmoBd2 nor the iron loaded spmoB showed activity for either assay. These data
eliminated the possibility that a binuclear iron site in the zinc crystallographic site or a
trinuclear cluster in the intramembrane space could represent active sites for methane
oxidation in pMMO.659
To distinguish between the mononuclear and binuclear site being responsible for methane
oxidation, the authors also studied several site directed mutants of spmoB. The
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spmoB_H48N variant, which eliminates the mononuclear copper site, binds 1.86 ± 0.52
copper ions per protein and had specific activities for propylene epoxidation and methane
oxidation of 2.3 ± 0.4 and 14.8 ± 9.2, respectively. The spmoB_H137,139A and
spmoB_H48N_H137,139A double and triple variants, which eliminate only the binuclear
and both the binuclear and mononuclear copper sites, respectively, both bound copper ions
(0.73 ± 0.15 and 0.82 ± 0.36, respectively), yet had no measurable activity. Interestingly, the
authors note removal of the mononuclear copper site does not completely eliminate activity,
even for the methane oxidation assay. These results show that the binuclear copper site can
oxidize methane to methanol in pMMO. Now, it remains to determine the mechanism for
this important reaction in pMMO.
Since no intermediates have been identified in pMMO to date, the current insight into the
mechanism of pMMO has largely been derived from models–both experimental and
computational. Below, we first summarize the computational studies that have appeared and
follow with a description of the one well defined copper active site model for the methane to
methanol conversion–specifically the zeolite Cu-ZSM-5.
3.5.5.2 DFT Calculations of C-H activation of methane by CuxOy Complexes: Quantum
chemical calculations related to pMMO have mainly focused on evaluating the reactivity of
a few CuxOy species. These structures are encompassed by trinuclear (5, considered to be a
copper cluster where O2 is reduced to a µ3 and a µ2 oxo), binuclear (2, 3, and 4), and
mononuclear (1) copper complexes and are presented in Table 25. Methane oxidation has
been modeled with two reaction mechanisms: concerted oxene insertion and hydrogen atom
abstraction (Figure 129). The experimental data presented in Section 3.5.2 that indicate the
presence of a KIE (5.2 ± 0.4 for [1-3H1,2H1]ethane and 5.5 ± 0.7 for [1-3H1,2H1,
2-2H3]ethane at 30 °C) and complete retention of stereochemistry for alkane hydroxylation
have been used to argue for a concerted oxene insertion. However, these data cannot rule out
a hydrogen atom abstraction mechanism. Of the structures in Table 25, 1, 3, and 4 were used
to evaluate a hydrogen atom abstraction mechanism. Of these, 4 had the lowest calculated
activation energy at 9.5 kcal/mol. 4 is disfavored relative to 3, however, because of the
higher energy of formation, and 1 can be eliminated as it is formed at the mononuclear
copper site, which is not conserved across pMMOs. Therefore, a hydrogen atom abstraction
mechanism is most viable for intermediate 3. However, higher energy transition states are
found in the complete reaction profile for 3. These represent C-O bond formation and
rebound, which predicts a rate-limiting step other than C-H bond cleavage, in disagreement
with the KIE for ethane hydroxylation.
A concerted oxene insertion has been evaluated for 2, 3, and 5. The activation energy for 2
is 44.0 kcal/mol719 (a barrier of 21.0 kcal/mol has also been reported;720 however, these
calculations were performed using a spin restricted methodology, so the number is not likely
reliable as the transition state should be spin polarized), which is much too high to represent
the reactive species in the mechanism of pMMO. Activation energies of 21.7 and 15.0
kcal/mol have been reported for 3 and 5, respectively (a barrier of 40.5 kcal/mol has also
been reported for 3. Here, upon formation of the transition state, a Cu-NH3 bond is lost
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while a Cu-CH3 bond is formed, which likely contributes to the high energy of this
transition state). Thus, the oxene insertion mechanism favors 5.
It is difficult to draw conclusions based on the computational results reported thus far. In
only one case are the activation energies for both mechanisms reported for one structure (3).
More specifically, the hydrogen atom abstraction mechanism has yet to be considered for 2,
which is known to abstract hydrogen from alkyl C-H bonds. Furthermore, low reaction
barriers can be obtained when high energy reactants are generated, which is the case for 4.
In summary, computational studies have yet to establish insight into the activation of a
binuclear copper site for reaction with inert C-H bonds of substrate. That is, what geometric
and electronic properties of the reactant, transition state, and product contribute to the
thermodynamics (i.e., O-H bond strengths) and the activation energy of the reaction (i.e.,
FMOs).
3.5.5.3 pMMO Active Site Models: Only very recently have copper containing molecular
models been made that can oxidize methane to methanol. A series of tricopper complexes
have been shown to oxidize hydrocarbons,722,723 including methane.724 Heterogeneous
systems, such as zeolites, offer alternatives for the study of the methane to methanol
conversion by copper active sites.39,725,726 Zeolites are microporous materials that can be
impregnated with metal ions. Dioxygen (as well as N2O and NO) can be used as a reagent
for the generation of reactive, yet well isolated, Mx/Oy species in the zeolite channels. In
many ways, this resembles the strategies adopted by Nature in the function of
metalloenzymes. The protein structure directs substrate access and guidance to a reactive
species, the formation and isolation of which is well controlled in order to prevent
deleterious side reactions with the protein. This active site isolation allows for the direct
spectroscopic study of molecular structures that would be very difficult to generate, trap, and
study in solution. This approach makes heterogeneous structures such as the zeolites or
metalorganic frameworks (MOFs) a powerful approach to studying reactive Mx/Oy species.
The interaction of O2 with various transition metal ion-containing zeolites has recently been
reviewed.727 Despite these attractive properties, however, one problem in studying zeolites,
as well as heterogeneous catalytic systems in general, is that the active site usually
represents a minority species, constituting only ~5% of the total metal content. This presents
a unique problem relative to the spectroscopic study of metalloproteins, in which the metal
cofactor is present in only ~0.2 weight % but in a spectroscopically silent (between 280 nm
and 2 µm and diamagnetic) protein background. In order to gain insight into the active site in
these systems, a direct spectroscopic handle on the active site and its reactivity is required
(vide infra).
The zeolite frameworks which are currently known to selectively oxidize methane include
ZSM-5, mordenite (MOR), ferrierite (FER), and beta (BEA).726 Both O2 as well as N2O
activated Cu-ZSM-5 and N2O activated Fe-ZSM-5 (O2 does not activate Fe-ZSM-5) can
oxidize methane into methanol at low temperature (100–150°C). Cu-MOR can oxidize
methane at 150°C as well, but there is an increase in methanol yield when reaction
temperatures reach 200 °C. This result has been ascribed to the presence of a second, less
reactive core in Cu-MOR. Both the Cu-FER and Cu-BEA require reaction temperatures
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above 200°C. The nature of the reactive species in zeolite-based systems has remained
elusive; however, recently the formation and reactivity of the reactive species in Cu-ZSM-5
have been elucidated in some detail.39,718 We review these results here.
Reduced Cu-ZSM-5 reacts with O2 at 450°C and produces an intense absorption feature at
22,700 cm−1 (~440 nm) (Figure 130 Inset A) due to the formation of a Cux/Oy species. This
O2 derived active oxygen species was shown to stoichiometrically oxidize methane into
methanol at temperatures as low as 100°C. Upon exposure to CH4, the 22,700 cm−1 band is
eliminated and CH3OH is produced. The low energy of the absorption band combined with
EXAFS data (Cu-Cu distance of 2.87 Å) were initially used to assign this species as a bis(µ-
oxo)dicopper(III,III) core (see Section 3.2).728 However, from the analysis of the amount of
methanol formed, it was estimated that only ~5% of copper existed in the activated
form,725,726 thus making the EXAFS results irrelevant as this is a bulk spectroscopic
method. Also, an absorption band does not elucidate the nature of a species. In order to
definitively define the methane oxidizing active core in Cu-ZSM-5 an appropriate
spectroscopic method was needed. Laser excitation into the 22,700 cm−1 absorption band of
O2 activated Cu-ZSM-5 resulted in a very rich and informative resonance Raman spectrum.
The data obtained after 16O2 and 18O2 (which generates CH318OH) activation are given in
Figure 130. Isotope sensitivity is observed for features at 237 cm−1 (Δ(18O2) = 3 cm−1), 456
cm−1 (Δ(18O2) = 8 cm−1), 870 cm−1 (Δ(18O2) = 40 cm−1), 974 cm−1 (Δ(18O2) = 10 cm−1),
1725 cm−1 (Δ(18O2) = 83 cm−1), and 1852 cm−1 (Δ(18O2) = 52 cm−1). These vibrational
data immediately ruled out the previous assignment of a bis(µ-oxo) dicopper(III,III) species
due to the lack of an intense resonance enhanced 600 cm−1 vibration (See Table 26 for a
compilation of the vibrational data of known Cux/O2 species) and are also inconsistent with
either a µ-η2-η2 dicopper(II) (ν(Cu-Cu) at ~270 cm−1, ν(O-O) at ~750 cm−1) or Cu(II)-
superoxo (ν(O-O) at ~1,000–1,150 cm−1) species. However, due to the observation of the
870 cm−1 isotope sensitive vibration, the 16,18O2 data alone allowed the possibility that the
Cux/Oy core has an O-O bond as η1-hydroperoxide Cu(II), trans-µ-1,2-peroxo Cu(II), and
hydroperoxo 2Cu(II) species can contribute in this region (Table 26). However, these
alternatives were eliminated by using mixed-isotope O2 to activate Cu-ZSM-5 (a statistical
(1:2:1) mixture of 16O2:16/18O2:18O2). An O-O bond would show three vibrational features
with a 1:2:1 intensity distribution pattern with the frequencies of the 18O2, 16,18O2
and 18,16O2, and 16O2 at 830, ~850, and 870 cm−1, respectively, for Cu-ZSM-5. Activation
of Cu-ZSM-5 with mixed-isotope O2, however, resulted in the rR data in Figure 130 Inset B
green. These are identical to the 1:1 normalized sum of 16O2 and 18O2 (black), which
indicates that there is no O-O bond in the active species. Thus, the rR data ruled out all
known Cu/O2 structures in inorganic chemistry.
The most intense isotope sensitive feature was observed at 456 cm−1 (Δ(18O2) = 8 cm−1).
The 870 cm−1 feature (Δ(18O2) = 40 cm−1) had low intensity, while its second quantum, the
1725 cm−1 (Δ(18O2) = 83 cm−1) vibration, had an intensity that is six times higher than the
fundamental. This supported the assignment of the 456 and 870 cm−1 vibrations as
symmetric (νs) and antisymmetric (νas) stretches, respectively, of a mono-oxo group
bridging two copper centers. Note that even quanta of antisymmetric modes are symmetric
and rR allowed. Also, the energy of 2νas in 16O2 activated Cu-ZSM-5 was not exactly two
times νas (1740 cm−1 instead of 1725 cm−1). This difference is due to a Fermi resonance
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between the 18O-isotope sensitive fourth quantum of νs, which is predicted to be at 1,824
cm−1, and the 18O-isotope sensitive 2νas. Thus, the combination of an intense symmetric and
a weak antisymmetric stretch was used to unambiguously assign the active species in Cu-
ZMS-5 as a bent [Cu-O-Cu] core. The energy splitting of these symmetric and
antisymmetric vibrations and their isotope shifts via normal coordinate analysis gave a Cu-
O-Cu angle of ~140°. This represented the first definitive characterization of a mono-oxygen
bridged binuclear copper site in any system, synthetic, bioinorganic, or heterogeneous. It
should be noted that, from UV-Vis, rR, and reactivity data, the identical site also forms with
N2O.
Monitoring the disappearance of the 22,700 cm−1 absorption feature as a function of
temperature allowed for the determination of an activation energy of 15.7 ± 0.5 kcal/mol
(from Arrhenius plots of the reaction with CH4 between 110 and 200 °C). Reaction with
C2H4 resulted in an increased Ea of the reaction by 3.1 ± 0.5 kcal/mol. These data show that
O2 activated Cu-ZSM-5 performs H-atom abstraction of the strong C-H bond of methane
with a low barrier. The electronic structure contributions to the high reactivity of this core
were defined using spectroscopically calibrated DFT calculations. A Cu2O core with an
angle of ~140° was modeled in the 10-membered ring of the ZSM-5 lattice and fit with two
Al T-sites separated by two Si spacers (Figure 131). Both Cu(III)2O and Cu(II)2O models
were considered; however, the former was eliminated due to the fact that the singlet
wavefunction contained an internal instability. This relaxed the formally copper based holes
into the zeolite lattice to form a Cu(II)2O core and an electron deficient lattice. Thus,
calculations were conducted using a [CuAII-O-CuBII]2+ species in the ferromagnetically
coupled triplet state (predicted to be ~2 kcal/mol lower in energy than the
antiferromagnetically coupled singlet state). DFT calculations on this Cu(II)2O core
accurately reproduced the vibrations observed from rR spectroscopy as well as the energy of
the intense absorption feature (i.e. an oxo to CuII CT). A transition state for hydrogen atom
abstraction was found using this model. It had a calculated Ea of 18.5 kcal/mol, which
increased by 1.3 kcal/mol in the reaction with C2H4. These were in reasonable agreement
with experiment. It was therefore shown that the computational Cu(II)2O model in Figure
132 reproduced the low Ea determined experimentally for H-atom abstraction from CH4.
Complete hydrogen atom abstraction (addition of both a proton and an electron) generated a
delocalized [CuA-OH-CuB]2+ intermediate and a carbon centered radical. This step was
calculated to be endothermic by only 13.8 kcal/mol. This indicates that a strong O-H bond is
formed in this intermediate (~90 kcal/mol, calculated), which contributes to the low barrier.
Further insight into the contributions to the reactivity of this core came from an analysis of
the electronic structures of the transition state. It was found that there are two low lying
singly-occupied orbitals (SOMOs) of the Cu(II)2O core which contribute to the reactivity
and the low activation barrier for C-H bond cleavage (Figure 132A). Upon formation of the
transition state the frontier molecular orbitals (FMOs) of the [CuAII-O-CuBII]2+ core
becomes strongly polarized to a [CuAI-O−·-CuBII] “oxyl” species. This type of species,
although yet to be observed experimentally in model chemistry, would be highly reactive as
it has a low-energy unoccupied orbital with large O-character for overlap with the C-H
bond. Indeed, the top SOMO in Figure 132B reflects this, showing 24% O and 60% CH4
character, which is delocalized along the O-H-C vector. This strong orbital polarization at
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the transition state is responsible for the low activation energy for methane oxidation. Thus,
both Cu-ZSM-5 and pMMO oxidize CH4 at a binuclear copper active site, which makes Cu-
ZSM-5 a very promising molecular model of the reactivity of the enzyme.
A precursor to the mono(µ-oxo) dicopper(II) species in Cu-ZSM-5 has also been observed
and spectroscopically characterized, which allows for a direct correlation of the zeolite
model to binuclear copper enzyme chemistry.718 Reaction of reduced Cu-ZSM-5 with O2 at
room temperature yields a different absorption spectrum than when this reaction is carried
out at 450°C. Under low temperature conditions, a band at ~29,000 cm−1 was rapidly
formed (Figure 133A). Subsequent heating resulted in the direct transformation of the
~29,000 cm−1 band into the ~22,700 cm−1 band observed for the [Cu2O]2+ mono(µ-oxo)
(Figure 133B). The ~29,000 cm−1 feature does not form with N2O; only the ~22,700 cm−1
band is formed, even at RT. rR spectroscopy with laser excitation at 363.8 nm on a RT, 16O2
activated sample yields a spectrum with vibrational features at 269 and 736 cm−1 (Figure
134A, blue). Only the 736 cm−1 feature showed isotope sensitivity (Δ(18O2) = 41 cm−1).
The absorption and rR data are characteristic of a µ(η2-η2)peroxo dicopper(II,II) species
with the ~29,000 cm−1 band assigned as the π*σ to Cu(II) CT and the 269 and 736 cm−1
vibrations assigned to the Cu-Cu and O-O stretch, respectively. This is very similar to what
is observed upon O2 binding in Hc and Ty (Sections 3.1 and 3.2). Furthermore, upon heating
the RT, 16O2 sample, the 368.3 nm resonance enhanced features associated with the µ(η2-
η2)peroxo dicopper(II,II) species disappear while the 457.9 nm resonance enhanced features
of the [Cu2O]2+ species grow in (Figure 134B). Thus, this coupled binuclear µ(η2-η2)-
[Cu2(O2)]2+ species is a precursor complex and converts directly into the [Cu2O]2+ species,
which oxidizes methane into methanol. Temperature programmed desorption (TPD)
experiments showed that the second oxo atom transfers to the ZSM-5 lattice. The two
electrons required to cleave the peroxo O-O bond appears to derive from spectator Cu+
located in ion-exchange sites. The resultant cycle for active site formation and reaction is
summarized in Figure 135.
The reactivity cycle for Cu-ZMS-5 may have implications for the catalytic cycle of pMMO.
Like ZSM-5 and sMMO, the cycle for pMMO may begin with a precursor type of complex
in which O2 is activated to a peroxo level species (vide supra, Section 3.5.4). The Cu-Cu
separation of ~3.3 Å in the zeolite likely drives O2 binding and the reduction of dioxygen to
the peroxo level in a µ-η2-η2 structure as in oxy Hc/Ty. Here, branching between the zeolite
relative to the coupled binuclear copper sites may occur. In the zeolite, the Cu-Cu separation
is not likely to change to a large extent during formation of the precursor and its subsequent
transformation into the mono(µ-oxo) dicopper(II) species. This geometric constraint (i.e. an
entatic type state associated with the zeolite lattice) on the Cu-Cu distance may play a role in
driving the formation of a mono-(µ-oxo) as opposed to a bis(µ-oxo) species.
3.6 Structure/Function Correlations of O2 Activation by Copper Sites
From Sections 3.1 – 3.5 we have observed that O2 is activated by mononuclear copper sites
in the non-coupled binuclear copper enzymes (the CuM center) and in cofactor biogenesis by
GO and by binuclear copper sites in the coupled binuclear copper enzymes and pMMO.
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For the mononuclear copper sites, research efforts to this point have strongly indicated that a
Cu(II)O2− (i.e., cupric-superoxide) end-on triplet catalyzes a one-electron H-atom
abstraction reaction. For both the non-coupled binuclear copper enzymes and the biogenesis
reaction in GO, the X-H bonds are activated at ~87 kcal/mol, which would be accessible
based on the [Cu(II)O2]+ → [Cu(II)O2H]+ homolytic bond strength. Depending on the
ligation and protein environment, this bond strength would be in the range of ~80 kcal/mol.
The interesting issue in these mononuclear copper sites is the activation of O2 by one
electron reduction. The reduction potential for this process is −330 mV vs SHE depending
on the conditions, and thus the ligation at the copper would have to tune down the potential
and stabilize the Cu(II)-O2•− bonding interaction (i.e., allow formation of an inner sphere
complex). There can also be an entropic contribution depending on whether the O2 replaces
a coordinated H2O.
In the coupled binuclear copper enzymes a [Cu(II)2O22−]2+ peroxy intermediate species is
clearly generated. The substrates are aromatics with strong C-H bonds (~110 kcal•mol−1),
and thus this reaction proceeds through an electrophilic aromatic attack, a two-electron
process. This involves the transfer of the two electrons into the peroxide σ* orbital to cleave
the O-O bond, either directly from the substrate or from the coppers if the bis-µ-oxo species
is in fact formed along the reaction coordinate. Again this reaction is energetically
accessible as the two-electron reduction potential of peroxide is ~300 mV vs NHE.
pMMO is rather unique in that the C-H bond is strong yet the enzyme uses a binuclear
copper site to perform a one-electron H-atom abstraction. This would seem to require the
formation of a strong O-H bond in the initial product as found to be the case in the Cu-
ZSM-5 [Cu(II)2O2−]2+ active site where the strength of the O-H bond formed is ~92
kcal•mol−1. If an oxo (bridged or terminal) intermediate were indeed involved in pMMO,
this would require that the 2Cu(I) reduced site react with O2 to proceed to the 2Cu(III) state
to reductively cleave the O-O bond. In this regard, it is interesting to note the significant
structural differences in pMMO relative to the coupled binuclear copper enzymes where the
3 His/Cu of the latter are replaced by two endogenous ligands/Cu in pMMO, and one of
these is a terminal amine. This strong equatorial donor ligation could promote further
oxidation of the two coppers and the short Cu-Cu distance (~2.6 versus ~3.6 Å in the
coupled binuclear copper enzymes) would also favor O-O cleavage. Clearly, it is important
to define the factors in the pMMO binuclear copper site that activate it for H-atom
abstraction from a strong C-H bond and in fact whether this is the correct description of the
mechanism. As a final point, in the only intermediate in the CH4 → CH3OH reaction thus
far characterized, the [Cu(II)2O]2+ FMO has the important property of polarizing to a
Cu1+O−• (i.e., oxyl) species at the transition state. This is also the case for Fe(IV)=O
intermediates at their transition states and is likely a key requirement for H-atom abstraction
from strong C-H bonds.729
3.7.1 Multicopper Oxidases
Multicopper oxidases (MCOs) constitute a large and diverse family of enzymes, where
oxidation of various substrates is coupled to the four-electron reduction of dioxygen
generating two water molecules.730 Common to all MCOs, this activity is carried out by a
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minimum of four copper ions, arranged in a mono-nuclear Type 1 (T1) Cu site, which is the
entry point of electrons from substrate, and a trinuclear Cu cluster (TNC), which accepts the
substrate electrons and utilizes these in the 4 e− reduction of dioxygen.730 The diversity of
MCOs is inferred primarily at the T1 Cu site, where differences in coordination
environments and solvent accessibility result in different substrate
specificities.731,732,733,734,735 Based on this, MCOs can be divided into two classes where
members of the first target a variety of phenolic substrates, with broad specificity, while
members of the second has high substrate specificity towards one- or two metal substrates
(see Table 27). Some broad substrate MCOs have traits of both classes, with high specificity
towards a single substrate, e.g. ascorbate or bilirubin, while still showing significant activity
towards a broad range of phenolic substrates.736,737 The following sections will provide an
overview of the enzymological (see also Table 28), kinetic, spectroscopic, and mechanistic
properties of the MCOs.
3.7.1.1 Enzymology
3.7.1.1.1 Fungal laccases: The most abundant group of MCOs is the so-called laccases (EC
1.10.3.2), which are found throughout nature, and classified as broad substrate MCOs.
Fungal laccases are the most well described MCOs, with over 100 enzymes purified and
characterized.757 Apart from being easily accessible, this is evidently related to their interest
from a commercial standpoint, where many functions have been proposed and several
already implemented.758,759
Fungal laccases have primarily been identified in basidiomycetes, with white-rot fungal
species being particularly abundant, and brown-rot fungi only described at a limited level.760
Fungal laccases are also present in ascomycetes and deuteromycetes, whereas no enzymes
have been identified in zygomycetes or chytridiomycetes.760 Fungal laccases are usually
present in several isoforms within the same organism, mainly identified by a genetic
approach or by iso-electric focusing. The typical fungal laccase is a monomeric protein, with
a molecular weight of approx. 60–70kDa, including a carbohydrate content of 10–25%. The
pIs of fungal laccases fall in the acidic range, with most enzymes between 3–5.760,761 An
interesting property of fungal laccases is their heat tolerance, with optimum activity often
reported at more than 55° C.762,763,764,757 This is one of the features that make fungal
laccases interesting from an industrial perspective. In addition to activity, fungal laccases are
also relatively stable at elevated temperatures, with half lives for decay reported to be
several hours.762,765,757 Fungal laccases are most often extracellular, but several
intracellular enzymes have been identified.760,766,767
Due to their ability to oxidize various poly-phenolic compounds, fungal laccases have long
been suggested to participate in lignin degradation.768 Conclusive evidence for this
functionality was presented in the late 1990’s by Bermek and Eriksson, who showed that
laccase mutants from Sporotrichum pulverulentum were incapable of degrading lignin, in
contrast to the wild-type enzyme.742 Despite the relatively early elucidation of lignin-
degrading functionality, the precise mechanism by which this occurs in fungal laccases is
still not known.769 Other proposed biological functions of fungal laccases include
pathogenesis and detoxification as well as development and morphogenesis of fungi.743
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3.7.1.1.2 Plant Laccases: Although not as abundant as fungal laccases, plant laccases have
played a pivotal role in the study of MCOs (vide infra). In particular laccase from the
Japanese lacquer tree, Rhus vernificera laccase (RvL), has been subject to numerous studies,
both with respect to biological function and molecular mechanism.
Plant laccases are glycoproteins, with a carbohydrate content ranging from ~20–45%.770,771
Molecular weights have been reported in the range from ~60–130kDa,772,773 whereas pI
values vary from 7.0–9.6. Most plant laccases are secreted proteins, with a few exceptions
predicted to be targeted to the mitochondria.769
Previously, plant laccases were believed to be scarcely distributed, but recent studies have
shown that they are in fact widely distributed in higher plants, particularly in angiosperms,
but also in gymnosperms.774 An investigation of laccase gene sequences in Arabodopsis
thaliana among others, showed that plant laccases can be divided into six divergent
phylogenetic groups. Interestingly, groups 1–3 contain both gymnosperms and angiosperms,
indicating that these genes had evolved prior to the division of gymnosperms and
angiosperms some 300 MYA.774
A characteristic feature of plant laccases, is the high degree of isoform occurence in
different plants, with 17 laccase genes being identified in Arabidopsis thaliana.774 Along
with the complexity of plant extracts in general, this provides a significant challenge in
determining the biological function of plant laccases,
One of the most well established functions of plant laccases, is wound healing in
R.vernicifera.738 In response to stem cuts, an oxidative polymerization reaction of the
alkylcathechols in the latex sap, is initiated by laccase. This produces a hard seal over the
wound that serves to protect the stem. A more controversial role of plant laccases, is the
involvement in lignin formation. This issue has been heavily debated over the years, but so
far no conclusive evidence has emerged, although several strong indications have been
reported. The first indication of a possible role in lignin formation came in 1992 when
Sterijiades reported on the oxidative capability of a maple laccase on the three lignin
precursors, sinapyl, coniferyl, and p-coumaryl alcohols.739 This finding was in contrast to
previously conducted studies on R.vernicifera laccase, which indicated that this enzyme was
not involved in lignin formation.775 Recent studies indicate that some laccase isoforms in
Arabodopsis thaliana are involved in lignin formation, but that the majority are not.774 In
contrast, strong evidence has been presented that links the formation of lignin to the class III
peroxidases.776 An interesting hypothesis, in that respect, is the involvement of laccases in
formation of the early primitive forms of lignin, whereas the later emerging, more complex,
lignin structures are proposed to have been synthesized by peroxidases.776 Other putative
functions of plant laccases include flavonoid oxidation,740 and cell wall formation,741 which
also involves oxidation of phenols. Finally, it should be mentioned that Hoopes and Dean
reported ferroxidase activity of a plant laccase from Liriodendron tulipifera in a 2004
study.777 However, no further information has been presented on this subject.
3.7.1.1.3 Prokaryotic Laccases: Bacterial laccases were first described in Azospirrillum
lipoferum in 1993.778 Several other bacterial laccases have been purified, expressed and
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characterized since then.779 In addition, a significant number of bacterial laccase genes have
been identified in a variety of bacterial strains.757 Recently, prokaryotic occurrence of
laccase was extended to archae, with the reported purification and characterization of a
glycosylated enzyme showing activity towards laccase substrates like syringaldazine, 2,2’-
azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), and 2,2’-dimethoxypropane
(DMP).780 Furthermore, the archael laccase showed activity towards bilirubin. Based on
this, the enzyme would more correctly be grouped with other Bilirubin Oxidases (BODs), as
described below. This is also the case for the best studied bacterial laccase, CotA.751 From
an evolutionary standpoint, fungal BOD structures actually group with the bacterial
laccases,781 and it is likely that several of the putative prokaryotic laccases may indeed turn
out to be BODs. Whereas bacterial laccases seem to be widely distributed in bacteria; only a
few archael enzymes have been proposed based on genetic analyses.782 This may be related
to the mostly anaerobic nature of archae.
Compared to fungal laccases, only limited information is available on the properties of
prokaryotic laccases. Molecular masses have been reported from 50kDa to 250kDa.779 In
addition to “traditional” laccase structures, prokaryotic laccases also include the so-called
two-domain or small laccases (SLACs), which are significantly different with respect to size
and structure.783 The molecular weight per active site is as low as 30kDa and the enzymes
have two domains rather than three.784
With respect to other properties, prokaryotic laccases differ significantly from fungal
laccases. Generally, they have been reported to have higher pI’s. Salt tolerance is another
featured property of prokaryotic laccases. Lastly, it should be mentioned that prokaryotic
laccases are generally expressed intracellular, again in contrast to most fungal laccases.779
The functionality of prokaryotic laccases have so far been elucidated only for a few species,
and include melanin formation, spore resistance against UV-light and hydrogen
peroxide,744,745 and morphogenesis.785 Studies on the laccase functionality of CotA
revealed that the mutated enzyme were incapable of forming spore pigment.786 Similar
conclusions were made in a study of Azospirillum lipoferum mutants.787 In a study on EpoA
from S.griseus, morphogenesis was shown to be inhibited in mutated protein.785 However,
upon incorporation of an epoA-induced plasmid, activity was restored.
3.7.1.1.4 Insect Laccases: Laccase-like activity has been known in insects for more than 50
years.788 Despite this, only limited information on insect laccases has been gathered and
only a few enzymes have been purified and characterized.789 Studies have, however,
identified laccase-like genes in a number of insects, and shown these genes to be present in a
variety of tissues.789 Further, laccase-like activity has been identified in more or less
purified samples from a number of insects, where the active enzymes showed properties
such as acidic pH-optimum and thermal stability of up to 60–70°C.789
As for other laccases, the biological function of insect laccases is difficult to elucidate,
primarily due to the complexity of samples. One function has, however, been
unambiguously assigned for insect laccases, namely cuticle formation in Tribolium
castaneum.746 Knock-out of the so-called laccase 2 gene resulted in a lethal phenotype with
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soft, unpigmented cuticle, observed in larval, pupal, and adult stages. The same gene has
been identified in the cuticle of several other insect species.790–793
3.7.1.1.5 Ascorbate Oxidase: The existence of a unique ascorbic acid oxidizing enzyme was
proposed more than 80-years ago,794 and finally established in 1941.795 Over the years,
ascorbate oxidase (AOx) has attracted much interest both with respect to elucidation of the
biological function, but also in various structural and mechanistic studies. In 1989,
Messerschmidt et al. published the first crystal structure of a multicopper oxidase; that of
AOx from green zucchini.796
Ascorbate oxidase is most commonly found in higher plants,750 but has also been identified
in fungi.781 AOx is characterized by having a high activity towards ascorbate, whereas
“normal” laccase substrates are less efficient. Based on this activity, AOx is defined as a
unique subclass of enzymes (E.C. 1.10.3.3), separate from laccase and other multicopper
oxidases. This is consistent with a phylogenetic analyses of MCOs that group plant and
fungal AOxs together, clearly separate from laccases and ferroxidases.781
In plants, AOx forms homodimers with molecular weights of approx. 130kDa,797 whereas
the sole fungal AOx characterized is a monomer with a molecular weight of 80kDa,
including a carbohydrate content of approx. 11%.798 Another interesting property is the
conserved functionality of fungal AOx at pH’s as low as 3.798 Furthermore, the fungal
enzyme is thermostabile up to ~60°C,798 whereas plant AOs has a t1/2 of only 20min at
55°C.799
Despite intense investigation, the biological function of plant and fungal AOs has still not
been fully elucidated.800 Numerous studies have led to different proposed functions, among
those, involvement in plant growth, which was initially proposed by Mertz based on cellular
localization of maize AO.747 Later studies on this hypothesis have been somewhat
contradictory. Lin and Varner,801 and Kato and Esaka802 supported the hypothesis by
showing increased levels of AOx in expanding cells in zucchini, and elevated AOx activity
in elongating tobacco cells, respectively. On the other hand, Sanmartin et al. did not detect
any effect of AOx overexpression on plant growth.803 Other proposed functions of AOx
includes a role as a terminal oxidase in an electron transport chain,748 and as a plant defense
system against insects, decreasing the level of available ascorbic acid and thereby the level
of antioxidants in the insect.749 A common feature of the above listed functionalities, is the
importance of the reducing substrate, ascorbate. Recently, Tullio et al. suggested a novel
functionality, which focuses on the oxygen reducing ability of AOx. The authors propose
that AOx can establish an O2 gradient across the cytoplasmic membrane, preventing
hyperoxia by releasing excess O2 to the apoplast.750
3.7.1.1.6 Bilirubin Oxidase (BOD): Bilirubin oxidases (EC 1.3.3.5) are multicopper
oxidases, categorized based on their ability to oxidize bilirubin to biliverdin, using dioxygen
as an electron acceptor.804 This reactivity has been known for a long time, and has
traditionally been observed in fungi.804 In addition to bilirubin activity, BODs also show
activity towards the traditional phenolic laccase substrates.804 Recently, the bacterial laccase
CotA from Bacillus subtilis was shown to have significant BOD activity,751 extending the
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occurrence of BODs to the prokaryotic kingdom. BODs are interesting in several respects,
first due to their diagnostic properties in medical examination of the liver. Also, they are
candidates for the cathodic reaction of biological fuel cells, where they show important
advantages compared to the fungal laccases, such as pH optima close to 7, and high
tolerance to NaCl.804 From a mechanistic point of view, BODs have provided significant
insight into the MCO family, primarily from mutational studies on Myrothecium
verrucaria.805–807 Recently, the first crystal structure of a BOD was published,808 and it
revealed an overall structure very similar to that of fungal laccases. Differences were,
however, observed in proximity to the T1 Cu binding site, which may provide insight into
the redox properties of this site.
Very little is known about the physiological function of BODs, but due to their similarity to
fungal laccases, it’s hypothesized that the enzymes are involved in lignin degradation.751
3.7.1.1.7 Phenoxazinone Synthase (PHS): Phenoxazinone synthase (EC 1.10.3.4, PHS) is a
bacterial MCO identified only in Streptomyces antibioticus.809 Other enzymes, classified in
the same group, have been found in other organisms, but none of these incorporate the four
copper motif characteristic for MCOs.809 The particular interest in PHS stems from its
ability to oxidize o-aminophenol to phenoxazinone, which is a precursor to the antibiotic
Actinomycin.810–812 A pivotal study from 2000 showed that depletion of PHS from S.
antibioticus had no affect on the formation of Actinomycin, indicating that this is not the
biologically relevant function of the enzyme.813 Instead it has been proposed that PHS is
involved in spore pigment production or spore morphogenesis.813 Interestingly, a crystal
structure of PHS revealed that the active form of the enzyme is a hexamer, which in addition
to the four catalytically relevant Cu ions per monomer, incorporates a structurally important
fifth Cu which is proposed to link together the individual monomers. This motif has not
been observed in any other MCOs (see section 3.7.1.3).
3.7.1.1.8 Ferroxidases: Fet3p, Ceruloplamin, and Hephaestin: Ceruloplasmin (Cp, EC
1.16.3.1), particularly the human enzyme, has been intensely studied since its discovery
more than 60 years ago.814 The enzyme displays a variety of fascinating properties, among
them binding ~95% of serum copper,815 a unique six domain structure,734,816 and
ferroxidase activity.817,818 Ceruloplasmin has been described in several organisms,
including rat and mouse, which showed amino acid identity of up to 90%.819,820 The crystal
structure of ceruloplasmin has been resolved, and it revealed a unique structure compared to
other multicopper oxidases.734,816 First, the enzyme consists of six domains per active site,
significantly different from the traditional three-domain MCOs and the newly discovered
two-domain SLACs. Furthermore, ceruloplasmin has six coppers distributed into three T1
sites (one of which is permanently reduced and possibly an evolutionary remnant) and one
trinuclear copper cluster. The six domain structure was recently proposed in another enzyme
showing ferroxidase activity, namely Hephaestin (Hp).821 This enzyme has 50% sequence
homology with ceruloplasmin, including conservation of copper ligating amino acid
residues.822 Hp has not been studied as intensively as ceruloplasmin, and so far no crystal
structure has emerged. Significant insight into the properties of this enzyme has, however,
been obtained from heterologous expression of the human protein in hamster.823 In this
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study, the recombinant enzyme showed significant ferroxidase activity, but only 3.13 Cu/
molecule. The electronic absorption spectrum revealed a band at 607nm, consistent with
oxidized T1 Cu, as generally observed for multicopper oxidases. The molecular mass of the
recombinant Hp is 130kDa. Hp is a membrane-bound protein that has been found in a
variety of tissues including the small intenstine, colon, and brain.824–826 A 582 base pair
deletion of Hp results in sex-linked anemia, a condition characterized by severe iron
deficiency.822 The exact function of Hp has not yet been determined, but has been proposed
to be linked to iron metabolism, with a possible role of oxidizing Fe(II), to the transferrin
receptive Fe(III) form.822,827 However, no direct interaction between Hp and transferrin has
yet been discovered.828
Cp is a glycoprotein with a molecular weight of ~130kDa,815 with small variations due to
differences in glycosylation. Two forms of Cp are expressed. The best characterized isoform
being serum Cp, which has been identified in spleen, lung, and testis.815 The second isoform
is a glycophosphatidylinositol (GPI)- anchored protein, occurring in astrocytes of the
Central Nervous System (CNS) and the epithelial cells of the choroid plexus.820 The precise
function of the anchored isoform is not known, but it is believed to be involved in iron-
mobilization on the blood-brain, blood-testis barriers.829
One of the main reasons for the interest in serum Cp is due to the mutational disease,
aceruloplasmenia. This fatal inherited genetic disorder leads to progressive
neurodegeneration (often diagnosed as dementia) in addition to diabetes caused by iron
accumulation in the liver and pancreas.830 Mutations in the ceruloplasmin gene prevents
loading of the trinuclear copper domain and thereby prevents ferroxidase activity
significantly hindering iron metabolism, which leads to rapid degradation of the protein in
blood plasma.830
Interestingly, the aceruloplasmin specific mutations in Cp does not lead to significant
abnormalities in copper metabolism, which is somewhat surprising considering the high
level of serum copper incorporated in Cp.831
In addition to the iron homeostatic functionality, Cp has also been suggested to be involved
in anti- or prooxidant actions, with somewhat contradicting studies supporting each
case.831,832
Fet3p is the functional homolog of Cp in yeast, in that it is critical for iron
homeostasis.833–835 The enzyme has been studied primarily in Saccharomyces cerevisiae,
but genetic analyses have revealed its presence in a range of fungal species.836 In
comparison to Cp, the structure of Fet3p resembles the traditional three-domain MCOs, with
a total of four Cu ions involved in the active site.733 Fet3p is a membrane-bound
glycoprotein with a molecular weight of approx. 100–120kDa.837
In the regulation of iron homeostasis, Fet3p has been shown to work in conjunction with a
transmembrane iron transporter, Ftr1p, together facilitating the transport of iron across
cellular membranes.837–840 The role of Fet3p is to oxidize Fe(II) to Fe(III), which is the
substrate for Ftr1p Several lines of evidence have been presented to support this
functionality, among them the presence of Fet3p being required for the correct targeting of
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Ftr1, the intracellular accumulation of Ftr1p upon Fet3p depletion, and the co-expression of
Fet3p and Ftr1p..733,752,841,842
In addition to ferroxidase activity, Fet3p also exhibits significant cuprous oxidase
activity.843 Mutational studies on Fet3p revealed that the enzyme plays a significant role in
copper homeostasis, by regulating the amount of free Cu, and thereby preventing the toxic
effects of this metal.753
3.7.1.1.9 Cuprous oxidase: CueO: CueO is a multicopper oxidase involved in copper
homeostasis in Escherichia coli.754 The periplasmic enzyme is co-expressed with a
membrane-bound ATPase, CopA, which together functions as a copper efflux system
leading to copper tolerance in the organism.754 Roberts et. al reported the crystal structure of
E.coli expressed CueO, highlighting, in addition to the general three-domain motifs, a 42
residue insert in domain three with a high occurrence of methionine residues.844 This region
was later found to ligate a labile fifth copper ion, a novel feature of CueO compared to other
MCOs.845 CueO has a high affinity for Cu(I), which is oxidized to Cu(II). This property has
been hypothesized to diminish the availability of toxic Cu(I), a metal ion involved in Fenton
chemistry, forming highly reactive radicals.755 CueO also shows considerable phenol
oxidase activity, especially in the presence of excess Cu.846 The role of the phenol versus
cuprous oxidase activity has long been debated, and was actually shown to be heavily
influenced by the aforementioned met-rich insert. In a mutational study of CueO, Kataoka et
al. investigated the influence on activity upon removal of the met rich region. It was shown
that cuprous oxidase activity was significantly diminished upon removal, whereas the
phenol oxidase activity was enhanced.847 In a more recent study, elegant experiments led to
the conclusion that CueO is solely a cuprous oxidase in vivo, and that phenol oxidase
activity is prevented due to the selective affinity of the met rich region for Cu(I) over
Cu(II).848
3.7.1.1.10 Manganese oxidases: Mn is an important trace metal in the environment as well
as in living cells. It occurs in a soluble reduced form, Mn(II), and in the insoluble forms,
Mn(III,IV). Mn(II) is highly stabile, and is only slowly converted to the oxidized
forms.849,850 Certain, primarily bacterial strains, have been shown to enzymatically enhance
the oxidation of Mn, an interesting property for bioremediation. Little is known about the
oxidative process by which these bacteria operate, but it has been suggested that MCOs play
a pivotal role.756,849 Several bacterial MCOs have been identified as putative manganese
oxidases. None of these enzymes have, however, been purified or expressed.851 The most
compelling evidence of involvement of MCOs in Mn oxidation came in a study on marine
Bacillus species, where a gel-band with Mn oxidase activity, was determined to have a
putative MCO, namely MnxG, based on mass spectrometry analysis.756 Interestingly, the
enzyme was proposed to convert Mn(II) to Mn(III), but also Mn(III) to Mn(IV).
3.7.1.2 Kinetics: The MCOs can be divided into two categories depending on their native
substrate either being a redox active organic molecule (organic oxidases) or a metal ion
(metalloxidases; Table 27). Comparing the parameters from steady-state kinetics in Table
29, the organic oxidases have variable KM values with the highest being the tree Lc from
Rhus vernicifera852 while the metalloxidases Fet3p843 and Cp have very low KM values.
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(CueO853 is comparable to CotA854,855 and AO.856) Therefore, the metalloxidases bind their
substrate significantly tighter than to the organic oxidases with a specific metal binding site
(vide infra). Additionally, the generally higher KM values of the organic oxidases are
consistent with their low substrate specificity and reflect the fact that the substrate binding
sites are more accommodating to various substrates. The turnover numbers for the
metalloxidases are generally slower compared to those of the organic oxidases. The organic
oxidases exhibit a wide range of optimal pH values (5.0 – 9.4) under catalytic conditions
while the metalloxidases have optima within pH = 6.0 – 6.8. This large pH variance in the
organic oxidizers has been shown to correlate with the isoelectric point of the protein.857
The mechanism for substrate oxidation at the T1 site has been investigated from kinetics.
kcat for a selection of laccases have been shown by Xu to correlate linearly with the
difference between the single electron reduction potential of the substrate and the T1 copper
site.857 This is consistent with substrate reduction of the T1 in organic oxidizers being an
outer-sphere electron transfer mechanism and the rate-determing-step in turnover.
Furthermore, the KM values for the laccases were shown to be invariant with respect to
reduction potential differences between the T1 and substrate. In steady-state kinetics, Fet3p
exhibited a significant increase in KM, while leaving kcat unaffected, upon sight-directed
mutation of key Fe(II) binding residues near the T1 site, implying that tight binding of the
metal ion is essential for its oxidation.753,860 Single turnover kinetics on these variants
exhibit marked rate depression of T1 reduction from >1200 s−1 in WT to ~141–2 s−1 in the
variants, establishing that these residues also provide a path for the electron to be transferred
to the T1.861 It is interesting to note the extremely fast reduction rate of the T1 Cu in Fet3p,
which is much faster than the turnover rate of the enzyme843, and therefore not involved in
the rate determining step, in contrast to the organic oxidases. A similar fast ET between Fe2+
and T1 Cu2+ is seen for Cp, the mammalian analog of Fet3p.862 However, Cp differs
markedly from Fet3p, in that it has a total of three T1 Cu sites, two of which are redox
active, while the third is permanently reduced.863 Kinetic and spectroscopic studies have
shown that the redox potentials of both of the active T1 Cu’s in Cp are almost identical, and
that ET between the two occurs at a rate of > 150 s−1.
Steady-state kinetics on dioxygen reduction by the MCOs, show similar values for KM(O2)
~ 20 µM and k ~ 6.0 × 106 M−1s−1 at 25 °C suggesting that the dioxygen reaction in the
reoxidation of the enzyme is comparable among all MCOs.852
Further understanding of the mechanism of the MCOs and their intermediates has come
from extensive single turnover kinetic studies. The best-characterized and most extensively
studied MCO, RvL, is considered here. Reduction of fully oxidized resting laccase proceeds
via a multiphasic process.864,865 Using hydroquinone as the reductant at physiological pH,
the T1 exhibits an initial reduction rate of 1.58 × 103 M−1s−1 and a final rate of 800 M−1s−1
while the T3 reduces initially at 1.45 × 103 M−1s−1 and finally at a substrate independent
rate of 0.40 s−1. A key observation here is that the T1 is reduced faster than the T3 implying
that there exists a slow intramolecular electron transfer between the T1 and T3 sites. Post-
steady-state kinetics of RvLc, where oxygen is limiting with respect to substrate, exhibits
second order decay at physiological pH of the T1 band to be 800 M−1s−1, while the decay at
340 nm (corresponding to the TNC Cu’s) exhibits biphasic decay with a substrate dependent
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rate of 1400 M−1 s−1 and a substrate independent rate of 0.3 s−1. It is important to note that
this contrasts the reduction kinetics of the resting laccase, where the T1 reduces faster than
the 340 nm species and therefore must be different from the process in catalysis. Pulse
radiolysis experiments have measured the intramolecular T1 to T3 electron transfer process
to be 1.1 s−1 in resting RvLc and were independent of the amount of reductant and extent of
reduced T1.866 This further suggests that the reduction of resting laccase is not relevant
under catalytic conditions since it is orders of magnitude slower than the maximal turnover
rate (560 s−1).852
Reaction of reduced native RvL with dioxygen rapidly forms the “native intermediate”
(NI) 864,867 at a bimolecular rate of 1.7 × 106 M−1 s−1 at 3 °C and 6.0 × 106 M−1 s−1 at 25
°C, in agreement with steady-state measurements.852 A derivative of the native enzyme was
generated where the T1 Cu has been eliminated either via the mutation of the T1 Cys ligand
to a Ser to give the T1 depleted form (T1D)868,869 or replaced chemically with a redox and
spectroscopic inactive Hg(II) ion to give the T1 mercury derivative (T1Hg).870,871 Both of
these derivatives contain a valid, reactive trinuclear Cu cluster that upon reduction reacts
with dioxygen at a comparable bimolecular rate with that of the native enzyme (2.2 × 106
M−1s−1 for reduced T1Hg Lc)872, however, yielding a spectroscopically distinguishable
intermediate from NI (vide infra) known historically as the “T1Hg intermediate” or more
recently as the “peroxide intermediate” (PI).873 Without the T1 Cu present, PI slowly decays
to NI, while in the native enzyme PI is not observed.874 Therefore, in the native enzyme, PI
converts to NI at an estimated unimolecular lower-limit rate of > 350 s−1. In the decay of PI
to NI, there is an observed 18O2 KIE of 1.11, which indicates that O-O bond cleavage occurs
in this step and is rate limiting. Another relevant derivative of Lc, is the T2 depleted (T2D)
form, where the T2 Cu of the trinuclear cluster has been reversibly removed leaving the T3
and T1 Cu’s.875 Exposure of dioxygen to reduced T2D Lc shows no reactivity therefore
establishing that the T3 site in the MCOs is different from the coupled binuclear Cu center
found in Hc, Tyr & CaOx (vide supra).8
The NI intermediate decays slowly in the absence of reductant to the resting fully oxidized
form with a first order rate constant of k = 0.05 s−1 at 25 °C.876 This rate is significantly
slower than that of the maximal turnover rate (560 s−1)852 and therefore NI must reductively
decay in the presence of substrate in catalysis. Therefore, NI is the catalytically relevant
fully oxidized intermediate, not the resting state of the enzyme (vide infra). Additionally,
since the intramolecular electron transfer from the T1 to the T3 in resting is slow, this
electron transfer must be greatly accelerated in the reduction of NI, to be consistent with
turnover.
3.7.1.3 Structure: Since the first report of a MCO crystal structure, that of ascorbate
oxidase published in 1989 by Messerschmidt,796 several structures have emerged, covering
almost all classes of MCOs. Invaluable insight has been obtained from these structures, both
with respect to overall structure of the enzymes and with respect to the active copper sites.
In this section we present the general three-domain MCO structure, as well as the deviations
from this motif, observed in ceruloplasmin, and more recently the two-domain MCOs. We
also provide a description of the various active site features, highlighting similarities and
differences for the T1 and trinuclear sites, respectively.
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3.7.1.3.1 Overall structure: The most widely distributed structure of MCOs is a globular,
three cupredoxinlike domain structure.877–879 Domain 1 incorporates the T1 copper site,
whereas the trinuclear site is situated in between domains 1 and 3, with ligated histidines
from both domains (Figure 136A). This structure is observed in laccases (except for the two-
domain laccases),880,881 CueO,844 BOD,844 Fet3p,733 and ascorbate oxidase.796 Generally,
two substrate channels are identified, one presumably facilitating dioxygen delivery to the
trinuclear site, terminating close to the binuclear T3 site, and a second channel, presumably
serving as an exit channel for the active site generated water molecules, originating at the T2
site (Figure 137).878
In contrast to the three-domain MCOs, Cp has a unique six-domain structure, which
incorporates a total of six copper ions in three T1 sites and one trinuclear site.734,816 The
mononuclear T1 sites reside in domain 2, 4, and 6, respectively, whereas the trinuclear site is
situated between domain 1 and 6 (Figure 136B), with ligands from both domains, similar to
the three-domain MCOs.
Recently, a new type of MCO has emerged, namely the two-domain laccases. So far, three
two-domain structures, all from bacterial sources, have been published.784,882,883 The
structures consist of six domains, arranged in three two-domain units, each pair
incorporating a T1 and a trinuclear cluster. As for other MCOs, the trinuclear cluster is
situated in between two domains, with the T1 site incorporated in either domain 1 or 2
(Figure 136C).
3.7.1.3.2 Active site structures: From the first MCO crystal structure published in 1989, the
unique active site including the T1 site and the spectroscopically predicted (in 1985),884
trinuclear Cu cluster was finally confirmed. Furthermore, the structure strongly supported a
mechanistic model of substrate oxidation in the vicinity of the T1 Cu, electron transfer via a
Cys-His pathway from the T1 Cu to the T3 Cu’s, and finally oxygen reduction to water at
the trinuclear center, also first demonstrated by spectroscopy.
3.7.1.3.3 Substrate binding and the T1 Cu site: The unique T1 Cu site in MCOs, single
domain blue Cu proteins, and nitrite reductase (see section 5.1), has been intensely studied.
Much knowledge has been gathered from a combination of structural, spectroscopic, and
biochemical experiments, and many of the properties determining electron transfer rates and
redox potentials of these sites have been elucidated.4,117,885A common trait of the T1 Cu’s
in MCOs is the ligation by two His and one Cys, with the latter being responsible for the
intense blue color of these enzymes. Furthermore, a fourth ligand, in the form of a weakly
coordinating axial Met, is often observed (Figure 138A). Alternatively, the axial position
can be occupied by non-coordinating residues e.g. Leu or Phe (Figure 138B), which tend to
result in a high redox potential for these T1 coppers.
Solved structures of fungal laccases from M. albomyces,735 T. versicolor731 and T. trogii886
with phenolic substrates and analogues have described the binding sites for substrate
oxidation. In general, the T1 sites in the organic oxidases are significantly solvent exposed
and the substrate binding sites near the T1 site are ~5–8 Å deep comprised predominantly of
hydrophobic residues. Therefore, the T1 site is particularly accessible to hydrophobic
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substrates. In the 2,6-DMP bound structures of M. albomyces, the oxygen of the phenol is
within hydrogen bond distance of H508 (Figure 139A), which is a ligand to the T1 copper
and therefore the principle electron acceptor in the oxidation reaction. This is further
supported by the structures of xylidine bound to T. versicolor and p-toluate bound to T.
trogii where the nitrogen and oxygen of the respective molecules are in similar orientation to
the T1 histidines. Additionally, these atoms bound to the T1 histidines are also within close
proximity to a nearby carboxylate residue, the only hydrophilic residue in each pocket. This
carboxylate is suggested to be the proton acceptor in phenol oxidation. The nature of these
substrate binding sites is consistent with the fact that these proteins are non-specific in terms
of their oxidase activity since the sites only contain two key interactions for substrate
oxidation.
Structural data of the metalloxidases Fet3p, Cp and CueO show that the T1 sites are far less
solvent exposed compared to the sites for the organic oxidases. Structures of divalent cations
bound to Cp show a substrate binding site composed of solvent exposed carboxylates (E272,
E935 & D1025) and H940 in near proximity (~8 Å) to the buried T1 copper (Figure
139B).734 In Cp, this T1 connects to the TNC via the Cys-His pathway. Ion bound structures
of Fet3p have not been reported, but a similar site comprised of solvent exposed
carboxylates is evident from the structure and kinetic experiments coupled to site-directed
mutagenesis suggesting that carboxylates D283, E185 and D409 bind ferrous substrate in
Fet3p.733,860–862 Spectroscopic studies of Fe(II) bound to Cp and Fet3p confirm that the iron
is bound in a six coordinate octahedral geometry in both enzymes.861 Therefore, both Fet3p
and Cp display specific ferrous ion binding to a carboxylate rich substrate binding site that
can facilitate e.t. to the T1.
A similar ion binding site has been structurally elucidated for CueO.845 Here, a fifth labile
copper is present at a site located ~8 Å away from the T1 and bound in a trigonal bipyamidal
fashion by two methionines (M355 and M441), two aspartate carboxylates (D360 and D439)
and an aquo ligand. D439 hydrogen bonds to the nearby T1 histidine and therefore provides
a pathway for electron transfer.
3.7.1.3.4 Trinuclear copper site: Common to all crystal structures of the MCOs, is the
coordination to a total of 8 His ligands of the three Cu ions in the trinuclear cluster, arranged
in four HXH motifs.877–879 Each of the T3 Cu’s are ligated to three His and the T2 Cu is
ligated to two (Figure 140). A water derived ligand is a third T2 ligand in all structures
except for M. albomyces, which has a Cl− coordinated in the similar position.887
Furthermore, all crystal structures contain a highly conserved 2nd sphere carboxylate
residue, hydrogen bonded to His residues from the T2 and T3β Cu (D77 in Figure 140). The
significance of this residue has been demonstrated in independent mutational studies, where
it was shown to be required for enzymatic activity.806,888 Another well-conserved
carboxylate residue is identified at the bottom of the trinuclear cluster, hydrogen bonded to
solvent channel water molecules (D456 in Figure 140). This residue has been demonstrated
to play a significant role in the protonation of the dioxygen-derived molecules generated in
the trinuclear cluster.889–892
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The redox states in the crystal of the individual Cu’s in the trinuclear cluster are difficult to
assign. In addition, solvated electrons generated during X-ray irradiation may result in
further reduction of the trinuclear Cu’s.893,894 A general feature of reported MCO crystal
structures is the high variability observed for Cu-Cu distances in the TNC, in particular
between the T3 Cu’s. This variability was shown, early on, to be related to the redox state of
the TNC Cu’s. Messerschmidt et al. obtained a crystal structure of AOx grown under
anaerobic conditions, with excess reductant, and found a T3 Cu-Cu distance of 5.1Å,
significantly longer than the spectroscopically calibrated fully oxidized resting form of AO,
that was found to be 3.7Å (Figure 141).796 In most crystal structures reported for MCOs, the
T3 Cu-Cu distance falls within this range, with a few examples of shorter distances, e.g. in
the structure of NI recently published.894 Another feature of the fully reduced structure of
the TNC was the lack of any di- or monooxygen derived electron density between the two
T3 Cu’s, consistent with the two T3 Cu’s having close to trigonal planar geometry (formed
by the three His ligands), a preferred geometry of Cu(I). In the fully oxidized structure, for
comparison, the geometry of the T3 Cu’s have trigonal pyramidal geometries (three His and
one oxygen derived bridging ligand), with open coordination positions oriented towards the
center of the TNC (Figure 140), consistent with the spectroscopically calibrated DFT
structure (vide infra).895 Interestingly, very little difference is observed in the reduced versus
oxidized geometry of the T2 Cu, with the two His ligands and a water derived ligand (OH−
from spectroscopy)895 resulting in a square planar geometry, with an open coordination
position oriented towards the center of the TNC (Figure 140).
In most MCO crystal structures, mono- or dioxygen assigned electron density is observed in
the TNC, showing a range of different confirmations. Only in very few cases, however, have
the investigators made any attempt to spectroscopically calibrate the grown crystals either
before or after exposure to radiation.893,894,896 A number of studies have reported changes
in the oxygen derived species upon increasing radiation doses, most systematically in a
study by Halkulinen and coworkers, where at low dose, a dioxygen was observed, which,
upon increased radiation resulted in observation of single oxygen species.896 Several groups
have employed the observations of different oxygen derived species to propose solution-
relevant mechanisms for MCOs, often with obvious contradictions to spectroscopically well
defined reaction intermediates.893,897,898 This illustrates that although much information can
be obtained from X-ray crystallography, there is a need for more rigorous evaluation of the
crystal growing conditions, as well as the effect of radiation on a given crystal structure.
3.7.1.4 Electronic Structure
3.7.1.4.1 Resting Enzyme: The resting oxidized state of the MCOs exhibits spectral features
associated with all four of its coppers. The absorption spectrum (Figure. 142, top) exhibits
two main features, a band at 330 nm (30,300 cm−1), assigned as µ2-OH to T3Cu(II) CT
transitions and another at ~ 600 nm (16,700 cm−1) assigned as the SCys,π to T1Cu(II) CT.
The EPR spectrum shows contributions from two S = ½ Cu(II) ions, the T1Cu(II) (g∥ ~ 2.30,
A∥ = 40 – 95 × 104cm−1) and the T2Cu(II) (g∥ ~ 2.24, A∥ = 140 – 200 × 104cm−1) (Figure
142, bottom). The T3 coppers are EPR silent due to antiferromagnetic coupling via a µ2OH
superexchange pathway leading to an S = 0 ground state with an observed lower limit of −2J
> 550cm−1 from SQUID magnetic susceptibility experiments.730
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The spectroscopic features of the T2/T3 trinuclear cluster of the resting state have been
further refined in the T1Hg derivative where the T1 Cu does not contribute and the TNC is
unperturbed.871,895 This allows the LF transitions to be observed; the T2 in LT MCD as it is
paramagnetic, and the T3 in CD. From a LF analysis of the d → d transitions observed in
LTMCD (Figure 143A), and its EPR signal (Figure 142, bottom), the T2 copper has a d(x2-
y2) ground state in an approximately square planar geometry with a vacant equatorial
position pointed towards the center of the TNC. Additionally, the T2 Cu(II) is coordinated
by a solvent derived hydroxo ligand external to the cluster, which (from ESEEM) remains in
this protonation state over its functional pH range.895 The spectral features of the T3
Cu(II)’s are resolved in the RT CD spectrum (Figure 143B). More than four LF transitions
are observed indicating the two T3 Cu(II)’s are inequivalent, likely related to the ε
coordination of one His residue on T3α (vide supra). The LF’s of the T3 Cu’s are best
described as trigonal bipyramidal with d(z2) ground states with the z-axis of each half
occupied orbital oriented toward the µ2OH giving the AF coupling, and open coordination
positions in the equatorial plane on each T3 Cu oriented toward the center of the cluster.895
Density functional theory derived surface plots of the trinuclear cluster also show LUMOs
on the T3 Cu-α/β and the T2 Cu directed towards the center of the cluster, where small
molecules can bind in a bridging mode (Figure 144).895
Key observations of the properties of the resting oxidized state of the MCOs, came from
spectroscopic characterization of exogenous ligand binding to the trinuclear cluster. In a
study from 1985, Allendorf et al. provided the first evidence, based on rigorous
spectroscopic evaluation of azide and fluoride binding to native RvL, that the T2 and T3 Cu
sites form a trinuclear copper cluster (TNC).884 These data were further elaborated upon in a
subsequent study by Spira-Solomon et al.899 From room temperature absorption and
LTMCD experiments, azide was found to bind in a high affinity form (K ≥ 104M−1) and a
low affinity form (K ~ 200M−1). Two features from the high affinity bound azide were
resolved in LTMCD at 445 and 510 nm. The intensity of these features maximized at less
than one enzyme equivalent of azide, and this high affinity form was eliminated upon
treatment with peroxide. XAS studies showed that purified resting tree laccase contains ~
25% reduced T3 Cu, which is oxidized by addition of peroxide. Based on this, the high
affinity feature was assigned as T2 Cu(II) bound azide, formed in the presence of a reduced
T3 Cu site.
Upon additional titration of native laccase with azide, several new features were observed in
Abs, LT MCD, and LT EPR. Figure 145A shows the Abs. and LT MCD spectra in the azide
to Cu(II) charge transfer region, baseline corrected by subtracting the intensity of the high
affinity azide binding features. Several important features were observed. First, two
prominent transitions are present in the Abs spectrum; an intense feature at 400nm and a
shoulder at 500nm. Both transitions increase in intensity with the addition of azide.
Comparing these transitions with transitions in the LT MCD spectrum revealed that only the
500nm shoulder has a corresponding paramagnetic contribution. The negative feature in LT
MCD at 485nm is seen to increase with addition of azide, whereas the 385nm positive MCD
feature first increases and then decreases with increasing azide concentration, inconsistent
with the intensity pattern of the 400nm band in Abs. Based on this, the 400nm absorption
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band was assigned as an azide to T3 Cu(II) CT transition (AF coupled so no corresponding
feature in LT MCD), whereas the 500nm absorption (485nm LTMCD) band was assigned as
a to T2 Cu(II) CT transition. Additional features in LT MCD at 330nm (−) and 440nm (−)
showed intensity patterns identical to those of the 385nm LT MCD band. Finally, azide
titrated laccase was also probed by LT EPR. Here, a characteristic new feature emerged at g
= 1.86 (Figure 145B). The spin integrated intensity of this signal, correlated with that of the
340, 385, and 440nm LT MCD transitions. Importantly, these LT MCD transitions as well
as the LT EPR signal showed a pH- dependent behavior, with increasing intensity at low pH,
consistent with protonative uncoupling of the µ2-OH T3 bridge. This uncoupled species has
been investigated in significant detail in subsequent studies (vide infra).
Returning to the 400nm Abs with no corresponding LT MCD intensity, and the 485/500nm
LT MCD/Abs features, complimentary fluoride binding experiments were conducted in
order to obtain more information on exogenous ligand binding to the different copper sites.
When fluoride was added to native laccase, pre-treated with 9 equivalents of azide, doublets
were observed in the hyperfine EPR signal, indicating that fluoride bound to the T2 Cu(II)
(vide infra). This F− binding, significantly decreased the intensity of all the azide CT
transitions, both to the T2 and to the T3 Cu(II)’s. Importantly, the stoichiometry of the
reaction revealed that only one fluoride bound to the enzyme, i.e., one fluoride bound to the
T2 eliminated azide binding at both the T2 and the T3 Cu(II)’s. This led to the conclusion
that the T2 and T3 Cu sites of MCOs are arranged in a trinuclear cluster. This was later
confirmed in all reported crystal structures of MCOs.
A further resolution of the above mentioned spectroscopic features of azide binding, was
obtained in a study from 1990 by Cole et al.871 Here, azide titrations were performed on the
T1Hg derivative of RvL, eliminating the spectral complications of the T1 Cu. This study
showed that the low affinity binding, associated with the 400 and 500nm bands, could be
further resolved into two different binding events, with binding constants of 780M−1
(500nm feature) and 270M−1 (400nm feature), respectively. Also, the protonative uncoupled
species was shown to correlate with binding of the first azide, and upon binding of the
second azide, these features, including the 385nm MCD band and the LT EPR signal at g =
1.86, decreased in intensity (Figure 145A and B), indicating that the second azide binding
perturbs the first azide bound trinuclear structure and thus its corresponding spectroscopic
features.
Additional information of the nature of the uncoupled species has been obtained from more
recently conducted experimental and computational studies.900 Here, a species with identical
spectroscopic features to those of the uncoupled species but much more intense, was
generated by azide addition to the native intermediate (NI). NI is the fully oxidized,
catalytically relevant species in turnover of MCOs (vide infra, section 3.7.1.4.3). This azide
bound NI (NIaz) was found to decay to the one azide bound resting species (Raz, the first
azide species) elucidated by Cole et al.871 Also, interconversion of NIaz and Raz is reversibly
obtained by changing the pH, consistent with previous findings (vide supra). Figure 145C
presents a structural model for this interconversion, obtained through DFT optimized
structures calibrated by the spectroscopic data.
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Further insight into the properties of the TNC came from spectroscopic and computational
studies of T1Hg Lc in its fully oxidized resting form as well as a fully oxidized fluoride
bound form.895 Fluoride is known to bind to the TNC with >105 higher affinity than for
mononuclear Cu(II) sites.901,902 Since F− has In = ½, this results in characteristic doublet
EPR features (Figure 146). A correlation with RT Abs, CD, and LTMCD showed that one
fluoride binds to the open coordination positions at the center of the cluster, with only a
weak perturbation of the LF features (T2 in LT MCD and T3 in CD) and without
influencing the T3-OH bridge or the T2 coordinated hydroxide.895
These experimental results were correlated to DFT calculations, and binding energies were
calculated for F− and the possibility of water binding as OH− to the open coordination
positions of the center of the TNC. The results showed that F− binding was highly
exothermic (−69 kcal/mol), explained by a favorable electrostatic interaction between the
anion and the highly positive TNC, large enough to overcome the energy loss from
desolvation of the fluoride.895 A similar electrostatic interaction was observed in binding of
OH− to the TNC, again resulting in an exothermic process. However, due to the
energetically unfavorable deprotonation of water to produce the hydroxide, this process was
calculated to be less favorable by 48kcal/mol compared to fluoride binding. However, water
binding as OH− at the center of the TNC is still calculated to be an exothermic process
which is inconsistent with the coordination unsaturation of the resting enzyme (vide supra).
However, there are four negatively charged residues found within 10Å of the TNC in most
MCOs, counteracting the high positive charge of the resting TNC (+4 from 3 Cu(II)’s and 2
OH‘s). Including this charge contribution to the active site lowers the net positive charge
and thus the energy gain of anion binding by ~27kcal/mol, enough to make the binding of
OH− unfavorable as observed experimentally.895 Thus, the protein environment facilitates
open coordination sites in the center of the TNC, thereby tuning the redox properties of
these Cu’s. This is highly important in that it drives electron transfer from the T1 to the
TNC, a requirement for activation of the enzyme towards dioxygen reduction (vide infra).
3.7.1.4.2 Peroxy Intermediate: The intermediate formed upon dioxygen exposure to a fully
reduced TNC with the T1 redox inactivated (T1D and T1Hg) is the peroxy intermediate
(PI).903 This species has now been identified in a number of different MCOs.806,869,903–905
PI forms rapidly (vide supra) to give an EPR silent species exhibiting strong CT transitions
at 340 nm (29,400 cm−1) and 470 nm (21,300 cm−1) (Figure 147).903 In the T1Hg derivative
of RvL, PI decays slowly (k = 0.013 min−1) to an intermediate with an MCD signal of an
NI-like species (vide infra) and finally to a species with an EPR signal identical to that of the
T2 Cu in the resting enzyme.873 The decay of PI generated with 18O2 shows the appearance
of two H2 18O’s, monitored via isotope ratio mass spectrometry (IRMS) indicating that both
atoms of 18O2 must be present in PI since this labeled oxygen appears concomitantly with PI
decay (Figure 148).873 The CD spectrum of PI (Figure 149 left) exhibits LF features of
Cu(II)’s corresponding to the band observed in the Abs. spectrum at 600–800nm (Figure
147B), while no LT MCD intensity is observed (Figure 149, right). The absence of an MCD
signal is consistent with the EPR silence of PI and indicates that the two Cu(II)’s are AF
coupled (S = 0) with the third Cu in the TNC reduced. This confirms that PI is a two-
electron reduced peroxo level species. Importantly, the CT Abs spectrum of PI greatly
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differs from that of oxy-Hc, requiring that the peroxide bridging motif of PI is different from
the µ-η2: η2-peroxo structure of Oxy-Hc (Figure 150).903,906 SQUID magnetic susceptibility
studies further demonstrated AF coupling between the two Cu(II)’s in PI with a lower limit
of −2J > 200 cm−1.873 Finaly, the Fourier transform of the EXAFS spectrum of PI (Figure
151) shows a new strong outer shell peak consistent with a tightly bridged (ie. low Debye-
Waller factor) Cu-Cu vector at 3.4 Å, whereas this feature is absent in the EXAFS spectrum
of the resting TNC.873
A geometric and electronic structure model of PI has been developed from extensive DFT
correlations to the spectroscopic data (Figure 152).906 When O2 is bound to the reduced
trinuclear cluster, the geometry optimized structure observed is that of the µ-η2: η2-peroxo
between the two oxidized T3 Cu’s, a structure very similar to that of oxy-Hc in section 3.1
(Figure 152A) This, however, is inconsistent with the absorption features of PI compared to
oxy-Hc (Figure 150). Mutagenesis studies, in Fet3p, have shown that reaction with dioxygen
does not occur upon substitution of an MCO-conserved carboxylate residue, near the T2/T3β
edge (D94 in Fet3p, β indicates the T3 closest to D94) with charge neutral Ala/Asn.888 Since
a carboxylate residue at this position is required for dioxygen reactivity, it was included in
the computational model. Optimization of a D94-included active site yielded a µ3-1,1,2-
peroxo species bridged between the oxidized T3β (η2), oxidized T2 (η1), and reduced T3α
(η1).906 These predicted oxidation states of the TNC Cu’s in PI have recently been
experimentally confirmed (vide infra).907 The T2 and T3β Cu’s are close to D94, suggesting
that the negative charge of the carboxylate residue lowers the redox potentials of the T2 and
T3β Cu, resulting in favorable two-electron transfer to dioxygen from these Cu’s. This is
seen in the electronic structure of PI (Figure 152B) where the T2 and T3β Cu(II)’s have their
half occupied dx2-y2 orbitals strongly overlapping the π*σ orbital of the peroxo, providing
the superexchange pathway leading to their antiferromagnetic coupling in the µ2-1,1,2
bridged structure (Figure 152B). The LF of the T2 Cu(II) is lower than the LF of T3β Cu(II),
therefore the CT transitions to the T2 Cu(II) will be lower in energy.906 Also, as described in
section 3.1, the O22− has a low energy π*v and high energy π*σ CT transition, which lead to
the assignment of the O22− to T2 and T3β Cu(II) CT transitions of PI, given in Figure
150.906
3.7.1.4.3 Native Intermediate: As described above, PI is generated in the absence of a redox
active T1 Cu. When the fully reduced native enzyme (T1 and TNC are all present and
reduced) reacts with dioxygen, a different intermediate,908 NI is formed. This is
characterized in Abs. by intense charge transfer bands at 318 and 365nm associated with the
TNC, and also a 614nm band (Figure 153A top),909 the latter indicating that the T1 site has
been oxidized. Therefore, at least one additional electron has been transferred to dioxygen,
relative to PI. The 77K EPR spectrum only shows features resembling those of the T1
Cu(II). This led Reinhammar, who first reported NI, and others, to assign NI as a three
electron reduced hydroxyl radical species, with electron transfers from the T1 Cu and two
type 3 Cu’s.876,910–912 However, Cu K-edge XAS and MCD spectroscopies were not
consistent with a hydroxyl radical species (vide infra).909
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Although NI studies have mainly been conducted in RvL, due to favorable kinetic
properties, its occurrence in Cp,913 BOD, 806 and CueO904 indicate that this intermediate is
part of the reaction cycle in MCOs in general.
NI displays a range of interesting spectroscopic features, summarized in Figure 153, all
contributing to the final determination of its geometric and electronic structure.909 From Cu
K-edge XAS the lack of a 8984eV feature characteristic of Cu(I) showed that all Cu ions in
NI are oxidized (Figure 153B), clearly inconsistent with a three electron hydroxyl species.
Instead, dioxygen is reduced to the water level by four electrons. As mentioned, the 77K
EPR spectrum shows the typical T1 Cu signal with narrow AII, but no contribution from the
TNC. However, upon lowering the temperature, new rhombic features emerge with g-values
of 2.15, 1.86, and 1.65, drastically different from “normal” Cu(II) signals (e.g. the T2 Cu in
the resting MCOs) that generally do not have g values below 2.00 (Figure 153D). The new
features also show markedly different power saturation behavior with temperature relative to
the T1 Cu, indicating a low lying excited state at the TNC in NI. The LT MCD spectrum of
NI shows an intense pseudo-A term signal (ie. derivative shaped) with features at 318nm
(31,780cm−1) (+) and 365nm (27,560cm−1) (−), corresponding to the two CT Abs features
(Figure 153A bottom). Furthermore, saturation behavior of the LT MCD signal with varying
magnetic field at low temperature shows the unusual g values of NI are associated with an
STOT = ½ ground state (Figure 153C). Finally, the temperature dependence of the MCD
intensity at high field shows an unusual behavior. Normally, the MCD intensity of
paramagnetic species follows a 1/T Curie type behavior.909 From Figure 153E, the intensity
at 25,000cm−1 does initially decrease with increasing temperature up to 30K. However,
when the temperature is raised further the intensity increases, a non-Curie behavior
indicative of population of the low-lying excited state with a more intense positive MCD
feature at this energy, compared to the ground state. By fitting the intensity at 25,000cm−1 to
a Boltzmann population model, an excited state energy of ~150cm−1 is obtained (Figure
153F). Furthermore, by simulating the temperature dependence at each wavelength, the
MCD spectrum of the excited state can be modeled (vide infra). The excited state energy of
150cm−1 is supported by the relaxation studies (power at variable temperature) of the EPR
signalat g = 1.65 signal indicating an Orbach process. In summary, there are three unique
spectroscopic features of NI: a low lying excited state at 150cm−1, a ground S =1/2 with g-
values below 2.00, and a CT pseudo-A term in MCD.909
An additional important spectroscopic input was obtained from EXAFS, which revealed that
at least two Cu’s of the TNC in NI are tightly bridged together at a Cu-Cu distance of 3.3Å
(Figure 154A).909 From magnetostructural correlations, this distance is consistent with a
pair of Cu’s with a singlet/triplet splitting of ~520cm−1 for a singly bridged species (Figure
154B). Accounting for the presence of a third Cu(II) in the TNC 155, left), a singly bridged
structure should have a ground doublet with excited doublet and quartet states at 520cm−1.
When a bridge is introduced to the third Cu(II), this excited degeneracy is lifted (Figure 155,
middle), but the lowest energy excited state remains at ~500cm−1 above the ground state,
inconsistent with the 150cm−1 observed experimentally. Introducing a third bridge to close
the triangle leads to spin frustration that significantly lowers the energy excited state
transitions. As presented in section 2.4, spin frustration arises when all three bridging
Solomon et al. Page 125
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
interactions are antiferromagnetic and of similar magnitude. In that limit, each of the Cu(II)
pairs want to be antiferromagnetically coupled, but this is obviously not possible in an all
bridged triangle. The significant lowering of the doublet excited state energy is consistent
with the low lying excited state observed in NI. From the constraints of the bridging
interaction of 520cm−1 and the 150cm−1 low lying excited state, limits of the two remaining
exchange couplings can be estimated to be 440–520cm−1 and 435–445cm−1, respectively.
These limits can be further refined by evaluating the contribution of each Cu(II) in the TNC
to the ground- and excited state MCD spectra in Fig 156A. The MCD C-term has
contributions from each of the three Cu’s of the TNC, representing the coupling coefficients
of the individual Cu(II)’s to the overall ground- and excited state wavefunctions of NI.
These are given by:
where C0 and C’0 are the total C-term intensity of the ground and first excited state MCD
spectra, respectively, and C0(i) is the C-term contribution from Cui. The coupling
coefficients, c(i), are dependent solely on the J couplings, and from these, ground and excited
state coupling coefficients can be evaluated within the above mentioned limits (Figure
156B). Inspection of the ground and excited state MCD spectra of NI (Figure 156A) reveals
three different behaviors with respect to intensity and sign of the transitions. Bands labeled
8, 11, and 12 are negative in the ground state but have large positive intensities in the
excited state. Band 9 is large and positive in the ground state with very limited intensity in
the excited state. Finally, band 10 is positive in both the ground and excited state. Evaluating
these behaviors in connection with the possible coupling coefficients of Fig 156B, gives AF
exchange interactions of 520 (fixed from EXAFS distance), 470, and 430cm−1 (Figure
156C). Importantly, this analysis shows that the different Cu centers contribute to the
different CT transitions in the MCD spectrum of NI (labeled in Figure 156A) and the three
large J-values (Figure 156C) require that all 3 Cu’s of the TNC are bridged.909
As discussed in section 2.4, a spin frustrated trinuclear Cu(II) center can undergo a zero field
splitting due to antisymmetric exchange which would lead to g-values well below 2.00 as
observed for NI in Figure 153D. From section 2.4, antisymmetric exchange requires good
ground state exchange coupling between two Cu(II)’s, SOC to an excited state on one
Cu(II), and good exchange coupling between this excited state and the ground state on the
adjacent Cu(II). There are two possible allbridged structures of NI, and model complexes
exist for both.914,915 On possibility, TrisOH as shown in Figure 157A, would result from
reduction of O2 to H2O to produce two bridging OH-‘s, and a third bridge would derive
from the H2O solvent. In the alternative µ3-oxo stucture (Figure 157B), the O would derive
from full reduction of O2. Both structures have the appropriate orbital arrangements for
ground to ground and ground to excited state exchange coupling to have significant
antisymmetric exchange (Figure 157C) and indeed we have observed this
experimentally.66,916,917 Single crystal EPR experiments on TrisOH, Figure 158, show that
very low g-values are in fact observed for this structure, when the field is perpendicular to
its z-axis.918 From Figure 157C, for TrisOH two dx2-y2 ground state orbitals on two Cu(II)’s
strongly antiferromagnetically couple, and SOC on one Cu gives a dxy excited state on that
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Cu, that can strongly couple to the dx2-y2 ground state of the adjacent Cu, thus fulfilling the
requirements for efficient antisymmetric exchange. A similar mechanism is realized for µ3-
oxo when the µ3-bridging oxo group resides in or close to the plane of the three Cu(II)’s.917
In this case, each dz2 ground state can SOC to a dxz excited state on an adjacent Cu(II) via
the Lz orbital angular momentum operator. Thus both TrisOH and µ3-oxo are possible
structures for NI.
In order to distinguish between these models and determine the geometric and electronic
structure of NI, we performed an analysis of the LT excited state CT MCD features of these
trinuclear model complexes and applied the results to NI.916 TrisOH (Figure 159A), µ3-oxo
(Figure 159B), and NI (Figure 153A) all share the common feature of an intense derivative
shaped pseudo-A term in the charge transfer region of their MCD spectra. In order to have
pseudo-A term MCD intensity, two perpendicular CT transitions are required, that can spin
orbit couple in a third mutually perpendicular direction. Due to the 1/r3 dependence of spin-
orbit coupling, this can be approximated as a single center, one electron operator. Thus for
two CT transitions to SO couple, they must have the same donor and different acceptor
orbitals (or vice versa) that share a common metal- or ligand based center. These
requirements give rise to two different scenarios: CT from two ligands to a given Cu
(TrisOH, Figure 159C) with metal based SOC, or CT from an oxo bridge to two different
Cu’s (µ3-oxo, Figure 159D) with oxo centered SOC.
From Figure 159A, an intense symmetric pseudo-A term feature is observed for TrisOH in
the energy region between 27,000cm−1 and 35,000cm−1.916 VTVH MCD of this feature
shows four individual transitions, all x,y polarized, which then requires the spin-orbit
coupling to be in the z-direction. Analyzing the orbital origin of these transitions indicates
that only metal-based SOC can lead to significant pseudo-A intensity, coupling transitions
from two different OH-ligands to the same metal site. This is possible due to the highly
covalent Cu-OH σ-bonds that allow for significant metal character in the charge transfer
states. As observed in Figure 159A, the pseudo-A term of TrisOH consists of a negative
lower energy and a positive higher energy band. The signs of these bands can be
theoretically predicted by evaluating the signs of the transition moment dipoles and the SOC
operator as they relate to the MCD C-term. The sign of the transition moment dipole is
obtained from the transition densities, which are the products of the donor and acceptor
wavefunctions, whereas the sign of the SOC operator is given by ligand-field theory. From
these assignments, the predicted signs of the pseudo-A term in TrisOH are a negative low
energy and a positive high energy band, consistent with the experimental data in Figure
159A.
For the µ3-oxo complex, only ligand-based SOC is possible (Fig 158D).916 The MCD
spectrum of µ3-oxo shows an intense pseudo-A term in the CT region (Figure 159B), with
the low energy band positive and the high energy band negative. (Note: these transitions are
eliminated by protonation of the bridge to µ3-OH). While this complex has an S = 3/2
ground state, DFT calculations of a more planar S = ½ µ3-oxo structure, predict that the
corresponding pseudo-A term will also have a positive low energy and negative high energy
band, as observed experimentally in Figure 159B, and opposite to that of the TrisOH
complex.
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Finally this analysis was applied to the MCD features of NI.916 From Figs. 156A ground
state MCD spectrum, the characteristic pseudo-A term has a positive low energy
(27,560cm−1) and a negative high energy band (31,780cm−1). The VT MCD data further
show that the pseudo-A term consists of CT transitions to the different Cu(II) centers
(Figure 156A bottom). The fact that more than one Cu center is involved in the pseudo-A
term, unambiguously assigns NI as having a µ3-oxo-like structure, since only the ligand-
based SOC mechanism allows coupling of CT’s to two different Cu centers (Fig 159D). This
assignment is further supported by the sign of the pseudo-A term of NI (Figure 153A and
156A ground state), with the positive band lower in energy than the negative band,
consistent with the µ3-oxo but not the TrisOH spectrum in Fig 158B and A, respectively.
One issue remains regarding the structure of NI, namely whether the second oxygen atom of
O2 reduction stays bound to the TNC as in Figure 160 (the origin of the proton on the µ2OH
will be resolved in the next section). EXAFS and DFT calculations were conducted in order
to address this issue.900 In EXAFS, NI was compared to an azide-bound NI derivative
(NIaz), where a single azide molecule is internally bridged to all three TNC Cu’s, with no
additional bridging interactions. The first shell Cu-N/O interaction shows a higher
coordination number in NI vs. NIaz, indicative of a second bridging interaction between the
two T3 Cu’s. Also, DFT calculations predict that protonative loss of the µ2OH T3 bridge in
Figure 160, will rotate one of the T3 Cu orbitals away from the x,y plane, resulting in
ferromagnetic coupling with the other Cu ions, clearly inconsistent with the above described
spin frustration features of NI. Finally, it is in fact calculated to be ~17 kcal/mol more
favorable to protonate the µ3-oxo than the µ2OH. These results allow the assignment of NI
as a µ3-oxo species, with an additional µ2OH bridge between the two T3 Cu(II)’s (Figure
160). This structure for NI is also consistent with QM/MM calculations.919,920
In summary, extensive spectroscopic and theoretical studies have identified two fully
oxidized TNC structures in MCOs. The resting enzyme with AF-coupled T3 Cu’s via a µ2-
OH and a magnetically isolated T2 Cu (Figure 144), and NI with an all-bridged µ3-oxo
structure (Figure 160). The all-bridged nature of NI tunes its redox properties and allows for
facile e.t. from the T1 Cu to each of the TNC Cu’s through µ3-oxo superexchange pathways;
a significant feature in terms of the reactivity of the MCOs (vide infra).
3.7.1.5 Molecular Mechanism
3.7.1.5.1 Molecular mechanism of O2 reduction in MCOs: Reduction of dioxygen to water
by the MCOs occurs at the TNC, with four electrons being transferred in two two-electron
transfer steps. A generally accepted mechanism, as depicted in Figure 161, has been
formulated.921 The starting point is the fully reduced enzyme where O2 binds and gets
reduced by two electrons from the T2 and T3β Cu, forming the spectroscopically
characterized peroxy intermediate, PI. Two additional electrons are then rapidly transferred
to PI (one from the T3α of the TNC and one from the T1 Cu), resulting in O-O bond
cleavage and formation of NI, where the oxygen atoms of the original O2 are reduced to the
water level. In the presence of reducing substrate, NI will undergo fast reduction back to the
fully reduced enzyme. Alternatively, with no excess reductant, NI will slowly decay to the
thermodynamically more stable resting oxidized enzyme. The resting TNC is only slowly
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reduced by the T1 at a rate inconsistent with turnover. This mechanism is a result of many
years of spectroscopic, kinetics, and computational studies by our group and others that are
summarized in the following sections.
3.7.1.5.2 Reactivity of the T3 binuclear Cu site: A significant achievement in the
elucidation of the mechanism by which MCOs reduce O2 to water, has been in determining
the individual role of each of the Cu’s in the TNC. From Figure 161, the T2/T3β Cu(I)’s
deliver the electrons in the first two-electron transfer step. This was shown experimentally
as well as computationally (vide supra). Prior to this, the T3 binuclear Cu’s were assumed to
be the active Cu’s in this step,730,922 mainly due to the resemblance of the site with that of
the coupled binuclear Cu enzymes like hemocyanin, tyrosinase, and catechol oxidase
(section 3.1 and 3.2), which in their reduced state bind and reduce dioxygen in a two-
electron reversible step. Experimental insight into the reactivity of reduced T3 Cu sites in Hc
(deoxy-Hc) and T2D RvL (deoxy-Lc) with dioxygen, was obtained by probing the redox
state of the T3 Cu’s, by Cu K-edge XAS. Spectra of reduced enzymes were compared to
those of these enzymes shortly after exposure to dioxygen.730 As seen in Figure 162A, a
reduced T3 Cu site in deoxy Hc has significant intensity in the 8984eV region, consistent
with the spectra of Cu(I) model complexes.8 After exposure to dioxygen, however, this
intensity is eliminated showing oxidation of the two Cu ions in Hc. In contrast, no change is
observed in the XAS spectrum of T2D deoxy-Lc after exposure to O2 (Figure 162B),
showing a lack of reactivity of the reduced T3 Cu site in the MCOs in the absence of the T2
Cu. This is interesting considering the apparent similarity in ligand environments, where
both the Hc T3 and RvL T3 Cu sites have 6 highly conserved 1st sphere His ligands. A
recent study by Yoon et. al, provided insight into this reactivity difference (cf. section
3.1.5).333 This was based on computational evaluation of energies of the deoxy forms of the
enzymes, as well as binding energies of O2 to the fully reduced sites. Models for each
binuclear deoxy site were generated, imposing frozen αC positions of the His ligands as
dictated by crystallography of Hc vs. MCOs. By varying the Cu-Cu distance, Potential
Energy Surfaces (PES) were generated (Figure 52, filled symbols), with the most
energetically favored structures obtained at 4.2 and 6.5Å for deoxy-Hc and T2D deoxy-Lc,
respectively. A significant destabilization of ~6.9kcal/mol was observed for deoxy-Hc
compared to deoxy-Lc. Subsequently, PES with the αC constraints removed, were generated
(Figure 52, open symbols), revealing that the main contribution to the difference in energy is
the electrostatic repulsion of the closely spaced Cu ions in deoxy-Hc. Additionally, O2-
binding energies of the two deoxy sites were evaluated on S=0 and S=1 reaction
coordinates, generated by introducing an O2 molecule into the center of the binuclear sites.
For deoxy-Hc, O2 binding was observed to be exothermic by 2.9kcal/mol, with a spin cross-
over from S=1 to S=0 occurring at ~4.0Å with no additional barrier, resulting in a final µ-
η2;η2 peroxy-level (S=0) structure with a Cu-Cu distance of ~3.6Å, consistent with
experimental data (vide supra). In contrast, O2 binding to T2D deoxy Lc was energetically
unfavorable by 5.6 kcal/mol (Figure 163), where a peroxy structure was obtained, similar to
that of oxy-Hc (Cu-Cu distance of 3.7Å), with spin cross-over occurring at ~4.0 Å and an
energy barrier of ~9.0 kcal/mol. Thus, while O2 binding to deoxy-Hc is exothermic with a
barrier-free spin crossover, O2 binding and reduction by deoxy T3 in T2D Lc is
thermodynamically as well as kinetically, unfavorable. It is interesting to note, that the
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calculated total energy of the O2 bound structures of Hc and RvL, respectively, only differs
by 1.9kcal/mol, but due to the energy difference of the deoxy forms, only deoxy-Hc is
capable of facile reaction with O2. This difference is a property of the backbone constraints
imposed on the T3 Cu coordinating His residues, as illustrated in Figure 164.333 Here, it is
observed that most of the His residues, in Hc, reside at the end of rigid α-helical motifs,
whereas, in MCOs, the corresponding residues are mainly situated on long flexible loops.
The flexibility in the MCOs, is reflected in reduced and oxidized crystal structures,
respectively, where T3 Cu-Cu distances are seen to vary from ~3.4 to >5Å (see section
3.7.1.3).
3.7.1.5.3 T2 and T3 Cu’s deliver electrons in the first two-electron step: While the T2D
MCOs do not react with O2, the T1 depleted forms, with full TNCs, do rapidly react with O2
to form PI. From spectroscopic experiments, two electrons are transferred from the TNC to
O2 to form a peroxide bridged structure. The stabilization energies of possible PI structures
of the TNC were evaluated.906 With a relatively small model, including only the three TNC
Cu’s and their first coordination sphere (8 His and one T2 Cu OH), a side-on peroxy
structure, bridging the two T3 Cu’s was found (Figure 152A, left). This is clearly
inconsistent with reactivity- and spectroscopic results (vide supra). Therefore, an extended
version, including a highly conserved aspartate residue (D94 in Fet3p, see Figure 165), was
included in the model. A µ3- 1,1,2 peroxy structure was now found, with the peroxide
bridging all three coppers, bidentate to T3β and monodentate to T2 and T3α (Figure 152A,
right). Furthermore, calculated spin densities revealed that the T2 and T3β Cu were
oxidized, and thereby responsible for the first two-electron reduction of dioxygen.
Experimental studies, supporting these calculations, have been carried out, focusing
primarily on variants of Fet3p, including first and second sphere residues of the TNC Cu’s.
In one study, the conserved aspartate residue (D94) was mutated to Glu, Gln, and Asn, in the
holo forms of the enzyme, as well as the T1D forms.888 All mutated varients were expressed
and purified with intact TNCs, but only D94E/T1DD94E showed facile reactivity towards
dioxygen. While no reactivity was observed upon reaction of reduced T1DD94A/N with O2,
for T1DD94E, a peroxy intermediate with almost identical spectroscopic features to those of
PI, was rapidly formed. This indicates that having a negatively charged residue in the
vicinity of the T2 and T3β Cu’s is critical in the O2 reduction process of MCOs. Similar
results were later presented for bilirubin oxidase variants.806
Experimental verification of the role of each of the Cu’s in the first two-electron transfer
step, was obtained from a mutational study focusing on H126Q and H483Q variants of
Fet3p (ligands to the T3α- and T3β Cu, respectively) (Figure 165).907 These two residues
mirror each other in that they both connect to T2 Cu residues via a backbone N-H H-bond to
C=O.733 The effect of the mutations was probed by XAS, CD, MCD, and EPR. Compared
to the WT enzyme, small variations in energies and intensities were observed in the CD
spectra of T1DH126Q and T1DH483Q, reflecting the change in electronic structure of the
T3α- and T3β Cu. Furthermore, the observed changes in the EPR and MCD spectra, which
selectively probe the paramagnetic mononuclear T2 Cu (vide supra), highlighted the above
mentioned connectivity due to the H-bonding network in the vicinity of the TNC. Whereas
only small perturbations were observed in the resting forms of the mutated enzymes, large
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structural changes of the reduced forms were observed in Cu K-edge XAS spectra. The
8984eV feature, probing the geometry of the reduced Cu’s, were observed to be more
intense in the mutated enzymes compared to the WT. This is consistent with the mutated
residues not being able to bind to their respective Cu’s in the reduced state, resulting in a
close to linear geometry of the remaining ligated His residues. In comparing the reactivity of
the reduced TNCs of T1DH126Q and T1DH483Q with that of WT T1D, only T1DH126Q
was capable of facile reaction with dioxygen, as observed in the resulting absorption spectra
in Figure 166. Importantly, in the CD spectra, which can resolve different components, the
T1DH126Q O2-generated species is identical to PI (Figure 167). This verifies that the T3α
Cu is reduced in PI, since the mutated H126Q clearly perturbs the T3α Cu in the resting
form. Despite the similarities of the T3α- and T3β Cu’s of the TNC, it is evident that these
Cu’s possess an inherent asymmetry with respect to reactivity; mutating His to Gln on T3α-
and T3β Cu, respectively, results in similar spectroscopic perturbations. However, only
mutation of a T3α residue (stabilized in a redox inactive form) still allows facile two-
electron reduction of dioxygen.
A closer look at the environment of the two Cu ions provides insight into the origin of this
asymmetry. The conserved aspartate (D94), is close to the reactive T2-T3β Cu edge of the
TNC (Figure 165), thereby lowering the potential of these Cu’s.733,888 Secondly, from
crystal structures of fully reduced MCOs and corresponding XAS Cu Kedge features of T2D
Lc, Figure 162 (more intense 8984eV feature in deoxy-Lc compared to deoxy-Hc), it is
observed that the T3α Cu is situated in the plane of the coordinating His-N’s, whereas the
T3β Cu is held out of the plane by as much as 0.3Å.333 This further stabilizes the T3α Cu(I)
relative to the T3β Cu(I) (verified by potentiometric redox titrations of T1DH126Q and
T1DH483Q),907 thus deactivating T3α towards oxidation. This asymmetry leads to
irreversible O2 binding and its activation for reductive cleavage of the O-O bond by the
TNC.
3.7.1.5.4 Second two-electron step- cleavage of the O-O bond: The second two-electron
transfer step in the reduction of O2 by the MCOs, involves cleavage of the O-O bond and
formation of NI. As for the first two-electron step, insight into this step has been obtained
from experimental as well as computational studies. On the experimental side, T1 inactive
MCOs (primarily T1D in Fet3p and T1Hg in RvL) has been critical in evaluating the PI to
NI conversion, due to the altered kinetic properties of the reaction. In a study from 1996,
Shin et. al showed that T1Hg-generated PI slowly decayed, eventually regenerating the
resting form of the enzyme.873 Monitoring the decay process by MCD established that PI
decays via NI, before regenerating the resting form. This was significant because it allowed
the study of the PI to NI conversion, which is not accessible in the holo enzyme, where this
conversion is extremely fast and not rate limiting (vide supra). This study found a pH
dependence of PI decay, with the decay rate at low pH being ~10 fold higher than at high
pH. This was ascribed to protonation of a carboxylate residue in close vicinity to the TNC
(vide infra). In a subsequent study, Palmer et. al investigated the Kinetic Isotope Effect
(KIE) of 16O2/18O2 generated PI decay, and found a k16/k18 of 1.11, verifying that O-O bond
cleavage is an integral part of this process.874 Furthermore, an inverse SKIE was observed at
low pH, while no SKIE was observed at high pH, indicating that a proton assists in the O-O
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bond cleavage at low pH, but is not required at high pH. Finally, Palmer et. al evaluated the
more than 106 decrease in rate of PI to NI conversion, observed in the redox inactive T1
enzyme compared to holo enzyme. By employing a model for dissociative electron transfer,
developed by Saveant and coworkers,923 activation energies for one electron (T1 depleted
enzyme) and two electron (holo enzyme) cleavage of the O-O bond were predicted at 8.5–
12.5kcal/mol and 2–3kcal/mol, respectively, consistent with the difference in experimentally
determined activation energies. This difference correlates to the redox potentials of the one
and two electron reductions of peroxide, ~0.38 and ~1.37V,924 resulting in the Morse
potential energy surfaces in Figure 168. The high driving force of the two-electron reduction
results in a low activation barrier, in contrast to the one electron process.
To obtain further insight into the origin of the pH effect on PI decay, mutational studies on
Fet3p were conducted, focusing on the two highly conserved carboxylate residues (D94 and
E487, Figure 165) in the second coordination sphere of the TNC.889 D94E, E487D, and
E487A type 1 depleted variants were generated and analyzed with respect to their PI decay
rates at high and low pH, and their SKIEs. PI decay rates are shown in Figure 169 and
summarized in Table 30. All variants, except for E487A, show accelerated PI decay rates at
low pH. This unambiguously ascribes the low pH accelerating effect to E487. The position
of this residue, close to the T3 binuclear Cu’s,733 indicates that this pH effect is connected to
the formation of the µ2-OH bridge, which, as previously described, is an important feature of
the NI structure. Secondly, the SKIE of PI decay shifts from inverse (~0.89) in the WT
enzyme to normal (2.0) in E487D. By employing the Westheimer model,925 the extent of µ2-
O-H bond formation in the transistion state of O-O bond cleavage can be evaluated. An
inverse SKIE is indicative of a strong O-H bond being mostly formed in the transition state,
whereas a normal SKIE indicates that the proton is further away from the product
position.889 This is consistent with the shorter carboxylate side chain of Asp in E487D,
compared to Glu in WT, being less efficient in proton transfer to the T3 bridging oxygen.
This is also reflected in the decreased rate enhancement at low pH in E487D vs. WT (3-fold
vs. 10-fold). Finally, from Figure 169 and Table 30, D94E has a normal SKIE at low pH,
and the rate of decay is slower at all pH’s.889 In the WT T1D, changes in pH led to changes
in the MCD spectrum. This was ascribed to perturbation of the T2 Cu OH ligand, induced
by protonation of the D94 residue; a property of the aforementioned hydrogen bonding
network in the vicinity of the T2 Cu. This connectivity is lost in the D94E variant, where no
change in the MCD spectrum of the resting enzyme is observed upon changes in pH. The H-
bonding network has a mechanistic role. In the WT enzyme, D94 is capable of removing a
proton from the H2O ligand at the T2 Cu in PI. This results in increased electron density at
the T2 Cu, thereby enhancing the electron transfer from this Cu to the bound peroxide. This
enhancement is lost in the D94E variant, resulting in the significantly lowered decay rate,
compared to the WT enzyme.
We combine the above results into an overall model for the O-O bond cleavage step in
native MCOs, as presented in Figure 170.906 The starting point (hypothetical), is a one
electron reduced PI, PI`, where an electron has been transferred from the T1 Cu to the T2 Cu
(vide infra), setting up a two electron reduced TNC capable of facile reduction of PI to NI.
At low pH we assume that E487 is protonated, while D94 is deprotonated as required for
reactivity (vide supra). The reaction coordinate towards the transition state involves proton
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transfer from E487, via a water molecule to the proximal oxygen atom of PI`, and a
concerted deprotonation of the T2 Cu-bound water molecule via a H-bonded water molecule
to D94. The combined effect of these proton rearrangements is to weaken the O-O bond of
PI and decrease the redox potential of the T2 Cu, both of which will promote the O-O bond
cleavage. At high pH, both of these proton transfer mechanisms are disrupted, resulting in
the decreased reaction rate and less involvement of the µ2-O-H bond in the transition state,
as reflected in the lack of a SKIE.889
The above spectroscopically defined structures of PI and NI, as well as the experimental
kinetic and mechanistic insight, led to a computational evaluation of the energetics of O-O
bond cleavage.906 The starting point of the reaction is ‘PI + e-‘ (Figure 171), where electron
transfer from the T1 to the T2 Cu generates a structure with the T2-PI-O1 bond broken, and
two TNC electrons available for reduction of PI to NI, at the T2 and T3α Cu’s. As shown in
Figure 171, PI + e− to NI conversion involves O-O bond cleavage and protonation by E487
of the µ2-O2− bridge. Based on this, a pD potential energy surface plot was generated
(Figure 172) where individual points on the grid correspond to varying O1-O2 and O2-H
bond distances ranging from 1.45 and 1.85Å to 2.4 and 1.0Å, respectively. The 2D plot
reveals a highly exothermic reaction. Two separate pathways can be identified, both with
low activation barriers. Following the dashed line from PI + e− in the rear corner along the
O-O bond cleavage coordinate leads to transition state 1 (TS1) (at ~1.70Å), with a low
activation energy of ~5.9 kcal/mol, consistent with the experimentally estimated value.
Subsequent proton transfer, results in NI formation with no additional activation barrier.
Alternatively, following the H+-transfer coordinate leads to PI + e− + H+ formation, where
the proton from E487 has been transferred to the T3 bridging oxygen, with no significant
change in O1-O2 bond distance. Subsequent elongation of the O-O bond results in NI
formation, via TS2, obtained at ~1.70Å, with a barrier of ~5.4kcal/mol relative to PI + e− +
H+. It is interesting to note that no intermediate reaction pathway, with concurrent O-O
elongation and O-H contraction, is observed in the 2D energy plot. This correlates well with
experimental data, where the inverse SKIE observed at low pH is indicative of proton
transfer before the transition state, resembling the PI + e− + H+ pathway, TS2, whereas a
SKIE of 1, at high pH, is consistent with the PI + e− pathway, TS1, where proton transfer
occurs after the transition state.889
Geometry optimized structures of both pathways, highlight a molecular orbital picture of O-
O bond cleavage, in MCOs, that leads to the low barriers at both high and low pH.906 First,
evaluation of the spin densities of the TNC Cu’s (Figure 173) shows that the T3β Cu
remains oxidized throughout the reaction, whereas the T2 and T3α Cu’s simultaneously gain
spin density as the O-O bond is elongated, verifying that the reduction of PI occurs via a
concerted two electron transfer mechanism. A closer look at the frontier molecular orbitals
of the TNC involved in the O-O bond cleavage, shows how the site is optimized for facile
electron transfer, due to significant overlap of the HOMO of the donors (T2/T3α), with the
LUMO of the acceptor (peroxide σ*), Figure 174. The overlap is enhanced as the energy of
the LUMO is lowered with O-O bond elongation, resulting in strong orbital mixing at the
transition state. The energy lowering is also enhanced by interaction of the oxidized T3β Cu
with the peroxide σ* orbital, thereby further lowering the barrier and defining a critical role
for this Cu in the reductive cleavage of the O-O bond. These features emphasize the
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significance of the triangular topology of the TNC (Figure 174) in the reductive cleavage of
the O-O bond resulting in an effective four electron transfer in the native enzyme.
3.7.1.5.5 Decay of NI to resting enzyme: The analysis of O-O bond cleavage, obtained from
experimental as well as computational studies, concludes the description of the O2 reductive
part of the catalytic cycle of MCOs. Now we address the decay of NI to the resting enzyme.
This occurs in the dioxygen reaction of the fully reduced enzyme in the absence of an
electron from a reducing substrate, see Figure 161. As for the PI to NI conversion,
spectroscopically defined structures of NI and resting oxidized enzyme, provide the scaffold
for computational evaluation of this process.900 This process includes two proton transfers
and release of one water molecule from the TNC, with the second oxygen from O2 bound to
the T2 in the resting form (Figure 175A). Two different starting structures of NI were
evaluated, only differing in the protonation state of the T2 Cu bound water derived ligand
(NIH2O and NIOH). These structures include both the µ3-oxo and the T3 µ2-OH bridge, as
dictated by spectroscopy and computations (vide supra). The first step of NI decay involves
protonation (from solvent) of either the µ3-O or the µ2-OH. Protonation of the µ3-O was
found to be energetically favored by 17 and 25 kcal/mol for NIH2O and NIOH, respectively.
Also, protonation of the µ2-OH results in loss of the bridging interaction, thereby generating
a ferromagnetic structure, inconsistent with spectroscopic observations (vide supra). A
second proton can then be transferred, either to the µ3-OH or to the µ2-OH. Both lead to the
same result; protonative decoupling of the µ2-OH bridge, generating an isolated T3β Cu with
a water molecule bound, with the T2 and T3α Cu’s still bridged via the µ-OH (Figure
175A). The T3β Cu-bound water molecule is subject to facile exchange with solvent water
molecules, while the second oxygen atom of the original dioxygen remains bound to the T2
and T3α Cu’s of the TNC. The subsequent steps in the decay of NI, involve rearrangement
of this oxygen from its position inside the cluster to outside the cluster, terminally at the T2
Cu, as suggested from 17O experiments911 (vide supra). As shown in Figure 175B, this
rearrangement occurs via proton transfer from the T3β Cu-bound water molecule to the
rotating OH−, allowing for regeneration of the µ2-OH bridge between the two T3 Cu’s.
Transfer of this H2O from inside to outside the cluster has a significant activation barrier,
with a lower limit of 8.5 kcal/mol, consistent with the experimental value of 8.8–13.9 kcal/
mol,876 making this step rate determining in the conversion of NI to resting oxidized
enzyme. As mentioned earlier, this process is too slow to be in the catalytic cycle and
therefore NI reduction must be catalytically relevant.
3.7.1.5.6 Reduction of NI: Recently, the first report of kinetics on the reduction of NI
showed that the rate of intramolecular electron transfer from the T1 to the TNC is > 700 s−1,
consistent with turnover.926 Additionally, and under identical conditions, the rate of
intramolecular electron transfer from the T1 to the TNC in the reduction of the resting
enzyme was found to be 0.11 s−1, consistent with the aforementioned slow kinetics in
section 3.7.1.2.866 The reduction of the resting TNC also exhibits a deuterium solvent
kinetic isotope effect, which implies that both the reduction of resting and NI are a proton
coupled electron transfer (PCET) processes. Importantly, these results indicate that the
reduction of the resting TNC that is observed crystallographically, is not in the catalytic
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cycle and establishes the reduction of NI as the relevant process in the rereduction of the
MCOs.
This difference of more than three orders-of-magnitude in ET rate produces a unique
opportunity to determine the molecular factors that control electron transfer rates in the
MCOs.926 In Marcus Theory, these rates are dependent on the thermodynamic driving force,
reorganization energy, and the electronic coupling matrix element between donor and
acceptor.64 Calculations were performed on the reduction and protonation of these TNC
active sites (resting and NI in Figure 176) to determine which of hese contributions account
for the large rate difference. It was computed that the proton coupled electron transfer
driving force was more favorable for NI than resting by 7 kcal/mol, while estimates of
reorganization energy were comparable; since the T3a copper was reduced in both T1 to T3a
ET processes, the electronic coupling matrix element (through the T1 Cys-His pathway) can
be considered equivalent in both processes. Therefore, the kinetic difference originates from
a more favorable driving force for proton-coupled electron transfer to the TNC of NI
relevant to resting. On the basis of the structures (Figure 176), this is attributed to the µ3-oxo
ligand of NI since this group is significantly more basic than the µ2-OH of the resting site.
This new insight presents a unifying mechanism for both O2 reduction and enzyme
rereduction since this µ3-oxo ligand originates from the reduction of O2 and the protonation
of this group supplies the driving force for the rapid rereduction.926 Current studies focus on
understanding the molecular mechanism of all the three ET steps in the reduction of NI to
the fully reduced enzyme in the catalytic cycle.
3.7.2. Heme-copper respiratory oxidases
3.7.2.1. Enzymology: Heme-copper oxidases (HCOs), also referred to as heme-copper
oxygen reductases, are a superfamily of membrane-bound enzymes that are located in the
inner mitochondrial membrane of eukaryotes and in the cytoplasmic membrane of many
prokaryotes. These catalyze the terminal step of respiration, the complete reduction of
dioxygen to water. ~90–95% of all dioxygen is processed through HCO. During this process
low energy electrons are removed from the respiratory chain. The overall dioxygen
reduction is exergonic in nature. This reaction (O2 + 4H+ + 4e−→ 2H2O) at 815 mV versus
NHE per e− coupled to the oxidation of the reducing agent (Fe2+-cytochrome c → Fe3+-
cytochrome c + 1e− at 235 mV) provides an overall driving force of 580 mV per electron
(13 kcal/mol). This driving force is used to pump protons across the cytoplasmic (or
mitochondrial) membrane (~5 kcal/mol required per proton) from the negative to the
positive side (Equation 37).
[37]
Thus, for every electron reduction of O2, two protons can be translocated. The resulting
proton gradient is used by ATP synthase to convert ADP and inorganic phosphate to ATP.
These dioxygen reduction, electron transfer and proton pumping functions performed by
HCO are illustrated in Figure 177A.
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In all HCO, the fast reduction of dioxygen to water takes place at a bimetallic heme-copper
site (Figure 177B) without generating toxic partially reduced oxygen species. This site is
uniquely designed to overcome the first, one electron reduction of dioxygen, which is uphill
(−350 mV at pH 7.0 vs NHE). The copper center, known as CuB, is positioned ~4.3–.4 Å
from the high-spin heme center depending on the exogenous ligation and oxidation states of
the metals. The heme iron has a conserved axial histidine ligand. CuB is ligated to three
histidines. Most HCO undergo a post-translational modification resulting in a covalent bond
between one of the ligating histidines and a tyrosine residue. This cross-link is thought to be
functionally relevant.
In addition to the bimetallic site, HCO contain between one to three other redox cofactors,
which include a bimetallic CuA site and/or heme(s). These redox sites function in electron
storage and transport from the external reductants to the heme-copper catalytic site. All
HCO contain a second low-spin heme site (Figure 177A). In all HCO, this low-spin heme
has two conserved axial histidines that are connected to the protein backbone. HCO may
also contain a CuA center that can exist in an oxidized delocalized mixedvalent state.59 Each
copper ion of CuA is bound to two bridging cysteines and one histidine. In addition, one
copper has a weakly bound axial methionine whereas the other copper has an axial backbone
carbonyl oxygen from a glutamate forming a long Cu-O ligand distance.
The HCO superfamily is quite diverse in terms of electron donors, heme types, and subunit
composition leading to different electron and proton transfer channels. The HCO
superfamily can be subdivided into three major functional and evolutionary families: A
(containing subfamilies A1 and A2), B, and C (Figure 178).927 Mitochondria contain only
type A1 oxidases, whereas prokaryotes contain all types of HCO. Among the prokaryotes,
bacteria are known to contain all families of HCO, whereas archaea contain types A1 and B.
Type C is observed only in two bacterial groups: 1) purple bacteria and 2) Flexibacter,
Bacteroides and Cytophaga.927
The A and B HCO require in addition to the central subunit (I), at least one other subunit
(II). The type C HCO contain a central subunit (N) and either one (O) or two (O, P)
additional subunits that are completely different from type A and B subunits. HCO
belonging to type A use at least two proton pathways (D- and K-channels), whereas type B
and C HCO require only one (a modified K-channel). Type A is further divided into A1 and
A2 subfamilies depending on the residues along the D-channel. The details of the proton
pathways (channels) will be discussed later. The proton pumping stoichiometry is not 1 H+/
e− for all families. Family A generally has a stoichiometry closer to 1 whereas families B
and C have ~0.5 H+/e−. The lowered proton pumping stoichiometry in B and C families is
energetically disadvantageous compared to the A family, requiring more O2 to be consumed
to generate an equivalent membrane potential. Organisms encoding the B or C HCO have
high apparent affinities for O2 and are usually expressed in organisms under low O2 or
microaerobic conditions. It is not clear why nature would select for a less efficient enzyme
in environments in which oxygen is limiting.
Nitric oxide reductases (NOR) have a close evolutionary link to HCO based on structural
similarities. Subunit I in NOR is reminiscent of subunit I in HCO with the six histidines that
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bind the metal centers. The other subunit of NOR resembles subunit O (that contains a
mono-heme) of the C type HCO (Figure 178). NOR’s, however, catalyze a different reaction
—the reduction of NO to N2O. In addition, this enzyme has an Fe instead of CuB at the
catalytic site. Also, there is no tyrosine crosslinked to a histidine of this non-heme iron
center. Interestingly, type C cbb3 oxidase can also reduce NO to N2O. It is not surprising,
therefore, that NOR’s have the closet homology with C type HCO.
In addition to the three families, the HCO can be further divided into two subgroups,
cytochrome c oxidase (CcO or COX) and quinol oxidase (QO), depending on the source of
the electrons required to reduce dioxygen. CcO, located in the mitochondrial membrane of
all eukaryotes and in the cytoplasmic membrane of certain bacterial prokaryotes, use water
soluble ferrocytochrome c as the source of electrons whereas QOs, present only in some
bacterial and archaeal prokaryotes, use membrane soluble ubiquinol or menaquinol as their
electron source. Ferrocytochrome c and ubiquinol are the most oxidizing electron carriers of
the respiratory chain. CcO contain the mixed-valent CuA site that is not present in QO. CcO
span across all three HCO families; QO is present in only type A1 and B families.
There are three types of heme sites present in HCO’s: heme a, heme b, and heme o (Figure
179). A subscript 3 denotes the O2-binding heme site whereas lower case letters denote
protein-bound hemes. The high-spin heme can be a3, b3 or o3, whereas the low-spin heme
can be either a or b. Heme a contains a formyl group in position 8 and a farnesyl tail of
unsaturated isoprenoid groups in position 2, both of which are not present in heme b. Heme
o has the same structure as heme a except for a methyl group in place of the formyl
group.928 Only heme a is present in most mitochondrial CcO. Heme b has also been
identified in submitochondrial particles. In bacteria, all three heme groups a, b and o can be
present.929
In addition to the structural subunits, a large number of accessory factors are involved in the
assembly and maintenance of active HCO’s. Loss of function of some of these auxiliary
proteins or mutations in the mitochondrially-encoded core subunits, although relatively rare,
lead to CcO deficiency and are associated with a wide spectrum of clinical phenotypes
ranging from isolated myopathy to multisystem disease. Most isolated CcO deficiencies are
inherited as autosomal recessive disorders, which generally have a very early age of onset
and a fatal outcome. Patients afflicted with these diseases present heterogeneous clinical
phenotypes, including Leigh syndrome, hepatic failure and encephalomyopathy.
HCO’s are susceptible to inhibition by a variety of substrates including CO, sulfide (H2S),
cyanide (HCN), azide and formate (HCOOH).930,931 Of these, H2S have been implicated in
normal cellular signaling events because it can be readily metabolised by oxidative
processes within CcO resulting in the enzyme acting as a physiological detoxifier of sulfide.
Inhibition of CcO can also lead to toxic effects. Inhibition by cyanide and sulfide leads to
acute respiratory failure, whereas with azide poisoning, the proximal cause of death is
suggested to be circulatory collapse. CO is known to competitively bind to the reduced
cytochrome a3 and prevent its oxidation by oxygen; azide and formate un-competitively
bind to the oxidized forms and prevent the reduction of this group; cyanide and sulfide
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produce non-competitive inhibition towards oxygen. The five inhibitors all compete for the
same or different oxidized forms of the enzyme, which are reversibly connected.
The endogenous production of NO in cells is also known to inhibit CcO activity.932 Low
concentrations of NO for a short period of time has been proposed to be involved in the
physiological and/or pathological regulation of respiration rate by extending the availability
of O2 either to cells at different distances from capillaries or within the mitochondrion.
Higher NO levels and prolonged exposure, or conversion of NO to one of its more reactive
oxides (peroxynitrite, nitrogen dioxide or nitrosothiols) results in the irreversible inhibition
of respiration and other damage to mitochondria. It is known that NO inhibition of
mitochondrial respiration has a role in cell death, by either necrotic or apoptotic
mechanisms.
Two alternative pathways have been identified for the reaction of NO with CcO that depend
on the rate of electron flux through the respiratory chain.932 At high electron reflux (i.e. high
ferrocytochrome c concentrations), NO undergoes heme binding at the binuclear center in
competition with O2, whereas at low electron reflux, NO binds to oxidized CuB. Both
pathways lead to effective, fully reversible inhibition of respiration and can be discriminated
on the basis of the differential photosensitivity of the inhibited state. The oxygen sensitive
NO binding to the reduced heme Fe to form a six-coordinated structure causes immediate
inhibition of O2 consumption and the formation of a light-sensitive nitrosyl derivative (Fe2+-
NO). The inhibition of O2 consumption is greater at lower O2 levels. The process is reversed
when the NO is dissociated as a free, reactive radical. This pathway has been proposed to
function both in regulating the formation of hydrogen peroxide from the respiratory chain
and in signal transduction and controlling O2 gradients in complex organs such as the liver
or heart. Maladaptation in this pathway, in the presence of normal or enhanced levels of O2,
leads to a mitochondrial dysfunction that has some of the characteristics of hypoxia,
including a deficit in ATP. NO binding to the oxidized CuB site of resting CcO, and to the
CuB site of intermediates P, F and O formed during turnover (see section 3.7.2.2.3) yields a
light-insensitive Cu(I) nitrosonium (NO+) complex. This Cu(I) nitrosonium can be oxidized
to give nitrite, which can in turn inhibit the oxidase. The oxidase then recovers activity upon
reduction, releasing nitrite into the bulk. Therefore, of relevance to cell pathophysiology,
this pathway involving the oxidative degradation mechanism, disposes toxic NO in the form
of less toxc nitrite.
3.7.2.2. Kinetics and Thermodynamics
3.7.2.2.1 Resting versus pulsed: The as-isolated, fully oxidized CcO has been shown to be
different from the fully oxidized species formed after the four electron oxidation of the fully
reduced enzyme.933–935 These species are commonly referred to as the resting and the
pulsed forms, respectively. The interconversion between pulsed and resting forms at low pH
(pH<8) is fairly slow.933,935 Armstrong and colleagues have shown that the pulsed form is
converted to the resting enzyme within ~3 hrs at pH 7.2 (half-life of 40 min at 2 °C).935
Complete reduction of the resting form followed by complete oxidation produces the pulsed
form. O2 is physiologically involved but not necessary for the production of the pulsed state.
The reduction potential of cytochrome a3 in the resting enzyme is lower than that of the
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more physiologically relevant pulsed enzyme with the rate of intramolecular reduction of a3
being significantly faster in the latter.934 The initial velocity for the steady-state reaction at
pH 7.4, starting from the pulsed form is 4 to 5 fold faster than with the resting form with
roughly stoichiometric additions of CcO and reduced Cyt c.933 Thus, the pulsed enzyme
reaches steady state turnover sooner than the resting enzyme (pH 7.4).936 When Cyt c is in
excess, the two forms proceed with roughly the same overall velocity.933 These observations
are consistent with the model that the resting enzyme is not an intermediate in catalysis but
is transformed into an active species after being fully reduced in the presence of O2. Thus,
the pulsed enzyme is the catalytically competent form that slowly decays to the resting form
in the absence of additional reducing equivalents.
3.7.2.2.2 Slow versus fast: The resting form was originally taken to be the enzyme as-
isolated. The as-isolated form can be inhomogeneous and contain a mixture of a fast and a
slow form.937 Some authors have equated the resting form only with the slow form.937,938
The fast and slow forms are defined according to their rate of reaction with exogenous
anionic ligands such as cyanide (CN−), fluoride (F−), and formate (HCOO−).939 Alternately,
the resting form has also been equated to the chloride-ligated fast form, which binds cyanide
at a rate slower than the fast form but faster than the slow form. The term resting has thus
become ambiguous. A fast form predominates when the enzyme is isolated under mildly
alkaline conditions, whereas a slow form dominates in preparations at low pH. The fast form
can be converted to the slow form upon incubation at low pH (pH <8) or with prolonged
dilution of the enzyme.940 The reversal of the process is controversial. The slow form of
bovine CcO exhibits a weak derivative shaped EPR signal with a g' = 12 in X-band that is
not observed for the fast form,938,941 the difference arising from different magnetic
interactions between the CuB and heme a3 (the precise nature of the spin coupling in each
case is not known). The slow form with the g' =12 EPR signal was not observed in the
mitochondrial membrane and is suggested to have been produced as a consequence of one or
more of the manipulations employed during purification. The slow form is, thus, considered
an artifact of purification and not physiologically relevant. Spectroscopic properties of the
fast and pulsed forms are very similar, which result in some authors incorrectly equating the
two to be the same species.937 However, the pulsed form is metastable whereas the fast form
is stable.942 The two forms also have different rates of reduction (discussed below). The
metal ion ligation and coordination geometries of the fast and slow forms are not known. It
appears that enzyme X-ray structural studies have not yet revealed differences between the
two forms because all the crystal structures seem to be of the fast form (crystallographic
studies, that do not explicitly mention whether they have a fast form, used enzyme purified
at slightly alkaline conditions, which would suggest a fast form). Therefore, it is important
to identify which form of the as-isolated enzyme, fast or slow, is present in a reaction,
especially when dealing with single turnover kinetics. However, neither of these forms is the
catalytically competent fully oxidized form that is the pulsed enzyme.
3.7.2.2.3 Single turnover kinetics: The catalytic cycle of HCO consists of two phases
(Figure 180)—an oxidative phase where the reduced enzyme undergoes 4e− oxidation by
O2, and a reductive phase where the oxidized enzyme is reduced before it can bind the next
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O2 molecule. Two protons are translocated during the oxidative phase while two more
protons are translocated during the reductive phase.
The four electron reduction of dioxygen has been extensively studied in two forms of CcO
—the fully reduced (R or R4) enzyme and the two electron reduced mixedvalence (MV or
R2) enzyme. The MV enzyme is formed by incubating the fully oxidized CcO with CO. The
CO reduces the CuB and heme a3 sites of the enzyme by two electrons and binds to the
binuclear site.943 Dioxygen reduction has also been studied in the three electron reduced
(R3) enzyme, which is obtained by titrating the MV form with one electron equivalent of a
reductant (such as TMPD, ascorbate, cytochrome c944 or NADH945). In the MV+e form,
heme a and CuA are partially reduced and in an intramolecular redox equilibrium. Kinetic
rates of the intermediate states formed in single turnover of the enzyme with O2 have been
studied by flow-flash photolysis of the bound CO in the presence of O2 by a variety of
biochemical and spectroscopic methods including Abs, rR and EPR.
Several kinetic intermediates have been resolved for the reaction of fully reduced, R-CcO
with O2. Transient absorption spectroscopy in the visible region (830 nm) suggests that O2
first binds to the CuB site in the binuclear center with a rate constant of 108
M−1s−1.939,946,947 The O2 then weakly binds to heme a3 with KD of ~0.3 mM, forming
intermediate A (Figure 181) with a pseudo-first-order microscopic rate constant, k1 =
1.2×105 s−1 at [O2] = 625 µM.948
When the CuA and heme a sites are reduced, as in R-CcO, intermediate A converts to PR
with an electron transfer from heme a to the binuclear center with a rate constant k2 of 1–
3×104 s−1 (Figure 181).948–951 The formation of PR is independent of pH in the range 6.5–
9.0, with no proton uptake. Nevertheless, the rate is slowed in D2O (kH/kD of 1.4–1.9),
which suggests that transfer of an internal proton or hydrogen atom is involved in the rate-
limiting step of PR formation.951
The decay of PR to form F is the first step that shows a pH dependence with lower rates
observed at higher pH values with a pKa of 7.9 and kH/kD of 1.4 at pH 7.4. This suggests
that a proton is taken up during this kinetic phase with a rate constant k3 of ~1×104 s−1 (time
constant τ = 80 µs) resulting in the formation of F.949,952 It appears likely that a proton is
taken up by the tyrosinate covalently crosslinked to the histidine ligand of CuB, rather than
by CuB2+-OH based on the higher pKa of the former.
The reaction proceeds via a fast electron transfer between CuA and cytochrome a with an
apparent lifetime of F of ~50 µs (rate constant of 2×104 s−1),953,954 to form intermediate F′.
Earlier work by Gray and coworkers estimated a shorter lifetime for intermediate F of 1.2–
25 µs.955 The equilibrium constant, K1, for the F↔F′ conversion is close to 2.948 A
tryptophan residue (Trp272 for P. denitrificans) has also been suggested by de Vries and
colleagues as an electron donor to the binuclear center after the formation of F to form FW*
with a rate constant of ~8×102 s−1.956
The final intermediate is formed with the transfer of the second electron from the CuA/heme
a site leading to the formation of OH (the pulsed form of the HCO discussed above) with k4
of ~6–9×102 s−1 (τ = 1.2 ms).949,954 The formation of OH is pH dependent, slower at higher
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pH, with a kH/kD of 2.5 measured at pH 7.4952 and is rate-limited by proton uptake. The
transmembrane voltage generated is biphasic with rate constants of ~830 s−1 (coincident
with electron transfer coupled to proton transfer) and 220 s−1 (associated with proton
transfer) with relative amplitudes of 1:3.954 The second electron transfer to the binuclear
center, thus, completes the oxidative phase of the enzyme in Figure 181. The OH
intermediate can then be re-reduced to form R with the injection of four electrons from
cytochrome c that is coupled to the uptake of four additional protons (two chemical and two
pumped protons) as discussed in below.957
The overall proton pumping for the oxidative phase of the cycle starting from the fully
reduced R state to OH has been measured by Hallén et al. at pH 7–8. They report that 2.6
protons were released on oxidation of the fully reduced CcO.952 Mitchell found a similar
number of 2.4 protons in the pH range of 7.5–8.5, which is in reasonable agreement.958 0.4
of these protons have been associated with heme a/CuA, and the remaining two with the
binuclear center. This proton pumping observed is now known to be coupled to the PR→F
and F→OH steps.
Starting from the MV form of CcO (as well as the three electron reduced form), the fast O2
binding to CuB is again observed with a similar rate constant (108 M−1s−1) as with R (or R4).
The O2 then proceeds to bind to heme a3 forming intermediate A. The amplitude of this
phase has been shown to decrease with a decrease in the initial degree of reduction of CcO
(R4 to R3 to R2/MV).946
Intermediate A decays to PM (in MV-CcO) with k`2 ~5×103 s−1 where the O-O bond has
been cleaved (Figure 182).959 The formation of PM is ~5–6 times slower than the formation
of PR (formed from R4). Intermediate PM has been the subject of extensive controversy.
Only three of the four electrons required to cleave the O-O bond are readily available in the
binuclear site. In MV-CcO the source of the fourth electron has been suggested to be the
tyrosine crosslinked to the CuB imidazole ligand or a highly conserved tryptophan residue
that π-stacks with one of the CuB histidine ligands.959 Palmer and coworkers have provided
arguments against the porphyrin ring of heme a3 being a potential electron donor.960 With
MV-CcO, the reaction stops at PM that is found to decay with a rate constant of 1.5×102 s−1.
No pH dependence is detected in any of the phases with MV-CcO.949 A kinetic isotope
effect (kH/kD of 1.4–1.8) is observed during the A→PM conversion, which is similar to that
observed in the formation of PR.951
For the fully reduced (R4) and three electron reduced (R3) forms of the enzyme, it is
possible that the PM state also forms but is not observed because it is rapidly converted to
PR. The rate constant for the conversion of PM to PR is then required to be significantly
faster (half-life of 1 ns) than the rate constant for the formation of PM (half-life of 32 µs).956
Single electron reduction of the PM state (formed from MV-CcO) has been studied by laser-
flash excitation of a ruthenium complex (e.g. tris(2,2'-bipyridyl)ruthenium(II)), which is a
photo-activatable electron donor. The PM→F transition occurs upon rapid electron transfer
from heme a to the binuclear center (presumably to the Y244 radical) with a time constant
of 0.3 ms (rate constant of 4000 s−1).961 This electron delivery is coincident with the
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generation of a transmembrane voltage, which is triphasic with time constants of 0.3 ms, 1.3
ms, and 7 ms (rate constants 3300 s−1, 770 s−1, and 140 s−1, respectively). The relative
amplitudes are 1:1.3.961 Hence, a portion of the voltage generation is coincident with
electron transfer, while the rest of the charge transfer across the membrane occurs after the
ET step. A charge movement from heme a to the binuclear site is parallel to the plane of the
membrane and will, therefore, not directly result in the generation of a transmembrane
voltage. It is proposed that electron transfer is accompanied by the transfer of a proton from
residue E242 at the gate site (to be discussed in section 3.7.2.3.) to the active site (a
chemical proton, vide infra) along with reprotonation of E242 during the 0.3 ms phase. In
the slower 1.3 ms phase, it is proposed that a second proton is transferred from E242 to the
proton loading site or translocated to the P-side of the membrane followed by a rapid second
protonation of E242.
The PM→F conversion is significantly slower than the PR→F conversion in the fully
reduced enzyme (0.3 ms for PM, ~80 µs for PR). The PR→F conversion has been assigned to
a monophasic proton uptake.961 The final F state formed is identical in both cases. In the
three electron reduced form of the enzyme, the PR→F conversion is also observed but to a
lower extent.946
A second single electron transfer (by flash photolysis of tris(2,2'-bipyridyl)ruthenium(II))
from heme a to the binuclear site results in an F→OH conversion with a similar rate constant
as seen for the fully reduced CcO.961 This electron transfer step (1.5 ms [~7×102 s−1]) is 4–5
fold slower than the electron transfer in the PM→F transition (0.3 ms). Associated with the
F→OH transition there is an electrogenic proton transfer that occurs in two phases with time
constants of 1.2 ms and 4.5 ms. The first protonic phase corresponds roughly to the electron
transfer to the binuclear site (1.5 ms). The ratio of the amplitudes of the two phases is 1:1.2,
which is close to the value for the PM→F transition.961
The second half of the catalytic cycle after the four electron oxidation of CcO by O2 is the
four electron reduction of the fully oxidized enzyme OH. The OH, which is the pulsed form
described above, formed at the end of the oxidative part of the catalytic cycle is metastable
and decays to the resting form of the oxidized enzyme. Bloch et al estimated the lifetime of
the OH state to be at least ~30 s at room temperature and at pH 8.0 for P. denitrificans to
decay to the fast form.962 The reduction of the oxidized enzyme in the OH/pulsed form is
different compared to the non-pulsed, fast form. Reduction of OH, but not of the resting
form of the enzyme, leads to two successive proton-pumping events (Figure 183).
Proton pumping has been best documented for PM→F and F→OH transitions as described
above, where a large part of coupled proton transfer occurs after electron transfer is
complete. The proton pumping process observed during the OH→EH and EH→MV steps
(Figure 183) are less clear because the reduction kinetics depend on the way the oxidized
enzyme was prepared. Only the OH/pulsed form pumps a proton coupled to electron transfer
to the binuclear site.
Brand et al has demonstrated that photoinjection of an electron into the OH form of bovine
CcO, results in rapid reduction of heme a (ET from CuA to heme a in bovine OH has a rate
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constant of 2×104 s−1), followed by biphasic electron transfer from heme a to the binuclear
center with rate constants of 750 s−1 and 110 s−1 (time constants of 1.3 ms and 9 ms,
respectively), with relative amplitudes of 25% and 75%.954 The heme a and CuA are 63%
reoxidized. It is proposed that the first phase of electron transfer is coupled to proton
translocation while the second phase of electron transfer is coupled to the uptake of a
chemical proton. The midpoint potential of CuB is significantly more positive in the OH state
compared to the resting, fast form of the enzyme. The one electron injection results in the
electron residing mostly on CuB. In contrast, when OH is allowed to decay to the fast,
resting form, O (Figure 183), one electron injection leads to form E (Figure 183) by
monophasic reoxidation of heme a with a slower rate constant of 90 s−1, with only 30% of
heme a/CuA being reoxidized. In addition, no proton pumping is observed. Thus, there is a
significant difference between the kinetics of the pulsed and fast resting forms of the bovine
enzyme. It should be noted that in a separate study, Jancura et al observed no difference in
the kinetic properties of the pulsed versus the fast oxidized bovine CcO.963 In addition, they
saw a monophasic electron transfer from heme a to the binuclear center with a rate constant
of 80 s−1 without the small fast phase at 750 s−1. The reason for the difference is not clear.
When the bacterial CcO’s from P. denitrificans and R. sphaeroides are used instead of
bovine CcO, only a monophasic electron transfer from heme a to the binuclear center is
observed during the OH→EH transition with rate constants of 3000 s−1 and 760 s−1 ,
respectively.954 The heme a reoxidation was only ~25% in both cases. The non-pulsed, fast
resting form of these bacterial enzymes gave similar rate constants as their pulsed
counterparts for the OH→EH transition.954 Belevich et al found a biphasic reduction of heme
a during the OH→EH transition (rate constants of 6700 s−1 and 1250 s−1, with equal
amplitudes) with bacterial P. denitrificans.964 The reason for the difference is not known.
Ruitenberg et al found time constants of ~20 µs (50,000 s−1) associated with the reduction of
heme a and a single slower phase of 175 µs (6000 s−1).965 The slower phase is deuterium
sensitive with kH/kD of ~2 that is assigned to the uptake of a proton. They also provide
evidence that this proton uptake occurs via the K pathway and not the D pathway (vide
infra). A remaining question is whether electron transfer from CuA to heme a or the
subsequent reduction of the binuclear center leads to proton uptake. The study by
Ruitenberg et al on P. denitrificans suggests the former.965 Thus, there is some discrepancy
about the exact electron transfer rates during the OH→EH transition and its coupling to
proton uptake. In addition, the difference in rates between the pulsed (OH) and the non-
pulsed fast (O) form of CcO is controversial. What is known is that only the pulsed form
pumps a proton coupled to electron transfer. Further studies are needed to elucidate the
structural basis for the functional difference observed between the two oxidized forms.
The one-electron reduction of state EH was studied by a stopped-flow flash technique.
Single electron injection from a reduced ruthenium dimer results in biphasic electron
transfer from heme a to heme a3 to form the MV state (Figure 183) with rate constants of
1100 s−1 and 90 s−1, and relative amplitudes of 11% and 89%.966 The second electron
reduction of the binuclear site is also coupled to the uptake of one chemical proton and one
pumped proton. This proton translocation is also not observed with the non-pulsed O
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enzyme (Figure 183). The two electron reduced MV form can then react with O2 to form PM
(Figure 182).
Ruitenberg et al generated EH by chemical treatment. First, F was generated by adding
excess H2O2 to O.967 After removing the excess H2O2, CO was added to reduce F by two
electrons to generate state EH. Injection of a single electron to EH by laser-flash of a bound
ruthenium complex, generated a membrane potential that had three phases: τ ~27 µs (40,000
s−1), ~0.2 ms (~5000 s−1), and ~1.5 ms (~700 s−1), with relative amplitudes of
0.26:0.25:0.49. The fast phase corresponds to electron transfer to heme a, the intermediate
phase corresponds to the uptake of a charge-compensating proton, while the slow phase has
been identified as pumping one proton across the membrane.967 There is also evidence that
the charge-compensating proton is taken up via the K-pathway while the pumped proton is
taken up via the D-pathway (discussed in section 3.7.2.3).
3.7.2.2.4 Thermodyanmics: Study of the thermodynamic properties of the different redox
sites provides important information about the level of reduction of each site during steady-
state turnover (considered below). This is challenging because the redox properties of the
four metal sites in CcO interact with each other anticooperatively and do not exhibit the
same redox potentials as the isolated sites. The Cyt a and a3, in particular, are influenced by
more than one inter-site interaction.968 Spectroelectrochemical studies monitoring changes
in absorbance, MCD and EPR features with changing potential have been commonly used to
estimate the extents of reduction of Cyt c, a and a3, and CuA. CuB potentials have been more
challenging to study because they cannot be monitored optically and thus, these potentials
have been obtained indirectly by their effect on the absorption of hemes with changing
amounts of charge injected.969 More recently, ATRFTIR has also been used to study the
redox properties of all metal sites.970
Dutton and others have shown that the midpoint reduction potential (Em) of Cyt c is 235 mV
at pH 7.2 when bound to phospholipid vesicles, inside mitochondria or in submitochondrial
particles and increases to 283 mV when isolated and solubilized (Table 31).971,972 Thus, Cyt
c binding inside beef heart submitochondrial particles was found to lower the Em by as
much as 60 mV.971 Lindsay et al estimated the mean midpoint potential of CuB to be 340 ±
10 mV independent of pH (Table 31).973 Contrary to this alternatively, Mitchell et al
reported that the potential of CuB has a pH dependence approaching −60 mV/pH.958 A pH
dependence of −52 mV/pH was observed in the alkaline region with a midpoint redox
potential of 366 mV at pH 8.0.970 Potentiometric titrations of the isolated CcO with Cyt c
present by Tiesjema et al showed that the CuA, heme a and a3 sites titrate as single-electron
acceptors with midpoint potentials of 280 mV, 230 mV and 370 mV, respectively, at pH 7.1
(Table 31).974 Dutton and others have reported that the hemes of CcO in intact mitochondria
and in isolated CcO titrate with similar Em values (195–220 mV for heme a and 340–390
mV for a3 at pH 7.2) (Table 31).969,971,975–977 Note that these potentiometrically separable
Em values of Cyt a and a3 may be influenced by heme-heme interactions.
Higher levels of heme a reduction were obtained in studies using detergent-solubilized
CcOs.979 Detergents, such as Triton give relatively slow enzyme turnover rates that lead to
higher heme a redox potentials and result in a higher steady-state reduction of heme a
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compared to a3. In such cases, heme a appears to be approximately in equilibrium with Cyt
c with an Em of 305 mV for pulsed CcO.975
Alternatively, stoichiometric reductive titrations performed in the absence of exogenous
ligands under anaerobic conditions revealed that Cyt a and a3 are reduced to approximately
the same extent at all points in the titration starting with the fully oxidized enzyme.980 Thus
both hemes have similar redox potentials when both hemes are oxidized. EPR data of the
half-reduced CcO (isolated CcO and submitochondrial particles) show two forms of high-
spin ferric hemes with a ~1:1 ratio. These signals appears with a half-reduction potential of
about 380 mV in anaerobic redox. This behavior agrees well with the appearance of the high
potential component in optical titrations. The data have been interpreted in terms of an
equilibrating 1:1 mixture of a3+a32+:a2+a33+ (Keq = a3+a3 2+/a2+a33+ = 1). The reduction of
CuA initially lags the reduction of the two hemes but in the final stages of the titration is
completely reduced prior to either heme a or a3. This indicates that reduction of one of the
hemes lowers the redox potential of the second heme making the second heme harder to
reduce, hence the buildup of reduced CuA.978,980 Further reduction of hemes take place with
Em of ~220 mV. From these apparent Em values of 380 mV and 220 mV and the Keq of 1,
the true Em values of heme a and a3 are calculated to initially be quite positive and similar
(362 mV). Reduction of one of the hemes, decreases the redox of the other by ~124 mV to
be 238 mV (Table 31).978
In addition to heme a-a3 interaction, heme a participates in anticooperative thermodynamic
interactions which involve the two Cu sites.968 Spectroelectrochemical studies show that the
interaction manifested at heme a is about 110 mV. The interaction between heme a and CuA
is roughly 20–40 mV in CO adducts of the oxidase where heme a3 and CuB are stabilized in
the reduced form.981 Thus, interaction between CuA, and heme a, causes the reduction
potential for one of these sites to be decreased by approximately 40 mV upon reduction of
the other.981 Studies with cyanide inhibited CcO, with heme a3 stabilized in the oxidized
form, show 10–45 mV interaction between heme a and CuB. The remaining interaction
manifested at heme a is from heme a3. The interaction evident at heme a3 is about 70 mV
and involves the CuB and heme a sites.
The redox potential of heme a is only moderately dependent upon pH (less than - 30 mV/pH
unit) when all other sites are oxidized.968 A 30 mV decrease with an increase of one pH unit
implies that the reduction of heme a is linked to the uptake, on the average, of only about 0.5
protons at pH 7.0, and significantly less at the higher pH values relevant to the
mitochondrial matrix. These values are similar when the enzyme is inhibited with cyanide
where heme a3 is oxidized. When the other redox sites are reduced, the pH dependence is
weak (less than −10 mV/pH unit, on average). This is similar to the value obtained with the
CO-adduct where heme a3 and CuB are reduced. The thermodynamic properties of heme a3
decreased steeply with increasing pH (about - 56 mV/pH unit), indicating stoichiometric (1
H+/e−) coupling of protonation to reduction.978 The pH dependence of the heme a and a3
sites have important implications on the mechanism of proton pumping that will be
discussed later.
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3.7.2.2.5 Steady-state turnover: In turnover kinetic measurements, a reducing agent such as
ascorbate or N,N,N’,N’-tetramethyl-1,4-phenylenediamine (TMPD) is commonly added to
the reaction mixture containing reduced Cyt c and oxidized CcO in the presence of O2 to
recycle oxidized Cyt c formed during reaction. The sequence of reduction is described by by
the reaction sequence:
The general mechanism that is used to describe the kinetic data observed is given in
Equation 38:
[38]
where, E is CcO, S is Cyt c2+, and P is Cyt c3+.982 The dissociation constants (KD = k−1/k1)
for oxidized and reduced Cyt c from the enzyme are found to be roughly equal.983
The rate of enzyme turnover (Vmax) increases with the concentration of both the enzyme and
Cyt c. At high enzyme concentrations, the overall activity is limited by the rate of re-
reduction of Cyt c. The reaction between Cyt c2+ and CcO between pH 6.0–8.0 has an
apparent first-order rate constant with respect to Cyt c. The KD (enzyme-substrate
dissociation constant, Equation 38) calculated for the kinetics of the overall reaction was
found to be 30 µM for isolated CcO and 30–40 µM for particulate CcO.984 Gibson and
others found the reduction of CcO by Cyt c to be second-order giving a value for k1 of 106–7
M−1s−1 between pH 6.0–8.0.979,985 Using this value of k1, the values of k−1 and k2 for
Equation 38 were found to be 1.2×103 s−1 and 3×102 s−1, respectively.
Sinjorgo et al studied the steady-state reaction of detergent-solubilized CcO over a broad
range of [Cyt c] (1–6 orders of magnitude in excess of [CcO]) at different pH values (pH
5.4–8.6) and ionic strengths (I = 25–200 mM).986 The concave Eadie-Hofstee plots obtained
at low ionic strengths (I< 100 mM), pH 7.8 at 25 °C, were described by two reactions
between Cyt c and CcO with apparent Km values of 40 µM (low-affinity reaction) and 40
nM (high-affinity reaction) with maximum velocities (Vmax) of 230 s−1 and 33 s−1,
respectively. At high I (>100 mM), which is close to the physiological value, the Eadie-
Hofstee plots were linear and reflect only one reaction (with Km = 20 µM and Vmax = 210
s−1 at I = 200 mM, pH 7.8). Both the values of Km and Vmax with excess Cyt c are sensitive
to the enzyme concentration. Maximal turnover numbers along with the apparent Km were
also affected by pH, with a decrease in both with increasing pH. With increasing ionic
strength the apparent Km and Vmax values increased implying that the dissociation rate of
Cyt c from CcO is enhanced. No optimum Km or Vmax is observed. These kinetic data are
consistent with the presence of only one catalytic binding site for Cyt c with CcO.986
There are four ET steps relevant to the reduction of the O2 binding site summarized in
Equation 39
[39]
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Steady-state turnover experiments on intact mitochondria best capture physiological
properties exhibited by the five redox sites in Cyt c and CcO. Andreasson and others have
shown that the initial rate of electron transfer from Cyt c to CcO is ~1×106–7
M−1s−1.983,985,987 The nature of the binding between Cyt c and CcO is unclear and may be
ratelimiting. Heme c and CuA are found to be approximately in redox equilibrium in
turnover (where ascorbate is employed as the reductant and TMPD as the redox
mediator)975 while heme a remains relatively oxidized. The level of reduction of Cyt c and
CuA do not increase linearly with enzyme turnover, whereas the reduction of heme a tracks
the rate of enzyme turnover (k2 = 3×102 s−1, Equation 38). This suggests that the reduction
of heme a is the rate-limiting step with a rate constant of about 2×102 s−1.975 The inherent
ET from CuA to heme a in single turnover experiments is 2×104 s−1. Therefore, the
reduction of heme a is possibly rate-limited not by ET but by a structural change or a
coupling to proton transfer during turnover.
The heme a ↔ heme a3 redox equilibrium constant is calculated to be roughly 4, with
forward and reverse rate constants for electron transfer of kF = 2.4×105 s−1 and kR = 6×104
s−1.988 The equilibrium constant of electron transfer between the two hemes is pH-
independent between pH 6.5–9.0.970 The forward rate constant (thought to be a lower limit
of the true ET rate) is much faster than any observed process in the (flow-flash) reoxidation
of the fully reduced enzyme by O2.946 Thus, electron transfer from heme a to the binuclear
site cannot be significantly rate-determining during catalysis and heme a is not fully reduced
during steady state turnover. This suggests that physiologically the enzyme reacts with O2
without reaching the fully reduced R4 state, has important implications regarding the O2
reduction mechanism and proton pumping.
3.7.2.3. Structure: A detailed description of the crystallography of the HCOs is given in
this thematic issue by Yoshisawa et al. Here is presented a structural overview that enables
correlation to electronic structure and mechanism in the next sections. To date X-ray
crystallographic structures of HCO’s from six species have been determined (Table 32). The
crystal structures along with amino acid sequence alignment studies show that there is close
structural similarity among A and B family CcO’s from different organisms (mammalian
versus bacterial) and between CcO and QO from these families. The eukaryotic enzyme is a
dimer in its active form and is composed of seven (in Dictyostelium discoideum) to 13 (in
mammals) subunits. The prokaryotic enzyme contains fewer subunits (generally 4 subunits).
Subunits I-III (referred to as the core subunits) are present in most A and B type HCO’s. A
CcO has been shown to be fully active with respect to O2 reduction to H2O and proton
pumping with only subunits I and II, suggesting that these form the essential catalytic core.
The type C HCO’s, comprising ~20% of all HCO’s, have very different amino acid
sequence from types A and B. These contain two core subunits, N and O. In this section, we
will present an overview of the structure of bovine heart CcO that has been most widely
studied and where mutagenic studies have aided in elucidating electron and proton transfer
pathways and compare and contrast this to the other classes of HCO’s.
The overall structure of bovine heart CcO consists of 13 subunits (Figure 184A). There are
four metal binding sites in bovine CcO. The binuclear center, heme a3 and CuB, and the
third metal center, heme a, are in subunit I (yellow), whereas the fourth metal domain
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containing CuA is positioned in subunit II (green). The four metal sites and their ligation are
shown in Figure 184B. CuB is ligated to three histidines (His240, His291 and His290). One
of the histidines (His240) is covalently crosslinked at the epsilon nitrogen to a tyrosine
residue (Tyr244). Heme a3 has an axial histidine ligand (His376). The second heme a site,
where the Fe is low-spin, has two axial histidines (His61 and His378). Both the hemes are
non-covalently bound to the protein. A similar binuclear center and a second low-spin Fe
heme site are present in all HCO’s consisting of all the same coordinating ligands to the
redox centers. The cytochrome c (substrate) docking site is located on the surface of subunit
II relatively close to the CuA site. Each of the Cu sites in CuA is bound to one His and two
Cys residues. In addition, one Cu is coordinated to one Met whereas the second Cu is ligated
to the backbone carbonyl oxygen of a Glu residue. The overall CuA site is approximately
symmetric with respect to its two His and the two Cys ligands. The two thiolate groups act
as bridging ligands between the copper atoms. In place of CuA, cbb3 oxidase from P. stutzeri
contains three heme c molecules each with two axial ligands—one His and one Met.
The two hemes in bovine CcO are buried within the enzyme approximately 15 Å from the
periplasmic surface. The hydroxyethylfarnesyl group of the high-spin heme is positioned
into the lipid bilayer such that protons can enter the binuclear site from the cytoplasmic side
of the membrane. The hydroxyehteylfarnesyl side chain of the low-spin heme points into a
hydrophobic region that blocks access to the heme from the cytoplasm. In QO that contains
a low-spin heme b, the space occupied by the hydroxyethylfarnesyl tail of heme a in CcO is
filled with bulky hydrophobic residues.
3.7.2.3.1 Enzyme-substrate interactions: The HCO superfamily use two types of electron
donating substrates—CcO uses a water soluble protein, cytochrome c, whereas QO use a
membrane soluble ubiquinol as its electron donor. The binding of the substrate to HCO is
thought to be due to the electrostatic interactions between the substrate and enzyme. There is
still a lack of microscopic detail concerning these interactions and little is known about the
orientation adopted by the substrate when it docks at the enzyme binding site and the
number and identity of the intermolecular interactions formed.
The substrate docking site in bovine CcO is next to subunit II on top of subunit I (Figure
185, right). The acidic amino acid residues, Glu109, Asp119, Glu127, Asp139, Glu157, and
Asp158 of subunit II (shown in green), in this region could interact with the basic
cytochrome c, to stabilize the enzyme-substrate complex. Among these amino acids Glu109
and Asp139 are well conserved even in bacterial enzymes, suggesting a strong role in
binding of cytochrome c.989 Residue Asp158 is thought to be the probable partner for
cytochrome c Lys13.995 Site-directed mutagenesis of CcO isolated from Paracoccus
dentirificans996 confirmed that a patch of negatively charged residues on subunit II are
indeed critical for the catalytic activity of the enzyme. These studies detected two carboxylic
residues (Glu246 and Asp206) corresponding to Glu198 and Asp158 respectively of subunit
II of bovine CcO that are of particular significance. With regard to the substrate, cytochrome
c, little is known about the identity of their electrostatic “partners” with the exception of
Lys13.
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In contrast to the cytochrome c oxidases, subunit II of QO does not contain a substrate
binding site. Instead, the membrane-spanning region of subunit I (Figure 185 left, yellow)
contains a cluster of polar residues. Although a high degree of homology is observed
between subunit I of CcO and QO, the sequence in this polar cluster is completely different.
Mutation studies show Arg71 and Asp75 in the C-terminal half of helix I, and His98 and
Gln101 in the N-terminal half of helix II (green), exposed to the interior of the lipid bilayer
that is not present in the cytochrome c oxidase, form the quinone binding site.991 The
presence of a second, lower affinity site in QO remains uncertain.
3.7.2.3.2 Active site: The crystal structure of CcO from bovine heart997 was determined in
1995 to a resolution of 2.8 Å and was later improved to 1.8 Å998. Yoshikawa et al also
determined the structures of the bovine enzyme at different reduction states and with
different ligands bound to the binuclear center.999 The binuclear center of bovine CcO,
shown in Figure 177B, is located in subunit I and is 13 Å and 30 Å from the P- and N-sides,
respectively. The epsilon nitrogen of His240 is covalently bonded to a tyrosine residue
(Tyr244) at the ortho carbon of the ring as shown in Figure 177B. The CuA site is naturally
present in CcO (except for in cbb3 from P. stutzeri) but not in QO (bo3 from E. coli). The
CuA-heme a and CuA-heme a3 distances are 20.6 and 23.2 Å, respectively, when measured
from the central point of the two copper atoms of the CuA to the iron atoms.997
3.7.2.3.3 Resting oxidized and reduced CcO: Crystal structures of resting oxidized CcO
show a continuous electron density between the heme iron and CuB (Figure 186). There has
been some controversy about the identity of this bridging species. Recent X-ray data have
enabled interpretation of this density as a peroxide dianion (O22−) bridge between the two
metals with a long O–O distance (1.7 Å).1000,1001 The CuB-O1 distance is 2.17 Å whereas
the Heme a3 Fe-O2 distance is 2.24 Å.1000 Table 33 lists crystallographic parameters of all
the oxidized and reduced bovine CcO characterized to date. The Cu···Fe distance in the
oxidized enzyme is between 4.34–5.02 Å whereas in the reduced enzyme the distance
increases to between 5.00–5.19 Å. No electron density is observed between the binuclear
center in the reduced enzyme. Another notable change that occurs on reduction is a 4.5 Å
movement of the carboxylic group of Asp 51 along with the segment from Gly49-Asn55
towards the cytosolic surface in bovine CcO.1002 Apart from these, no other significant
changes are observed. In the case of CcO from R. sphaeroides, there is an additional redox
change that is not apparent in bovine CcO. The O-O distance between the Y288-OH and the
OH group of the heme a3 hydroxyl farnesyl tail decreases from 4.05 Å in the reduced state
to 2.63 Å in the oxidized state (Figure 187. dotted [oxidized],1003 dashed [reduced])1004.
The implications of this redox change to proton pumping will be discussed below.
X-ray crystallographic structures of several ligands bound to the binuclear active site have
been solved.999,1000,1002 The main structural parameters are summarized in Table 34. These
structures shed light into the possible motifs of O2 binding. Analyses of the fully reduced
CO- and NO-bound CcO (with CO and NO bound to Fea3) reveal a close to linear
coordination structure for CO (Fe-C-O angle is 164 degree) and a bent, end-on coordination
structure for NO (Fe-N-O angle is 131 degree; Figure 188 A and C).999 After being photo-
dissociated from Fea3, the X-ray structure of the CO derivative determined at 100 K
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indicates that CO is now bound to CuB in a side-on fashion (Figure 188 B). The Cu-C and
Cu-O distances are 2.4 and 2.7 Å indicative of a weak CuB-CO bond. The 3.0 Å distance
between CO and Fea3 suggests that no significant bonding interaction exists. The most
dramatic change occurs upon binding cyanide to the binuclear center. The crystal structure
of the fully reduced CN-bound form indicates that CN− is located roughly equidistant (2.3–
2.4 Å) from Fea3 and CuB (Figure 188 D). Upon binding CN−, His290 is displaced and
moves to a distance of 2.8 Å away from CuB.
3.7.2.3.4 Electron transfer pathways: The crystal structures enable identification of possible
electron transfer pathways between the metal active sites in CcO. The location of CuA is
consistent with its role as the initial electron acceptor from cytochrome c. In aa3-type CcO’s
from Paracoccus denitrificans, bovine heart, yeast, and Rhodobacter sphaeroides it is now
generally accepted that electrons are transferred from cytochrome c to CuA and then from
CuA to the low-spin heme a. The electron transfer pathway between cytochrome c and CcO
is less well understood due to the absence of any enzyme-substrate crystal structure. The
crystal structure of bovine heart CcO revealed two efficient, conserved possible electron
transfer pathway between CuA and heme a.989 Pathway 1 through His204 via Arg438 to
heme a, shown in Figure 189 blue, consists of 14 covalent and 2 hydrogen bonds (one short
H bond at 1.87 Å and one longer H bond at 2.35 Å).1009 Pathway 2 (Cys200 to heme a),
shown in Figure 189 green, involves a total of 17 covalent bonds and travels from Cys200 to
Ile199, through a short 1.83 Å H-bond to Arg439, then through a 1.92 Å space jump to the
propionate chain and into the heme. The covalent Cu-S bond activates this path making it
~20 fold more efficient and competitive with pathway 1.1009 A third pathway (pathway 3,
Figure 189 red) through Cys196 via Tyr440 and Arg439 has also been explored.1009 This
path involves 24 covalent bonds and 2 hydrogen bonds and has a calculated rate 270 times
less efficient than that of pathway 1, indicating that this pathway is not a major contribution
in the CuA to heme a ET path.
The electron is subsequently transferred from heme a to heme a3. The proximity of heme a
to heme a3, shown in the crystal structures of bovine heart and bacterial enzymes, suggests
that heme a serves as an effective electron donor to heme a3. The two hemes are nearly
perpendicular to one another, and while the Fe-Fe distance is ~13.4 Å, the edges of the
hemes approach each other to ~4.5 Å (dashed line in Figure 190) with 14 covalent bonds
between the two Fe’s. A fully covalent path also exists composed of 16 bonds between the
two Fe’s through His378, Phe377 and His376. In addition, the phenyl plane of Phe377
observed half way between the two planes of the heme a3 and one of the imidazole ligands
of heme a (His378) has been proposed as an electron transfer pathway (Figure 190). The
distances between the phenyl plane and the two heme planes on both sides are as short as 3.5
Å. Any change in the orientation and position of the phenyl group, induced by changes in
the oxidation state of hemes, could affect the electron transfer between Fe a and Fe a3.
In the case of QO, the CuA site is not present and electrons are directly transferred from
ubiquinol to low-spin heme b and subsequently to the heme-CuB binuclear center. The fast
electron transfer from ubiquinol to heme b can be achieved through the conserved
hydrophobic residues Phe103 and Met79 that are situated between the two moieties and
within van der Waals contact distance of heme b (Figure 191).991
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3.7.2.3.5 Proton transfer pathways: Electron transfer and O2 reduction are coupled to
proton pumping. The coupling mechanism will be considered in section 3.7.2.5.2. Here the
proton transfer pathways are summarized. HCO’s pump protons from the cytoplasm or the
inner matrix of mitochondrial membrane (negative N-side) to the periplasm or mitochondrial
intermembrane space (positive P-side). The unidirectionality of proton transfer is thought to
be achieved by a gating mechanism that prevents backflow of protons to the cytoplasm
(Section 3.7.2.5.2). 1010,1011
The protons to be translocated (pump protons) as well as those used for the chemical
reaction (chemical protons) are transported, to some extent, through common channels.
Protons are transferred most effectively through H-bonded chains of water and amino acid
residue systems via Grotthuss shuttling.1012 The water molecules are present inside cavities
within the protein matrix. These cavities provide space for conformational changes of side
chains that can induce a new H-bond system. Any conformation change induced by changes
in redox or ligand binding states could control proton transfer. Thus a conformationally
controlled network composed of hydrogen bonds could function as a proton pump coupled
with dioxygen reduction.
X-ray structures, along with site-directed mutagenesis and sequence alignments have
revealed two candidates for proton uptake, the D and K channels, for the mitochondria and
mitochondria-like enzymes (Figure 192). Table 35 lists the important residues along the D
and K proton pumping pathways for bovine CcO and will be summarized below. A third
pathway has been identified in several HCO’s (H channel in bovine and P. denitrificans, E
channel in P. denitrificans, and Q channel in T. thermophilus) but these are less well
understood. Additionally, the proton exit pathway for pump protons en route to the outer
periplasmic surface (P-side) remains enigmatic. This channel is thought to start from the site
that accepts protons from the gate site. The likely candidates for the acceptor site are a
cluster of heme propionates, two arginines, and associated waters.
The D-pathway is thought to be used for the transfer of all four pumped protons as well as
the uptake of two chemical protons during reaction of the fully reduced CcO with
O2.1013,1014 This pathway starts at residue Asp91 and ends at Glu242 in bovine CcO.
Mutation of Asp91 to Asn has been shown to abolish enzyme activity suggesting that the D
channel is involved in the uptake of chemical protons (Figure 192 left).1007,1015 Mutation of
the E286 residue to Q in R. sphaeroides CcO, which is the equivalent of E242 in bovine
CcO (at the end of the D pathway), results in almost total loss of activity and inhibition of
proton transfer during oxygen reduction (reaction starting with O2 and the fully reduced
enzyme stops at the PR intermediate).992 Chemical protons can flow from E242 to CuB, at a
distance of ~10–12 Å, through a short series of waters that can be modeled into a
hydrophobic cavity between E242 and the active site. E242 has been invoked to be a key
residue and also function as the gate site that minimizes leakage of protons to the
cytoplasm.1016
The K-channel in bovine CcO spanning from Lys265 at the entrance to the cytoplasmic N-
side, via Tyr244 ends at His240, a ligand to CuB, and therefore is thought to be a channel for
chemical protons (Figure 192 right). The K-pathway is not used during oxidation of the
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reduced enzyme with O2.1017 During the reduction of CcO (O→R), one to two chemical
protons are taken up through the K-pathway.1013,1017 The strong hydrogen bonding between
Y244-OH (corresponds to Y288 in R. sphaeroides) and heme a3 farnesyl-OH (Figure 187) is
proposed to function as a closed K path gate, since its presence prohibits proton transport via
this path to the active site.1018 The K-channel is considered to involve residues K319 and
T316 of subunit I in bovine CcO (corresponds to K362 and T359, respectively, in R.
sphaeroides, Figure 187) (Table 35). This is because the mutation of K362 and T359 in R.
sphaeroides results in a major loss of activity (up to 99.95% for K362M).1019,1020 Despite
important details that are now known, the mechanism by which ET is coupled to proton
transfer at the molecular level remains unclear.
The H-pathway proposed in bovine CcO, defined first by crystallographically, conducts only
pumped protons and extends from the N-side of the membrane surface to the P-side via a
water channel and a H-bond network (Figure 193).1021–1025 The pathway starts with a water
channel that allows access from the N-side. The pathway then extends to the formyl group
of the low spin heme a, which is hydrogen bonded to R38. The hydrogen bond network from
R38 extends to D51, which is located near the intermembrane surface of CcO, via the
peptide bond between Y440 and S441. Blockage of either the water channel by a double
mutation (V386L and M390W) or proton transfer through the peptide by a S441P and D51N
mutation was found to abolish the proton pumping activity but not the O2 reduction activity.
Mutation of D51 was also found to result in loss of pumping ability. Note that the amino
acid residues of the hydrogen bond network and the structures of the low spin heme
peripheral groups are not completely conserved amongst members of the HCO superfamily.
3.7.2.4. Electronic Structure: Cytochrome oxidase (cytochrome aa3) contains three metal
sites: 1) a binuclear copper electron transfer site (CuA, gz = 2.18, gy = 2.02, and gx = 1.99 in
the oxidized state), 2) a bis-His ligated low-spin heme (heme a, gz = 3.0, gy = 2.2 and gx=
1.5 in the oxidized state), and 3) the hetero-binuclear heme-copper active site (heme a3 –
CuB) in which the heme, with its open coordination site, is high-spin. As previously
described, QO (cytochrome bo3) lacks the CuA site, transferring electrons from ubiquinol to
the ET heme directly. The reaction of dioxygen with heme-copper oxidases is extremely
fast, and thus definition of the early sequence of transient intermediates during the catalytic
cycle comes from spectroscopic measurements on microsecond freeze-hyperquench
prepared samples or from in situ time-resolved spectroscopic measurements based on the
flash-flow method developed by Greenwood and Gibson.1026 The kinetic scheme developed
in Section 3.7.2.2 is R → A → P → F → OH → EH → R, of which only a single state, fully
(four electron) reduced state R4, has been crystallographically defined (Resting CcO has also
been crystallographically characterized but is not on the catalytic pathway).
3.7.2.4.1 Compound R: The UV/Vis spectrum of fully reduced CcO is dominated by the
heme spectral features at 443 and 605nm.1027 Reduced CcO is EPR silent. XAS has been
performed on Compound R in both the cytochrome oxidases and the QOs (cytochrome bo3.
and aa3-600) as a probe of the copper coordination environment and oxidation state.1028,1029
As the QOs contain a single copper ion, spectral interpretation is simpler. In the Cu K-edge
XAS spectrum, a pre-edge feature was observed at 8983 eV, and was assigned as the
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diagnostic 1s → 4p transition, consistent with a Cu(I) oxidation state (Figure 194). The
intensity of the Cu first shell scatterer in the EXAFS of Compound R is markedly decreased
from that in the resting (oxidized) form of the enzyme, an observation that has been
interpreted as significant weakening (or loss) of one of the Cu histidine ligands upon
reduction. However, this observation has not been made in the crystallography of reduced
forms of the enzyme (see Section 3.7.2.3) and thus possibly reflects some sample
heterogeneity, with substoichiometric amounts of bound Cl− or CO having been observed in
the A. ambivalens aa3 QO.1030
3.7.2.4.2 Compound A: The primary intermediate observed upon exposure of reduced
enzyme to dioxygen is compound A. Given its short lifetime, information on this state has
come from time-resolved UV/Vis and resonance Raman measurements. In the UV/Vis
difference spectrum, the Soret of compound A is shifted to ~422 nm from that observed in
the fully reduced enzyme (443 nm).948,1031–1033 Time-resolved resonance Raman
interrogation of this optical change results in enhancement of a feature at 568 cm−1, which
downshifts to 547 cm−1 in the 18O2 isotopologue (Figure 195).1034–1038 Based on
comparison of the energy and isotopic shift of this feature to those observed in
oxymyoglobin and oxyhemoglobin, the feature was assigned as a νFe—O stretching mode of
an analogous Fe-O2 intermediate.
3.7.2.4.3 Compound P: Rapid decay of compound A yields compound P. While initially
compound P was thought to have an intact O—O bond (P stood for peroxy), it is now known
that the O—O bond has already broken in this state. This observation was first reported by
Weng and Baker based on the comparison of UV/Vis spectral features in P to cytochrome c
peroxidase compounds I and II,1039 and subsequently by room temperature MCD studies of
Thomson and coworkers.1040,1041 The absorption spectrum of P (in cytochrome aa3) is
dominated by a Soret band at 428 nm, and a 607 nm feature in the difference spectrum with
resting. Resonance Raman spectral interrogation of P (in cytochrome aa3) produced either
during catalysis (using time-resolved methodology), or artificially (by reaction with partially
reduced MV-CO with dioxygen or fast oxidized with H2O2) results in observation of an
isotope sensitive feature at 803 cm−1 (769 cm−1 in the 18O isotopologue) consistent with
assignment as a ferryl-heme νFe-O (Figure 196).957,1042,1043 Unequivocal demonstration
that the O—O bond was indeed broken in Compound P comes from reaction of fast oxidized
with H216/18O2, in which no other oxygen isotope sensitive bands were observed.1044
Despite the similarities in the UV/Vis absorption and resonance Raman spectra of
Compound P generated by different methods (differentiated as PR from the fully reduced
enzyme plus dioxygen, PM from the mixed-valent enzyme plus dioxygen, and PH from the
oxidized enzyme plus hydrogen peroxide), it is noteworthy that these states are in fact
different, as they are generated from reactants with different redox states, and thus have
different numbers of electrons available. Specifically, in the generation of PR, four electrons
are available within the metal sites (1 in heme a, 2 in heme a3, 1 in CuB) to cleave the O—O
bond. In contrast, the generation of PM (and PH) only has three electrons available and thus
is deficient by one electron (PM: 0 in heme a, 2 in heme a3, 1 in CuB; PH:0 in heme a, 1 in
heme a3, 0 in CuB, 2 in H2O2). Thus, PM (and PH) must obtain a fourth electron from a non-
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metal site of the protein in order to cleave the O—O bond. Careful analysis of the UV/Vis
spectral features of PR and PM by principle component analysis (specifically by singular
value decomposition) has revealed slight spectral differences.1045 One method that could
potentially resolve the issue of the fourth electron is EPR. Indeed, a variety of tryptophan
and tyrosine radicals have been observed in PH.1046,1047 However, the current
consensus1048–1051 is that these radicals are related to generation of P with hydrogen
peroxide, and that the on-pathway PM heme a3-CuB site is EPR silent due to magnetic
coupling of the tyrosine radical with the copper ion, implying the His-Tyr crosslink
functioning as a superexchange pathway for the antiferromagnetic interaction. A
magnetically coupled Y•-Cu(II) state in PM is supported by the study of a model complex
bearing a phenol functionalized imidazole ligand, [CuII(BIAIP)], that was demonstrated to
be EPR silent;1052,1053 however, this proposal has been challenged by an alternate model
study with a similar ligand architecture1054 wherein the Cu(II) and phenoxy radical were
uncoupled.1055 We note that in our own computational studies, the coupling of a Cu(II) and
the radical phenolate through an imidazole is dependent on the phenolate-imidazole dihedral
angle, varying from anti- to ferromagnetic as the ring (and thus the magnetic orbital of the
ligand) is oriented in and out of plane, an observation that perhaps could explain some of the
empirical differences. While the PM state is EPR silent, the PR state has a characteristic Cu
EPR signal, which definitively indicates the Cu is in the +2 oxidation state.1056
Chemical evidence for the Tyr as the origin of the fourth electron, and thus being a neutral
radical in state PM, comes from a radioactive iodide experiment followed by degradative
mass spectroscopic analysis of Babcock and coworkers.1057 In this experiment, reaction of
PM with iodide led to the observation of labeled Tyr-His in state PM (albeit in 3 % yield) –
the reaction of iodide with other states (F and O) did not lead to labeled tyrosine. The
assertion of a Tyr244• radical in PM is further supported by FT-IR data of Wikström and
coworkers,1058,1059 in which the difference spectrum of PM with O shows a band at 1519
cm−1, consistent with a neutral tyrosine radical (Figure 197). PM further lacks a band at 1311
cm−1, observed in PR, and attributed to a tyrosinate anion. The lack of the 1311 cm−1 band
in PM also indirectly supports a neutral tyrosine in PM and directly suggests a deprotonated
tyrosinate in PR.
3.7.2.4.4 Compound F: The rate of decay of Compound P is associated with isotope effects
(Section 3.7.2.2) and thus a proton translocation is involved in the P → F conversion. The
UV/Vis absorption spectrum of Compound F is quite different from that observed for
Compound P, yet remains dominated by the heme spectral features with a Soret band at 428
nm and Q band features at 580 nm and 535 nm in the difference spectrum (cytochrome aa3).
The resonance Raman spectrum of Compound F displays two oxygen isotope sensitive
features at 786 cm−1 and 355 cm−1, which downshift to 749 cm−1 and 339 cm−1 in the 18O
isotopologue. These features have been assigned as the νFe—O and δN—Fe—O of an
Fe(IV)=O (Figure 198).957,1060 FT-IR of Compound F shows a feature at 1308 cm−1, which
has been ascribed to a tyrosinate anion (analogous to the tyrosinate in PR) which suggests
that the proton that is taken up (see Section 3.7.2.2) generates a copper-bound aquo ligand.
Solomon et al. Page 154
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
3.7.2.4.5 Compound OH: The absorption spectrum of OH is dominated by heme features,
and has a Soret at 424 nm, consistent with an oxidized ferric-heme cofactor. The resonance
Raman spectrum of Compound OH is associated with an isotope sensitive feature at 450
cm−1 (under single turnover conditions in cytochrome aa3), which downshifts to 425 cm−1
in the 18O isotopologue.1037,1060–1062 This feature is sensitive to deuterium substitution and
thus OH has been assigned as having a hydroxide bound to the heme a3.
3.7.2.5. Molecular Mechanism: Heme-copper oxidases catalyze the oxidation of cyt c
using dioxygen as the terminal electron acceptor. This process is thermodynamically
favorable, and some of the excess free energy gained from this redox process is used to
pump protons. It has been shown in specific mutated CcO variants that the proton pumping
function can be eliminated without loss of the oxygen reduction activity. Thus, the
elementary kinetic steps of the mechanism of oxygen reduction can be studied decoupled
from those of pumping.
3.7.2.5.1 Reductive cleavage of O2: The general landscape for O2 reduction that has been
outlined in Section 3.7.2.2 comes from time resolved single turnover studies, which yield the
following simplified sequence of intermediates R → A → P → F → OH. The identities of
these intermediates have been explored spectroscopically in Section 3.7.2.4 and have been
assigned as Y-Cu(I)-Fe(II) → Y-Cu(I)-Fe(III)-O2•− → Y•-Cu(II)OH-Fe(IV)=O → Y−-
Cu(II)OH2-Fe(IV)=O → Y−-Cu(II)OH2-Fe(III)-OH (Figure 199). Thus, the O—O bond is
broken in the A → P step concomitant with the proposed net H• abstraction from the
crosslinked tyrosine. In CcO, this A → P transformation is generally considered from the O
—O bond cleavage perspective. It is also interesting to consider the A → P step from the net
H• perspective to draw insight into the factors required for O—O bond cleavage and
parallels to other heme oxidases (i.e. cytochrome P450). Both CcO and cytochrome P450
react with dioxygen to form an early superoxo complex, which is followed in a subsequent
step by a high-valent Fe(IV)=O with a ligand centered radical (PM in CcO and compound I
in cytochrome P450). A major difference between these parallel reactions is that in
cytochrome P450, an additional intermediate has been observed — a ferric-hydroperoxo
called compound 0 — while no additional intermediate has been observed in CcO. This
observation stimulates the question as to whether the ferric-superoxo in compound A of CcO
is the oxidant or whether an unobserved intermediate peroxo functions as oxidant. The
question can only be answered experimentally at present by model studies since no
intermediate peroxo has been observed in CcO. While an emerging body of evidence
suggests ferric-superoxo complexes may be competent for net H• reactions, it is noteworthy
that only one ferric-heme-superoxo complex has been reported to be competent for reaction
with phenols (Figure 200).1063 In this work of Collman and coworkers employing a picket
fence porphyrin derivative with a copper binding site,1064,1065 the authors demonstrated
both inter- and intra-molecular reactivity with phenols to yield high-valent Fe(IV)=O
adducts and phenoxy radicals.1066,1067 The reaction requires copper to proceed, highlighting
its parallels to the CcO active site.
Alternatively, a system has recently been reported by Karlin and coworkers wherein a ferric-
heme-peroxo-copper complex is competent for reaction with phenols to yield high-valent
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Fe(IV)=O and phenoxy radicals (Figure 201).1068 A common structural motif between the
functional Collman and Karlin systems is the presence of an axial imidazole ligand,
analogous to the axial His present in heme a3 of CcO. The axial ligand is essential because
in the Karlin system, the spin of the heme is modulated by the presence or absence of the
axial ligand,1069 and only the low-spin peroxo bridged Cu(II)-O22−-Fe(III) complex with the
axial ligand bound is reactive, perhaps suggesting spin as a factor in catalysis. The effect of
spin on O—O bond rupture has been assessed in studies on non-heme ferric-hydroperoxo
complexes,1070–1072 and the higher reactivity of the LS versus the HS complex was
attributed to kinetic control; during O—O bond rupture the reaction on the low-spin surface
proceeds with a lower barrier as a result of good overlap of the redox active orbitals. It
should be noted that while the heme of CcO is ligated by an axial His residue suggestive of a
low-spin oxidant, it has been proposed that in the evolutionarily related NO reductases (see
Section 3.7.2.1), the axial His dissociates from the heme during catalysis. This observation
has not been addressed in CcO. Nonetheless, the issue of active oxidant has been explored
theoretically. Calculations that reproduce both the barrier and driving force of O—O bond
cleavage invoke intermediacy of a bridging peroxo level adduct (IP).1073,1074 Further
calculations extended from a magnetostructural correlation observed in the low-spin
functional heme-peroxo-copper model of Karlin and coworkers suggest that a bridging
peroxide allows for O—O bond cleavage without spin surface crossing (Figure 202).1075 To
break the O—O bond of a putative peroxide intermediate in CcO, a pair of electrons must be
transferred into the σ* orbital of the peroxide. If the consensus mechanism in Figure 199 is
correct, these electrons originate from the Fe and the tyrosine. The electron from the Fe must
be spin down, to generate the S=1 Fe(IV)=O, and therefore the electron that comes from the
tyrosine must be spin-up, thus the residual unpaired electron on the Tyr• is spin down. If the
Tyr• and Cu(II) in PM are antiferromagnetically coupled (Section 3.7.2.4), the unpaired spin
on the Cu(II) must then be spin up. Since the electrons on the copper would not be involved
in a IP → PM transformation, the electron on the Cu(II) would start spin up, implying that
the putative IP in CcO consists of a ferromagnetically coupled Fe—O—O—Cu core if the O
—O bond is to be broken without a spin surface crossing. The origin of this expected
ferromagnetic coupling comes from a magnetostructural correlation developed in the low-
spin heme-peroxo-copper model complex. Specifically, if the protein enforces a Cu•••Fe
distance of greater than 4.6 Å (Section 3.7.2.3), this would require that a putative
intermediate Fe-O-O-Cu peroxo intermediate adopt a dihedral angle > ~150°. This large
dihedral would result in a ferromagnetic (S = 1) ground state as a result of orthogonal
magnetic orbitals leading to the lack of a superexchange pathway between the magnetic
orbitals of the low-spin ferric heme and the Cu(II), in contrast to an unconstrained model
complex, in which a more acute Fe-O-O-Cu is accessible and results in an antiferromagnetic
(S = 0) ground state. A key question that remains is how large an effect this spin topology
plays during catalysis. This is likely dependent on the magnitude of the coupling between
the Cu(II) and Y•, a value which has not been measured at present.
While the balance of experimental and theoretical observations suggest an unobserved
bridged peroxo as the key intermediate, it is paradoxical that the resting “as-isolated” form
of CcO has been crystallographically defined as containing a peroxide group spanning the
heme and copper,1000,1002,1076 as sufficient electrons are available to allow the O—O bond
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in this state to spontaneously cleave. This issue has not been resolved, but we note that in
resting CcO, the heme a3 is high-spin (S = 5/2) based on 1) the λmax of the heme Soret band
in the absorption spectrum of resting CcO that appears at 424 nm, indicative of a high-spin
electronic structure,1077,1078 2) SQUID magnetization studies that have demonstrated that
the heme a3—CuB pair is antiferromagnetically coupled to yield an overall S = 2 spin
system,1079,1080 and 3) EPR and MCD on resting ubiquinol oxidase that further indicates a
small, anisotropic superexchange parameter (J ≈ 1 cm−1) and a large positive zero-field
splitting (D = 5 cm−1) for heme a3.1081 These spectroscopic observations are contradictory
to those for the heme-peroxo-copper model complex, wherein the analogous end-on
bridging peroxide causes the heme to be LS.1069 A HS peroxide in resting CcO would
suggest a weak interaction of the peroxide with the heme which would necessitate poor
overlap of the redox active orbitals needed to cleave the O—O bond. Alternatively, given
the observation of a spin correlation to reactivity in the heme-peroxo-copper model
complex, perhaps the spin state is the reason that the peroxo in resting CcO does not cleave.
These issues of spin and active oxidant thus remain unresolved in understanding the O—O
bond rupture process in CcO.
Given the lack of certainty regarding the active oxidant, it is difficult to ascertain the order
in which protons and electrons enter the A → P transformation. Nonetheless, based on the
evidence for a neutral Tyr• in PM,1057,1082 it is likely that the electron comes from the fully
conserved Tyr, which makes the active site Tyr-His crosslink of central interest. Mutated
CcO variants in which the Tyr244 was eliminated failed to bind copper in an appreciable
amount, and thus the crosslink was believed to perform a structural role.1083 However an
alternative role of the crosslink could be as an electron transfer pathway to get the fourth
electron to the oxygen derived ligand to facilitate cleavage.1075
The crosslink functioning as an electron transfer pathway hypothesis only finds utility in the
case of a bridging intermediate peroxo. In the case where the Fe(III)-superoxo is the active
oxidant, it is more likely that to break the O—O bond the three electrons are taken from the
heme, followed by electron backfilling from the crosslinked Tyr through the heme farnesyl
substituent-crosslinked tyrosine hydrogen bond.1074 In either case, the factor that would
determine the origin of the electron is the redox couple of the Tyr versus the redox couple of
the heme, for which the protonation state of the tyrosine would be of central importance (i.e.
a deprotonated tyrosine would have a more favorable redox couple for oxidation). Based on
FT-IR, Compound P contains a deprotonated Tyr, which supports direct electron transfer
from the Tyr. As the Tyr hydroxyl substituent would be greater than 5Å from a dioxygen
bound to heme a3, an active site water relay may be needed as a means to transmit the
proton. The issue is particularly relevant because it signifies the entry of protons into the O
—O cleavage, and thus of the coupling of O—O cleavage to proton pumping.
3.7.2.5.2 Proton Pumping: A detailed description of the proton pumping mechanism is
presented by Wickstrom et al. in this thematic issue. Here, we present a brief overview for
correlation to the mechanism of dioxygen reduction. In general, proton pumping by CcO is
driven by the alternating redox states of the cofactors coupled to protein motion.1084 The
movement of electrons from site to site provides an electrostatic driving force for
translocation of protons in order to compensate the charge of the electrons.1085 Thus, proton
Solomon et al. Page 157
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
movement is strongly coupled to electron transfer. In order to move the large distances
through the protein, the protons shuttle rapidly through hydrogen bonded chains of water
and amino acid residues, called Grotthuss shuttling. Detailed mechanistic understanding of
the factors in proton pumping is an area of significant active research and a diversity of
scientific opinion. There are, however, a few concepts regarding the minimal requirements
for pumping that have emerged:1086 1) the free energy to pump the protons comes from the
large redox potential drop of the reduction of dioxygen to water relative to cyt c, which
primarily provides an electrostatic driving force to maintain electroneutrality among high
proton affinity sites, 2) the existence of a proton loading site in which the affinity for protons
dramatically changes depending on redox states and protein conformations, 3) proton
channels constructed of protein residues and water as a means to conduct the protons, and 4)
a gating mechanism to prevent backflow of protons.
While the free energy used to pump protons in heme-copper oxidase comes from the large
redox potential drop in the reduction of oxygen to water, it is nonetheless possible to
decouple the pumping of protons from the oxidation of cyt c and concomitant reduction of
oxygen to water, which allows for the study of electron transfer and proton translocation
independently. One specific variant that highlights this feature of heme-copper oxidases is
the N139D variant (R. sphaeroides), a mutation along the D- pathway that eliminates proton
pumping and increases the rate of O2 reduction. The role of the dioxygen reduction is to
provide a driving force for the stepwise transfer of electrons from heme a. The changes in
the electrostatic environment by movement of the electrons between heme a and heme a3
drives the movement of protons. It is interesting to consider that the electron transfer from
heme a to heme a3 is perpendicular to the translocation of pumped protons which indicates
that sidechain and water reorganization during the modulation of the electrostatic
environment must play a role. We note in passing that the area of decoupling of proton
pumping from the oxygen reduction there is an emerging body of evidence that suggests that
regulation of pumping by the organism is a viable aspect of catalysis, including variability in
the number of protons pumped per electron. Two mechanisms under consideration for the
attenuation of pumping are either via leakage of protons back across the membrane, or
dissipation of the excess free energy from the oxygen reduction as heat. The regulation of
proton pumping, while an area in early development, has significant physiological
implications for organisms that have a need for heat as well as ATP.
The identity of the pump site within heme copper oxidases has not been resolved. Because
pumping is driven by redox catalysis, it is likely that the pumping site is located in close
proximity to redox sites. Current proposals implicate functional groups on the P side of the
heme a3/CuB site, including the heme a propionates,1087 the heme a3 propionates, and
residues in their immediate vicinity as the leading candidates. The key attribute of the proton
loading/pump site is that the affinity for the proton must vary in order to either take up or
release a proton at the appointed time during the sequence of electron transfer events. The
local electrostatic environments over the series of redox states have been investigated
computationally,1088–1090 and suggest that the dominant contributors to the change in proton
affinity of a potential proton loading site is electrostatics and coupled protein motions.
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Based on crystallography (see Section 3.6.2.3) and a variety of mutational studies, the
proton entrance channels are moderately well defined (the K- and D-channels) while the
other channels, in particular the H-channel, is somewhat less well understood. Early on, it
was appealing to define the K- and D-channels as responsible for translocating pumped and
chemical protons respectively. However, mutational studies of uncoupled variants indicate
that the K-channel provides two chemical protons and the D-channel provides two chemical
and all four pumped protons. It is not known what the advantage of two uptake channels
would be. Current mechanistic thought requires barriers to separate chemical from pumped
protons. The D-channel would appear to violate this idea, but does contain a residue
believed to function as a branch point (E286 R. sphaeroides, Section 3.6.2.3) to separate the
chemical and pumped proteins. There has further been discussion regarding the role that
water plays in the channels to facilitate temporal separation of pumped versus chemical
protons.1091,1092 While the description of the H-channel was based on crystallography
(Section 3.6.2.3), recent mutagenesis work on the H-channel of bovine CcO has revealed
that D51X variants turn off pumping while retaining the ability to reduce dioxygen.1023 This
suggests that in bovine CcO the Hchannel plays a major role in proton pumping.
Much progress on the mechanism of gating has been made recently. The starting point of
these studies of these studies comes from X-ray crystallography. Specifically, the E286
residue at the interior end of the D-channel that has been found in a “down” and “up”
configuration (Figure 203),1093 with the “down” state preferred by 2 kcal/mol with a 6
kcal/mol barrier to interconversion.1094,1095 MD simulations of this residue are found to
vary significantly depending on the hydration in the cavity and the choice of membrane
environment around the enzyme in the model. Recent simulations by Voth and coworkers
that explicitly allow for proton transport (multi-state empirical valence bond methodologies)
reveal that deprotonation of the “up” conformer leads to rapid transition to the “down” state
only when heme a and heme a3 are reduced and oxidized respectively, providing a means to
reorient E286 into the proton channel to rapidly accept another proton and prevent back-
leaking.1089 It should be noted an equivalent residue to E286 has not been identified in T.
Thermophilus CcO (cytochrome ba3). Instead, it is thought that the ba3 and caa3 oxidases
use a tyrosine and serine residue (called YS pair) to perform an equivalent gating
function.1096 Alternative gating schemes have been proposed, one particularly intriguing
recent suggestion is the dual gating proposed in bovine CcO along the H-channel,1087 in
which the heme a farnesyl sidechain and formyl block proton exchange of the heme a
priopionate on the negative side, and Y440-S441 peptide bond blocks the positive side.
Oxidizing the heme a tautomerizes the Y440-S441 peptide bond to allow the proton to
escape. Reduction opens the heme a farnesyl and formyl interactions to allow for
protonation of the heme a priopionate. More general structural changes have also been
observed experimentally, in particular in the crystal structures of oxidized and reduced states
of CcO. In resting CcO, a tight hydrogen bond is present between the CuB bound His-Tyr
ligand and the heme a3 farnesyl hydroxide (Figure 204A). This hydrogen bond is lacking in
a reduced structure, and the lack of this hydrogen bond is correlated to increased hydration
in the K-channel (Figure 204B).1004 The tight hydrogen bond in the oxidized form thus
blocks entrance of protons into the heme a3/CuB from the K-channel, allowing for
alternating access of protons from the K-and D-channel to the binuclear site. It should be
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noted however, that the fully reduced enzyme may not be an intermediate during catalysis
(see Section 3.6.2.2).
The sequence of events of proton pumping are coupled to the electron transfer steps in the
transitions of states P → F, F → O, O → E, and E → R. Fadda and coworkers have
described a mechanism for each of the individual pumping events by three states defined by
the charge on the heme cofactors written as [0|1], [1|0], and [1|1], where the digit on the left
and right are the overall charge on heme a and heme a3 sites respectively (Figure 205).1097
Starting from the [0|1] state wherein the heme a is reduced thereby raising the pKa of the
pump/proton loading site (PLS), a proton is delivered to the PLS which raises the redox
couple of the binuclear site such that an electron is transferred from heme a to generate the
[1|0] state. Next, a chemical proton is recruited to the binuclear site to generate a [1|1] state,
in which the pKa of the PLS changed resulting in proton release from the PLS. Finally heme
a is rereduced by CuA to generate a [0|1] state. This sequence of events is capable of
describing the kinetics of ET and proton release. In the steady state P → F transition,
examination by single-turnover studies reveals the transition occurs in two steps, PM → PR
→ F, in which an electron is transferred in PM → PR and the proton in PR → F. Immediately
prior to O2 cleavage, the heme-copper site is electron rich, and drives the loading of a proton
in the pump site. Dioxygen reacts to generate the superoxidized PM, a [0|1] state with a
presumably loaded PLS site. Next, an electron is transferred from heme a to the heme-
copper site to create PR, a [1|0] state. This electron rich PR state then recruits a chemical
proton generating a [1|1] state, equivalent to state F, which then modulates the pKa of the
PLS to eject the proton to yield intermediate F*. In a similar manner, these three states are
repeated four times per pumped proton. This scenario also implies a rich set of protonation
microstates during the F → O, O → E, and E → R transformations. However, while this
overall mechanistic sequence provides a coarse picture of proton pumping, many of the
molecular level details are still unresolved. In particular, aspects of the architecture of the
binuclear site including the Tyr-His crosslink, heme a3 axial imidazole coordination, role of
the copper, and identity of the proton loading site and gate sites remain among the open
questions. Details are emerging regarding these structural components and their role for O2
reduction; presumably these structures are integral components for the coupling of oxygen
reduction to proton pumping as well.
3.8 Reduction of O2 to H2O
While many enzymes formally reduce O2 to H2O in their catalytic cycles (for example as
presented in section 3.2-catechol oxidase couples O2 reduction to H2O to two, two-electron
oxidations of catechol) only the MCOs and HCOs are capable of an effectively concerted
four electron reduction of O2. In both classes, the second two-electron reduction (of
peroxide) is fast indicating a low activation barrier for O-O bond cleavage; thus far only in
the case of variants of the MCOs where electron transfer from the T1 is eliminated can a two
electron peroxide intermediate be observed. The low barrier for this second two-electron
reduction of O2, derives from the trinuclear nature of the catalytic sites in both classes (the
TNC in the MCOs and the hemea3/CuB/Tyr in the HCOs, Figure 206). In the MCOs, the
second two-electrons derive from two CuI’s that, in the triangular topology of the TNC,
have good overlap with the peroxide σ* orbital, and the third CuII of the TNC acts like a
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proton in lowering the energy of the σ* LUMO. In the HCOs the second two-electrons
derive from hemea3FeIII and the covalent Tyr (through a superexchange pathway involving
the CuB) with oxidation of Tyr coupled to proton transfer to the peroxide to promote O-O
bond cleavage. In both classes of oxidases there is thus a low intrinsic overpotential for O2
reduction, and ~800 mV/electron (at pH = 7) is available for either oxidizing high potential
one-electron substrates (in MCOs), or low potential Cyt c with the excess energy used in
proton pumping (in the HCOs).
A second parallel between these two classes is that the trinuclear centers are buried in the
protein and electrons enter from the substrate via a T1 or CuA center near the surface of the
oxidase and are transferred rapidly over 13–18Å to the catalytic site. A key difference is that
Cu is only capable of one-electron redox while the heme-a3 FeII is capable of two-electron
redox and the covalent Tyr is also redox active. Thus in the MCOs all four Cu’s are oxidized
in the four-electron reduction of O2 to H2O which provides an efficient mechanism for
substrate oxidation in that the T1 at the surface of the enzyme is immediately available for
redox. Alternatively in the HCOs all four electrons derive from the catalytic site, therefore
four holes are stored here for proton pumping. The HCOs therefore have the additional
feature of the buried heme-a3 FeII for transfer of each of the four electrons that are coupled
to the proton pumping in the reduction of the hemea3/CuB/Tyr active site.
A final interesting correlation is that in both classes of four-electron oxidases the oxidized
form of the enzyme obtained in turnover (NI in the MCOs, the pulsed enzyme in the HCOs),
but not the resting form, is catalytically active. In the MCOs it is clear that NI loses its µ3-
oxo in going to the resting enzyme and this drastically slows electron transfer from the T1
Cu. Thus, the crystallographically defined resting TNC is not involved in catalysis. In the
HCOs the crystallographically defined resting enzyme form has a peroxide bridging the
hemea3-CuB center. It is important to understand the origin of this bridging peroxide and
why it is inactive rather than spontaneously undergoing O-O bond cleavage to generate the
four-hole hemea3 FeIV=O/CuII/Tyr• catalytic state.
4. Substrate Activation by CuII Sites
Reactions between triplet O2 and singlet organic substrates are spin-forbidden, leading to
very slow rates despite the reactions being thermodynamically favorable. Two possible
catalytic strategies for overcoming this barrier using a mononuclear metal center are
observed in bioinorganic chemistry: O2 activation by a reduced metal and substrate
activation by an oxidized metal. These complementary strategies are observed in
mononuclear iron enzymes, where FeII-dependent enzymes such as the extradiol
dioxygenases activate O2 while FeIII-dependent enzymes perform substrate activation in two
possible ways: the intradiol dioxygenases by binding the substrate as a ligand and promoting
the reaction with O2 via a concerted LMCT mechanism where FeIII acts as a spin buffer; the
lipoxygenases by using an FeIII-OH site to perform H-atom abstraction from the substrate
(to form an FeII-OH2), resulting in a substrate radical activated for reaction with O2.1098 A
similar pattern is observed for the two different redox states of copper in mononuclear
copper enzymes. In Sections 3.3 and 3.4, O2 activation by mononuclear copper sites in the
reduced CuI state was discussed. The alternative strategy utilizing mononuclear CuII for
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substrate activation is employed by the enzyme quercetinase, in the cofactor biogenesis
reaction of the copper-containing amine oxidases (including lysyl oxidase) and also in one
possible biogenesis mechanism in the enzyme galactose oxidase as described in Section
3.3.4. In this section, what is known about the reactivity of CuII in quercetinase and in amine
oxidase cofactor biogenesis will be discussed, concluding with thoughts on the nature of
substrate activation by CuII active site.
4.1 Quercetinase
4.1.1 Enzymology—Quercetinase (quercetin 2,4-dioxygenase, 2,4-QD, EC 1.13.11.24
[named “quercetin 2,3-dioxygenase”, but this does not reflect the reaction done by the
enzyme]) is an extracellular enzyme expressed by some microorganisms when grown on
rutin, a quercetin precursor (Figure 207), as the sole carbon source.1099,1100 It catalyzes the
degradation of quercetin and related flavonols to the depside (diphenolic ester) 2-
protocatechuoylphloroglucinol and CO (Figure 207).1101 Quercetin and other flavonols are
nutrients present in foods such as onions, red leaf lettuce, and tea and are of interest for their
antioxidant and anti-inflammatory properties.1102 They are used as herbal medicines and as
part of traditional Chinese medicine.1103 Quercetin is being investigated as a treatment for a
variety of diseases,1104 including cardiovascular disease,1105 and a variety of
cancers.1106,1107 The mechanism of action of fungal and bacterial quercetinases may be
related to the metabolism of quercetin by microflora in the intestinal tract.1108 In addition,
quercetinase has been investigated as a food preservative. 1109
Quercetinases have been isolated from the fungi Aspergillus flavus,1099 Aspergillus
niger,1110 Aspergillus japonicus,1111 and Penicillium olsonii1112 and the prokaryotes
Bacillus subtilis1113,1114 and Streptomyces sp. FLA.1115 All quercetinase enzymes are
glycoproteins with 16–47% sugar content (w/w). Sequence data for the quercetinases from
A. japonicus, P. olsonii, B. subtilis, and Streptomyces have been reported and there is a high
degree of sequence similarity between enzymes from different source organisms (compared
to P. olsonii, 61% similarity with A. niger, 58% with A. japonicus, but only 15% with B.
subtillis and 30% with Streptomyces).1112 Despite this sequence similarity, there are large
differences in quaternary structure between 2,4-QDs from different sources. All 2,4-QDs
belong to the cupin superfamily, but 2,4-QDs from A. japonicus, P. olsonii, and B. subtillis
are bicupins while Streptomyces 2,4-QD is a monocupin.1115 The 2,4-QDs from A.
japonicus and B. subtilis are homodimers1111,1116 while the P. olsonii 2,4-QD is a
monomeric protein1112 and the A. niger 2,4-QD is a heterotrimer.1110
The metal ion content of quercetinases from different organisms is a topic of ongoing
research. All quercetinases isolated from fungal sources (the Aspergillus and Penicillium
enzymes) contain ~ 1 Cu atom per monomer,1111,1112,1117 excepting A. niger 2,4-QD, which
binds ~2 Cu per trimer.1110 The copper is in the CuII redox state, since a cuproine assay by
Oka and Simpson detected very little CuI in the as isolated enzyme.1117 A. niger 2,4-QD is
also isolated with variable Ni content in addition to CuII, but the amount of nickel present
does not affect the enzyme activity.1110 In contrast, the prokaryote quercetinases from B.
subtillis and Streptomyces are expressed in E. coli and bind many different divalent metals,
depending on the metal content of the culture media. 1118,1119 B. subtilis 2,4-QD was
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originally isolated containing a mixture of FeII and FeIII, but bound Fe can be removed by
DDTC and EDTA chelation and full activity is only restored by incubation with CuII or CoII
(MnII and FeIII also show some activity).1116 Experiments to determine the divalent metal
that gave the highest activity in crude cell extracts of B. subtilis and Streptomyces 2,4-QD
indicate that MnII and CoII are most active in B. subtilis 2,4-QD1118 while NiII and CoII are
most active in Streptomyces 2,4-QD.1119 When 2,4-QD is isolated with these metals, the
metal stoichiometry is not consistent with tight binding to the proposed active site (1 site per
subunit) as CoII and NiII bind in less than stoichiometric amounts (0.65 CoII per subunit in
B. subtilis, ~0.5 CoII or 0.5 NiII per subunit in Streptomyces) and MnII binds in excess (1.8
MnII per subunit).1118,1119 Despite the work that has been done on the metal content and
activity of the bacterial quercetinases, it is not clear which metal is bound in the native
enzyme in these systems. Alternatively, it is clear that CuII is the native metal in the fungal
quercetinases. Further arguments can be made from comparing the kinetics of quercetinases
isolated with different metals (vide infra) that quercetinase should be considered to be a CuII
enzyme and the incorporation of different metals is due to the E. coli expression system.
4.1.2 Kinetics—Early experiments on 2,4-QD by Simpson et al. used atom labelling to
identify the precise reaction performed by 2,4-QD. Labelling the C3 carbon in rutin, which
is transformed to quercetin in vivo by the enzyme rutinase, with 14C shows that the C3
carbon of quercetin is released as CO by 2,4-QD from A. niger (Figure 207).1101 When the
reaction is carried out with 18O2 by A. flavus 2,4-QD, the CO produced does not contain 18O
while the depside product contains both atoms from 18O2, incorporated at C2 and C4
(detected by MS and IR spectroscopy).1100 Performing the reaction in H2 18O resulted in no
change in the amount of 18O in the water, so 18O from H2 18O is not incorporated into either
product and the O of the CO released comes from the original C3-OH group of the
substrate.1100 On the basis of these results, 2,4-QD can be identified as a 2,4-dioxygenase.
Experiments by Oka et al. show that 2,4-QD substrates bind to anaerobic resting 2,4-QD
from A. flavus and react upon addition of O2.1120 Kooter et al. and Steiner et al. have
reproduced this result for A. japonicus 2,4-QD.1121,1122 In contrast, Hund et al., using 2,4-
QD from A. niger, find that no difference is observed in the EPR spectrum of the enzyme
upon anaerobic incubation with a threefold excess of quercetin.1110 They propose that the
presence of O2 may be required for substrate binding. This discrepancy may be related to the
insolubility of quercetin in aqueous solutions, which was overcome in the experiments of
Oka et al. and Kooter et al. by the addition of DMSO (10% (v/v) Oka, 5% (v/v) Kooter), an
additive not present in the EPR experiment of Hund et al. Oka et al. have investigated the
structural requirements for substrates of 2,4-QD. 2,4-QD will dioxygenate a variety of 3-
hydroxyflavones where a C3-OH group, a double bond between C2 and C3, and a
substituent on C2 are all found to be required for substrate reactivity.1120
Maximum specific activites and KM values have been reported for several copper containing
2,4-QDs (182 µmol min−1 mg−1, 5.2 µM quercetin, and 0.12 mM O2 for A. flavus,1099 73
µmol min−1 mg−1 and 6.6 µM quercetin for A. niger,1110 175 µmol min−1 mg−1 and 1.1 µM
quercetin for P. olsonii1112) but full Michaelis-Menten kinetics with several different
substrates are reported only for 2,4-QD from P. olsonii (Table 36). Various substitution
patterns on the B and C rings of the flavonoid result in variations in the KM and relative
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rates of reaction, due to the structural constraints of binding the substrate in the active site
pocket.
The higher KM values reported for 2,4-QD from P. olsonii in Michaelis-Menten kinetics
studies are due to a higher % DMSO used in the assay. Tranchimand et al. investigated the
effect of % DMSO and found that it increases the apparent KM (19 µM with 20% DMSO
v.s. 1.1 µM with 1% DMSO for quercetin).1112 There is also a pH effect on the enzyme
activity that varies with the enzyme source: while A. flavus shows maximum activity pH
5.5–6.0,1123 P. olsonii shows an optimum pH of 6.51112 and A. niger shows no pH effect on
activity pH 2.0–6.7.1110 The origin and significance of the pH profile of the enzyme activity
of 2,4-QD remain to be studied. Single turnover experiments on the 2,4-QD ES complex
with O2 have not been reported and are an interesting future direction for kinetics studies.
2,4-QD is inhibited by reducing agents such as sodium dithionite, 2-mercaptoethanol and
dithiothreitol but recovers from this inhibition after exposure to air or mixing with air-
saturated buffer. This reactivation is not retarded by p-chloromercuribenzoate, so it results
from reduction of the copper site rather than from reduction of disulfide bonds in the
protein.1120 This establishes that CuII is the active redox state in 2,4-QD. Pre-incubation of
the enzyme with substrate prevents inactivation by a reducing agent, suggesting that
substrate binding makes the copper site more difficult to reduce (either by decreasing E° or
by blocking access to the metal site).1120 Various copper-specific chelating agents inhibit
Cu-loaded 2,4-QD, most commonly ethylxanthate, diphenylthiocarbazone, toluene-3,4-
dithiol, and diethyldithiocarbamate (DDC).1110,1120 Attempts to use copper chelators like
DDC to remove the copper from quercetinase were unsuccessful. Reactivation of
quercetinase by divalent metals after inactivation and attempted copper removal with DDC
is ascribed to removal of the DDC inhibitor from the copper site by competitive binding to
excess free divalent metal, rather than to reconstitution of the active site with another
metal.1110
Several recent studies report activity for the bacterial quercetinases with alternative divalent
metals, including FeII, NiII, CoII, and MnII. The initial studies of a bacterial 2,4-QD by
Bowater et al. and Barney et al. identify 2,4-QD from B. subtillis as an iron-containing
enzyme.1113,1114 However, the as-isolated Fe-loaded 2,4-QD has an activity that is 2–3
orders of magnitude lower than that observed for Cu-loaded 2,4-QD while having similar
KM(substrate) values (3.8 µM and 0.8 µM respectively for quercetin).1118 This result could
reflect the activity of Fe-loaded 2,4-QD being due to 1% or less copper present while the
majority of the active sites contain iron and are inert. However, Barney et al. rule this out by
showing that Fe-loaded 2,4-QD is not inhibited by copper-specific chelators (ethylxanthate,
diethyldithiocarbamate, kojic acid) but instead by 1,10-phenanthroline and 2,2’-dipyridyl,
which are better iron chelators.1118 2,4-QDs from B. subtillis and Streptomyces purified in
E. coli could also be isolated containing MnII, CoII, or NiII.1118,1119 These enzymes show
KM values in the µM range, kcat values at least an order of magnitude lower than those
reported for Cu-loaded 2,4-QD, but kcat/KM values similar to those reported for P. olsonii
2,4-QD (8.8×106 M−1 s−1 for Cu-loaded 2,4-QD from P. olsonii;1112 7.9×106 M−1 s−1 and
7.0×106 M−1 s−1 for Mn-loaded and Co-loaded 2,4-QD from Streptomyces1119 with
quercetin as the substrate). However, since the KM for P. olsonii was artificially lowered by
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having a higher % DMSO than was used in the other studies, the correct comparison gives at
least a 20 fold higher kcat/KM for Cu-loaded 2,4-QD.
Considering that copper is known to be the native metal in fungal quercetinases, that Cu-
loaded 2,4-QD has higher activity, kcat and catalytic efficiency than 2,4-QDs containing
other metals, and that in systems with other metals residual copper may be responsible for
some of the activity, quercetinase should be regarded as a copper enzyme unless further
work establishes the presence of another metal in a native enzyme system.
4.1.3 Structure—Crystal structures of 2,4-QD from A. japonicus have been solved for the
resting enzyme at pH 5.2 (PDB ID: 1JUH),1111 the enzyme with the substrates quercetin and
kaempferol (Table 36) bound anaerobically (PDB IDs: 1H1I, 1H1M)1124 and the enzyme
with the inhibitors diethydithiocarbamate and kojic acid bound (PDB IDs: 1GQG,
1GQH).1125 The crystal structure of B. subtilis 2,4-QD with iron as the active site metal has
also been reported, but will not be discussed here (PDB ID: 2H0V).1116
The crystal structure of resting A. japonicus 2,4-QD at pH 5.2 was determined at 1.6 Å
resolution by Fusetti et al. after deglycosylation by endoglycosidase-H. 2,4-QD is a ~100
kDa homodimeric protein with 350 amino acid residues.1111 An ordered heptasaccharide
chain that was not removed by deglycosylation treatments spans the dimer interface and
forms significant surface contacts between the monomers. Each monomer is composed of
two similarly structured domains, comprising 2 antiparallel β sheets, 8 strands forming a β
sandwich and two α helices (Figure 208). The domains are joined by a linker of 60 amino
acid residues, one part of which is disordered in the crystal structure. In each domain there is
a large hydrophobic cavity, which in the N-terminal domain contains the copper site. The
active site is 10 Å from the protein surface and is solvent-exposed, due to disorder in a 9
amino-acid stretch of the interdomain linker, which would otherwise act as a lid for the
hydrophobic active site cavity. Consistent with elemental analysis, only the N-terminal
domain of 2,4-QD binds Cu; in the C-terminal domain, the positions occupied by the three
His residues which ligate copper in the N-terminal domain are replaced by other non-
coordinating residues.1111
The protein-derived copper ligands are three histidine residues (His66, His68, and His112)
and a glutamate residue (Glu73), the first known case of an endogenous carboxylate residue
serving as a ligand in a copper protein. Two geometries are observed for the copper site in
resting 2,4-QD (Figure 209A and B). The major form (70%, Figure 209A) is a tetrahedral
site where the copper is ligated by His66, His68, His112 and a solvent-derived ligand at a
bond distance of 2.2 Å from the copper, with Glu73 in an off-copper conformation and H-
bonding to the solvent-derived ligand. The minor form (30%, Figure 209B) is a distorted 5
coordinate site in which Glu73 is an additional monodentate ligand to the copper center and
the solvent derived ligand shifts to an equitorial position 2.4 Å from Cu and is H-bonded to
the non-coordinating O of Glu73. The solvent derived ligand and His68 are the axial ligands
of the 5 coordinate site and His66, His112 and Glu73 are the equatorial ligands. The
presence of two different forms of the copper site is consistent with EPR studies of the
resting enzyme, which show a mixture of two copper species in a pH-dependent equilibrium
(vide infra).1121 Modeling quercetin into the active site cavity of quercetinase shows that the
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shape of the hydrophobic cavity imposes an orientation on quercetin that requires
monodentate coordination to copper through its C3-OH group, rather than the bidentate
coordination via the C3-OH and C4=O groups that is observed in model complexes.1111
The crystal structures obtained for the ES complex of 2,4-QD with the substrates quercetin
(5,7,3’,4’-tetrahydroxy flavonol) and kaempferol (5,7,4’-trihydroxy flavonol) anaerobically
bound confirm the binding mode proposed by modelling.1124 The substrates bind through
the C3-OH group, displacing the solvent-derived copper ligand (Figure 209C). No disorder
is observed in the coordination environment of the copper site in the ES complex. The
copper site is a 5-coordinate distorted square pyramid, with His66, His68, His112, and
Glu73 as protein-derived ligands (His68 is the axial ligand). The non-coordinating O of the
Glu73 ligand is within H-bonding distance of the C3-OH group of the substrate (2.66 Å for
quercetin and 2.43 Å for kaempferol), suggesting that the proton of the C3-OH group is
retained in a hydrogen bond and that in addition to being a ligand Glu73 may have a
mechanistic role as an active site base. Steiner et al. propose that the C3-OH proton is
transferred to Glu73 upon substrate binding to quercetinase and this assignment is supported
by a DFT calculation of the ES complex performed by Siegbahn.1126 While the pKa’s of the
two groups – 4 for Glu and 7 for quercetin – are more consistent with the proton remaining
on the quercetin hydroxyl group, that of the C3-OH would be lowered by coordination to the
CuII. When bound to quercetinase, the B ring of the substrate is not coplanar with the rest of
the molecule, but is instead bent out of the plane by 10–12°, consistent with some sp3
character on the C2 position.1124 While this could indicate radical character on the C2
carbon, EPR spectra of the ES complex do not show the presence of an organic radical or
reduction of the copper site (vide infra). Instead, the shape of the active site cavity could
account for this distortion, because positioning the B ring to be coplanar with the A and C
rings would result in significant steric clashes with two protein sidechains, Phe75 and
Phe114. DFT calculations on quercetin show that the bending observed in the crystal
structure only costs 1 kcal/mol. The enzyme-substrate binding is further stabilized by van
der Waals interactions with many residues in the active site pocket. Particularly, a van der
Waals interaction between the A ring of the substrate and Pro164, part of the flexible
interdomain linker, leads to ordering of the linker to form a lid on the active site cavity and
further stabilize substrate binding. There are no protein-derived hydrogen bond donors in the
hydrophobic active site pocket, but two ordered water molecules supply hydrogen bonds to
the O7 and O4’ hydroxyl groups of quercetin.1124
Crystal structures of quercetinase with two different inhibitors have also been reported:
diethyldithiocarbamate (DDC, KI ~ 10−7 M) and kojic acid (KOJ, KI ~ 10−3 M), the latter a
weak inhibitor whose structure resembles the B ring of quercetin.1125 The overall structure
of the protein, including the disorder of the linker region that covers the active site, is not
changed by the binding of these inhibitors. As in the substrate-bound crystal structures, only
one coordination environment for the copper site is observed in the inhibitor-bound
structures, but the coordination observed depends on the inhibitor. Both inhibitors bind to
the copper site as bidentate ligands, displacing the solvent-derived ligand. DDC coordination
yields a 5-coordinate site, with copper ligated by His66, His68, His112 and the two sulfur
atoms of DDC. DDC is bound asymmetrically (Cu-S1 2.2 Å, Cu-S2 2.9 Å) in a distorted
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square pyramidal geometry. Glu73 is rotated away from the copper site to H-bond to a
conserved water molecule. In contrast, KOJ yields a 6-coordinate structure with His66,
His68, His112, Glu73 (monodentate) and the two oxygens of KOJ as ligands. KOJ
coordination is also asymmetric (Cu-O3 1.89 Å, Cu-O4 2.58 Å) due to differences in the
nature of the two oxygen ligands (O3 being the alkoxide and O4 the carbonyl). Both
inhibitors bind with their molecular planes perpendicular to the observed orientation for
quercetin in the active site cavity, blocking access to the portion of the active site pocket that
binds the B ring of quercetin. Blocking the active site pocket so that quercetin cannot bind to
the enzyme is proposed as a common mode of inhibition for chelating inhibitors.1125
4.1.4 Spectroscopy and Electronic Structure—Absorption, EPR, and XAS
spectroscopies have been used to investigate the copper-containing quercetinases from the
Aspergillus sources in their resting forms, upon anaerobic substrate binding, and in the
product-bound state observed after reaction of the substrate-bound enzyme with O2. As with
the X-ray crystallography, the most complete studies have been performed on 2,4-QD from
A. japonicus. The spectroscopy of these species in A. japonicus and A. flavus will be
discussed first and then compared to the spectroscopy of A. niger, which has some
spectroscopic differences.
The absorption spectrum of the resting form of 2,4-QD has been reported by Oka et. al for
the A. flavus enzyme. The absorption spectrum contains no absorption peaks in the 350–800
nm range,1120 although very concentrated solutions of the enzyme (2.7 mM in protein) are
faintly green colored.1117 This indicates that the resting copper site has no significant ligand
to metal charge transfer transitions (Figure 210A), which is consistent with a normal copper
site (Type 2) with the ligand set of histidine, water, and possibly a 30% contribution from a
carboxylate as reported by X-ray crystallography. The EPR spectrum of the resting enzyme
from A. japonicus, reported by Kooter et al., shows a mixture of two species in an
approximate 70:30 ratio at pH 6.0 (Figure 211A).1121 The 70% component has g// = 2.330
and A// = 149×10−4 cm−1 while the 30% component has g// = 2.290 and A// = 134×10−4
cm−1. The g and A values of the minor species can be resolved by a pH perturbation of the
resting enzyme, since at pH 10.0 the enzyme is reversibly converted to the minor form
(Figure 211B, gz= 2.289(4), Az= 128×10−4 cm−1; gy= 2.178(5), Ay= 61×10−4 cm−1; gx=
2.011(3), Ax= 56×10−4 cm−1).1121 Kooter et al. compare these parameters to copper model
complexes and suggest that the high pH form of the active site has a trigonal bipyramidal
coordination geometry. However, this would have a dz2 ground state with a g⊥ > g// = 2.0,
whereas the reported EPR parameters of the high pH site (gz > gy > gx ≈ 2) are
characteristic of a distorted tetragonal site with significant dz2 mixing into a dx2-y2 ground
state. This is consistent with the two active site geometries observed in the crystallography,
performed at pH 6.0, where a tetrahedral form contributes 70% and a distorted 5 coordinate
site contributes 30% (vida supra).1111 Cu K edge XAS spectroscopy performed by Steiner et
al. is also consistent with this assignment.1122 The XAS spectrum of the resting enzyme at
pH 6.0 shows no features in the pre-edge region. Steiner et al. fit the EXAFS spectrum to
each of the two possible coordination models observed in the crystal structure (4 coordinate
3His+O at 2.00 Å or 5 coordinate 3His+2O at 2.01 Å) and determined that both models fit
the EXAFS spectrum equally well. They use a valence bond sum analysis to suggest that a
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coordination number intermediate between four and five is consistent with the data,
corresponding to a heterogeneous coordination environment with one four-coordinate and
one five-coordinate component as observed in both the EPR spectroscopy and X-ray
crystallography of resting A. japonicus 2,4-QD.1122
Upon anaerobic incubation of the resting enzyme with the flavanol substrates: quercetin,
morin, and 3-hydroxyflavone, the absorption spectrum is dominated by the absorption band
of the substrate, shifted to lower energy into the 300–500 nm region due to binding to the
enzyme (free quercetin absorption Figure 210 B, ES complex Figure 210C).1120 The shift in
the wavelength of substrate absorption upon addition to the enzyme does not occur if the
enzyme had been preincubated with a copper chelating agent (e.g. ethylxanthate). This is
consistent with substrate binding to the copper site of A. flavus 2,4-QD under anaerobic
conditions. Additionally, EPR spectra have been reported after anaerobic incubation of A.
japonicus 2,4-QD with a variety of flavonol substrates: quercetin, kaempferol, galangin,
myricetin, morin, datiscetin, fisetin, 7-hydroxy flavonol, and flavonol.1121 A single CuII
species is observed in these EPR spectra with g// = 2.310–2.337 and A// = 110–142 G,
depending on the substrate (quercetin yields g// = 2.336 and A// = 124×10−4 cm−1, Figure
211C). These parameters are similar to those observed for the dominant species in the
resting enzyme, characterized by X-ray crystallography as a tetrahedral site without Glu73
bound to Cu. However, the substrate-bound site characterized by X-ray crystallography is 5-
coordinate with Glu73 bound, nominally more similar to the minor component of the resting
enzyme.1124 No reduction of CuII to CuI or evidence of an organic radical is observed upon
substrate binding in EPR spectra recorded at 77 K, which contrasts a substrate radical
suggestion based on the pyramidalization of the substrate C2 carbon in substrate-bound
crystal structures.1121 Steiner et al. also report the XAS spectra of 2,4-QD with the
substrates quercetin and myricetin bound.1122 The absence of a pre-edge feature at 8984 eV
(characteristic of CuI complexes) and the consistent position and shape of the K-edge in the
resting enzyme and the substrate-bound enzyme additionally demonstrate that there is no
reduction of the copper site upon substrate binding, consistent with the EPR data. The
EXAFS data for the substrate bound 2,4-QD are best fit as a single species with a single
shell of 3 His and 2 O ligands with an average distance of 2.00 Å. Attempts to refine the fit
to include two shells of ligands yielded a possible fit to shells at 1.96 Å and 2.05 Å, but
Steiner et al. set aside these results because of insufficient resolution in their data.1122 These
EXAFS results agree with the conclusions from X-ray crystallography and EPR
spectroscopy of the ES complex that substrate coordination imposes order on the
coordination environment of the copper site (vide supra).
When samples of the substrate-bound enzyme are exposed to oxygen, turnover occurs and
the absorption band of the bound substrate decays, resulting in a featureless absorption
spectrum similar to that of the resting enzyme (Figuer 210D).1120 However, the EPR
spectrum of the product when EPR samples of the ES complex are exposed to O2 is different
from that of the resting enzyme (Figure 211D, a single species with gz = 2.295(4), Az =
131×10−4 cm−1; gy = 2.169(5), Ay = 43×10−4 cm−1; gx = 2.014(3), Ax = 63×10−4 cm−1).1121
The spectrum after turnover is very similar to a spectrum of the product-bound enzyme
obtained by adding the depside product to resting 2,4-QD and spectral features of the resting
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enzyme could be recovered by repeated buffer exchange. On this basis, Kooter et al. identify
the species after turnover as the enzyme with the product bound at the copper site.1121
However, the spectrum after turnover is also very similar to the minor component of the
resting site (observed cleanly at high pH) and this similarity should be investigated. A
detailed spectroscopic study is required to elucidate the electronic structure of the resting,
substrate-bound, and product-bound 2,4-QD.
There are large differences between the spectroscopic data reported for 2,4-QD from A.
japonicus (discussed above) and those reported by Hund et al. for 2,4-QD from A. niger.1110
The EPR spectrum of resting 2,4-QD from A. niger shows contributions from only one
species, which has g// = 2.293 and A// = 166×10−4 cm−1 and a superhyperfine contribution to
the g⊥ region. Simulation of the g⊥ region without the superhyperfine contribution lead to
values of gy = 2.055, gx = 2.01 and Ay = Ax = 9×10−4 cm−1. The superhyperfine
contribution is a pattern of nine lines split by 13 G in the g⊥ region, indicating coupling with
4 equivalent nitrogen ligands. However, A. niger and A. japonicus 2,4-QD have 66%
sequence similarity and there are no additional His residues in the vicinity of the A. niger
2,4-QD active site. Indeed, all the key active site residues (copper ligands and key second
sphere residues involved in substrate binding) are conserved.1112 This raises the possibility
that there may be an exogenous ligand bound in A. niger 2,4-QD. The EPR spectrum does
not change upon anaerobic addition of substrate, which would be expected if the active site
were blocked by the binding of an exogenous ligand.1110 Alternatively, the lack of change in
the EPR spectrum upon anaerobic addition of quercetin may be due to substrate insolubility
in the absence of added DMSO (vide supra). These differences in EPR spectroscopy
between 2,4-QD from A. niger and A. japonicus have been previously interpreted by Kooter
et al. as an indication that there is a significantly different coordination environment in the
A. niger resting enzyme and an alternative mechanism for 2,4-QD activity may be
required.1121 However, in view of the high degree of sequence similarity between the
enzymes, the origin of the spectroscopic differences needs to be clarified further by
structural and spectroscopic studies of A. niger 2,4-QD before any conclusions can be drawn
about whether there are in fact significant structural or mechanistic differences from A.
japonicus 2,4-QD.
4.1.5 Molecular Mechanism—A general mechanism has been proposed for quercetinase,
on the basis of the structural and spectroscopic studies of the enzyme ES complex (Figure
212).1124 The resting copper site exists in equilibrium between a Glu73-off form (1A) and a
Glu73-on form (1B). Substrate binds to the copper site as a monodentate ligand via the C3-
OH group (2A), which is deprotonated and hydrogen bonds with Cu-on Glu73. The CuII-
substrate complex is throught to be in an equilibrium with a CuI-substrate radical complex
(2B) formed by an intramolecular electron transfer, but this equilibrium is shifted far to the
left, so the CuI-substrate radical form is not experimentally observed (alternatively, this step
has been described by Siegbahn as the formation of an excited state of the CuII-substrate
complex, vide infra). After formation of the CuI-substrate radical, O2 could react at the
substrate radical (3A) or at CuI, forming a CuII-superoxo species (3B). Formation of the C2-
O bond is followed by formation of the second C-O bond at C4, forming an endoperoxide
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intermediate (4). This endoperoxide intermediate decays in a concerted step, which includes
O-O bond cleavage and the release of CO, to form the depside product (5).
Siegbahn has used DFT calculations to evaluate this reaction pathway and particularly
distinguish between the two possible sites where O2 could react in a CuI-substrate radical
complex.1126 His results show that the formation of the CuII-superoxide is 14 kcal/mol
lower in energy than O2 attack on the substrate radical. Reaction between the ES complex
and O2 is the rate limiting step of the reaction, with ΔH = 9.6 kcal/mol (a transition state and
barrier for this step were not calculated). The entropy loss in this step is estimated to be ~5
kcal/mol, yielding ΔG = 14.6 kcal/mol (entropy contributions were not included in the
calculations of the other steps of the reaction). Upon formation of the CuII-superoxo, the
quercetin radical dissociates from the copper site (Figure 212 3B) and rotates relative to
copper so that attack of the superoxide on C2 from the top becomes possible with ΔH‡ = 1.1
kcal/mol and ΔH = −18.3 kcal/mol. Formation of the second C-O bond to yield the
endoperoxide intermediate then proceeds with ΔH‡ = 7.1 kcal/mol and ΔH = 1.7 kcal/mol.
In this step, the hydrogen bond from Glu73 shifts from O3 to O4, stabilizing the extra
charge on C4. The subsequent concerted O-O bond cleavage and CO release has ΔH‡ = 0.2
kcal/mol and is highly exothermic, with ΔH = −101.8 kcal/mol. The whole reaction is
exothermic by 96.7 kcal/mol.1126 The point at which these calculations substantially
disagree with experimental results is in the attack of the CuII-superoxo on the quercetin
radical. The dissociation of the quercetin radical from CuII and its repositioning prior to
superoxo attack may also not be possible given the constraints of the substrate binding
pocket. Indeed, Steiner et al. suggest that the CuII-superoxo attack on C2 may not be
geometrically possible if quercetin is constrained in the position observed in the crystal
structure of the ES complex.1124
Some mechanistic insight into the reaction performed by 2,4-QD has been obtained from
model complex studies. The dioxygenation of the simplest flavonol, 3-hydroxyflavone,
occurs in the presence of O2 under many conditions, including base-catalyzed dioxygenation
in protic and aprotic solvents,1127,1128 radical-initiated dioxygenation,1129,1130
stoichiometric dioxygenation of ZnII,1131 CoII,1132 CuII,1133 and CuI1134 flavonolate
compounds, and dioxygenation catalyzed by CuII model complexes with nitrogen donor
ligands.1133,1134 Several recent reviews cover this model chemistry.1132,1135 When the
flavonol is deprotonated, the free flavonolate anion reacts with O2, yielding the same
products as the enzymatic reaction. A study of the reaction of potassium flavonol with O2
has shown that in the absence of a redox-active metal this reaction proceeds by a single
electron transfer pathway in which the deprotonated flavonolate directly transfers an
electron to O2 in a rate-limiting outer sphere electron transfer step.1128 The reaction has a
first order dependence on O2 and free superoxide has been detected by nitro blue tetrazolium
in these reactions while the flavonolate radical has been observed by EPR. Radical coupling
of the flavonolate radical and superoxide produces a peroxide which goes to the product via
an endoperoxide intermediate, resulting in incorporation of both atoms of O2 into the
depside product (verified by 18O2 labelling). However, the rate of the reaction of flavonolate
with O2 is rather slow, as indicated by a second order rate constant for non-enzyme
potassium flavonolate dioxygenation of 0.33±0.01 M−1 s−1 at 80°C in DMF.1128 This
Solomon et al. Page 170
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
contrasts with a high catalytic efficiency for the enzyme reflected by a kcat/KM on the order
of 1×108 M−1 s−1 at room temperature and pH 6, where the flavonol rather than the
flavonolate is present (in 20% DMSO, vide supra).1112 Thus the reaction catalyzed by 2,4-
QD involves an activation of the flavonol substrate towards reaction with O2 rather than
simple deprotonation of the flavonol by 2,4-QD followed by direct reaction of the
flavonolate with O2.
Attempts have been made to obtain further insight into the CuII substrate activation process
that is involved in enzymatic catalysis by studying CuII flavonolate complexes of the form
CuIIL(fla), where L is a chelating nitrogen donor ligand. Interestingly, a comparison of the
rates of dioxygenation for representative CuII, CuI and ZnII model complexes (Table 37)
shows that the transition metal-containing complexes react with O2 three orders of
magnitude slower than potassium flavonolate under similar conditions and that there is little
difference between the rates observed for similar CuII, CuI, and ZnII complexes. For each of
these reactions, a second order rate constant for the dioxygenation reaction was obtained
from the rate law k2[fla][O2], showing that a bimolecular reaction with O2 is the rate-
limiting step.
Thus, coordination of the flavonolate to a transition metal decreases its reactivity towards
O2. This can be rationalized by considering that coordination to a metal will lower the
energy of the flavonolate HOMO through bonding interactions with the metal (a Lewis acid
interaction, in the case of ZnII or CuI), making the flavonolate harder to oxidize. Therefore,
the coordinated flavonolate will be less reactive towards the single electron transfer
mechanism that leads to dioxygenation of the free flavonolate. It is possible that the reported
reactivity of these complexes is due to ligand dissociation, yielding a small amount of free
flavonolate in solution which then reacts with O2, a mechanism that has not been directly
tested.
This leads to an interesting issue as to the nature of the substrate activation performed by the
2,4-QD enzyme and how the enzyme differs from the CuII model complexes, such that
coordination to CuII in the enzyme activates the flavonol substrate rather than deactivating it
by making the flavonolate harder to oxidize. A key structural difference between the 2,4-QD
ES complex and known CuII flavonolate model complexes may contribute to this difference.
The model complexes all bind flavonolate as a bidentate ligand via the C3 hydroxyl and the
C4 carbonyl groups, in contrast to the enzyme, which binds the substrate as a monodentate
ligand. These different coordination modes will lead to different orbital interactions and
monodentate coordination may lead to an electronic structure that is more favorable for O2
attack. Pap et al. argue that a monodentate or asymmetric bidentate coordination mode will
increase the radical character on the flavonolate ligand, allowing direct reaction with O2
without requiring an initial slow outer-sphere electron transfer as in the free flavonolate
reaction.1135
Additionally, some CuII flavonolate model complexes, typically those with phenanthroline
or bipyridyl ligands or of the form CuIIL(fla)2, perform a different dioxygenation reaction
from the enzyme.1137 These yield an O-benzoylsalicylic acid product, produced by a 2,3-
rather than a 2,4-dioxygenation of 3-hydroxyflavone. This alternative dioxygenation
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proceeds through a 1,2-dioxetane intermediate which decays via chemiluminescence, rather
than the endoperoxide intermediate proposed for the enzyme. Thus, there are two possible
dioxygenation pathways from a proposed intermediate alkylperoxide: attack on the C4
carbonyl, leading to an endoperoxide intermediate, or peroxidation of the double bond by
attack on C3 to form a 1,2-dioxetane intermediate (Figure 213). The factors in the active site
of 2,4-QD that direct the enzymatic reaction toward the endoperoxide rather than the 1,2-
dioxetane route (and therefore perform 2,4-dioxygenase rather than 2,3-dioxygenase
chemistry) are an interesting topic for future study.
4.2 Cofactor Biogenesis in the Copper Amine Oxidases
4.2.1 Enzymology—The copper-containing amine oxidases are a family of enzymes
found in all forms of life excepting Archaea (EC 1.4.3.21 and EC 1.4.3.22; note that not all
amine oxidases are copper-containing). Amine oxidase (AO) performs the oxidation of
primary amines and diamines to aldehydes and ammonia, producing H2O2 as a byproduct
(Figure 214). AO is a quinoprotein, containing a protein derived organic cofactor, 2,4,5-
trihydroxyphenylalanine quinone (topaquinone, TPQ), which is the key reactive
functionality of the active site. The active site also contains a Type 2 or normal copper site.
A wide variety of roles have been discovered for AO in biochemical processes. In
prokaryotes and yeast, AO allows the organism to use amines as the sole source of carbon
and nitrogen for cell growth.1138 In plants, AO is associated with cell wall formation and
wound healing.1139 In mammals, the role of AO is less clear and multiple roles are likely,
including amine metabolism, cell signaling (via H2O2), and amine-promoted apoptosis.1140
High levels of AO in serum are associated with a variety of diseases, including type 1 and
type 2 diabetes, liver disease, hypertension, atherosclerosis, and congestive heart
failure.1141–1144 AO is being investigated as a treatment for anaphylaxis (for its anti-
histamine properties) and has been considered as an antitumor agent (due to its role in
apoptosis).1145,1146
AO has been isolated from eubacteria (Escherichia coli ECAO;1147 Arthrobacter
globiformis AGAO1148), yeasts (Hansenula polymorpha, HPAO;1149 Pichia pastoris,
PPLO1150), plants (pea seedling, PSAO;1151 lentil seedling, LSAO1152), and mammals
(bovine serum, BSAO;1153 pig kidney, PKAO;1154 human vascular adhesion protein-1,
VAP-1;1155 human diamine oxidase, hDAO1156). AOs from different sources have relatively
low sequence similarity, despite having similar tertiary and active site structures (vide infra).
The sequence similarity typically falls in the range of 20–30% of residues identical,
excepting BSAO and VAP-1, which have 84% of residues identical.1157 However, several
key active site residues are strictly conserved in all AOs, including a consensus sequence
containing the covalently bound cofactor (Thr-X-X-Asn-Tyr-(TPQ)-Asp/Glu-Tyr), an Asp
proposed to be the active site base involved in catalysis, and a Tyr residue that hydrogen
bonds to the cofactor.1158
It was recognized early in the study of AOs that the enzymes contain a novel chromophore,
a cofactor that contains a carbonyl group that reacts with phenylhydrazine.1159 This
chromophore was originally proposed to be the known cofactor pyridoxyl phosphate, but
this was ruled out by comparison of the resonance Raman spectra of the phenylhydrazine
Solomon et al. Page 172
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
derivatives.1160 Following the suggestion that the cofactor was a quinone, a covalently
bound form of pyrroloquinoline quinone (PQQ) was proposed, since protein digestion of
phenylhydrazine-derivatized protein gave a low molecular weight molecule identical by
HPLC to the phenylhydrazine derivative of pyrroloquinoline quinone.1161,1162 However,
attempts to confirm this identity for the cofactor were unsuccessful, and finally Janes et al.
were able to isolate the cofactor-containing peptide fragment and show by MS and NMR
that the cofactor was not PQQ but rather the wholly novel protein-derived cofactor 2,4,5-
trihydroxyphenylalanine quinone (TPQ).1163 Subsequent work by Mu et al. showed that the
cofactor is formed through a post-translational modification reaction (cofactor biogenesis)
where a precursor Tyr residue is modified to TPQ.1164 It was further demonstrated that
cofactor biogenesis of TPQ from the precursor Tyr occurs by a self-catalyzed reaction
involving the mononuclear CuII site and O2 rather than by a chaperone protein.1165,1166
The active site of AO therefore performs two quite different reactions: the first turnover (the
cofactor biogenesis reaction), which processes Tyr to TPQ, and, after the cofactor has been
formed, the catalytic oxidation of amines.1167 The cofactor biogenesis reaction involves
substrate activation by CuII, while in catalytic turnover the copper site plays a role in
activating O2 for reduction during regeneration of the cofactor. A comprehensive review of
cofactor biogenesis in a series of enzymes is presented in this thematic issue by Klinman et
al. Here we focus on the biogenesis reaction as it relates to the broad theme of substrate
activation by an oxidized CuII active site.
The catalytic turnover of AO proceeds in two half reactions, the reductive half reaction, in
which amines are converted to aldehydes and the TPQ cofactor is reduced to an aminoquinol
(TPQN-red, Figure 215A) and the oxidative half reaction, in which O2 reacts with the active
site to regenerate the oxidized TPQ cofactor and release hydrogen peroxide and ammonia
(Figure 215B).856 The mechanism of the reductive half reaction is well established.1168 The
primary amine substrate reacts with the C5 carbonyl of TPQ, forming a Schiff base.
Deprotonation of the α carbon of the amine substrate converts this to a product Schiff base,
reducing the cofactor. Hydrolysis of this Schiff base releases the product aldehyde, leaving
TPQN-red. There is continuing controversy, however, over the mechanism of the oxidative
half reaction and the role that the copper site plays in this process.856 The resting TPQN-red
site obtained after reduction of the protein by the substrate amine exists in equilibrium
between a CuII-aminoquinol form and a CuI-semiquinone form (Figure 215B), which can be
observed directly in the absorption and EPR spectra of the resting substrate reduced AO
from certain sources (PSAO, AGAO)1169,1170 but is not observed in AOs from other sources
(HPAO, BSAO).1171,1172 In AOs where the CuI-semiquinone form has been observed, a
mechanism for the reductive half reaction has been proposed where O2 is activated by the
CuI site in the CuI-semiquinone form of the reduced site and subsequently oxidizes the
cofactor back to TPQox, releasing NH3. Single turnover kinetics experiments on the reaction
of O2 with amine-reduced AGAO, performed by Shepard et al., confirm that the CuI-
semiquinone reacts rapidly with O2 and oxidation of the aminoquinol cofactor proceeds
through the CuI-semiquinone.1173 In contrast, the reaction of O2 with amine-reduced HPAO,
where the CuI-semiquinone form is not observed, proceeds at the same rate in CuII-
reconstituted and CoII-reconstituted enzyme.1174 This suggests that the oxidation of the
cofactor proceeds by an outer sphere electron transfer to O2, with the metal site later
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involved in stabilizing the superoxide generated in this step. Thus, there is ongoing
controversy as to whether the oxidative half-reaction in the catalytic turnover of AO
proceeds by an inner sphere or an outer sphere mechanism and whether copper is involved
in redox chemistry or just provides a charge stabilization effect.
Lysyl oxidase (LOX) is a specific AO involved in the cross-linking of collagen and elastin
during the maturation of connective tissue. LOX has been purified from Drosophilia.1175
LOX from Drosophilia has been shown to be a 38 kDa monomeric protein that contains a
similar mononuclear copper active site to other AOs but contains a different covalently-
bound cofactor, lysine tyrosylquinone (LTQ).1176,1177 As with other AOs, the biogenesis of
the cofactor is a self-processing reaction requiring CuII and O2 to transform a Tyr and a Lys
residue to LTQ.1175 The mechanism of LTQ biogenesis is closely related to that of TPQ
biogenesis and very little independent study of it has been performed. Instead, the majority
of studies have been done on TPQ biogenesis and can be related to LTQ biogenesis (vide
infra).
Protein-derived cofactors have also been observed in other enzyme systems.1178 Most are
crosslinked amino acid residues closely associated to a metal site, like the Cys-His crosslink
found in some binuclear copper proteins (mollusc hemocyanin, plant catechol oxidase and
fungal tyrosinase, mentioned above), the His-Tyr crosslink in the active site of CcO and the
Tyr-Cys radical cofactor in GO (vide supra). These crosslinked cofactors can perform a
structural role in the protein or perform redox chemistry in catalysis by donating or
accepting an electron (CcO, GO). Quinone cofactors like TPQ and LTQ add an electrophilic
site in the protein and are involved in the catalysis of reactions with amines. These are the
only quinone cofactors that do not require an external mechanism but instead have self-
catalyzed biogenesis reactions involving CuII. This copper dependent biogenesis reaction is
the focus of this section.
4.2.2 Kinetics—Apo-AO (protein lacking TPQ and copper cofactors) can be prepared in
metal free conditions and is isolated with the precursor Tyr instead of with TPQ. The apo
enzyme can be reconstituted with divalent metals to study the kinetics of TPQ biogenesis
(apoAO reconstituted anaerobically with CuII is referred to as “preprocessed AO” and
contains the copper cofactor but lacks TPQ).1166 Defining the preprocessed CuII site and the
initial reaction of this site with O2 are key to understanding the nature of the substrate
activation involved in AO cofactor biogenesis.
The stoichiometry of the TPQ biogenesis reaction has been measured by Ruggiero et al.
using a spectrophotometric assay to monitor H2O2 production (measuring formation of a
quinoneimine dye) and monitoring O2 consumption using a Clark electrode.1179 These
experiments confirmed that 2 moles O2 were consumed per TPQ produced and 1 mole H2O2
was generated in the process. Nakamura et al. have determined that the C2 carbonyl of TPQ
is derived from solvent, because the stretching frequency of this carbonyl observed in the
resonance Raman spectrum shifts when the biogenesis reaction is performed in H218O.1180
The origin of the C5 carbonyl could not be determined, because this oxygen undergoes
exchange with the solvent, but it is presumed to come from O2. Ruggerio et al. have also
demonstrated that the rate of TPQ biogenesis is not affected by the concentration of CuII
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above stoichiometric amounts, indicating that only copper bound in the active site
participates in the biogenesis reaction.1181 In some biogenesis experiments reported in
HPAO, only a third of the available sites are oxidized to TPQ. This may reflect incomplete
copper loading in these experiments (vide infra).1182
Initially, it was assumed that CuII was the redox state active in TPQ biogenesis because,
upon reconstitution of the apo-enzyme with CuII in the presence of O2, the TPQ biogenesis
reaction proceeds spontaneously.1166 CuII has been confirmed to be the active redox state by
Samuels and Klinman by comparing the rate of TPQ biogenesis in apo-HPAO reconstituted
with CuII with the rate observed in apo-HPAO reconstituted with CuI.1183 When apo-HPAO
is reconstituted with CuII and exposed to air, TPQ forms with kTPQ = 0.08±0.03 min−1,
while when the apo enzyme is reconstituted with CuI, the rate of biogenesis is slower by a
factor of 17, with kTPQ = (4.7±0.2)×10−3 min−1. Samuels and Klinman also used EPR
spectroscopy to monitor the redox state of Cu during the biogenesis reaction of CuI-
reconstituted HPAO. No CuII intermediate species is observed and the rate of oxidation to
CuII obtained from the EPR experiment is identical to the rate of TPQ formation, indicating
that oxidation of CuI to CuII is rate-limiting. At the end of the reaction, only 26% of the
active site has been transformed to TPQ, which corresponds 1:1 with the amount of loaded
CuI that has been oxidized to CuII. This result further confirms that oxidation from CuI to
CuII is required for the biogenesis reaction to proceed. This definitively establishes that the
biogenesis reaction involves a CuII substrate activation process.
During the biogenesis of preprocessed HPAO, an intermediate with an absorption band at
350 nm (ε≈3200 M−1 cm−1) is observed.1184 The intermediate forms with a rate constant of
0.51±0.01 min−1 and decays with a rate constant of 0.076±0.003 min−1, which is identical to
the rate of TPQ formation in air (kTPQ = 0.08±0.03 min−1). An isosbestic point is observed
between the 350 nm intermediate and the 480 nm band of the product TPQ, indicating that
the decay of the 350 nm intermediate is rate-limiting in TPQ formation. The amount of the
350 nm intermediate that accumulates is greater by a factor of 3 when the biogenesis
reaction is performed at pH 8.5 relative to when it is performed at pH 7. This is associated
with a 5-fold increase in the rate of biogenesis going from pH 7 to pH 9, with a pKa of 8.45.
The 350 nm intermediate has been tentatively assigned as a CuII-tyrosinate species (vide
infra) and the pKa of 8.45 attributed to the precursor Tyr, deprotonation of which would lead
to greater accumulation of a CuII-tyrosinate species. Despite this central role proposed for
the 350 nm intermediate in biogenesis in HPAO (its decay is rate-limiting and it is assigned
as the key intermediate in CuII substrate activation, see section 4.2.5), the 350 nm
intermediate is not observed in biogenesis in AGAO.1181 The rate of biogenesis is also an
order of magnitude slower in HPAO than in AGAO (kTPQ (HPAO) = 0.16±0.008 min−1,
kTPQ (AGAO) = 1.5±0.2 min−1 at saturating O2). The dependence of kTPQ on the
concentration of O2 (vide infra) accounts for the difference between the value of
kTPQ(HPAO) = 0.08±0.03 min−1 reported above for experiments in air and the value for
kTPQ(HPAO) reported for saturating O2 (kTPQ = 0.16±0.008 min−1). Since the rate of TPQ
formation is faster in AGAO than in HPAO, DuBois and Klinman suggest that the 350 nm
intermediate may occur in AGAO, but on a faster timescale that could potentially be
observed with stop-flow techniques.1185 Another option is that the relative rates of different
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steps in the biogenesis reaction may differ between HPAO and AGAO, so that the 350 nm
species does not accumulate in experiments with AGAO. The observation of this key
intermediate in biogenesis in HPAO but not in other AOs is an issue that remains to be
resolved in refining the mechanism for TPQ biogenesis.
The effect of a range of variables on the kinetics of TPQ formation has been evaluated in
order to identify the nature of the rate-limiting step in TPQ biogenesis or at least rule out
certain possibilities. The consumption of O2 during the reaction can be measured directly
and exhibits single phase kinetics.1186 Since two molecules of O2 are consumed in this
reaction, single phase kinetics for O2 consumption indicates that reaction of the first
molecule of O2 is slow relative to reaction of the second O2. Deuteration of the precursor
Tyr ring at the C3 and C5 positions has no effect on the rate of biogenesis, which rules out
decay of a proposed aryl-peroxide intermediate as a possible rate-limiting step (since this
would involve deprotonation of the ring at the C5 position).1182 The rate of biogenesis is not
affected by buffer viscosity, so O2 binding to the protein is not rate-limiting.1186 These
results are consistent with the proposal of Klinman et al. that the rate limiting step is attack
of the first molecule of O2 on the preprocessed site, after prebinding of O2 to a binding
pocket in the protein (required by a faster rate for O2 consumption than TPQ formation, vide
infra).1182 A rate-limiting step of O2 attack on a CuII-tyrosinate species is also consistent
with DFT calculations performed by Prabhakar and Siegbahn on the biogenesis reaction (see
Section 4.2.5).1187 The temperature dependence of the rate of biogenesis has been measured
by Schwartz et al., who obtain an Arrhenius activation energy of Ea = 8.4±0.5 kcal/mol for
the rate-limiting step in TPQ biogenesis.1186 Definitive identification of the rate-limiting
step is required in order to interpret the chemical significance of this activation energy.
In a variety of kinetic experiments performed on TPQ biogenesis, particularly those that
measure the dependence of rates on the concentration of O2, the biogenesis reaction is
initiated by adding CuII to a solution of the apo-enzyme that has been preequilibrated with a
known concentration of O2.1182,1186 This contrasts with the method previously described for
studying biogenesis (vide supra), in which apoAO is anaerobically pre-loaded with CuII and
TPQ biogenesis is initiated by exposing the preprocessed enzyme to O2.1181,1184 Several
kinetic studies directly compare rate constants and kinetic parameters obtained by these two
methods, which requires the assumption that CuII binding to the active site of AO (an
additional kinetic step in the aerobic CuII addition method) is fast. To establish that this
assumption is valid, Schwartz et al. report identical rates for TPQ biogenesis measured using
the two methods, which implies that CuII binding is fast relative to biogenesis.1186 However,
in biogenesis experiments initiated with CuII addition, the 350 nm intermediate previously
observed when preprocessed HPAO reacts with O2 does not accumulate, suggesting that the
rate limiting step changes when biogenesis is initiated by adding CuII aerobically.
Instead, in experiments where TPQ biogenesis is initiated by adding CuII, a species with a
380 nm absorption band is observed to accumulate rapidly and decay with a rate constant of
k380 = 0.06±0.01 min−1, which is identical to the rate of TPQ formation (kTPQ = 0.08±0.03
min−1 under these conditions).1184 However, this species is observed when copper is added
to HPAO even when the active site is already occupied by CuII or ZnII. In addition, in
mutated active site variants of HPAO in which the rate of biogenesis is significantly
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decreased, the kinetics of growth and decay of the 380 nm species are not altered. Therefore,
Dove et al. conclude that the 380 nm species is not involved in the biogenesis reaction since
it is not an active site copper species. DuBois and Klinman have subsequently proposed that
the 380 nm absorption feature may be due to a transient copper binding site involved in Cu
loading into the active site.1185 The rate of copper binding in AOs other than HPAO has also
not been investigated and whether CuII binding contributes to the kinetic and spectroscopic
data for TPQ biogenesis in AGAO is not known.
The rate of TPQ biogenesis is dependent on the concentration of O2. This dependence has
been measured by DuBois and Klinman, enabling a comparison between the rates of TPQ
formation and O2 consumption (CuII addition to apoHPAO was used to initiate biogenesis in
these experiments).1182 The dependence of kTPQ on the concentration of O2 is hyperbolic
with kmax = kTPQ(sat’d O2) = 0.16±0.008 min−1 and KM= 233±35 µM (these do not
correspond to Michaelis-Menten kcat and KM values because the biogenesis reaction is a
single-turnover process). The kinetics of O2 consumption during the biogenesis reaction
have also been measured and saturation kinetics are observed with a kmax(O2) = kO2(sat’d
O2) = 0.27±0.02 min−1 and KM= 216±45 µM. An interesting feature of these results is that
O2 is consumed faster than TPQ is produced. DuBois and Klinman propose that O2 binds in
an O2 binding pocket before reaction with the preprocessed active site during TPQ
formation. Another interesting observation that can be made from comparison to previous
experiments is that the 350 nm intermediate is formed faster than O2 is consumed. If the 350
nm species is formed without the participation of O2 but is triggered by O2 being present (as
proposed by Dove et al.),1184 this suggests that the 350 nm intermediate is a CuII-tyrosinate
complex formed due to an O2 triggered conformational change of the active site. However,
the faster rate of 350 nm intermediate formation relative to O2 consumption could also be
due to the different experimental conditions, since the O2 consumption was initiated by
adding CuII to aerobic apoHPAO while the spectroscopic experiments were initiated by
adding O2 to preprocessed HPAO with CuII preloaded.
Attempts to chemically trap a CuI-tyrosyl radical intermediate in biogenesis have been
unsuccessful. Addition of DEANO (a reagent used to generate NO in situ) to the biogenesis
reaction had no effect on TPQ formation, indicating that no tyrosyl radical accumulates
during the reaction.1184
Several variants of first and second sphere active site residues have been used to gain insight
into the cofactor biogenesis reaction. Mutation of His ligands at the CuII site (vide infra) to
non-coordinating residues in AGAO (H431A, H433A, H592A) leads to no formation of
TPQ, underlining the importance of the copper site in TPQ biogenesis.1188 A variant of one
of these His ligands to Cys in HPAO (H624C) does perform TPQ biogenesis, but at a greatly
reduced rate (kTPQ = 0.07±0.04 hr−1).1184 The intermediate previously observed in WT
HPAO also accumulates in H624C, but the absorption band is shifted to 390 nm with an
order of magnitude slower formation and decay (kform = 0.042±0.003 min−1, kdecay = kTPQ
= 1.2×10−3 min−1). Interestingly, the mutation of a second sphere Met residue which forms
part of the putative O2 binding pocket in the holo enzyme (M634) shifts the intermediate
absorption maximum to energy as well as retarding the rate of biogenesis.1182 The
magnitude of this effect on the rate is linearly related to volume of the hydrophobic
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sidechain that replaces M634, which DuBois and Klinman interpret to mean that M634
forms part of binding pocket for O2 in the active site. Finally, mutation of a conserved active
site Tyr residue, which H-bonds to the TPQ cofactor in the holo enzyme (Y305A, Y305F),
results in an alternative product for the biogenesis reaction, identified by an absorption
feature at 400 nm.1189 The formation of TPQ relative to the alternative product is pH
dependent, with TPQ primarily formed at low pH, while the 400 nm product forms at high
pH. The 400 nm product exhibits no reactivity with phenylhydrazine and is, therefore, not a
quinone. The 400 nm species was originally proposed to be an alkyl-peroxide and it has
recently been confirmed by X-ray crystallography that the product is a doubly-peroxidated
ring (see Section 4.2.3).1190
Contrary to early reports about TPQ biogenesis, metals other than copper are also competent
to perform the reaction, albeit at greatly reduced rates. CoII, NiII, and ZnII bind tightly to
apo-AO and cannot be displaced by subsequently added CuII.1191 ZnII is inert with respect
to TPQ biogenesis, but TPQ is slowly formed in CoII-AGAO and NiII-AGAO in the present
of saturating O2 with kTPQ(CoII) = 0.079±0.002 hr−1 and kTPQ(NiII) = 0.075±0.001 hr−1.
Biogenesis with an alternate metal is also observed in NiII-HPAO with kTPQ(NiII) =
0.044±0.001 hr−1 and Ni remains EPR-silent throughout the reaction.1192 The rate for TPQ
biogenesis with an alternate metal is over three orders of magnitude slower than the rate of
biogenesis with CuII and thus could be due to trace copper in the metal salt. Okajima et al.
address this by using high purity CoII and NiII salts and additionally showing that intentional
doping of 5% CuII in the CoII or NiII does not perturb the rate of biogenesis, indicating that
trace CuII is not responsible for the observed reaction.1191 Instead, the large difference in
rates may indicate that biogenesis proceeds by a different mechanism with other metals. It is
interesting to note that redox activity may not be necessary for cofactor biogenesis, since
NiII and CoII will perform the reaction, but the metal must also be more than just a Lewis
acid, since ZnII is inert. The nature of substrate activation by metals, and particularly by
CuII, which is most active in this reaction, becomes an even more interesting question in
light of these results.
To summarize, the kinetics studies that have been performed on TPQ biogenesis have shown
that; a) CuII performs this reaction, not CuI, and CuII is significantly better than other
divalent metals; b) an intermediate can be observed in biogenesis in HPAO that is proposed
to be a tyrosinate CuII LMCT species; c) decay of this intermediate is the rate limiting step
in biogenesis and d) O2 prebinding in an O2 binding pocket occurs during biogenesis. The
rate-limiting step of biogenesis must involve the first equivalent of O2 but is not the decay of
an aryl-peroxide. These kinetics suggest that the ratelimiting step of cofactor biogenesis is
the step involving the CuII substrate activation process. Spectroscopic and structural studies
that identify the observed intermediate and the rate-limiting step would be valuable in
elucidating the mechanism. In addition, differences observed in the kinetics of biogenesis
between HPAO and AGAO and between the two different methods for studying biogenesis
in HPAO (CuII initiated and O2 initiated) need to be resolved. Additionally, CuII binding to
the protein could have a significant effect on some of these kinetics results but has yet to be
thoroughly investigated.
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4.2.3 Structure—X-ray crystal structures of copper amine oxidases have been reported
from a variety of organisms, including from eubacteria (e.g. AGAO), yeasts (e.g. HPAO),
plants (e.g. PSAO) and mammals (BSAO and VAP-1). The majority of these crystal
structures are of the processed enzyme, including wild-type and mutanted variant structures,
inhibitor complexes, and structures with Xe to characterize potential O2 channels. Only the
few crystal structures relevant to understanding the CuII substrate activation involved in
cofactor biogenesis will be discussed here. A summary of the available crystal structures of
processed copper amine oxidases is presented in Table 38.
The overall protein structure of AO is similar in all crystal structures, regardless of the state
of the active site (apo, preprocessed, or processed). The significant sequence differences
between AOs from different sources do not affect the overall fold of the enzyme or the
structure of the active site. AO is a homodimer, with each monomer containing three
subunits (Figure 216). The largest subunit, containing 394 residues in AGAO, is an 18-
stranded β sandwich (colored in light blue and yellow).1194 The smaller subunits (100 and
82 residues in AGAO) pack on the surface of the large subunit, in slightly different positions
depending on the source organism. Two β ribbon arms extend from each monomer to the
surface of the large subunit of other monomer, stabilizing the dimer. The active site is buried
in the large subunit, near to a large, solvent filled cavity on the dimer interface and close to
where the β ribbon arm from the other monomer is positioned.
In processed AO, two possible conformations of the TPQ cofactor are observed.1194 In the
on-Cu conformation, TPQ is a ligand to the copper site through its C4-OH group and three
His residues additionally coordinate to Cu, two Nε-coordinated and one Nδ-coordinated
(Figure 217B). The geometry of the copper site in this conformation is tetrahedral distorted
towards trigonal pyramidal (where the Cu-OTPQ bond length is long, 2.4 Å). AO obtained
by dissolving these crystals is inactive. The alternative conformation of TPQ, observed in
active enzyme, involves rotations around the Cα-Cβ and Cβ-Cγ bonds so that TPQ is
positioned away from the copper into a pocket in the active site lined by Tyr284, Asp298,
and Tyr296 (Figure 217A, residue numbers from AGAO). In this conformation, TPQ
hydrogen bonds with Tyr284, a conserved residue which has been shown to be chemically
important (vide infra), and the reactive C5=O carbonyl of TPQ is positioned towards the
substrate entrance channel gated by Tyr296 and towards Asp298, the proposed active site
base. In this active conformation, the copper site is bound by the same three His residues
and additionally two solvent-derived ligands in a square pyramid. These general features of
the active site of processed AO have been observed in AOs from all the source organisms
studied, although the number of localized solvent molecules bound to the copper site varies
between different structural determinations. In some AGAO structures, two conformations
are observed for the residue His592, which is Nδ-coordinated to the copper.1194,1195 This
conformational flexibility, which is not observed in AOs from other sources, is proposed to
be due to incomplete occupancy of the site by copper and likely is not significant.
Several crystal structures relevant to AO cofactor biogenesis have been obtained and are
summarized in Table 39.
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These include structures of apo AO (lacking both CuII and TPQ, from AGAO and
HPAO)1194,1230 and of apo AO reconstituted with ZnII,1231 CoII,1191,1230 and CuI1230
(metals that do not catalyze the biogenesis reaction or, in the case of CoII, perform it slowly)
showing the position of the precursor Tyr residue in the presence of a metal cation. Two
different stages of the biogenesis reaction have been directly observed in crystals of
preprocessed AGAO (containing CuII but prior to TPQ biogenesis); one of the preprocessed
enzyme with CuII anaerobically bound and one of a dopaquinone (DPQ) intermediate in the
biogenesis reaction.1195 In addition, crystal structures have been obtained of the HPAO
variant Y305F, which reacts with O2 but does not form the mature TPQ cofactor and instead
shows a unique partially processed form of the substrate Tyr residue where the ring is
multiply-peroxidated,1190 and the AGAO variant D298K, which forms the LTQ cofactor
that is present in lysyl oxidase.1233 The overall structure of the AO enzyme in these forms is
the same and the only significant differences are observed at the active site.
The crystal structure of apoAO, lacking CuII and TPQ, was first reported by Wilce et al. and
later by Klema et al. for HPAO (see Table 39).1194,1234 In these structures, the precursor Tyr
residue (Tyr382 in AGAO) is pointing towards the site that will bind CuII (defined by the 3
His residues that are copper ligands in the processed enzyme, Figure 218A). From the apo
structure, it appears that the ligands are positioned so that copper binding will result in a
tetrahedral site in which the precursor Tyr residue is coordinated to CuII. This geometry is
indeed observed in the active site of preprocessed AOs reconstituted with ZnII and CoII,
where the metals are coordinated by the 3 His residues and the precursor Tyr in a tetrahedral
geometry. In the ZnII and CoII structures, the metal-Tyr distances are clearly consistent with
a MII-phenolate bond (2.02 Å and 1.87 Å for the two ZnII structures1231 and 2.19 Å for the
CoII structure,1234 Table 39). However, in the sole available crystal structure of apo AGAO
reconstituted anaerobically with CuII (1.9 Å resolution), the copper is bound to the three His
residues and the precursor Tyr points towards CuII, but the Cu-O distance of 2.58 Å is too
long to be described as a Cu-phenolate bond and the geometry of the site is not tetrahedral
(Figure 218B).1195 Several explanations have been proposed for the long Cu-O distance
observed in the anaerobic CuII bound structure. This may reflect reduction to CuI in the
experiment, although at low temperature in the crystal the tyrosine should be limited in its
ability to change position. This hypothesis is supported by a crystal structure obtained for a
CuI loaded form of preprocessed HPAO, which shows a very similar site geometry to that
reported by Kim et al. for CuII in preprocessed AGAO.1230 Alternatively, the long CuII-
tyrosine distance may reflect the tyrosine remaining protonated at the pH used for
crystallography (pH 6.8, pKa(Tyr) ≈ 10), resulting in a weak CuII-tyrosine interaction rather
than a CuII-tyrosinate bond, although the presence of a bond with CuII would be expected to
drive the deprotonation of Tyr. Finally, it could be that tyrosine is not a copper ligand in
anaerobic preprocessed AO and only binds to copper after O2 is added to initiate cofactor
biogenesis, a hypothesis supported by the possible assignment of the 350 nm intermediate
observed by Klinman et al. as a CuII-tyrosinate species (vide supra). Further resolution of
the structure of anaerobic CuII-bound preprocessed AO by complimentary spectroscopic
studies is necessary to unambiguously determine the starting point of the biogenesis
reaction, in which the tyrosine is activated for reaction with O2.
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Further insight into TPQ biogenesis can be obtained from crystal structures that contain
partially processed forms of the cofactor.1195 When crystals of the preprocessed Cu-bound
enzyme from AGAO are briefly exposed to O2 and then frozen, it is observed that 50%
monooxidation of the tyrosine ring has occurred (from 50% occupancy of an oxygen atom at
C5 of the ring), generating a dihydroxyphenylalanine or dopaquinone intermediate (Figure
218C), the oxidation state of which cannot be determined due to the low resolution of the
crystal structure (2.1 Å). The C4-O group of the intermediate is directed towards Cu,
possibly indicating that it is bound to the copper site, but again the Cu-O distance is long for
a bond (2.6 Å). After longer exposure to O2, the crystals contain a ring with oxygen atoms at
the C2, C4, and C5 positions and coordinates to the CuII site in the geometry observed for
the inactive conformation of TPQ with a Cu-O bond length of 2.3 Å (Figure 218D). A short
distance is observed between the C2-O group of the ring and Thr403 (O-O 2.3 Å) that has
been described as a hydrogen bond. This together with the absence of an absorption feature
at 480 nm in this crystal suggest that the ring, while oxygenated, has not yet been oxidized
from the reduced (TPQred) to oxidized (TPQox) form of the cofactor in this crystal. The
crystals could be further incubated with O2 to generate the processed active site with the
active off-Cu conformation of TPQ and the 480 nm absorption band corresponding to
TPQox (Figure 218E). Therefore, Kim et al. propose that oxidation of the cofactor is
required to promote the conformational change from the inactive on-Cu (Figure 218D) to the
active off-Cu TPQ conformation (Figure 218E).1195 However, since independent evidence
shows that the fully oxidized cofactor can adopt an on-Cu conformation and that enzyme
exhibiting this structure is inactive,1194 this conformation may not be relevant to cofactor
biogenesis.
Partially processed forms of TPQ have also been observed in some AO variants. A crystal
structure of the Y305F variant of HPAO (Tyr305 in HPAO corresponds to Tyr284 in
AGAO) has been reported showing that an alternative product is obtained in the biogenesis
reaction.1190 Instead of the quinone ring formed in the native biogenesis reaction, a doubly
peroxidated ring is present in this variant. The crystal structure data required the presence of
two different peroxidated ring structures, each at 50% occupancy: 5-hydroxo-2,4-
peroxophenylalanine and 5-hydroxo-3,4-peroxophenylalanine. In addition, a second sphere
residue near the copper site, Met634, had been oxygenated. These results indicate that the
absence of Y305 blocks cleavage of the O-O bond in biogenesis, leading to uncontrolled
oxidation of the precursor Tyr. Another mutation performed in AGAO, D298K, allows
trapping of covalet trapping of the dopaquinone intermediate in biogenesis.1233 Nucleophilic
attack of the variant Lys residue on the dopaquinone intermediate leads to formation of a
crosslink similar to the one present in lysyl oxidase. This is proposed to be the mechanism
for formation of LTQ, the lysyl oxidase cofactor, since lysyl oxidase does contain a Lys
residue at the appropriate position in its sequence.
4.2.4 Spectroscopy and Electronic Structure—Three key species in AO cofactor
biogenesis are targets for spectroscopic study: anaerobic preprocessed AO, the 350 nm
intermediate, and processed AO. Spectroscopy of the anaerobic preprocessed enzyme can
give an electronic structure description of the species that reacts with O2 to initiate cofactor
biogenesis. A key intermediate in the biogenesis reaction, defined by an absorption feature
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at 350 nm, can be characterized by spectroscopy to reveal its geometric structure and thus its
role in the biogenesis reaction. Despite the importance of a spectroscopic and electronic
structure definition of these early stages of biogenesis to define that nature of the activation
of the precursor Tyr by CuII, relatively little spectroscopic characterization of these first two
species has been performed. Alternatively, a large amount of spectroscopic characterization
has been performed on the processed enzyme, which provides a starting point for
understanding the limited spectroscopic data available for the preprocessed enzyme.
The copper site in processed AO had been elucidated by spectroscopy well before the first
crystal structure of the enzyme was published. The EPR spectrum of the copper site in a
resting processed AO was first reported by Yamada et al. in 1963.1235 The spectrum was
further analyzed by Suzuki et al., who reported an axial EPR spectrum with g∥ = 2.29, g⊥ =
2.06, A∥ = 175×10−4 cm−1.1236 These results are consistent with more recently reported
EPR parameters for processed AGAO (Figure 219C, red line, g∥ = 2.29, g⊥ = 2.07, A∥ =
187×10−4 cm−1), BSAO (g∥ = 2.28, g⊥ = 2.06, A∥ = 172×10−4 cm−1), and HPAO (g∥ = 2.30,
g⊥ = 2.06, A∥ = 163×10−4 cm−1). The EPR spectrum of BSAO by Suzuki et al. also showed
superhyperfine coupling in the g⊥ region with 2–3 14N donor ligands (5–7 lines, AN = 14
G). EXAFS studies on BSAO identified 3–4 histidine donor ligands based on a comparison
to Cu(imid)4 2+, and a square pyramidal structure with three equatorial His ligands and two
water ligands was proposed for the processed copper site.1237 Studies using pulsed EPR
techniques (ENDOR and ESEEM) agreed with this structure and further determined that the
equatorial water ligand is more tightly bound than the axial water ligand.1238 The optical
absorption spectra of processed AO are dominated by contributions from the oxidized TPQ
cofactor. The absorption feature at 460–480 nm (depending on the enzyme source) with ε ≈
3300 M−1 cm−1 can be assigned to the first π→π* transition of the quinone cofactor and
gives AO its characteristic pink color (Figure 219A, red).1236 The CD spectrum of processed
AGAO has a positive band at 370 nm and a negative band at 430 nm which are associated
with TPQox, while a broad negative band at 700 nm has been assigned as a d-d transition
(Figure 219B, red).1181 This spectroscopic analysis accurately predicted the structure of the
copper site in processed AO, which was later confirmed by X-ray crystallography.
Preprocessed AGAO has been studied by absorption, CD, and EPR spectroscopy.1181 The
preprocessed site has no significant absorption feature (Figure 219A, black spectrum). The
CD spectrum shows a negative band in the 700–800 nm region which has been assigned as a
CuII d-d transition, but the other d-d transitions of the site have not been resolved (Figure
219B, black). A feature at 380 nm in the reported CD spectrum of preprocessed AGAO is
not reproduced in our unpublished work. The EPR spectrum of the preprocessed site is axial
with g∥ = 2.32, A∥ = 153×10−4 cm−1, g⊥ = 2.07 and superhyperfine coupling with 3 N donor
ligands with AN = 14 G (Figure 219C, black). Spectroscopic work recently performed in our
lab suggests that the features that have been reported for the preprocessed site in fact have a
significant contribution from copper bound to a secondary copper binding site in the protein.
Thus, the contributions of several copper species must be resolved to obtain the
spectroscopic features of the active site copper in preprocessed AO. This work is the focus
of ongoing study.
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Very little spectroscopy has been performed on the 350 nm intermediate observed in
HPAO.1184 The intermediate has been identified as a CuII LMCT species because the
absorption maximum shifts from 350 nm to 390 nm when the copper ligand His624 is
mutated to Cys, suggesting that the copper site contributes to the electronic structure of the
intermediate. Dove et al. note that the absorption feature of the intermediate (λmax = 350 nm
= 28,600 cm−1, ε ≈ 3200 M−1 cm−1) is consistent with a variety of chemically plausible CuII
species, including a CuII-tyrosinate complex, a CuII-superoxide, and a CuII-aryl
peroxide.1184 Attempts to perform resonance Raman into the 350 nm band to identify the
species were unsuccessful and trapping of the intermediate for study by other spectroscopic
techniques has not been reported. While a tentative assignment of this intermediate as a
CuII-tyrosinate has been made by ruling out the other plausible options using kinetics data,
further spectroscopic investigation to confirm its identity would be valuable.1185
In the absence of detailed spectroscopic and electronic structure information on either the
anaerobic preprocessed site or the 350 nm intermediate, tetrahedral model complexes of the
form [CuL(OPh-4-F)]+, where L represents a tridentate N-donor ligand (L1 = HB(3,5-
iPr2pz)3 or L3 = HB(3-tBu-5-iPr2pz)3), have been studied (Figure 220A and B,
respectively).1239 These models closely represent the tetrahedral [Cu(His)3Tyr]+ structure
that has been proposed for the preprocessed site based on X-ray crystallography and for the
350 nm intermediate, but do not display reactivity with O2 (perhaps due to sterics).
However, the Cu-phenolate bond lengths in these models are significantly shorter than what
has been observed in the preprocessed enzyme1195 (L1 Cu-O 1.731 Å, L3 Cu-O 1.837 Å),
confirming that the Cu-Tyr interaction in the preprocessed enzyme is not a tyrosinate-copper
bond. The key difference between these two complexes is the orientation of the phenolate
ring relative to the N-donor ligation (Figure 220). In the L1 complex the phenolate ring is
oriented perpendicular to the Cu-O-C plane, which is close to the orientation of the Tyr ring
in the crystal structure of preprocessed AGAO obtained by Kim et al.,1195 while for L3 the
phenolate ring is approximately in the Cu-O-C plane. A summary of the spectroscopic
features of these complexes is presented in Table 40 and the spectra are given in Figure 221
and Figure 222.
The rhombic splittings of the g values observed in the EPR spectra (Figure 221) reflect
significant dz2 mixing into the dx2-y2 ground states of these complexes (6.9% for L1, 11.5%
for L3 from DFT calculations). The spin density found on the phenolate ring in the ground
state wavefunctions, 14% for L1 and 9% for L3, reflect only a small amount of radical
character on the phenolate ring resulting from binding to CuII. The different orientations of
the phenolate ring lead to different orbital contributions to bonding in the L1 and L3
complexes. The LUMO of the L1 complex has a π-bonding interaction between the dx2-y2
orbital on CuII and the phenolate out-of-plane (oop) π valence HOMO (Figure 223A), while
the L3 complex has a σ-bonding interaction between the dx2-y2 orbital and the phenolate in-
plane (ip) π valence HOMO-2 (Figure 223B). Therefore, the nature of the phenolate-CuII
bond depends on the orientation of the phenolate ring relative to the dx2-y2 orbital. This
difference in bonding is reflected in the significant differences in the energies and intensities
of the phenolate to CuII LMCT transitions in the two complexes. In the L1 complex, the two
phenolate to CuII LMCT transitions are split by 11,420 cm−1 (bands 6 and 10 in Figure 222
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left top) relative to a splitting of 23,166 cm−1 (band 8 and a band too low in energy to
observe in Figure 222 right top) in the L3 complex. This large energy difference reflects the
fact that in the L1 complex the phenolate oop orbital is lowered in energy by bonding,
decreasing the energy splitting of the oop and ip phenolate orbitals, while in the L3 complex
the energy of the phenolate ip orbital is lowered by bonding, increasing this energy splitting.
The observed CT transitions (Figure 222) result from both of these phenolate donor
interactions with the dx2-y2 acceptor orbital. In addition, in the L1 complex the lower energy
oop LMCT is the more intense transition (ε = 2363 M−1 cm−1 compared to ε = 842 M−1
cm−1 for the ip LMCT) because of better overlap between the oop phenolate HOMO with
the singly occupied dx2-y2 orbital, while in the L3 complex, the higher energy ip LMCT is
more intense (from TD-DFT calculations, since the oop LMCT is predicted to be too low in
energy to be experimentally observed in the L3 complex) due to better overlap of the ip
phenolate HOMO-2 with the dx2-y2 acceptor orbital in the CT process (Figure 223B). Thus
in the absorption spectrum of the L1 complex (Figure 222 left top) the most intense
transition is band 6, the oop phenolate to Cu CT, while in the absorption spectrum of the L3
complex (Figure 222 right top) the most intense transition is the ip phenolate to Cu CT, band
8.1239
The electronic structure description obtained from these model complexes leads to the
following conclusions about preprocessed AO and the nature of CuII substrate activation.
First, the spectroscopy currently reported for preprocessed AO (vide supra) is not consistent
with the Cu(His)3Tyr ligand set suggested by X-ray crystallography, since there is no
intense LMCT feature in the preprocessed AO absorption spectrum and the EPR spectrum is
axial rather than rhombic. This can also be deduced from the large difference in Cu-O bond
length between the preprocessed site in the enzyme (2.58 Å) and the model complexes
(1.731 Å and 1.837 Å). Insufficient spectroscopic information is available on the enzyme to
fully evaluate whether this could be a reasonable structure for the 350 nm intermediate.
However the similarity between the ring orientation of the L1 complex and the positioning
of the precursor Tyr suggests that there should be an intense low energy phenolate to Cu CT
in the enzyme, at an energy lower than the observed 350 nm band if this intermediate were a
Cu(His)3 Tyr complex. Second, while some radical character is present in the ground state
of CuII-phenolate complexes, this radical character in itself is insufficient to allow the
complex to react with O2. A lack of reactivity was predicted using DFT calculations, which
give a large, positive ΔG° value for the formation of the CuI-superoxoquinone complex,
produced by O2 attack on the phenolate ring of the CuII complex (51 kcal/mol for the L1
complex and 80 kcal/mol for the L3 complex).1239 These large ΔG values reflect the
energies of the phenolate to CuII CT transitions, which reduce CuII to CuI (L1 14,730 cm−1
= 42 kcal/mol, L3 27,850 cm−1 = 80 kcal/mol), and the reaction of the resultant phenoxyl
radical with O2. Therefore, additional studies are necessary to understand the ability of the
CuII site in preprocessed AO to catalyze a reaction between tyrosine and O2.
4.2.5 Molecular Mechanism—A mechanism for TPQ biogenesis in AO has been
proposed based on the kinetic work of Klinman et al.1185 and the X-ray crystallography of
Kim et al.1195 (Figure 224). Starting with the preprocessed site (1), O2 binds in a pocket in
the protein (2) triggering a conformational change that causes the precursor Tyr to bind to
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CuII (3A). This CuII-tyrosinate complex is thought to have some tyrosyl radical character
(3B), so O2 can react with the ring to form a CuII-coordinated peroxoquinone (4). O-O bond
cleavage of this intermediate is promoted by Tyr305, and yields the crystallographically
observed DPQ intermediate (5). Hydrolysis of DPQ is promoted by the CuII site (6),
yielding the reduced form of the TPQ cofactor (7) which can react directly with O2 to
generate fully oxidized TPQ (8).
Key steps of this mechanism have been evaluated by DFT calculations and studies of model
complexes. Prabhakar and Siegbahn have calculated the reaction coordinate for this
proposed mechanism, starting from the CuII-tyrosinate complex formed after O2 binding to
the protein.1187 The complex has a spin population of 0.7 on the tyrosinate ring and only 0.3
on Cu, which suggests dominant tyrosyl radical character. O2 reaction at CuI in this species,
forming a CuII-superoxide-tyrosyl radical complex, has a ΔG of 6.0 kcal/mol (including a
loss of entropy upon binding O2 worth 8.4 kcal/mol), which is 11.7 kcal/mol more favorable
than direct reaction with the tyrosyl radical to form the CuI-superoxoquinone (transition
states and barriers for this step were not reported). The barriers calculated for the succeeding
steps are 8.4 kcal/mol for formation of the CuII-coordinated peroxoquinone, 11.4 kcal/mol
for O-O bond cleavage, 16.0 kcal/mol for the hydration of DPQ, 12.6 kcal/mol for
aromatization of hydrated DPQ to form TPQred, and 2.1 kcal/mol for oxidation of TPQred to
TPQox by O2. According to these results, hydration of DPQ should be the rate-limiting step,
but Prabhakar and Siegbahn argue that the barrier for this step is overestimated because the
step as calculated did not involve direct attack by the CuII-coordinated hydroxide on the
DPQ ring, but instead a long range proton transfer through a chain of water molecules to
form free hydroxide that attacks the C5 carbon of DPQ and B3LYP does not accurately
calculate the barriers of long-range proton transfer reactions. Instead, it is argued that the
first two steps calculated should be considered as a unit, making binding of O2 to Cu and
attack by the superoxide product at the C5 carbon of the tyrosyl radical the rate limiting step
with a barrier of 6+8.4 = 14.4 kcal/mol. Overall, the TPQ biogenesis reaction is calculated to
be exothermic by 69 kcal/mol.1187 These calculations indicate that the key intermediate in
the TPQ biogenesis reaction having an absorption band at 350 nm should have significant
Tyr radical character and that reaction of O2 with this species should occur at the CuI rather
than directly with the tyrosyl ring.
The calculations by Prabhakar and Siegbahn contrast recent calculations by Ghosh et al.
inspired by [CuIIL(OPhen)]+ complexes which model the CuII(His)3(Tyr) structure proposed
for the 350 nm intermediate.1239 These calculations show only a small amount of radical
character on the phenolate ring (14%-9% spin density) relative to 70% in the calculations of
Prabhakar and Siegbahn. This is not due to large differences in the structures of the models
relative to the protein active site, but instead reflects the difference in the choice of
functional (BP86 with 38% HF exchange for Ghosh et al. and B3LYP for Prabhakar and
Siegbahn). The smaller amount of HF exchange in B3LYP (20%) is known to result in more
spin density on the ligands of metal complexes, and this effect on the spin densities has in
fact been observed in calculations on the L1 and L3 model complexes using B3LYP.1239 In
Ghosh et al., a comparison of different functionals in the model systems was made and BP86
with 38% HF was selected as the functional that best reproduces the electronic structural
parameters determined from spectroscopy, therefore giving the best description of these
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systems. In addition to the spin density differences, the ΔG for O2 attack on the phenolate
ring to form a non-coordinating CuI-superoxoquinone species calculated by Ghosh et al. is
at least 50 kcal/mol (depending on the phenolate ring orientation) compared to 17.7 kcal/mol
for Prabhakar and Siegbahn. This large energy difference may be due to the spin density
differences, to the differences in functional, or to other methodology differences. These
differences between the two sets of calculations result in significantly different mechanistic
conclusions in the two studies. While Prabhakar and Siegbahn favor formation of a CuII-
superoxo as the initial reaction of the preprocessed site with O2 (ΔG = 6 kcal/mol),1187
Ghosh et al. favour a concerted attack of O2 on both the Cu and C5 of the phenolate ring to
form a coordinated CuII-peroxoquinone (ΔG = 11kcal/mol, see Section 4.3).1239 Ultimately,
a comparison of the electronic structures from calculations with the spectroscopy of the
preprocessed active site is necessary to calibrate the calculation methodology before
accurate mechanistic conclusions can be drawn about the nature of substrate activation by
the CuII site.
The step in which DPQ is hydrated to form TPQred (6→7 in Figure 224) is proposed to be
copper-catalyzed because hydration of o-quinones does not occur via general base catalysis
in aqueous solution. To demonstrate that CuII can catalyze this step, model complexes have
been studied by Ling et al. which have a MII site with a tethered catechol group that can be
oxidized in situ to a DPQ-like functionality.1240 When MII is CuII, CoII, NiII or ZnII these
complexes undergo a subsequent hydration to form a TPQ-like hydroxyquinone product
(after further oxidation by periodate), albeit with an order of magnitude slower rates for NiII
and ZnII compared to CuII. The rate-limiting step is proposed to be attack of a metal-
coordinated hydroxide on the substrate quinone.
Attempts to chemically trap the DPQ intermediate in TPQ biogenesis by the mutation of the
adjacent Asp residue to Lys (D298K) result in the formation of a cofactor identified by
absorption, resonance Raman, and X-ray crystallography to be a tautomer of the LTQ
cofactor observed in lysyl oxidase (LOX).1233 Stabilization of the iminoquinol tautomer of
LTQ (Figure 224, 10) over the aminoquinone form (Figure 224, 9) is influenced by
hydrogen bonding from another second sphere residue, Y284, and so some of the second
sphere residues in LOX must also play a role in the stabilization of the active form of the
cofactor. These results establish a mechanistic proposal for LTQ biogenesis, where the early
steps of the cofactor biogenesis reaction (CuII substrate activation, O2 attack to form a CuII-
peroxoquinone and O-O bond cleavage to form DPQ) are the same in both TPQ and LTQ
biogenesis and the only difference is what nucleophile adds to the DPQ intermediate – CuII-
coordinated hydroxide (TPQ) or a Lys residue (LTQ biogenesis pathway, Figure 224).
4.3 The Nature of CuII Substrate Activation
The proposed mechanisms for 2,4-dioxygenation in 2,4-QD and TPQ biogenesis in AO
involve a common description of the nature of CuII substrate activation. Both mechanisms
invoke a step in which CuII-coordinated substrate transfers an electron to CuII, forming a
CuI-substrate radical species. Three descriptions of this step have been put forward which
attempt to invoke the presence of a substrate radical even though reduction of the CuII site
upon substrate binding is not observed: 1) The CuI-substrate radical is in equilibrium with
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the CuII-substrate site, via an intramolecular electron transfer, but the equilibrium is shifted
far to the left (as per Steiner et al.1124); 2) The reaction is performed by a substrate→Cu CT
excited state of the CuII-substrate complex (as per Seigbahn1126); 3) The ground state of the
CuII-substrate complex contains radical character which makes the substrate reactive
towards O2 (often written as a resonance hybrid of CuI-substrate radical with CuII-substrate
complex1185). It is an open issue as to whether any of these descriptions for the activation of
substrate as a radical is correct and there is evidence against each, primarily from the AO
cofactor biogenesis reaction. In the case of the equilibrium description (1), addition of
reagents that react with radicals or CuI (such as NO) might be expected to trap the substrate
radical by driving the equilibrium, but no substrate radical has been observed in these
systems by chemical trapping.1184 In the case of the excited state reactivity description (2),
the LMCT energy is included in the activation barrier for the O2 attack step. The lowest
energy determined for phenolate-CuII LMCT in a model complex, with a similar geometry
to the active site of preprocessed AO, is 14,727 cm−1 (41 kcal/mol), which is significantly
higher than the measured ΔH‡ for TPQ biogenesis (8.4 kcal/mol).1239 In the case of the
ground state radical character description (3), only a small amount of radical character is
observed on the rings of CuII-phenolate model complexes.1239 In addition, significant
radical character would be expected to yield observable spectral effects. While there may be
some evidence for this third description, given the pyramidalization of the C2 carbon of
quercetin in the ES complex of quercetinase observed by X-ray crystallography,1124 even in
this ES complex of 2,4-QD no reduction of CuII to CuI or CuI-radical species is observed by
EPR and XAS.1121,1122
Given the lack of evidence for the CuI-substrate radical required by current proposals,
alternative proposals for the nature of substrate activation by CuII coordination should be
explored. Calculations inspired by the CuII-phenolate model complexes have shown that
while direct attack by O2 on the phenolate ring at C2 has a high barrier (ΔG = 51 kcal/mol),
concerted attack on both the phenolate C2 and CuII to form a coordinated peroxoquinone has
a much lower barrier (ΔG = 11 kcal/mol).1239 In this concerted process, triplet O2
approaches the site oriented to bind bridging the CuII and the phenolate with an
antiferromagnetic alignment of the spins as in Figure 225 right and α spins from both the
phenolate HOMO and the Cu are transferred to the απ orbitals of O2. This is facilitated by
the fact that one O2 π* orbital has σ overlap with the HOMO of the phenolate (Figure 225A)
and the other O2 π* orbital has π overlap with the half occupied CuII dx2-y2 orbital (Figure
225B). The transfer of two α electrons to O2 occurs concertedly with the LMCT of an
electron with β spin from the phenolate HOMO to CuII to maintain the electron density on
CuII, effectively flipping the unpaired spin on CuII (Figure 225C). Thus the CuII acts as a
spin buffer that overcomes the spin-forbiddenness of the reaction without reduction of CuII
or the need to invoke a phenoxyl radical-CuI intermediate. This may be an attractive
alternative to the current mechanistic proposals. Another possibility is that the resting CuII-
OH could perform hydrogen atom abstraction from the Tyr, generating a tyrosyl radical that
can react with O2. However, this mechanism would also involve a tyrosyl radical
intermediate, which has not been observed. Further attempts to obtain evidence for a
substrate radical in the course of a CuII substrate activation reaction and extension of the
concerted CT spin-buffering proposal in Figure 225 to cofactor biogenesis in AO and the
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mechanism of quercetinase are required to understand the nature of CuII-substrate activation
for the spin forbidden reaction of singlet organic substrates with triplet O2.
5.0 Copper Sites in Bacterial Denitrification
Thus far this review has focused on copper containing enzymes that exclusively use
molecular O2 as the oxidant for performing redox chemistry. There are other important
biochemical pathways involving copper enzymes that do not use O2 or its other redox states
(such as peroxide) as oxidants. One such pathway is the global nitrogen cycle, which
involves a number of important and unique metalloenzymes that perform redox chemistry
on dinitrogen, ammonia, and nitrogen oxides (Figure 226).1241 Nitrogen fixation (N2
reduction to NH3) is catalyzed by nitrogenase, a binary protein system that involves an iron-
sulfur cluster containing reductase and an enzyme containing two large clusters, the [Fe8S7]
P-cluster implicated in electron transfer and the catalytic [MoFe7S9-Chomocitrate] FeMoco
cluster. The Mo in this cluster can be substituted by V and Fe in other homologues of the
nitrogenase enzyme. The six electron reductive process of ammonification (NO2− reduction
to NH3) involves a multiheme enzyme known as cytochrome c nitrite reductase.1242
Alternatively, denitrification, the multi-step reductive pathway that completes the nitrogen
cycle by reducing nitrogen oxides back to gaseous dinitrogen (Figure 226), involves four
interesting metalloenzymes, two of which contain copper.1243 The two electron reduction of
nitrate to nitrite is performed by a molybdopterin enzyme which can also contain an iron-
sulfur cluster (for membrane-bound nitrate reductases) or heme site(s). The one electron
reduction of nitrite to nitric oxide, the first dedicated step of denitrification, can be
performed by two alternative nitrite reductases: a copper containing metalloenzyme with a
type 1 (blue) copper electron transfer site and a type 2 (or normal) copper active site
(CuNiR) and a heme cd1 metalloenzyme (heme NiR). Denitrifying organisms express
exclusively either CuNiR or heme NiR depending on whether nitrite reduction is required
under aerobic conditions (heme NiR is less sensitive to O2 than CuNiR). Nitric oxide
reduction, which involves the two electron reductive coupling of two equivalents of nitric
oxide to form nitrous oxide, is performed by an enzyme that contains a unique heme/non-
heme iron binuclear active site closely structurally related to the active site in the heme-
copper oxidases (but without the Tyr crosslink, see Section 3.7.2). Finally, the terminal step
in denitrification, a two electron reduction which converts nitrous oxide to dinitrogen and
water, is performed by nitrous oxide reductase, which contains two copper sites, a binuclear
CuA electron transfer site and a tetranuclear copper sulfide cluster called CuZ.1243
Organisms are considered to be denitrifiers if they convert nitrogen oxides to a gaseous
product.1244 Not all denitrifying organisms possess the complete denitrification pathway and
some terminate denitrification by releasing gaseous nitrous oxide instead of dinitrogen.
These organisms lack the gene cluster responsible for nitrous oxide reductase
expression.1244 Denitrification can serve a number of cellular functions, including
detoxification of nitrogen oxides, particularly nitrite, and redox balancing (taking up excess
reducing equivalents when O2 and CO2 are not available).1245 However, the main purpose
of denitrification in most bacterial denitrifiers is respiration, the use of nitrogen oxides as the
terminal electron acceptors for the cell to concerve energy for growth in environments with
little or no oxygen, like the soil or deep ocean. The reductive steps of denitrification occur in
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the periplasm of denitrifying bacteria and electron transport across the cytoplasmic
membrane by the obligatory upstream source of electrons for all the denitrification enzymes,
the cytochrome bc1 complex, translocates protons across the membrane and establishes the
electrochemical gradient necessary to drive ATP synthesis.1245 This method of establishing
a proton gradient is less efficient than O2 respiration using cytochrome c oxidase so
denitrifying organisms have regulatory mechanisms to switch over to O2 respiration when
O2 is available. Several enzymes in denitrification, including copper nitrite reductase and
nitrous oxide reductase, are thought to be deactivated by O2.1244
In this review we will provide a brief summary of the chemistry of copper nitrite reductase
(Section 5.1) and focus in more detail on nitrous oxide reductase because of its unique
tetranuclear copper active site, unprecedented in either copper biochemistry or in synthetic
copper-sulfur chemistry, and the number of remaining questions about how this site reduces
N2O (Section 5.2).
5.1 Copper Nitrite Reductase
Copper nitrite reductase (CuNiR) performs the one electron reduction of nitrite to nitric
oxide and water (with uptake of two protons). The enzyme contains two mononuclear
copper sites, a type 1 (T1) or blue Cu site involved in electron transfer and a type 2 (T2) or
normal copper site where substrate binding and reduction occurs. Three states of CuNiR -
the resting state (both oxidized and reduced), the oxidized nitrite-bound state, and an NO
bound state - are structurally and spectroscopically well characterized and a large number of
X-ray crystal structures, including atomic resolution structures,1246 are available for all three
states. In each of these states, the coordination of the T1 site is not perturbed and differences
are due to ligand binding at the T2 site. While the physiological function of CuNiR is the
reduction of nitrite to NO, CuNiR also catalyzes the reverse reaction, converting NO to
nitrite.1247 The equilibrium constant for the conversion of nitrite to NO by CuNiR is pH
dependent and nitrite reduction is thermodynamically favoured (i.e. Keq > 1) below pH 6.2
(pH 6.2 is also the optimum pH for nitrite reduction in steady-state kinetics studies). In
addition, in the presence of excess NO, reduced CuNiR can catalyze the reductive coupling
of two NO molecules to form N2O.1248 While this coupling reaction is unlikely to be
relevant in vivo, it has been observed to complicate in vitro attempts to characterize a
product bound T2 Cu-NO complex obtained by treating reduced CuNiR with excess NO
(vide infra).
CuNiR is a homotrimer where each monomer contains a T1 and T2 copper site separated by
12.5 Å distance (one hexameric variant is known).1249 The T1 site is ligated by His95,
His145, Cys136, and Met150 (Figure 227). The T2 copper site is located at the interface
between the monomers and is ligated by three His ligands (Figure 227). Two His residues of
the T2 site come from one monomer (His100 and His135) and the third from another
monomer (His307), indicating that the trimer structure is necessary for function. Cys136, a
ligand of the T1 site, is adjacent to His135, a ligand of the T2 site, forming a Cys-His
pathway for rapid through-bond electron transfer as also present in the MCOs (Section
3.7.1). In the oxidized resting state of CuNiR, the T2 site is additionally coordinated by a
solvent derived ligand and has a tetrahedral geometry (Figure 228A).1249 When the resting
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state of CuNiR is reduced, this solvent derived ligand is lost while the remainder of the
coordination environment of the T2 site is not perturbed.1250 In the oxidized resting state,
the solvent-derived ligand is hydrogen bonded to a second sphere residue Asp98 which
additionally hydrogen bonds through a localized water molecule to another second sphere
residue, His255.1250,1251 These two residues have been identified by mutagenesis studies as
essential for enzyme activity.1252 They have also been implicated in the pH profile of the
activity of CuNiR, which has a maximum at pH 6.2 and decreases at low pH with a pKa of 5
(assigned as the pKa of Asp98) and at high pH with a pKa of 7 (assigned as the pKa of
His255).1253 Study of the pH dependence of the nitrite bound form of the T2 site has shown
that the pKa of Asp98 is 6.4 when nitrite is coordinated (vide infra).1254 Mutation of a
nearby hydrophobic residue, Ile289, decreases the rate of catalysis but does not totally
eliminate nitrite reduction.1253 The redox potentials of the T1 and T2 sites have been
measured in resting Alcaligenes xylosoxidans NiR as 255±3 mV and 244±18 mV,
respectively, at pH 7.1255 The redox potential of the T2 site decreases to 137 mV at pH 8.4
(from 218 mV in NiR from Rhodobacter sphaeroides), turning off electron transfer between
the T1 and the T2 sites at high pH, when Asp98 is deprotonated.1256 Additionally, site-
directed mutagenesis has been used to create a variant of CuNiR in which electron transfer
from the T1 to the T2 site is disrupted by mutation of one of the His ligands of the T1 site to
alanine (H145A), resulting in a high potential T1 site that remains permanently reduced.1257
Thus, three strategies are available for studying nitrite binding to the T2 site without T1 to
T2 electron transfer, which would lead to reduction of nitrite: 1) nitrite binding to fully
oxidized CuNiR (where the T1 site is oxidized), 2) nitrite binding to CuNiR at high pH (pH
> 8.4), where the T1 site can be selectively reduced, and 3) nitrite binding to the T2 site in
the H145A variant, which contains a permanently reduced T1 site.
Almost all of the structural studies of the nitrite bound state of CuNiR have employed the
first of these strategies: nitrite addition to fully oxidized resting CuNiR. A large number of
available crystal structures show that nitrite binds to the oxidized T2 site, displacing the
solvent derived ligand observed in resting and coordinating as a bidentate ligand with both
oxygens bonding to Cu (Figure 228B).1246 Nitrite is asymmetrically bound to the T2 site,
with the Cu-O bond closer to Asp98 being shorter by 0.2–0.6 Å (Table 41).
There is a hydrogen bond between Asp98 and the closer oxygen of nitrite (O-O distance of
2.8–3.4 Å). There is also some degree of variability in the orientation of the nitrite ligand
relative to the T2 copper (variable Cu-N distance, Table 41). In the one known crystal
structure where nitrite is added to a crystal of reduced NiR, the coordination geometry of
nitrite bound at the reduced T2 site does not differ substantially from the coordination
observed to the oxidized T2 site, except that the Cu-O bond lengths are slightly longer (by
0.05 Å and 0.27 Å, Table 41).1250 Mutanted variants of CuNiR where the second sphere
residues His255 or Ile257 are perturbed show a monodentate coordination geometry for
nitrite, which coordinates to the T2 site through one oxygen atom.1264 Spectroscopic
characterization of the nitrite-bound state of wild-type CuNiR has been performed at both
low pH with the T1 site oxidized and at high pH with the T1 site either oxidized or
reduced.1254 EPR spectroscopy of nitrite bound T2 site at pH 8.4 with the T1 site either
oxidized (Figure 229B) or reduced (Figure 229C) shows that nitrite binding is not perturbed
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by the redox state of the T1 site. However, a significant change in the nitrite-bound T2 site is
observed upon comparing EPR spectra at pH 8.4 and pH 5.5 (Figure 229B and Figure 229A,
respectively). Thus, the low pH form of the nitrite bound T2 site, which is the species
present at the pH of maximum enzyme activity, has one more proton than the high pH form.
DFT calculations have been used to evaluate models for both the high pH and low pH
nitrite-bound T2 sites to identify where these protons reside in the active site.1254 These
calculations favor a model where at high pH His255 is protonated and Asp98 deprotonated
while at low pH, both His255 and Asp98 are protonated, with a hydrogen bond between
Asp98 and the coordinated nitrite. Thus, protonation of Asp98 triggers electron transfer
from the T1 to the nitrite-bound T2 site. Further, when the T1 reduced, nitrite-bound
oxidized T2 state at pH 8.4 is rapidly lowered to pH 5.6 (a pH drop experiment), NO is
evolved and the absorption spectrum shows that the T1 site is rapidly oxidized.1254 This
indicates that protonation of Aps98 upon going from high pH to low pH triggers electron
transfer from the T1 to the nitrite-bound T2 site, resulting in turnover.
The structure of CuNiR complexed with the product of nitrite reduction, NO, was first
reported by Tocheva et al. in 2004 from crystals of reduced CuNiR that had been exposed to
excess exogenous NO.1260 There are several unusual features of this structure. First, the NO
molecule is bound side-on to the T2 copper site (Figure 228C). Second, the EPR spectrum
reported after identical NO addition to reduced CuNiR in solution shows an oxidized T2
copper signal with a nine line pattern in the g⊥ region due to superhyperfine coupling with
four nitrogen donor ligands (Figure 230A). A further study by Tocheva et al. shows that this
side-on NO species with a putative CuII EPR spectrum is observed when starting from both
wild-type CuNiR and the reduced and oxidized forms of the H136A variants (in which T1 to
T2 ET does not occur).1265 This leads to an initial assignment of the CuNiR NO complex as
a side-on CuII-NO− species,1260 different in both geometric and electronic structure from all
known mononuclear Cu-NO complexes, which are end-on coordinated and have CuI-NO•
radical EPR spectra. Subsequent spectroscopic investigations of this putative CuII-NO−
species in wild type CuNiR by EPR, MCD, and 14N and 1H ENDOR show that in fact the
CuII species observed in solution is identical to the nitrite-bound oxidized T2 site (with the
T1 site reduced, Figure 230B).1248 At short times after NO addition to reduced CuNiR in
solution, a CuI-NO• species is observed by EPR (Figure 230C), which subsequently converts
to the nitrite-bound resting form of CuNiR. In wild-type CuNiR, this occurs via reductive
coupling of two equivalents of NO forming N2O, which was detected directly by an assay
using nitrous oxide reductase.1248 This process oxidizes the T1 and T2 sites and
subsequently the reverse reaction of CuNiR proceeds, oxidizing NO to NO2−. This generates
the observed nitrite-bound oxidized T2 site and a reduced T1 site. How this proceeds in
CuNiR variants where T1 to T2 ET is affected has not been described, however identical
CuII EPR spectra are observed in these variants as in wild type,1265 so formation of the
nitrite-bound T2 site is likely the process that also occurs in solution. Thus, the NO adduct
of CuNiR that forms in solution has a CuI- NO• electronic structure, not the CuII-NO−
electronic structure that was initially proposed. This CuI-NO• species can also be observed
upon nitrite reduction by CuNiR and has been characterized by EPR and ENDOR.1266
Analysis of the orientations of the g- and A-tensors obtained from the EPR indicate that the
NO ligand is bound end-on with a ~160° Cu-N-O angle. 1H coupling features are observed
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in the ENDOR spectrum that arise from a magnetic interaction with the Cδ1 protons of the
sidechain of Ile289, indicating that the end-on NO molecule is oriented towards Ile289 in the
active site. These studies reveal an intriguing difference between how NO interacts with
CuNiR in solution versus in crystals. In solution an end-on bound CuI-NO• species is formed
that further reacts, eventually forming the nitrite bound oxidized T2 site, while in crystals a
side-on NO bound T2 site is stable. Several computational studies have been undertaken to
determine the interactions responsible for the stability of the side-on NO binding geometry
observed in CuNiR crystals and all show that the end-on structure is energetically favoured
by 3–10 kcal/mol. Recent calculations by Merkle and Lehnert which include the second
sphere residues Asp98 and Ile289 show that the side-on bound geometry is a local minimum
while the end-on geometry is the global minimum, with a small barrier of 1.0 kcal/mol
required for conversion from the side-on to the end-on structure.1267 Interactions that
contribute to stabilizing the side-on coordination geometry include hydrogen bonding from
Asp98, which is 1–2 kcal/mol stronger in the side-on case, and steric constraints from
Ile289, which restricts the geometry of the end-on NO complex. Thus, the side-on
coordination of the CuNiR NO complex observed in crystals may represent a metastable
form that relaxes to end-on coordination in solution when the positions of the sidechains of
Ile289 and Asp98 are more flexible.
A consensus mechanism for the reduction of nitrite by CuNiR is presented in Figure 231.
The first two steps of the mechanism are binding of NO2− to the T2 site and electron transfer
from the T1 to the T2 site (proudcing the T2 CuI Site). Whether these two steps are ordered
or if a random-sequential mechanism operates has been a matter of long debate in the
literature. However, both a recent single-molecule study1268 and a steady-state kinetics
study considering the substrate dependence of turnover support a random-sequential
mechanism,1269 where either ET or substrate binding could occur as the first step (Figure
231, pathways A and B) and this view has become generally accepted. When both nitrite
binding and T1 to T2 ET have occurred, the mechanism converges at a T2 reduced nitrite
bound intermediate. This is the active intermediate for N-O bond cleavage, which occurs via
transfer of a proton from Asp98 and oxidation of the T2 site, resulting in NO formation.
Computational studies of this step by Ghosh et al. suggest that the lowest energy pathway
involves first protonation of the bound nitrite followed by electron transfer to break the N-O
bond.1254 Computational investigations of three possible geometries for the CuI intermediate
with a protonated nitrite ligand (bidentate η2, monodentate η1κN, and monodentate
η1κO(H)) show that N-O bond cleavage only has a low barrier when the protonated nitrite is
a bidentate ligand, similar to the crystallographically observed geometry for nitrite binding
to the oxidized T2 site (Figure 230A). In this geometry, the reaction proceeds by direct
release of NO with a calculated ΔE‡ of 16 kcal/mol, which agrees well with the
experimental activation energy of 15 kcal/mol for nitrite reduction.1253 Thus the role of the
experimentally observed NO bound species in the catalytic reactivity of NiR remains to be
resolved. Possible roles of this species include as a product-inhibited form of the enzyme or
as an intermediate not in nitrite reduction but in the reductive coupling reaction catalyzed by
NiR in the presence of excess NO.
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5.2 Nitrous oxide reductase
5.2.1 Enzymology—Nitrous oxide reductase (N2OR) is the terminal enzyme of bacterial
denitrification and reduces N2O by two electrons, breaking the N-O bond to release N2 and
H2O. This reaction is exergonic by 81 kcal/mol1244 but has an activation barrier of 59
kcal/mol in the gas phase.1270 N2O release into the atmosphere is an environmental concern,
since N2O is the primary source of NOx in the stratosphere, leading to ozone depletion,1271
and is a greenhouse gas with 300 times the global warming potential of CO2.1272
Agricultural use of nitrogen based fertilizers is the primary source of anthropogenic N2O
emissions, as both nitrifying and denitrifying soil bacteria that lack a N2OR can generate
N2O from these chemicals.1273 N2O is also released as a byproduct of industrial processes
(particularly the production of adipic and nitric acids), by the combustion of biomass and
fossil fuels, and from wastewater treatment.1271 Combined, anthropogenic sources of N2O
account for 40% of all N2O emissions.1274 Capture and destruction of N2O through
chemical catalysis is a possible strategy for mitigating the effects of N2O on the ozone layer
and the global climate.1271,1273
The requirement of copper for nitrous oxide reduction in denitrifying bacteria was identified
in 1980 when it was shown that copper is essential for growth of the denitrifier Alcaligenes
faecalis under an N2O atmosphere, where N2O respiration is the sole source of energy for
growth.1275 This was later confirmed when it was shown that in the absence of copper, N2O
is the terminal product of nitrate-induced denitrification in Pseudomonas stutzeri.1276 The
role of copper as a cofactor in nitrous oxide reductase was identified when a previously
isolated copper protein from Pseudomonas stutzeri was shown to reduce N2O in vitro with
reduced methyl viologen as the electron source.1277 Since this discovery, N2OR had been
purified and biochemically characterized from 11 denitrifying bacteria: Pseudomonas
stutzeri (PsN2OR),1278 Rhodopseudomonas sphaeroides f.sp. denitrificans,1279 Paracoccus
denitrificans (PdN2OR),1280 Wolinella succinogenes (WsN2OR),1281 Achromobacter
cycloclastes (AcN2OR),1282 Pseudomonas aeruginosa,1283 Paracoccus pantotrophus
(PpN2OR),1284 Thiobacillus denitrificans (TdN2OR),1285 Alcaligenes xylosoxidans,1286,
Hyphomicrobium denitrificans,1287 and Pseudomonas nautica (PnN2OR, later reclassified
as Marinobacter hydrocarbonoclasticus).1288 A further 66 denitrifying prokaryotes have
thus far been identified through genomic analysis to contain the NosZ gene associated with
N2OR.1244
N2ORs are homodimers with molecular weights of 120–160 kDa, a copper content of ~12
Cu per dimer, and a sulfide content of ~2 S2− per dimer (Table 42).1289
N2OR contains two copper sites: CuA, a binuclear copper site with two Cys, two His, one
Met and the backbone carbonyl of a Trp residue as ligands, which acts as an electron
transfer site (as in the heme-copper oxidases, see Section 3.7.2), and CuZ, a tetranuclear µ4-
sulfide bridged cluster liganded by seven His residues, which is thought to be the site of
N2O binding and reduction (see Section 5.2.3).1292 The ligands of the CuA site were
identified from mutagenesis studies and its structure was determined by analogy to the
structurally characterized CuA site in the heme-copper oxidases, which has close to identical
properties to CuA in N2OR.58,1293,1294 In contrast, the structure of CuZ was determined by
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X-ray crystallography and is still a matter of active study (vide infra and discussion in
Section 5.2.3). The residues binding the CuA and CuZ sites are strictly conserved in all the
N2ORs, showing that the copper sites are present even in N2ORs which have not been
structurally or spectroscopically characterized.1244 There is a high degree of similarity
between N2ORs isolated from different sources (Table 42). The sequence similarity of all
purified N2ORs with PsN2OR is greater than 70%, with the noted exceptions of TdN2OR
and WsN2OR. TdN2OR is a membrane bound protein,1285 while other N2ORs are
periplasmic, and WsN2OR contains an additional domain with a heme cofactor,1281 which
accounts for the sequence differences. Despite the high sequence similarity between N2ORs,
AcN2OR and RsN2OR were initially reported to be monomeric based on gel filtration
results that did not show a band for the native dimer.1279,1282 However, in view of the
conclusion drawn from X-ray crystallography that the dimerization is necessary for function
(see Section 5.2.3), and a subsequent crystal structure showing that AcN2OR is in fact a
dimer,1295 it is likely that both AcN2OR and RsN2OR are dimers. In fact, the largest
biochemical difference between N2ORs from different sources is the large variability in their
analytical copper content, which can vary significantly between sources and for the same
source organism, depending on the protein purification conditions (vide infra). The initial
purifications of N2OR reported a low copper content of 8 Cu per dimer1278,1280 compared to
more recent results of ~10 Cu per dimer, but even these recent analytical results do not show
full copper loading (12 Cu per dimer, based on X-ray crystallography).1288,1289 This is
attributed to incomplete loading of CuZ in vivo or to loss of some CuZ during the protein
purification. Analytical sulfide quantitation in N2OR does not show the same variability,
although a sulfide concentration assay that is not susceptible to sulfide oxidation and using
the copper content to account for CuZ occupancy is required to accurately determine the
sulfide count per CuZ site.1289,1296
A gene cluster has been identified that is required for N2O reduction, which encodes the
N2OR protein and several ancillary proteins required for its expression, maturation, and
maintenance.1297,1298 The core of this cluster, which is the minimum required for N2O
reduction, contains six genes (NosRZDFYL) and is sometimes associated with a further
gene, NosX.1299 It is also associated with the Tat transporter system, which is responsible
for transporting the N2OR apo-protein into the periplasm, where the maturation of N2OR is
completed.1300 Preliminary investigations have described the characteristics and putative
functions of the protein products of the Nos gene cluster. The NosZ gene encodes the N2OR
apo protein.1301 In mutant strains that lack the NosDFY or NosL proteins or contain a
modified form of the NosR protein, the biogenesis of the CuA site is unaffected.1244 CuA
can be reconstituted in N2OR by exogenous copper in vitro while CuZ cannot be
reconstituted,1278 underlining the importance of a chaperone assisted biogenesis mechanism
for CuZ but not for CuA. CuA is thought to be loaded in vivo by the same route used for the
loading of CuA in the hemecopper oxidases, by transfer of CuI from a ubiquitous copper
chaperone.1244 The ancillary genes of the Nos gene cluster are therefore associated with the
biogenesis of the CuZ site and its maintenance in vivo or with regulation of NosZ
expression. NosDFY encodes an ABC type transporter where NosY is a membrane-
spanning protein, NosF is a cytoplasmic ATPase, and NosD is a periplasmic protein from
the carbohydrate binding and sugar hydrolase protein family.1298 Mutant strains lacking
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NosDFY express CuZ deficient N2OR, indicating that NosDFY is essential for CuZ
biogenesis.1299,1302 The exact role of this transporter system is not known, but it is proposed
to be the sulfur transporter that supplies the sulfide required for CuZ biogenesis.1244 NosL
encodes a lipoprotein which preferentially binds a single CuI and is thought to be the copper
transporter associated with CuZ assembly.1303,1304 However, active N2OR containing both
copper sites can be obtained in the absence of NosL, so an alternative Cu chaperone must
exist and NosL is not essential.1303 NosR encodes a transmembrane protein that contains a
flavin binding site in the N-terminal (periplasmic) domain and two [4Fe-4S] ferrodoxintype
iron-sulfur clusters in the C-terminal (cytoplasmic) domain.1305 In the absence of NosR, the
NosZ protein is not expressed, indicating that NosR has a regulatory role. However, in the
presence of modified forms of NosR where the flavin binding domain is deleted or the
ferrodoxin sites are modified, N2OR is obtained that contains both CuA and CuZ, but the
spectroscopic and redox properties of CuZ are modified (vide infra).1305 A similar
phenotype is obtained in the absence of the NosX gene product for organisms that contain
NosX, which codes for another periplasmic flavoprotein.1306 This suggests that NosR and
NosX are not involved in CuZ biogenesis but play a role altering the state of the CuZ site
during turnover and sustaining the catalytic activity of N2OR. If NosR and NosX are in fact
required to sustain N2O reduction in vivo, further study of the process of CuZ biogenesis and
maintenance will be necessary to define the full catalytic mechanism of N2OR.
Both whole cell and in vitro studies have been used to discover the identity of the
physiological electron donor to N2OR, not least so that its reactivity can be studied with the
native electron donor rather than with a non-physiological reductant. Whole cell studies in a
variety of bacteria confirm that a periplasmic cytochrome c is oxidized with the initialization
of N2O reduction.1307 In some cases the specific cytochrome c that is the physiological
electron donor has been identified. Strains that knock out particular cytochrome c proteins in
vivo have been used to identify cytochrome c2 as the electron donor to N2OR in R.
capsulatus.1308 In vitro reactivity studies have identified the endogenous electron donor of
PnN2OR as cytochrome c551 1309 and that of PpN2OR as cytochrome c552.1310 However,
PpN2OR,1310 AcN2OR,1291 and WsN2OR1311 will also turn over in vitro with mammalian
cytochrome c as the electron donor and PpN2OR1284 and AcN2OR1312 will also accept
electrons from pseudoazurin.1312 In contrast, PnN2OR is only reactive with the native
cytochrome c from P. nautica.1309 The interaction between cytochrome c and N2OR has
been studied using molecular dynamics docking simulations.1313,1314 These show
cytochrome c binding to a hydrophobic portion of the surface of N2OR near the CuA site,
with a 10–14 Å distance between the heme and CuA.
An interesting issue is that N2OR is observed to have different spectroscopic features, redox
properties, and reactivity depending on whether it is purified aerobically or
anaerobically.1278,1290,1315 In the absence of the NosR and NosX proteins accessory
proteins, N2OR purified under anaerobic conditions has identical characteristics to
aerobically purified protein.1305,1306 These differences take on new significance with the
recent publication of a crystal structure of anaerobically prepared PsN2OR which shows a
different structure for the CuZ site than that observed for aerobically prepared protein (see
Section 5.2.3).1296 Early biochemical studies and the recent X-ray structure agree that
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aerobically and anaerobically purified N2OR have identical molecular weights and protein
structure.1278,1296 Instead the observed differences result from changes in the CuZ site.
While most N2ORs have only been purified under one set of conditions, three different
studies have performed parallel anaerobic and aerobic purifications.1278,1290,1291 These
show that there is a lower copper content in aerobically isolated protein (first three
preparations in Table 42). This is attributed to sensitivity of the CuZ site towards O2, leading
to a loss of CuZ upon aerobic handling, which accounts for some differences in the relative
reactivity and spectral features of aerobically and anaerobically prepared N2OR (see
Sections 5.2.2 and 5.2.4).1291,1316 However, the majority of the differences cannot be
explained only by changing relative occupancies of the CuA and CuZ sites. The CuZ site is
also isolated in a different redox state depending on the purification conditions.1290 The
CuII3CuI (1-hole) redox state is the resting state of the CuZ site obtained from aerobic
purifications and the 2CuII2CuI (2-hole) redox state is obtained from anaerobic purifications
(the assignment of these redox states will be discussed in Section 5.2.4). Further, the CuZ
site has different redox properties in anaerobically and aerobically prepared N2OR. For
anaerobically prepared N2OR, a reversible redox couple between the 2-hole and 1-hole
states of the CuZ site can be observed with E’ = +60 mV versus NHE in addition to the
CuAox (Cu1.5-Cu1.5) to CuAred (CuI-CuI) redox couple at E’ = +260 mV versus NHE.1290
However, for aerobically prepared N2OR the CuZ site is redox inert under all conditions
except reduction with methyl viologen, which has been shown to reduce CuZ to the fully
reduced 4CuI redox state (see Section 5.2.2).1317 These differences in redox properties lead
several studies to propose that there are structurally different CuZ sites in anaerobically and
aerobically prepared N2OR, which have been named CuZ and CuZ* respectively.1290,1318
CuZ* is then considered to be an inactive form of the catalytic center generated by reaction
with O2. Prior to the recent crystal structure, this structural difference between CuZ and
CuZ* was thought to be a minor perturbation, perhaps due to a second sphere residue
interaction, since the spectroscopic properties of CuZ and CuZ* are very similar when they
are compared in the 1-hole redox state (see Section 5.2.4).1290,1318 However, the recent X-
ray crystal structure of anaerobic N2OR in fact indicates a significant structural difference,
with CuZ containing two bridging sulfide ligands while the previously described structure of
CuZ* contains only one.1296 These results will be discussed in Section 5.2.3. In light of this
new structural information, interpretation of the spectral features and electronic structure of
CuZ is required and the relationship between CuZ and CuZ* and their involvement in the
catalytic cycle must be addressed. Additionally, the roles of CuZ and CuZ* in vivo require
definition, since the relative abundance of these two forms of the cluster depends not only
on O2 but also on the ancillary proteins NosR and NosX. With the recent definition of the
structure of CuZ relative to CuZ*, the stage is set to address the questions that remain about
the differences between anaerobically and aerobically purified N2OR and the relevance of
these differences to N2OR reactivity.
5.2.2 Kinetics—N2OR reactivity is measured with a standard assay system that employs
reduced methyl viologen or benzyl viologen as the electron donor, which is present in large
excess.1319 The viologen can be reduced using clostridial hydrogenase,1277 a stoichiometric
amount of dithionite or photochemically by a flavin and UV light.1278 The reaction is
initiated either by adding N2OR to the reductant solution presaturated with N2O1309 or by
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injecting N2O into a mixture of the reductant and N2OR.1319 The reactivity can then be
monitored spectrophotometrically by following the decay of the absorption of the reduced
viologen or by GC analysis of the amount of N2O present over time. The rate of N2O
consumption is reported as a specific activity in µmol N2O min−1 mg−1 N2OR. A summary
of the activities of N2ORs isolated from various source organisms is presented in Table 43.
The specific activities of N2ORs isolated from different sources can be compared to the
activity of N2OR in vivo. This activity has been estimated in P. stutzeri by measuring the
consumption of N2O by whole cells and estimating the amount of N2OR in the cell
immunochemically.1278 This yields an activity range of 48–72 µmol min−1 mg−1 as the
minimum specific activity of PsN2OR in vivo. In comparison, the activity of N2ORs assayed
as isolated is in the range of 1–10 µmol min−1 mg−1, well below the minimum activity in
vivo, showing that N2OR from both aerobic and anaerobic preparations is obtained in an
inactive state and a chemical activation step is necessary to restore N2OR to full activity.1317
Thus, comparisons of the activities of as isolated N2ORs have limited usefulness for
understanding the kinetics and mechanism of N2OR. These values likely reflect the
reactivity of a small amount of active N2OR present in the assay. Instead, considering the
conditions required to activate the enzyme and its reactivity in an activated form are
required to understand the kinetics and molecular mechanism of N2O reduction by N2OR.
An exception to this is WsN2OR, which has a specific activity of 160 µmol min−1 mg−1
without prior activation.1281 The presence of the additional heme site in WsN2OR gives it
unique reactivity, including the ability to perform turnover with dithionite as the sole
electron donor, while other N2ORs are inactive unless methyl viologen or cytochrome c are
used as the electron source.
Two procedures have been discovered that activate as isolated N2OR, increasing its specific
activity by 1–2 orders of magnitude to values equal or greater than the minimum activity
expected based on whole cells. The first is a base activation procedure in which as-isolated
N2OR is dialyzed overnight against a high pH buffer (pH 9–10).1278 First reported for
PsN2OR, base activation results in a 14-fold increase in the activity of anaerobically isolated
PsN2OR but only a 6-fold increase in the activity of aerobically isolated PsN2OR. It has also
been observed for anaerobically isolated PaN2OR (54-fold increase in activity)1283 and
aerobically isolated PpN2OR (4-fold increase in activity).1284 The molecular basis for the
activation process is not known and no structural or spectroscopic studies have been
reported on N2OR after prolonged dialysis at high pH. Spectroscopic studies of
anaerobically purified AcN2OR and aerobically purified PnN2OR at pH 10 show only small
differences in the CuZ* site due to pH (see 5.2.4).1320 Whether there is a high pH effect on
the CuZ site or on CuA has not been investigated. Further study of the base activation
process has the potential to yield new insight into the reactivity of N2OR.
The second activation procedure is a reductive activation in which N2OR undergoes a
prolonged preincubation with reduced methyl viologen (kactivation=0.07 min−1), which is
already present in the activity assay.1317 This increases the activity of both anaerobically
and aerobically isolated protein by 2 orders of magnitude over the asisolated values, to
maximum values of 122 µmol min−1 mg−1 (anaerobic AcN2OR)1291 and 275 µmol min−1
mg−1 (aerobic PnN2OR).1317 The origin of this increase in activity was elucidated by Ghosh
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et al., who showed that the activation is correlated to a decrease in the EPR spin intensity
observed for the 1-hole CuZ* site (Figure 233).1317 Thus, the mechanism of activation is
reduction of the CuZ* site, initially in the resting 1-hole redox state (S=½, see Section 5.2.4),
to the fully reduced 4CuI state (S=0), which is the active redox state for reaction with N2O.
The 4CuI state can also react directly with N2O in the absence of additional reductant to
generate a two electron oxidized CuAox 1-hole CuZ* state of N2OR, with the reduction of
N2O to N2 confirmed by gas chromatography mass spectrometry detection of isotopically
labeled 15N2 produced from 15N2O during the single turnover.1321 High steady-state activity
with methyl viologen is not observed for any redox states of the CuZ site (with the 4Cu2S
site rather than the CuZ* 4Cu1S site).1290 When the [CuAox CuZ 2-hole], [CuAred CuZ 2-
hole], and [CuAred CuZ 1-hole] states are prepared from PpN2OR, their observed activities
are low for all three redox states in both aerobically and anaerobically prepared enzyme (8
and 2 µmol min−1 mg−1, respectively).1290 Thus, the 4CuI redox state is the active state of
CuZ* in the methyl viologen assay. It is likely that the small activities reported for other
redox states of N2OR are a result of reduction of a small amount (1–5%) of the N2OR by the
methyl viologen present in the activity assay, which then accounts for all of the observed
activity.
Despite this evidence that the 4CuI state is the active redox state of CuZ*, the reduction of
the resting 1-hole state of CuZ* to the 4CuI state is too slow to be part of the catalytic cycle
(kred = 0.07 min−1 in the presence of a 500-fold excess of reduced methyl viologen,1317
compared to kcat = 275 s−1 in the steady state turnover of PnN2OR).1309 Several
explanations for this discrepancy have been proposed, including that the slow rate and
requirement for a non-physiological reductant rule out the involvement of the 4CuI redox
state in vivo or that an alternative reduction step available in vivo rapidly converts resting 1-
hole CuZ* to the fully reduced state. A more attractive explanation is that the resting 1-hole
state of CuZ is itself not part of the catalytic cycle. Indeed, an alternative 1-hole intermediate
state of CuZ* has been observed in the single turnover of PnN2OR when fully reduced
[CuAred 4CuI CuZ*] N2OR is reacted with a stoichiometric amount of N2O.1322 CuA and
CuZ* are rapidly oxidized, but while CuZ* is observed to be in a 1-hole redox state, its
spectral features differ from those of the resting 1-hole state. In the absence of further
reaction, this intermediate species, designated CuZo, slowly converts to resting 1-hole CuZ*
(kobs = 0.3 min−1).1322 CuZo has high specific activity, equal to that of the 4CuI state,
indicating that it is kinetically competent and can be rapidly reduced in turnover. The decay
of this activity occurs with the same rate constant as the decay rate of CuZo obtained
spectroscopically (kdecay = 0.3 min−1), indicating that N2OR activity is dependent on the
presence of CuZo, not the resting 1-hole form of CuZ*.1322 This resolves the issue of the
slow rate of reduction of the resting 1-hole state, since turnover can proceed from the 4CuI
redox state through 1-hole CuZo without requiring a slow reduction step. It is important now
to determine how the 1-hole form of CuZo relates to that of CuZ* to understand the
effectiveness of this intermediate in turnover.
Steady state kinetic studies on reductively activated protein have been used to investigate the
dependence of N2OR reactivity on substrate concentration, reductant concentration, pH and
solvent deuteration.1291,1309,1323 Usually these have been done without controlling for the
ratio of CuZ* to CuZ present, but the values reported for aerobically purified N2OR should
Solomon et al. Page 198
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
correspond solely to CuZ* reactivity. The N2O concentration dependence of steady state
turnover, performed for anaerobically isolated AcN2OR1291 and aerobically isolated
PnN2OR,1309 yields similar kcat and KM value, with kcat on the order of 200 s−1 and
KM(N2O) values on the order of 20 µM, indicating weak binding of N2O (Table 43).
The reductant concentration dependence gives a KM(methyl viologen) of 12 µM. For
PnN2OR containing only CuZ*, the maximum specific activity is reported in the pH range of
8 to 9, with decreasing activity at low pHs with a pKa of 6.6.1309 Anaerobically isolated
AcN2OR shows a more complex dependence on pH.1323 The pH profile of activity shows
two maxima, indicating four separate pKa’s significant to turnover. The position and
intensities of these maxima also shift depending on the pH used for the preceding reductive
activation step. This complex dependence of N2OR reactivity on pH has not been fully
explained and how it relates to the possible presence of CuZ due to anaerobic isolation is
unclear. The dependence of the rate of the reductive activation step on pH has been
separately investigated in aerobically isolated PnN2OR and is 4-fold slower at high pH (pKa
= 9.0±0.2).1320 This pKa has been assigned to a Lys residue that protonates and hydrogen
bonds to a hydroxide ligand on the CuI-CuIV edge, raising the reduction potential of the
CuZ* site and making it easier to reduce (vide infra). A solvent deuterium isotope effect has
also been observed for AcN2OR with kcat = 163 s−1 and KM= 25 µM in H2O and kcat = 97
s−1 and KM= 35 µM in D2O.1291 The isotope effect on kcat indicates the involvement of a
solvent-exchangeable proton in the rate-determining step of N2O reduction, while the
difference observed in KM is consistent with a role for hydrogen bonding in the N2O binding
step.
Kinetic studies that use cytochrome c as the electron donor have been performed for
AcN2OR,1291 PnN2OR,1309 PpN2OR1310 and WsN2OR.1311 These show that cytochrome c
is indeed capable of reducing the CuA site and under appropriate conditions N2OR can
turnover in vitro with a cytochrome c (either the native cytochrome1309 or mammalian
cytochrome c1310) as the electron donor. However, significant kinetic differences are
observed when cytochrome c is used as the electron donor instead of methyl viologen.
Anaerobically isolated AcN2OR has a relatively high specific activity without prior
reductive activation when two equivalents of horse heart cytochrome c are used as the
electron donor (45 µmol min−1 mg−1 as isolated compared to 124 µmol min−1 mg−1 after
reductive activation with methyl viologen).1291 However, for aerobically isolated PnN2OR
turnover with cytochrome c551 requires prior reductive activation and occurs with a very low
specific activity, comparable to the activities observed for the inactive state of N2OR (2
µmol min−1 mg−1 with cyt c551 compared to 157 µmol min−1 mg−1 with methyl
viologen).1309 The rate of this turnover of PnN2OR with cyt c551 is independent of N2O
concentration, indicating that there is a different rate limiting step than for turnover with
methyl viologen, and the pH dependence of the activity also differs, showing a maximum at
pH 7 (pKa’s 5.5 and 8.3).1309 The rate of electron transfer from cytochrome c551 to PnN2OR
has been separately measured by cyclic voltammetry (k = 5.5±0.9 × 105 M−1 s−1) and is
consistent with the reported kcat, so under the conditions of the PnN2OR study electron
transfer from cytochrome c551 to N2OR is rate-limiting.1322 Rate limiting intermolecular
electron transfer from cytochrome c is also consistent with a study of anaerobically isolated
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PpN2OR which measured the rate of electron transfer from horse heart cytochrome c to
PpN2OR in the [CuAox 2-hole CuZ] state to be 150 s−1 when saturating concentrations of
cytochrome c are used.1310 Comparing this value to the kcat values for N2ORs with methyl
viologen shows that kET(cyt c → N2OR) < kcat(methyl viologen) and thus electron transfer
from cyt c should be rate-limiting in turnover when cyt c is the electron donor. Additionally,
the [CuAred 2-hole CuZ] state of PpN2OR will react with N2O in the presence of
stoichiometric reduced cytochrome c. A lag phase in this reaction may involve reduction of
the [CuAred 2-hole CuZ] state and may indicate that an allosteric effect on N2OR, induced by
cytochrome c binding, is necessary for reduction of CuZ.1310
Since there are significant differences between N2ORs purified anaerobically and
aerobically, comparisons of the specific activities of N2ORs obtained under different
purification conditions have been used to attempt to argue which form is physiologically
relevant.1296 Studies comparing N2ORs that have been purified from the same organism
under two sets of conditions and then assayed identically have been performed, but the
results are ambiguous. When aerobic and anaerobic PsN2OR are assayed as isolated, the
anaerobic enzyme is slightly more active than the aerobic enzyme, but both have only low
activity.1278 After base activation, anaerobic PsN2OR has 10-fold higher activity than the
aerobic form.1278 In contrast, PpN2OR assayed as isolated and in different redox states
shows lower activity for the anaerobic enzyme, but again these activities were low compared
to reductively activated PpN2OR.1290 Aerobically isolated AcN2OR is reported to have a
tenth of the activity of anaerobically isolated AcN2OR after reductive activation, but this is
attributed to a significantly lower copper content and active site occupancy in the aerobically
isolated protein (4.2±1.2 Cu/dimer).1291 The maximum specific activities reported for
anaerobic and aerobically purified N2ORs from any source organism following reductive
activation are comparable (122 µmol min−1 mg−1 for anaerobic AcN2OR1291 and 157 µmol
min−1 mg−1 for aerobic PnN2OR1309). In addition, all of these comparisons assume the same
occupancy of the tetranuclear copper site in N2ORs after difference isolation procedures. A
further assumption is the enzyme being studied is a pure species rather than a mixture of two
active site forms, CuZ and CuZ*, present in different relative amounts depending on the
purification conditions, as has been determined by spectroscopic study of anaerobically and
aerobically purified PpN2OR.1290 Due to the absence of controls for active site occupancy
and the ratio of CuZ to CuZ* present, it is not possible to distinguish the differential
reactivity of the anaerobic and aerobic forms of N2OR from the currently available data and
further study of the relative reactivities of anaerobically and aerobically purified N2OR is
required.
A variety of small molecules that inhibit N2OR have been identified, both from in vitro and
in vivo studies. Acetylene is a widely recognized inhibitor of N2OR activity in vivo 1324 but
is only weakly inhibiting in vitro.1280 Other in vivo inhibitors, such as hydrogen sulfide 1325,
have not been studied in purified N2OR so it is difficult to distinguish whether they directly
inhibit N2O reduction by interaction with N2OR or through a regulatory process. Some
inhibitors which have been tested in vitro include nitric oxide, nitrite, fluoride, isocyanate
and carbon monoxide.1280 While these molecules have been shown to perturb the steady-
state activity of N2OR, the type of inhibition, the mode of interaction of these molecules
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with the copper sites and which redox state they target has not been determined. Cyanide, 2-
mercaptoethanol, azide and some chelators irreversibly inhibit N2OR due to decomposition
of the active site.1278,1280 One crystallographic study indicates that iodide is an inhibitor of
N2OR, but the kinetic data are not reported.1295
5.2.3 Structure—A key turning point in the study of N2OR came with the publication of
crystal structures of PnN2OR and PdN2OR in 2000 by Brown et al., who discovered that the
CuZ site is a tetranuclear copper cluster, rather than a binuclear copper site, as had been
previously proposed (vide infra).1292,1326 Crystal structures for N2OR have since been
reported from four sources, PnN2OR (PDB ID 1QNI),1292,1326 PdN2OR (PDB ID
1FWX),1327 AcN2OR (PDB ID 2IWF)1295 and PsN2OR (PDB ID 3SBP, 3SBQ).1296 The
first three structures were obtained from aerobically purified and crystallized protein while
the recent PsN2OR structure is the sole example of a structure for anaerobically purified and
crystallized N2OR. In addition, two crystal structures have been reported with small
molecules bound to the active site, a structure of AcN2OR with the inhibitor iodide bound to
the CuZ* cluster (PDB ID 2IWK)1295 and a structure of PsN2OR showing the substrate N2O
bound near CuZ (PDB ID 3SBR).1296
The initial crystal structure of resting PnN2OR, obtained at 2.4 Å resolution, shows that
N2OR is a homodimer, with each monomer containing an N-terminal domain with a 7-
bladed β-propeller fold, containing the CuZ* cluster, and a C-terminal domain with a
cupredoxin fold, containing the CuA site (Figure 234).1326 The monomers are associated in a
head-to-tail fashion, with the C-terminal domain of one monomer forming contacts with the
N-terminal domain of the second monomer. The distance between the CuA and CuZ* sites in
the same monomer is 40 Å, while the distance between the CuA site in one monomer and the
CuZ* site in the second monomer is only 10 Å. This indicates a functional role for
dimerization in N2OR, since the 40 Å distance is too great for electron transfer between CuA
and CuZ* in the same subunit, but electron transfer across the dimer interface is possible.1326
The CuA site contains two copper atoms bridged by two Cys residues (Cys565, Cys561),
with one copper further ligated by His526 and Met572 while the other is ligated by His569
and the backbone carbonyl of Trp563 (Figure 235). Both His526 and His569 are equitorial
and Nδ-coordinated to Cu. The distance between the two copper atoms in CuA is 2.48 Å,
consistent with a Cu-Cu bond. The CuA site in N2OR is highly similar the CuA electron
transfer site in cytochrome c oxidase, as had previously been predicted by comparison of the
spectroscopy of N2OR and CcO (see Section 5.2.4).1326,1328,1329
CuZ* has been shown to be a tetranuclear copper cluster, unprecedented in biology or in
synthetic copper complexes.1326 The four copper atoms in the cluster are arranged in a
butterfly structure with a single atom bridging all four coppers, leading to a cluster with
approximate C2 symmetry where three of the coppers (CuI, CuII and CuIV) and the µ4
bridging ligand are coplanar (Figure 236A). In the initial report of the crystal structure of
PnN2OR, the µ4 bridging ligand in the cluster was assigned as an oxo (O2−).1326 However,
after spectroscopic and biochemical results that established that there are sulfur isotope
sensitive stretches in the resonance Raman spectrum of the CuZ* site and inorganic sulfide
quantification in N2OR giving a 1:6 ratio with Cu,1289 the structure of CuZ* was revised to
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be a µ4-sulfide bridged tetranuclear copper cluster. Subsequent higher resolution refinement
of crystal structures from PdN2OR and AcN2OR (1.6 Å and 1.86 Å resolution, respectively)
corroborated this assignment.1292,1295 The copper-copper distances in the CuZ* cluster are
not equal, with shorter CuII-CuIV and CuII-CuIII distances than CuI-CuIV and CuI-CuIII
distances (Table 44, copper numbering from Figure 236).
The cluster is ligated by seven histidine residues, with two His ligating each copper atom
with the exception of CuIV, which has only one His ligand. Five of the seven ligating His
residues are Nε-coordinated, while His437 and His79, bound to CuIV and CuII respectively,
are Nδ-coordinated. An important difference between the known structures of the CuZ
cluster is the number and identity of the ligands on the CuI-CuIV edge. In PnN2OR and
PdN2OR, one solvent derived ligand is observed on the CuI-CuIV edge, occupying a
bridging position in PdN2OR1327 (Figure 236A) but closer to CuIV in PnN2OR.1292 In
AcN2OR, two solvent derived ligands are observed, one bound to CuI and the other to CuIV
(Figure 236B).1295 The CuI-CuIV edge is the most open edge of the CuZ* cluster and
therefore is proposed to be the site of N2O binding.1326,1330 The variability in solvent
coordination at this edge is consistent with labile solvent derived ligands that can be easily
replaced by N2O. A crystal structure of AcN2OR with the inhibitor iodide bound to CuZ*
has also been reported (Figure 236C).1295 Iodide binds as a bridging ligand on the CuI-CuIV
edge, displacing the solvent-derived ligands and blocking the proposed site of N2O binding.
The proposed mechanism of inhibition for I− is thus competing with N2O for binding to the
CuI-CuIV edge of the cluster.
The recent publication of a crystal structure of anaerobically purified and crystallized
PsN2OR challenges the role of the CuI-CuIV edge as the N2O binding site and also sheds
new light on the differences between anaerobically and aerobically purified N2OR
(containing CuZ and CuZ*, respectively).1296 The overall protein fold and dimer structure of
anaerobic PsN2OR does not differ significantly from previous crystal structures. However,
significant changes are observed in the copper sites. The CuZ site has an additional sulfur
ligand bridging the CuI-CuIV edge, blocking the proposed N2O binding site (Figure 236D).
This edge ligand has been described as a sulfide but definitive assignment of its protonation
state is beyond the scope of X-ray crystallography. The remainder of the structure of the site,
including the bond lengths and angles between the copper atoms and the µ4-sulfide, is
conserved relative to the previously described 4CuS site in aerobically purified N2OR
(Table 45). This establishes the key structural difference between the copper sites in
anaerobically and aerobically purified N2OR: CuZ is a 4Cu2S cluster while CuZ* is a 4Cu1S
cluster with a solvent derived edge ligand. A change also occurs in the CuA site. His583, the
His ligand of the Cu atom further from CuZ, is not bound to the CuA site in this structure but
instead is swung away from the copper, leaving it three-coordinate. This difference is not
observed in cytochrome c oxidase but has been proposed in N2OR to be a switching
mechanism for triggering electron transfer from CuA to CuZ.1296
A structure has also been determined for anaerobic PsN2OR with N2O bound near the CuZ
site, obtained by pressurizing the anaerobic crystal with 15 bar of N2O followed by flash
freezing.1296 One localized N2O molecule is observed adjacent to the CuZ site, positioned
above the CuIV- µ4S-CuII face of the cluster and hydrogen bonding to two second sphere
Solomon et al. Page 202
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
residues, Met627 and through a localized water molecule to His626, which is also a CuA
ligand (Figure 237). The shortest distance between N2O and the CuZ site is 3.1 Å (N2-CuII),
which is too long to represent a coordination interaction. The N2O molecule is linear,
indicating that there is no significant back-bonding from the CuZ cluster. It is possible that
N2O is present in the protein channel through which it accesses the CuZ site but the redox
state of CuZ present in the crystal is not the correct one to coordinate N2O and activate it for
reduction. In an interesting detail, when N2O is bound between the CuA and CuZ sites the
His583 residue again ligates the more distant Cu of CuA.1296 The significance of this
conformational change of the CuA site to reactivity and how N2O binding can trigger this
change on the side of CuA that is more distant from its binding site needs future
investigation.
5.2.4 Spectroscopy and Electronic Structure—N2OR is a protein for which a rich
array of spectroscopic information is available. Early in the study of N2OR, different states
of the protein were qualitatively differentiated based on their color (e.g. anaerobically
isolated N2OR was identified as “the purple form” while aerobically isolated N2OR was
identified as “the pink form”).1278 These colors reflect the rich absorption spectra of the
CuA, CuZ* and CuZ sites, which contain intense absorption bands in the visible region due to
S→Cu ligand to metal charge transfer transitions from the sulfide ligand in the CuZ and
CuZ* clusters and the bridging Cys ligands in CuA. These intense LMCT transitions provide
an opportunity to study the vibrations of these sites by resonance Raman spectroscopy and
further result in increased intensity for the copper d-d transitions, which borrow intensity
from the LMCT transitions. Significant insights have also been derived from electron
paramagnetic resonance and X-ray absorption spectroscopy. Key insights that have been
obtained by spectroscopy include the identification of the µ4 sulfide ligand in CuZ*,1289 the
elucidation of the resting redox states of CuZ and CuZ*,1290,1331 and the role of a second
sphere Lys residue that hydrogen bonds to the solvent derived ligand on the CuI-CuIV edge
of CuZ*.1320 Some ongoing areas of study are the spectroscopic differences between
Cu005A, CuZ*, and CuZo, the insight these give into the electronic structures of these sites
given their different structures, and how these differences relate to reactivity.
The spectroscopic features and electronic structure of CuA have been extensively described
through the study of the CuA containing domain of CcO,1332 spectroscopic studies of an
N2OR mutant deficient in CuZ,1297 and synthetic constructs of CuA in azurin.62,1333 The key
spectral features of CuAox contribute to the spectroscopy of resting N2OR prior to reduction
and therefore are summarized here, while CuAred is spectroscopically silent. CuAox is a class
III MV Cu1.5-Cu1.5 site with a σu* ground state and a low-lying πu excited state (Figure
238).59,1334,1335 CuAox exhibits an axial EPR signal with g// of 2.18 and g⊥ of 2.02 and a
sharp 7 line hyperfine pattern in the g// region with A// = 44×10−4 cm−1 (Figure 239A,
spectra shown from a CuZ deficient mutanted varient of PsN2OR known as N2OR
V).1294,1336 The 7 line hyperfine pattern shows that the unpaired spin is delocalized over
two equivalent Cu nuclei (ICu = 3/2) and the small A// value indicates high covalent
delocalization of the unpaired spin onto the Cys thiolate ligands (26±3% S character by S K-
edge XAS).1337 The g// value of 2.18 is achieved through mixing with the low-lying πu
excited state at an energy ~3,500 cm−1 above the G.S.1335 CuAox has an absorption spectrum
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with three transitions at 20,800 cm−1 (480 nm, ε≈4000 M−1 cm−1), 18,500 cm−1 (540 nm,
ε≈4000 M−1 cm−1), and 12,800 cm−1 (780 nm, ε≈3000 M−1 cm−1) (Figure 239B).1334 The
absorption transitions at 20,800 cm−1 and 18,500 cm−1 correspond to an intense pseudo A
feature in the MCD spectrum of CuAox (Figure 239C) and are assigned to the
perpendicularly polarized S(px)→SOMO and S(py)→SOMO transitions. In a pure σu* G.S.,
only the S(px) orbital would have overlap with the SOMO, so the observation of two S(p)
→SOMO transitions is another result of the πu mixing into the G.S. Upon laser excitation
into the CysS(px,y)→SOMO CT transitions, dominant Cu-S(Cys) stretching modes at 259
cm−1 (mixed Cu-S(Cys)/Cu-N(His) stretching mode, Δ34S = −3.4 cm−1), 276 cm−1 (out of
plane “twisting” Cu-S stretching mode, Δ34S = −1.9 cm−1) and 347 cm−1 (Cu2S2 core
breathing mode, Δ34S = −1.6 cm−1) are enhanced.1318 In N2OR, the 347 cm−1 Cu2S2 stretch
is split into seven total 34S isotope sensitive modes ranging from 323–408 cm−1 in energy,
which arises from coupling with the Cys and His sidechain vibrations. The transition at
12,800 cm−1 in both the absorption and MCD spectra has been assigned as the intervalence
ψ→ψ* CT transition associated with the mixed valent nature of the 2Cu1.5 site.62 Laser
excitation into this transition resonance enhances the three vibrations discussed above and
additionally enhances an ~130 cm−1 core “accordion” mode involving motions of the two
Cu nuclei along the Cu-Cu bond vector, characteristic of a ψ→ψ* CT for a class III mixed
valent site. The relatively high energy of this ψ→ψ* transition indicates direct Cu-Cu orbital
overlap, due to the short 2.48 Å distance between the coppers in the CuAox site. The mixed
valent σu* G.S. of CuAox with its direct Cu-Cu bonding (Figure 238) results in significant
electronic delocalization that is essential for a low site reorganization energy, leading to
rapid and efficient electron transfer.62
All of the spectral features of CuAox can be observed in the absorption, MCD, and EPR
spectra of resting N2OR (Figure 240), whether it is isolated anaerobically (A) or aerobically
(B).1290 The 7 line hyperfine pattern of CuA appears significantly sharpened in N2OR that is
prepared anaerobically. This sharper hyperfine pattern is also seen for the CuZ deficient
variant N2OR V (Figure 240 A).1334 In both cases, the sharpness of the CuA signal is due to
the absence of spectral overlap with an additional S=½ signal, assigned to resting CuZ*, that
is present in aerobically isolated N2OR but absent in anaerobically isolated N2OR.1290 Thus,
no significant differences in the spectroscopy of CuAox in resting N2OR are observable
between anaerobically and aerobically isolated N2OR despite crystallographic evidence that
in anaerobically isolated N2OR CuA has one less His ligand.1296 Absence of a His ligand,
which is a strongly bound equatorial Cu ligand, would be expected to significantly perturb
the spin distribution of the site, which should be reflected in the EPR spectrum (as has been
observed for a His→Ala variant in a construct of CuA in azurin).716 The absence of such a
perturbation of the CuAox EPR spectrum in resting anaerobically isolated N2OR has yet to
be explained and developing an understanding of this is necessary to evaluate the effect of
the His(off)→His(on) conformational change on electron transfer by CuA and thus its
contribution to N2OR reactivity.
Spectroscopic studies of the CuZ* site, which assigned the spectral features and used these to
elucidate the electronic structure of the active site, were performed on the dithionite reduced
state of resting aerobically isolated PnN2OR.1330,1331 Under these conditions, CuA is
selectively reduced so it does not contribute and the remaining spectral features are due to
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CuZ*. Both the EPR spectrum and the magnetic saturation behavior of the MCD spectrum of
CuZ* indicate that the resting state of this site has a total spin of ½.1331 Two redox states
with S=½ are possible for a tetranuclear copper site: the 3-hole 3CuIICuI state (where two of
the oxidized coppers are antiferromagnetically coupled) and the 1-hole CuII3CuI state.
Fitting the intensity of the feature at 8984 eV in the pre-edge of the Cu K-edge X-ray
absorption spectrum, a feature characteristic of CuI complexes, was used to distinguish
between the two possibilities. The intensity at 8984 eV in the Cu K-edge XAS spectrum of
dithionite reduced PnN2OR (Figure 241) establishes the 1-hole state (i.e. CuII3CuI) as the
resting redox state of CuZ*.1331
The dominant absorption feature of 1-hole CuZ* is a broad absorption band at 15,600 cm−1
(640 nm, ε ≈ 4000 M−1 cm−1) that gives dithionite-reduced N2OR its blue color (Figure
242A).1330 This corresponds to an intense pseudo-A feature in the LT MCD spectrum
(bands 5 and 6 in Figure 242B).1330 The presence of a pseudo A feature requires two
perpendicularly polarized transitions that can spin-orbit couple in a mutually perpendicular
direction on a single center. In CuZ*, the only options that satisfy these conditions are the
S→Cu CT transitions from the p orbitals of the µ4 S2− to different copper centers (Figure
243). Upon laser excitation into the 640 nm absorption band, three intense S isotope
sensitive vibrational modes are resonance enhanced: 366 cm−1 (Δ34S = −2.1 cm−1), 386
cm−1 (Δ34S = −5.8 cm−1), and 415 cm−1 (Δ34S = −7 cm−1) (Figure 244A).1318 These
vibrations profile differently (Figure 244C) and the profile of the 386 cm−1 vibration
requires the presence of a third S→Cu CT transition (band 7 in Figure 242), in addition to
the two S→Cu CT transitions in the MCD pseudo A (bands 5 and 6).1330 On the basis of the
relative intensities of these three S→Cu CT transitions, band assignments rationalized from
an orbital overlap model indicate that band 6 (the most intense) is the Spx→Cu CT
transition, which has the greatest overlap between donor and acceptor MOs, band 5 is the
Spz→Cu CT transition, and band 7 is the Spy→Cu CT transition (where the orientations of
the different µ4 S2− p orbitals are given in Figure 243). The resonance enhanced vibrations
can be assigned as mixtures of the four Cu-S stretching modes based on normal coordinate
analysis and considerations of their enhancement profiles (Figure 244D). The 415 cm−1 is
thus assigned as the CuI-S stretch, the 386 cm−1 vibration as the symmetric breathing mode
of the cluster, and the 366 cm−1 as dominantly the CuII-S stretch. A total of thirteen
electronic transitions are required for a simultaneous fit of the low temperature absorption,
CD, and MCD spectra (Table 45).
Six of these transitions, including the three S(p)→Cu charge transfer transitions (bands 5–7),
have significant metal character based on their C/D ratios (bands 3–8 in Figure 242). The
remaining transitions with high C/D ratios (bands 3–4, 8) are assigned as d-d transitions of
the dominantly oxidized copper atom (vide infra) while the transitions with low C/D ratios
are assigned as His→Cu CT transitions (bands 9–13) and the intravalence CuII→CuI CT
transition (band 2).1330 The EPR spectrum of resting 1-hole CuZ*, determined at both X-
band and Q-band, is axial with a g// of 2.16 and g⊥ of 2.04 and hyperfine contributions in the
A// region from two copper nuclei in a ~5:2 ratio (A//1 = 61×10−4 cm−1, A//2 = 24×10−4
cm−1) (Figure 245).1331 The low g// value of 2.16 is due to the high energy of the dxy→dx2-
y2 transition (18,000 cm−1, band 8).1330 The axial nature of the EPR spectrum shows that
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the unpaired electron spin is in an orbital with dominant Cu dx2-y2 character and the
presence of two unequal A// values indicates that the unpaired spin is delocalized over two
copper atoms in a 5:2 ratio.1331 Thus 1-hole CuZ* is a class II mixed-valent site. This
correlates well with a ground state wavefunction determined from DFT using a model of the
active site with hydroxide as the CuI-CuIV edge ligand (Figure 246) in which the unpaired
spin is dominantly localized on CuI (33%) but there is a significant contribution from CuIV
(10%).1320 The spin is more localized on CuI because it has a higher coordination number
than CuIV (4 ligands rather than 3). The dominant bonding interaction in CuZ* involves the
µ4 sulfide px orbital overlap with the dx2-y2 orbitals of CuI and CuII. This σ bonding
interaction provides a superexchange pathway between CuI and CuII, which may be
important for the ability of the CuZ* site to perform 2 electron chemistry.1330 CuII may also
be on the electron transfer pathway between CuA and the CuZ* site, via a solvent bridge
between His79, a CuII ligand, and His569, the proximal His ligand of CuA, which are 5.68 Å
apart across a solvent-filled cavity.
The effect of pH on 1-hole CuZ* was further studied to confirm the protonation states of the
µ4 S ligand and the solvent derived ligand on the CuI-CuIV edge.1320 The pH dependence of
the electronic structure of 1-hole CuZ* was studied by comparing the spectroscopy of
dithionite reduced PnN2OR and AcN2OR at pH 6.0 and pH 10.5. The optical transitions of
1-hole CuZ*, determined from the LT absorption and MCD spectra, are not perturbed by pH.
The EPR spectra at these two pHs are also virtually identical, indicating that the ground state
wavefunction is not perturbed. Thus there is no change in the protonation states of the
solvent derived CuI-CuIV edge ligand or the µ4 S ligand over this pH range, since
protonating or deprotonating these ligands would significantly perturb the spin density
distribution of the cluster. Additionally, the S K-edge XAS spectrum is unaffected by pH,
confirming that the protonation state of the µ4 S does not change over this pH range. This
strongly favors the assignment of the sulfur ligand as a µ4-sulfide and the CuI-CuIV edge
ligand as hydroxide over the whole pH range.1320
While the electronic structure of the 1-hole CuZ* site is unaffected by pH, there is some
perturbation of the resonance Raman spectrum of 1-hole CuZ* at high pH.1320 At pH 10.5
the CuI-S stretch shifts up in energy to 424 cm−1 (from 415 cm−1 at pH 6.0) and shows an
H2 18O isotope shift of 9 cm−1, compared to pH 6.0 where all three Cu-S stretching
vibrations show no solvent 18O isotope sensitivity (Figure 244B). This can be attributed to a
shift in the position of the hydroxide ligand on the CuI-CuIV edge, leading to kinematic
coupling between the CuI-S stretch and the CuI-OH stretch at high pH. This pH effect has a
pKa of 9.2 and is attributed to the deprotonation of a second sphere Lys residue, Lys397,
which is 3.6 Å from the CuI-CuIV edge. Either indirect hydrogen bonding, through a
localized water molecule bridging between the hydroxide ligand and Lys397, or rotation of
Lys397 to form a direct hydrogen bond to the hydroxide are possible. In the DFT optimized
structure used to describe the ground state wavefunction of 1-hole CuZ* (vide supra), a
direct hydrogen bond with Lys397 is included. With this hydrogen bonding interaction, the
hydroxide ligand does not bridge the CuI-CuIV edge, but instead is only bound to CuI (CuI-O
1.95 Å, CuIV-O 3.30 Å).1320
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While the electronic structure of the 4Cu2S CuZ site has yet to be defined, a number of
previous studies have qualitatively described its spectral features, including the information
necessary to deduce its resting redox state. Anaerobically purified N2OR contains an
oxidized CuA site as well as the CuZ site. When CuA is selectively reduced with ascorbate,
leaving only the spectral features of resting CuZ, the dominant spectral feature of the site is
an intense absorption band at 17,900 cm−1 (~560 nm, ε ≈ 4000 M−1 cm−1) with a weaker
shoulder at ~15,900 cm−1 (Figure 240A, red).1290 The MCD spectrum of anaerobically
prepared N2OR after ascorbate reduction shows only the features of some amount of 1-hole
CuZ* (30% CuZ* according to Rasmussen et al.)1290 and no new features due to CuZ,
indicating that resting CuZ is diamagnetic. This is supported by EPR, which shows that the
resting state of CuZ is EPR silent (Figure 240A, red; a weak, featureless residual signal that
represents <2% of the spin of one CuII is again attributed to the presence of some CuZ*).1290
In principle, three redox states with S = 0 are available for a 4Cu2S site: fully oxidized 4CuII
(where two pairs of oxidized coppers are antiferromagnetically coupled), 2-hole 2CuII2CuI
(with two antiferromagnetically coupled Cu(II)’s), and fully reduced 4CuI. The fully
reduced state can be ruled out because of the presence of intense absorption transitions for
the site. While no spectroscopic method has yet been used to experimentally distinguish
between the fully oxidized and 2-hole redox states (e.g. XAS), the 2-hole redox state is
generally considered to be the resting redox state of CuZ, as it is likely to be more
energetically accessible than the highly charged [4Cu2S]4+ fully oxidized state.1338
The reducing agent dithionite can be used to reduce anaerobically isolated N2OR to a state
containing CuAred and 1-hole 4Cu2S CuZ. Its absorption spectrum is dominated by an
intense, broad feature at 14,900 cm−1 (~670 nm, ε ≈ 4000 M−1 cm−1; Figure 240A, blue)
that has a corresponding intense pseudo A feature at low temperature that is qualitatively
similar to that of 1-hole CuZ* (Figure 240A, blue).1290 The EPR spectrum of 1-hole CuZ is
axial with a g⊥ of 2.055 and a g// region that is poorly resolved in X band EPR (Figure
240A, blue). The resonance Raman spectrum obtained from laser excitation into the
dominant band of 1-hole CuZ shows two intense S isotope sensitive vibrations at 363 cm−1
and 382 cm−1.1318 Thus the spectroscopic features reported for 1-hole CuZ are qualitatively
quite similar to those of 1-hole CuZ*. Prior to the recent crystallographic definition of a
4Cu2S core structure for CuZ (see Section 5.2.3), this high degree of spectroscopic
similarity between the 1-hole forms of CuZ and CuZ* led to the conclusion that the
difference between the two sites was a matter of the protein environment or second sphere
interactions.1290,1318 In light of the significant structural differences between CuZ and CuZ*
that have recently been elucidated, further evaluation of the electronic structure of 1-hole
CuZ is required to understand both the similarities and the differences between the clusters.
Assignment of the protonation states of the two sulfur ligands in CuZ will be the necessary
first step towards assigning its spectroscopic features and elucidating its geometric and
electronic structure in both of its accessible redox states.
5.2.5 Molecular mechanism—On the basis of kinetic and spectroscopic studies of the
reaction of N2O with CuZ* that have identified the active redox state of this site and rate
information for a number of steps, a mechanistic proposal for the reaction of the 4Cu1S
CuZ* site with N2O in turnover has been developed.1322 Since much of this information is
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not known for the 4Cu2S CuZ site, particularly its active redox state, a proposed mechanism
for N2O reduction by the anaerobic CuZ enzyme is lacking. The mechanism for N2O
reduction by CuZ* will be discussed here. Further work to develop a mechanistic
understanding of the relative reactivity of the 4Cu2S CuZ site with N2O is an important
future direction for N2OR research.
The proposed mechanism for N2O reduction by CuZ*-containing N2OR is presented in
Figure 247.1322,1339 The active redox state of CuZ* has been identified as the fully reduced
4CuI state (see Section 5.2.2).1317 Thus, the reaction begins with the fully reduced state of
N2OR, in which both CuA and CuZ* are reduced (A). N2O then binds to the 4CuI CuZ* site
in a µ-1,3 bridging mode on the CuI-CuIV edge (B).1339 In the next step of N2O reduction, a
2 electron transfer from fully reduced CuZ* to N2O induces N-O bond cleavage, releasing
N2 and leaving the oxygen as an O2− ligand bound bidentate on the CuI-CuIV edge of a
putative 2-hole intermediate (C). This N-O bond cleavage is then followed by two electron
transfer and two proton transfer steps to regenerate fully reduced CuZ* and complete the
catalytic cycle. Based on DFT calculations (vide infra), alternating protonation and
reduction steps are favored, yielding a possible hydroxobridged 2-hole intermediate (D)
which is reduced by electron transfer from CuAred to generate the CuAox/CuZo 1-hole
intermediate that is observed experimentally in single turnover (E).1339 The first protonation
and reduction steps are rapid, since there is no observed accumulation of a 2-hole CuZ*
intermediate (C or D).1322 After reduction of CuAox by the physiological reductant,
cytochrome c, CuZo is rapidly reduced by CuAred to complete the catalytic cycle.1309 In the
absence of an external reductant, a slower non-reductive decay converts CuZo to the inactive
resting 1-hole state of CuZ* (F), which then must undergo a slow reductive activation
process to re-enter the catalytic cycle (vide supra).1322 Given the kinetics of electron
transfer to N2OR by cytochrome c (see Section 5.2.2),1309,1310 cytochrome c reduction of
N2OR is thought to be the rate limiting step in vivo, while with a faster, non-physiological
reductant such as methyl viologen the reduction of CuZo by CuAred is likely to be rate-
limiting.
A number of the details of the mechanism of N2O reduction have been evaluated using DFT
calculations, including the binding mode of N2O to the fully reduced state of CuZ*, the role
of backbonding in N-O bond cleavage, the role of hydrogen bonding in lowering the barrier
for N-O bond cleavage, and the thermodynamics of protonation and reduction of potential
CuZ* intermediate species.1339 DFT calculations using the BP86 functional and 6–311G*
basis set show that µ-1,3 binding of N2O is the lowest energy structure for N2O coordination
to 4CuI CuZ* (Figure 247, B).1339 In the optimized geometry (Figure 248A), the N2O ligand
is bent, with a 139° N-N-O angle. This bent binding allows significant backbonding from
the 4CuI site into the unoccupied π* orbital of N2O; the LUMO has 61% N2O π* character
(mostly on N) and 22% Cu character (Figure 248B). Backbonding results in the elongation
of the N-O bond from 1.184 Å in free N2O to 1.321 Å in the complex, indicating that N2O is
activated for the key N-O bond cleavage step. These DFT calculations yield an upper limit
for the activation barrier for N-O bond cleavage of 18 kcal/mol. This barrier could be further
lowered to 9–13 kcal/mol by hydrogen bonding to the O atom of N2O, which carries
significantly more charge in the transition state of N-O bond cleavage than in the initial N2O
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bound complex.1339 However, a model complex study by Bar-Nahum et al. suggests that a
µ-1,1-O binding mode for N2O coordination to CuZ* might be relevant and this possibility
should be compared to the µ-1,3 binding geometry.1340
DFT calculations have also been used to investigate the thermodynamics of protonation and
reduction of potential CuZ* intermediates (Figure 249).1339 Protonation of an oxo-bridged 2-
hole intermediate is thermoneutral (ΔG = 0 kcal/mol), which suggests that proton transfer
could be concerted with N-O bond cleavage. Subsequent reduction of a hydroxide-bridged
2-hole intermediate is downhill, suggesting that sequential protonation and reduction steps
are possible. In contrast, discrete protonation or reduction of a hydroxide-bridged 1-hole
intermediate is uphill (ΔG = +17 kcal/mol or ΔG = +15 kcal/mol, respectively), indicating
that PCET is required to generate the thermodynamic driving force for formation of the fully
reduced state. In the absence of the exogenous electron donor required to perform the second
reduction step (via reduction of CuAox, vide supra), a hydroxide-coordinated 1-hole
intermediate would be thermodynamically favoured over an oxo-bridged 1-hole species (ΔG
= +47 kcal/mol) or a water-coordinated 1-hole species (ΔG = +17 kcal/mol).1339 This
suggests that the experimentally observed CuZo intermediate should be a hydroxide-
coordinated 1-hole species. However, further spectroscopic characterization is required to
definitively assign the structure of CuZo and determine the factors responsible for its rapid
reduction in turnover.
Four interesting issues must be clarified to fully understand the mechanism of N2O
reduction: 1) determining which of CuZ (4Cu2S) and CuZ* (4Cu1S) is, in fact, the reactive
form of the cluster in vitro and in vivo, thus evaluating the importance of the CuI-CuIV edge
as an N2O binding site, 2) describing the mechanism by which the 4Cu2S CuZ site reacts
with N2O, 3) clarifying the nature of the 1-hole CuZo intermediate in the turnover of CuZ*
with N2O to elucidate its differences from resting CuZ* that account for its rapid reduction
and role in turnover, and 4) determining the nature of the two electron reduction of N2O by
trapping a 2-hole intermediate form of CuZ* in turnover before electron transfer from CuA,
perhaps in an N2OR variant lacking the CuA site. Thus a number of important directions for
research remain to fully understand nitrous oxide reductase and its unique tetranuclear CuZ
cluster active site.
6.0 Concluding Comments
In the different sections presented above, we have attempted to define the present state of Cu
active site catalysis and biogenesis. A number of topics in Cu biochemistry have not been
presented here. The blue Cu and CuA sites are described in passing in the sections on the
multicopper oxidases, nitrite reductases, N2O reductases, and cytochrome C oxidases but not
presented in detail. Recent reviews are available on their geometric and electronic structures
and their contributions to electron transfer.4,1341 Also, Cu/Zn superoxide dismutase, which
plays a key role in detoxifying superoxide, and its mutations that can lead to amyotrophic
lateral sclerosis (ALS) (also known as Lou Gehrig’s disease) has been the focus of a number
of reviews and is presented in the Valentine et al chapter of this issue.1342–1344 We have also
not covered the large field of copper homeostasis, transport, and storage which usually
involves Cu(I) binding to Cys ligands, which have been thoroughly reviewed.1345,1346
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Two particularly interesting areas of Cu bioinorganic chemistry are not explored here as
present knowledge is too limited. The GH61 enzymes or polysaccharide monooxygenases
(PMOs) have a single Cu center that activates O2 for H-atom abstraction from crystalline
cellulose embedded in lignin to break it into smaller soluble saccharides that can be used as
precursors for biofuel production (Figure 250A).1347 Crystal structures are now available
which show a Cu active site with two His (one methylated at the N-ε position), a terminal
amine, and a water-derived ligand.1348,1349 In one structure, the x-ray radiation has reduced
the site which has reacted with O2 to form what is proposed to be an end-on bound
superoxide (Figure 250B).1349 A mechanism parallel to that of the non-coupled binuclear Cu
enzymes in section 3.3, where the Cu(II) superoxide H atom abstracts from the C1 or C4
carbons of cellulose has been invoked,1350 and it will be interesting to see how the ligation
differences in GH61s relative to those of the CuM center in the non-coupled binuclear Cu
enzymes relate to new reactivities. Also, Cu sites have been strongly correlated to
neurodegenerative diseases.1351,1352 Cu(II)’s tightly bound to His, and perhaps deprotonated
amide ligands, are present in the prion proteins related to transmissible spongiform
encephalopathies, amyloid β proteins related to Alzheimer’s disease, and α-synuclein in
Parkinson’s disease. The functional and misfunctional roles of the Cu(II) are unclear but
appear to relate to protein folding, aggregation, and perhaps redox to generate reactive
oxygen species.
The field of Cu bioinorganic chemistry has developed far in the enzymology, modeling,
spectroscopy, and geometric and electronic structure correlation with reactivity. However, as
we have tried to emphasize throughout this review, there is still much to be understood in
the different classes of Cu enzymes described above and in new areas that are ripe for
exploration.
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Abbreviations
L-DOPA 3,4-dihydroxy-L-phenylalanine
DOPAquinone 3-(3,4-dioxocyclohexa-1,5-dien-1-yl)-L-alanine
DHI 5,6-dihydroxyindole
DHICA 5,6-dihydroxyindole-2-carboxylic acid
Abs Absorption
AO Amine oxidase
AF Antiferromagnetic
AGAO Arthrobacter globiformis Amine Oxidase
AOx ascorbate oxidase
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BOD Bilirubin Oxidase
CaOx catechol oxidase
Cp Ceruloplasmin
CT Charge Transfer
CD Circular Dichroism
CI Configuration Interaction
CuNiR Copper Nitrite Reductase
CB-PPOs Coupled Binuclear Polyphenol Oxidases
CcO Cytochrome c oxidase
DFT Density Functional Theory
DβM Dopamine β-monooxygenase
DPQ Dopaquinone
ECP Effective Core Potentials
Zeff Effective nuclear charge
EPR Electron Paramagnetic Resonance
ESEEM Electron Spin Echo Envelope Modulation
ET Electron Transfer
ENDOR Electron-Nuclear Double Resonance
HAB Electronic Coupling Matrix Element
EAS Electrophilic Aromatic Substitution
EXAFS Extended X-ray absorption fine structure
FMOs Frontier molecular orbitals
FCI Full Configuration Interaction
GO Galactose Oxidase
GTO Gaussian-Type orbital
GGA Generalized Gradient Approximation
GLOX Glyoxal oxidase
ZFS Zero Field Splitting
HPAO Hansenula polymorpha Amine Oxidase
HF Hartree-Fock
HCOs Heme-copper oxidases
Hp Hephaestin
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HOMO Highest Occupied Molecular Orbital
KIE Kinetic Isotope Effect
KS Kohn-Sham
LF Ligand Field
LFT Ligand Field Theory
LLCT Ligand to Ligand Charge Transfer
LMCT Ligand to Metal Charge Transfer
LDA Local Density Approximation
LT Low Temperature
LUMO Lowest Occupied Molecular Orbital
LTQ Lysine Tyrosylquinone
MCD Magnetic Circular Dichroism
MGGA Meta-Generalized Gradient Approximation
MMO Methane monooxygenase
MYA million years ago
MV Mixed Valent
MO Molecular Orbitals
MCO Multicopper Oxidase
IYT N-acetyl-diiodotyrosyl-D-threonine
dbed N,N-di-tert-butylethylenediamine
Ac-DiI-YG, IYG N-R-acetyl-3,5-diiodotyrosylglycine
NI Native Intermediate
NOR Nitric oxide reductase
N2OR Nitrous oxide reductase
PAL peptidyl-α-hydroxylglycine-α-amidating lyase
PAM peptidylglycine α-amidating monooxygenase
PHM peptidylglycine α-hydroxylating monooxygenase
PHMcc peptidylglycine α-hydroxylating monooxygenase catalytic core
PI Peroxy Intermediate
PHS Phenoxazinone synthase
PMOs polysaccharide monooxygenases
PES Potential Energy Surface
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PLS Proton loading site
QM-MM Quantum Mechanics-Molecular Mechanics
2,4-QD Quercetin 2,4-dioxygenase
QO Quinol oxidase
rR Resonance Raman
RvL Rhus vernificera laccase
RT Room Temperature
SKIE Solvent kinetic isotope effect
SOC Spin-orbit Coupling
SQUID Superconducting Quantum Interference Device
TD-DFT Time-dependent Density Fcuntional Theory
TPQ Topaquinone
TNC Trinuclear Copper Cluster
T1 Type 1
T1D Type 1 depleted
T1Hg Type 1 mercury
T2 Type 2
T2D Type 2 Depleted
T3 Type 3
TβM Tyramine β-Monooxygenase
Ty Tyrosinase
VBCI Valence bond configuration interaction
VTVH Variable temperature, variable field
XAS X-Ray Absorption Spectroscopy
XMCD X-ray magnetic circular dichroism
XPS X-ray photoelectron spectroscopy
XANES X-ray Absorption Near Edge Structure
Xα-SW Xα Scattered Wave
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Figure 1.
Copper active sites in biology.
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Figure 2.
Latimer Diagram for Oxygen Reduction at pH = 7.0 Adapted from References 5 and 6.
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Figure 3.
(Left) Ligand field splitting of Cu(I) 4p orbitals as a function of site geometry. (Right) K-
edge XAS of two-coordinate Cu(I) [Cu2(EDTB)](ClO4)2 (red), three-coordinate Cu(I)
[Cu(L1-pr)](BF4) (green), and four-coordinate Cu(I) [Cu(py)4]ClO4 (blue). (Reprinted with
permission from Ref. 8. Copyright 1987 American Chemical Society.)
Solomon et al. Page 263
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4.
(Left) Schematic of Cu K-β emission. The ligand ns and np (where n=2,3 depending on
ligand type) to metal 1s transitions occur via LMCT. L(np) and L(ns) = ligand p and s hole,
respectively. (Right) XES of ZnO (a d10 system).
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Figure 5.
XES spectra showing the satellite region of d9 Cu(II) complexes.
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Figure 6.
XES spectra showing the valence region of different d10 Zn2+ complexes. (A) Ligation to Zn
is varied from C, O, to F. (B) Ligation to Zn is changed from H2O to OH−. (Used with
permission from Ref. 10.)
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Figure 7.
Ligand Field Splitting of the d manifold. A. Octahedral to square planar to tetrahedral. B.
Square pyramidal to trigonal byparimidal. Rearrangements through Berry pseudorotation
(C2v) and associated ligand displacement (Cs) coordinates.
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Figure 8.
Zeeman effect on an S=1/2, MS =±1/2 system. The degenerate MS values split in a magnetic
field by gβHMS. This splitting equals the microwave energy hν, at a magnetic field where
microwave absorption occurs.
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Figure 9.
(top) A frozen solution EPR spectrum gives a powder pattern with all orientations (g||(H1)
→g⊥(H2)) weighted by the number of molecules with specific orientations. Thus the
intensity increases towards the field associated with the perpendicular direction. (middle)
The EPR spectrum is taken as the first derivative to enhance sensitivity. (bottom)
Anisotropic hyperfine coupling of the electron spin to the Cu nucleus spin I=3/2.
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Figure 10.
Delocalization of the electron spin onto the ligand Li by an amount . The ligand
valence orbital is a hybrid with s and pz character.
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Figure 11.
ENDOR experiment for an S=1/2, MS = ±1/2 metal site. Left, Levels for protons (I =1/2,
nuclear Zeeman large related to metal-ligand hyperfine) and Right, levels for other nuclei (in
particular N, I = 1, nuclear Zeeman smaller than metal-ligand hyperfine coupling).
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Figure 12.
The ESEEM spectrum: (top) Modulated decay of the spin echo and (bottom) The Fourier
Transform of the modulation.25,26
Solomon et al. Page 272
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 13.
The differences in σ and π overlap between the ligand and the copper valence orbitals leads
to low energy weak π and higher energy intense σ charge transfer transitions.
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Figure 14.
Resonance Raman spectroscopy: Excitation energy dependence of resonance intensity gives
the excitation profile. (Reprinted with permission from Ref. 39)
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Figure 15.
Cu K-edge spectra of CuII (black line) and CuIII (blue line) model complexes. The inset
amplifies the pre-edge region.
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Figure 16.
(Left) Orientation averaged Cu K-edge spectra of D4h CuCl42− and plastocyanin. Insets
show the expanded pre-edge region.(Right) Polarized Cu K-edge spectra of plastocyanin.
Inset shows the expanded pre-edge region. (Reprinted with permission from Ref. 43.
Copyright 1993 American Chemical Society.)
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Figure 17.
Configuration interaction formalism for the Cu K-edge near-edge analysis. A) Ground-state
wave functions determined by T and Δ parameters. B) Final-state wave functions with the
1s→4p + LMCT shakedown final-state (Ψs) separated from the main 1s→4p final-state
(Ψm) by the splitting W.
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Figure 18.
Z-polarized Cu K-edge spectra of D2d CuCl42−. Data (—) and fit (····). The intensity of the
main transition is not well established due to the rising-edge background. (Reprinted with
permission from Ref. 43. Copyright 1993 American Chemical Society.)
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Figure 19.
Cu L3-edge XAS spectra for D4h-CuCl42− and plastocyanin. Values listed are the amount of
Cu d character in the half occupied HOMO. (Reprinted with permission from Ref. 45.
Copyright 1993 American Chemical Society.)
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Figure 20.
Cu L-edge XMCD spectra for A) mononuclear blue Cu site in plastocyanin measured at
~0.3 K, and B) Cu center in [(F8TPP)FeIII-O-CuII(TMPA)](ClO4) heme-Cu dimer measured
at 2.2 K. C) Structure of [(F8TPP)FeIII-O-CuII(TMPA)](ClO4) heme-Cu dimer. (Reprinted
with permission from Ref. 47. Copyright 2004, American Institute of Physics.)
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Figure 21.
EPR spectrum of an S=1 system including the characteristic ΔMS =2 transition and the Zero
Field Splitting D of the ΔMS =1 transition which are anisotropic.
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Figure 22.
A) Magnetic couplings due to superexchange pathways (magnetic orbital overlap (left),
orthogonal magnetic orbitals (right)) and B) molecular orbital origin of antiferromagnetism.
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Figure 23.
Charge transfer transitions of bridging ligands: Large charge transfer excited state
antiferromagnetically coupling. This mixing into the ground state through covalency leads to
the antiferromagnetic coupling in the ground state.
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Figure 24.
Delocalization in mixed-valent systems is due to the electronic coupling matrix element
HAB associated with the direct bonding interaction between two metal ions and their
superexchange interaction through bridging ligand orbitals.
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Figure 25.
Mixed valence interactions. A) Two non-interacting potential energy surfaces, (left hole on
CuA, right for hole on CuB) and their associated distortions in the Q- mode. B), inclusion of
electronic coupling between the two Cu’s (HAB(i)) solid lines << HAB(ii) dashed lines).38
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Figure 26.
(top) Energy diagram of an antiferromagnetically coupled Cu(II) trimer (all J<0) with zero,
one and three equivalent bridging ligands. (bottom) The ZFS of the spin frustrated 2E
ground state due to antisymmetric exchange and the effects of a magnetic field on these
ground state sublevels. (Reprinted from Ref. 66, with permission from Elsevier.)
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Figure 27.
Molecular Orbital diagram of the CuII-Cl− bond. Left, too covalent description of the pure
BP86 functional. Right, d-manifold destabilized through a more ionic bond description. Cl
SALC abbreviates the Chloride symmetry adapted molecular orbitals.
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Figure 28.
Optimized Cu-Cl bond lengths (Å) and Mulliken Population Analysis (MPA) Cu spin
densities (electron) in D4h [CuCl4]2− at maximal and minimal density functional correlation
limits using saturated triple-ζ basis set.
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Figure 29.
A. Active site of Plastocyanin, showing the short Cu-S bond (equatorial) and the long Cu-S
bond from the thioether (axial). B. Ground state wavefunction (β-LUMO) of a blue Cu site.
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Figure 30.
Molecular orbital diagrams. A and B, Cu(II)-superoxo; C, Cu(III)-peroxo. A, end-on triplet;
B and C side-on singlet. Representative MO’s are shown at the top.
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Figure 31.
Isocontours for the lowest singlet state, side-on bound superoxo-Cu(II), hydrotris(3-
tertbutyl-5-isopropyl-1-pyrazolyl)-borate CuO2 with B3LYP (left) and BP86 (right)
functionals.
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Figure 32.
Equilibrium between μ-η2: η2 side-on peroxo Cu(II)2 and bis-μ-oxo species Cu(II)2
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Figure 33.
Isocontours (0.05) of μ-η2: η2 side-on peroxo Cu(II)2 LUMO calculated using BP86 (left)
and B3LYP (right).
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Figure 34.
Quarternary structure of mollusc and arthropod Hc. A molecular model determined from
cryo-electron microscopy of a decamer of Keyhole Limpet Hc (A) illustrates the subunit
order within the wall of the cylinder. A cutout from the center of the cylinder (right) reveals
the position of subunit g (light blue) in the arc and subunit h (gold) in the slab. The
hexameric structure of arthropod Hc (B) is arranged as a trimer of dimers (viewed from the
top on right) with each functional unit as a unique color. The tight dimmer interface (viewed
from the side-on the left) is between the blue and yellow subunit while the loose dimmer
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interface is between the blue and green subunit. (Reprinted from Ref. 134, with permission
from Elsevier.)
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Figure 35.
(A) The fraction of bound sites (θ) is plotted as a function of the O2 pressure for a
cooperative (red, n = 3) and non-cooperative (blue) protein that both have the same O2
affinity. (right) An example Hill plot (B) for a Hc with a P1/2 of 20 torr that lacks
cooperativity and a cooperative protein with the same affinity and n = 3.
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Figure 36.
The tertiary structure of the Hc functional units for the arthropod L. polyphemus (A) with the
α-helical domain one that shields the four helix bundle of domain two (in red) and the β-
barrel of domain three in blue. The mollusc tertiary structure from E. dofleini (B) is divided
into two domains: the copper binding domain one in red and the β-barrel of domain two in
blue (PDB 1NOL (A) and 1JS8 (B)).
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Figure 37.
A comparison between the deoxy (A) and oxy (B) Hc from L. polyphemus show a large
geometric change at the active site upon oxygen binding (the Cu-Cu distance shortens by 1.0
Å). While the overall topology of the active site in Hc is conserved, differences between
oxy-Hc from the arthropod L. polyphemus (B) and the mollusc E. dofleini (C) can be
observed especially at the CuA site. (PDB 1LLA (A), 1NOL (B), and 1JS8 (C))
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Figure 38.
Cu K-edge XAS of deoxy-Hc (black) and oxy-Hc (gray).
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Figure 39.
Comparison of the electronic absorption spectra and resonance Raman spectra (inset) among
copper-dioxygen adducts.
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Figure 40.
Molecular orbital diagram depicting the valence interaction between copper and dioxygen in
a side-on Cu2(μ-O2) adduct. The contours of the HOMO and LUMO are shown on the left.
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Figure 41.
Resonance Raman spectrum of {[(Tp)Cu]2-(μ-η2:η2-O2)}.
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Figure 42.
In plane normal vibrational modes of a side-on Cu2(μ-O2) dimer. Arrows represent the
motion of the respective atoms in the normal mode.
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Figure 43.
A) Absorption spectra of oxy-Hc ( ) and met-Hc (—), circular dichroism spectrum of oxy-
Hc ( ) (15K, acetate pH 5.0), B) Resonance Raman excitation profile of 765 cm−1 (○) and
287 cm−1(●) vibrational features of oxy-Hc superimposed over its absorption spectrum.
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Figure 44.
UV-Visible absorption spectra of a series of side-on peroxide-bridged binuclear copper
complexes in which the Cu2O2 geometry contains a progressively larger “butterfly”
distortion due to the ligand architecture where the most distorted complex is N3PY2.
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Figure 45.
Comparison of the spectral features of arthropod and mollusc hemocyanins. A: UV-Visible
absorption spectra of Cancer Irroratus ( ) and Busycon canaliculatum ( ) oxy-Hc; B:
Fourier transform EXAFS of deoxy-Hc ( ) and oxy-Hc ( ) from Cancer Irroratus; C:
Fourier transform EXAFS of deoxy-Hc ( ) and oxy-Hc ( ) from Busycon canaliculatum.
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Figure 46.
Charge transfer from a bridging peroxide to CuA (top) results in an excited state with a hole
on the peroxide (bottom). In the excited state, the singly occupied peroxide and CuB orbitals
strongly couple as a result of their direct overlap.
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Figure 47.
Configuration interaction diagram for mixing between valence bond states: left singlets,
right triplets; in order of increasing energy the ground configuration, the LMCT
configuration at an energy of Δ, the Cu to Cu CT configuration energy and the double CT
(two-electrons from the ligand to the 2 Cu) at the energy of EDCT
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Figure 48.
UV-Visible absorption and CD spectra of Busycon ( ) and Cancer ( ) met-Hc with azide
bound.
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Figure 49.
Spectral changes observed upon addition of azide to nitrite bound half-met-Hc results in
significant spectral changes. A. UV-Vis absorption of NO2− bound half-met-Hc ( ) and
N3− bound half-met-Hc ( ); B: EPR spectra of NO2− bound half-met-Hc ( ) and N3−
bound half-met-Hc ( ).
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Figure 50.
The distance d(X-X) between the center of mass of dioxygen and the Hc active site model
[{(NH3)Cu}2]2+ for the singlet (blue squares) and triplet surfaces (red circles) shows the
reaction coordinate of O2 binding (open symbols signify asymmetric coordination
geometries while closed symbols are symmetric). The figure illustrates the simultaneous
transfer of two electrons with parallel spin to dioxygen (right) forming peroxide. The
ferromagnetically coupled butterflied μ-η2-μ2 peroxo (center) then undergoes an inter
system crossing to form the antiferromagnetic singlet (left).
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Figure 51.
The spectral differences of the normalized XAS of arthropod, mollusc, and the binuclear
MCO reflect a changing coordination environment from trigonal in Hc to more planer in the
MCO.
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Figure 52.
A Cu•••Cu potential energy surface for deoxy-Hc (blue diamonds) and deoxy-T3 MCO (red
squares, MCOT3). A comparison of the constrained surface (frozen α-carbons represented
by filled symbols) and the unconstrained surface (open symbols) indicate that the energy
difference between deoxy-Hc and the deoxy T3 site is due to electrostatic repulsion between
the coppers.
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Figure 53.
An overlay of structural models for the tense (domain 1 in yellow and domain 2 in red, PDB
1LLA) and relaxed (domain 1 in light blue and domain 2 in orange, PDB 1HC1) states of
arthropod Hc show a large rotation in domain 1. This rotation is translated to the active site
via the formation of a π-π interaction between Phe 49 and His328, which increases the
Cu•••Cu separation (residues numbers are from L. polyphemus 1LLA).
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Figure 54.
The EPR spectra of the half-met spectral probe of mollusc Hc (Busycon canaliculatum)
directly probes geometric changes at the active site when the oxygenation state of the
adjacent subunits is altered.
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Figure 55.
Ty is a monooxygenase that converts L-tyrosine to L-DOPA by incorporating labeled
oxygen before oxidizing L-DOPA to L-DOPAquinone.
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Figure 56.
The initial steps of melanin monomer formation for eumelanin via the Mason-Raper
pathway and the formation of phenomelanin via the 5-S-Cysteinyldopa pathway.
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Figure 57.
In vivo, GriF converts 3-amino-4-hydroxybenzaldehide to the corresponding iminoquinone
while NspF converts 3-amino-4-hydroxybenzamide to a nitrosophenol.
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Figure 58.
The catalytic cycle for catechol oxidase activity in Ty.
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Figure 59.
The catalytic cycle of Ty. Red arrows indicate the preferred, steady state turnover pathway
for the monooxygenase activity.
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Figure 60.
A Hammett correlation between σ+ and the log(kcat) (s−1) is shown for mushroom
Tyrosinase in red squares and O. vulgaris Hemocyanin (functional unit g) in blue circles.
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Figure 61.
The active site of oxy-Tyrosinase (A) from the bacteria S. castaneoglobisporus and a
structure of met-Catechol Oxidase from I. batatas (B).
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Figure 62.
An overlay of phenylthiourea (PTU) bound to Catechol Oxidase and met-Catechol Oxidase
(green) from I. batatas (A). The structure of met B. megaterium Ty crystals soaked with
kojic acid (KA) (B) and met A. bisporus Ty crystals soaked with tropolone (TP) (C).
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Figure 63.
The structure of various small molecule inhibitors.
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Figure 64.
The structure of inactive, met-Tyrosinase PPO2 from the insect M. sexta has a unique base
in the actives site (Glu 395) as well as Phe88 from domain 1 (in yellow) that restricts access
to the active site.
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Figure 65.
Comparison of the spectral features of oxy-Tyrosinase and oxy-Hemocyanin. Left: UV-Vis
absorption; Right: resonance Raman (364 nm excitation).
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Figure 66.
The addition of mimosine to met-Ty leads to observation of a CT transition in the absorption
spectrum.
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Figure 67.
Changes observed in the EPR spectrum of half-met Ty upon addition of mimosine.
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Figure 68.
Interpenetrating mono and diphenolase catalytic cycles.
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Figure 69.
Peroxo & bis-oxo equilibrium.
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Figure 70.
Spectral changes accompanying peroxo (blue) to bis-μ-oxo (green) equilibrium in X-ray
Absorption Spectra (top), absorption (middle), and resonance Raman (bottom) spectra.
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Figure 71.
Correlation of the frontier molecular orbitals between a Cu2(O2) (left) and Cu2(O)2 (right).
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Figure 72.
Resonance Raman spectra (left) showing conversion of formation of a bis-μ-oxo upon
phenolate binding to the peroxo and (right) monooxygenated phenolate product, with
oxygen isotopic substitutions, bound to copper that is formed from the decay of the bis-μ-
oxo complex (inset).
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Figure 73.
Reactive frontier molecular orbitals (LUMO and LUMO+1) of {[(dbed)Cu(OPhMe)]-(O)2-
[Cu(dbed)]}+1 which represent σ and π acceptor channels for electrophilic aromatic
substitution of the phenolate ring.
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Figure 74.
Mechanism of biomimetic tyrosinase model complex
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Figure 75.
Thermal decay of [Cu2(NO2-XYL)(O2)]2+ results in an intramolecular ligand oxidation
product.
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Figure 76.
Resonance Raman spectra of the decay of a 4 mM solution of [Cu2(NO2-XYL)(O2)]2+ in
acetone which demonstrates the loss of the ν(O—O) band of the peroxide adduct
concomitant with the growth of a ν(C=O) of the product without presence of a Cu2(O)2
adduct (to a 0.005 mM detection limit).
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Figure 77.
Overlay of the transition states of monophenylase and phenylanilinase with similar Cu2O2
cores
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Figure 78.
Respective reactivity of the non-coupled binuclear copper enzymes
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Figure 79.
(top) Random mechanism for the formation of the ternary complex for DβM and TβM.
(bottom) Equilibrium ordered mechanism for formation of the ternary complex for PHM.
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Figure 80.
Mechanistic summary of the coupled binuclear copper enzymes
Solomon et al. Page 341
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 81.
Top. A representation of secondary structure of PHMcc, PDB code 1PHM. The backbone is
in gray, the strands are in cyan and the coppers are shown as green spheres. The ligands to
the two catalytic coppers are colored by element (carbon is gray, nitrogen is blue, sulfur is
yellow, and oxygen is red). Bottom. Coordination ligands of CuH and CuM sites. Coppers
are shown by green spheres and ligands are colored by element.
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Figure 82.
A. The precatalytic complex of PHM showing the relative position of bound substrate, N-
acetyl-diiodotyrosyl-D-threonine (IYT), and dioxygen at CuM site. The 2Fo-Fc electron
density is shown for dioxygen and the IYT peptide. Substrate and protein atoms are colored
by atom type; iodine atoms are purple. The water molecule is represented by a red sphere
and molecular oxygen by a red rod. Dotted lines indicate hydrogen bonds and bonds to the
copper atoms (green spheres). B. The structure of the dioxygen binding site showing the
precatalytic complex. Dioxygen (the red rod) is shown bound to CuM (the green sphere) in
an end-on manner. Amino acid ligands to CuM are shown colored by atom type. Simulated
annealing difference omit maps that leave out either both oxygen atoms (red mesh) or the
distal oxygen atom of dioxygen (blue mesh) are shown contoured at 8σ. In this crystal
structure, CuM-O-O angle is 110.2°, CuM-Oproximal is 2.106 Å, the O-O distance is 1.232 Å
and the distance between the α-C in the substrate and the CuB-O-O is about 4-5 Å. C. The
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backbone of IYT and the anchor residuals are shown: Arg240 forming a salt bridge, the
hydroxyl of Tyr318 and the side chain amide of Asn316 both in hydrogen bonds to the D-
threonine main-chain amide. The hydrogen bonds are shown in dotted lines. D. A structure-
based model of substrate dioxygen interaction. The structure of the PHM active site is
oriented looking down the copper-oxygen bond. The modeled position of the substrate
hydrogen atom that is abstracted during the PHM reaction is shown in turquoise. Rotating
the copper-oxygen bond by 110° brings the terminal oxygen of dioxygen within 2.2 Å of the
substrate hydrogen, a position consistent with hydrogen abstraction by an activated oxygen
species. (From Ref. 125. Reprinted with permission from AAAS.)
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Figure 83.
Optimized geometries by density functional theory of reduced CuM and CuH sites, based on
spectroscopic studies. A. Reduced CuM site. B. Reduced CuH site. . C. Oxidized CuM site.
D. Oxidized CuH site. Relevant bond lengths (Å) are indicated. Color codes: Cu, green; N,
blue; C, gray; O, red; S, yellow; H, light blue. (Reprinted with permission from Ref. 539.
Copyright 2004 American Chemical Society.)
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Figure 84.
A. Ligand field 5 °C CD and 5 K, 7 T MCD spectra of the resting PHMcc and 5 K, 7 T
MCD spectrum of the resting PHMcc with 2-3 equiv of AcYVG substrate; C. ligand field 5
°C CD and 5 K, 7 T MCD spectra of resting PHMcc with 350 mM N3− and the 5 K, 7 T
MCD spectrum with an additional ~4 equiv of AcYVG substrate; E. ligand field 5 K, 7 T
MCD spectrum of resting PHMcc with 300 mM NO2−; B., D., F. experimental (77 K) and
simulated X-band EPR spectra for the resting PHMcc (9.321 GHz), resting PHMcc with 350
mM N3− (9.319 GHz), and resting PHMcc with 300 mM NO2− (9.394 GHz) samples,
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respectively. In panel B, “*” denotes a cavity signal. The sharp signal at g ≈ 2.0 is due to a
radical signal of the quartz tube used in the EPR measurement. In panel E., the weak
derivative shaped spectral feature at ~24,500 cm−1 (“*”) is due to a small heme contaminant.
(Reprinted with permission from Ref. 539. Copyright 2004 American Chemical Society.)
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Figure 85.
A. Charge-transfer absorption spectrum (5 °C) of resting PHMcc with 350 mM N3− (dashed
lines are Gaussian fitted bands); B. Charge-transfer region (5 °C) CD and 5 K, 7T MCD
spectra of resting PHMcc with 350 mM N3− and 5 K, 7 T MCD spectrum with ~ 4 equiv of
substrate AcYVG added to PHMcc + N3−. (Reprinted with permission from Ref. 539.
Copyright 2004 American Chemical Society.)
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Figure 86.
Structural correlations of ligand field splitting patterns. Ligand field calculated d-d orbital
energy diagrams for CuH (oxidized, left) and CuM (oxidized, right). I.S.1 is an intermediate
structural model derived from CuM 1a where the axial methionine is removed and the
equatorial OH
-
 is replaced by a histidine ligand. I.S.2 is an intermediate structural model
with the axial methionine removed from CuM 1a. All energies are referenced to the lowest d
orbital, which is set to zero. Geometries of first coordination sphere atoms are shown on the
top. (Reprinted with permission from Ref. 539. Copyright 2004 American Chemical
Society.)
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Figure 87.
Density functional theory optimized geometry of tris-pyrazolborate Cu(II) hydroperoxo
model complex. Color codes: Cu, green; B, light pink; N, blue; C, gray; O, red; S, yellow;
H, light blue.
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Figure 88.
A. 220 K solution absorption spectrum of hydrotris(3-tert-butyl-5-isopropyl-1-
pyrazolyl)borate Cu(II)-hydroperoxo (referred as L3CuOOH) in tert-butylbenzene. B. 5 K, 7
T MCD spectrum of L3CuOOH in a toluene glass. The Gaussian-resolved bands are shown
in dashed lines along with their spectral assignments. (Reprinted with permission from
Ref. 596. Copyright 2000 American Chemical Society.)
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Figure 89.
77 K Resonance Raman spectra of L3Cu18O18 OH and L3CuOOH excited at 568.2 nm in a
tert-butylbenzene glass. (Reprinted with permission from Ref. 596. Copyright 2000
American Chemical Society.)
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Figure 90.
Energy optimized geometry of oxidized putative hydroperoxo intermediate CuIIM-OOH,
[CuIIM(Met)(His)2(H2O)(OOH)]+, relevant bond lengths (Å) are indicated. Color codes: Cu,
green; N, blue; C, gray; O, red; S, yellow; H, light blue. Surface contour plot of frontier
molecular orbital LUMO of the CuIIM-OOH model. Orbital decompositions (%) are given.
(Reprinted with permission from Ref. 65, copyright 2004 National Academy of Sciences,
USA.)
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Figure 91.
DFT optimized geometry of tris-pyrazolborate Cu(II)-superoxo model complex. The atoms
are colored by atom type, the copper is green and the boron is pink.
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Figure 92.
A. Resonance Raman spectra of hydrotris(3-tert-butyl-5-isopropyl-1-pyrazolyl)borate
Cu(II)-superoxo (referred as L3CuO2) excited at 406.7 nm (~24,590 cm−1). B. hydrotris(3-
adamantyl-5-isopropyl-1-pyrazolyl)borate Cu(II)-superoxo (referred as L10CuO2) excited at
482.5 nm (~20,725 cm−1) in CH2Cl2. (Reprinted with permission from Ref 121 Copyright
2003 American Chemical Society.)
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Figure 93.
SQUID measured effective magnetic moment μeff (B.M. = Bohr magneton) of L3CuO2.
Lines are the simulated curves assuming the S/T energy splitting (ES=1 – ES=0) = 1800,
1600, 1500, 1400, or 1200 cm−1. (Reprinted with permission from ref 121 Copyright 2003
American Chemical Society.)
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Figure 94.
A. UV/vis absorption spectrum of L10CuO2 in CH2Cl2 at −70 °C (solid line) with Gaussian
resolved individual transitions (dashed lines). Overlaid is the rR profile of the 1043 cm−1
vibrational mode of L10CuO2 (•). B. Variable temperature near-IR mull absorption spectra
of L10CuO2. Vibrational overtones of the mulling agent are labeled as “*”.(Reprinted with
permission from ref 121 Copyright 2003 American Chemical Society.)
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Figure 95.
Schematic diagram bonding interaction of the singlet ground state and the lowest triplet
state. (Reprinted with permission from ref 121 Copyright 2003 American Chemical Society.)
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Figure 96.
Energy optimized geometry of putative side-on CuIIM-superoxo, [CuIIM(Met)(His)2(O2)]+,
relevant bond lengths (Å) are indicated. Color codes: Cu, green; N, blue; C, gray; O, red; S,
yellow; H, light blue. Surface contour plot of frontier molecular orbital LUMO of the CuIIM-
OO− model. Orbital decompositions (%) are given. (Reprinted with permission from Ref. 65,
copyright 2004 National Academy of Sciences, USA.)
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Figure 97.
Crystal structure of the [TMG3trenCuO2]+ model complex .
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Figure 98.
A. Low temperature absorption and B. MCD spectra of [TMG3trenCuO2]+ C. Low
temperature (5K) absorption spectrum of [TMG3trenCuO2]+ (black) and rR profile for ν(Cu-
O) (435cm−1, blue) and ν(O-O) (1120cm−1, red) (77K). (Reprinted with permission from
ref 123 Copyright 2010 American Chemical Society.))
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Figure 99.
Schematic molecular orbital diagram of the copper-superoxo bonding in [TMG3trenCuO2]+.
The LMCT (red) and IL (blue) transitions are shown, as are the orbital energy separations
(Δ). The π*σ (+dz2) MO is dominantly superoxo-based and σ-bonding to dz2 and the
dz2(−π*σ) MO is dominantly copper-based and σ-antibonding to π*σ. (Reprinted with
permission from ref 123 Copyright 2010 American Chemical Society.))
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Figure 100.
Diagram (middle) showing the transition between end-on and side-on with frontier
molecular orbitals of [TMG3trenCuO2]+ as the end-on example and the frontier molecular
orbital of tris-pyrazolyl borate Cu(II)-superoxo as the side-on example.
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Figure 101.
The frontier πv* molecular orbital of a Cu(II)-superoxo modeled in PHM, at CuM site.
Reproduced by permission of The Royal Society of Chemistry (Reprinted with permission
from ref 597.))
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Figure 102.
Summary of the 2e− (left, blue) and 1e− (right, red for H atom abstraction, green for
subsequent steps) reaction pathways in PHM. For clarity, His and Met ligands are omitted in
the structures. Only species that are essential to the reactions are indicated in the figure. Free
energies are referenced to the initial reactions, which are set to zero. The proton and H2O
ligand in steps (v) and (a) and the H2O ligand in step (iii) are from the solvent. Reproduced
by permission of The Royal Society of Chemistry (Reprinted with permission from ref 597))
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Figure 103.
Reactions catalyzed by Galactose Oxidase
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Figure 104.
Ping-pong mechanism for the radical cofactor in Galactose Oxidase.
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Figure 105.
Proposed catalytic mechanism for substrate oxidation by Galactose Oxidase.
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Figure 106.
pH dependent reactions for the biogenesis of the cofactor in preprocessed GO-Cu(I).
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Figure 107.
Kinetic rates for the stoichiometric Cu(II) aerobic (a) and anaerobic (b) loading with
premature Galactose Oxidase. All rates are in s−1.
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Figure 108.
Molecular model of Galactose Oxidase, showing the three domains (red domain 1, yellow
domain 2 and blue domain 3) (a). Computer generated model of the second domain showing
the seven fold axis and the location of the copper ion inside the domain (b).
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Figure 109.
Active site of mature processed Galactose Oxidase showing residues Tyr272 (1.93 Å),
Tyr495 (2.69 Å), His496 (2.11 Å), His581 (2.14 Å) and Trp290 and the open coordination
position.
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Figure 110.
Crystal Structures of the active site of GO processing forms. (A) apo-GO, showing the
disorder on Tyr272. (B) Crystal structure after 3 minutes soak on Cu(II) solution, indicating
coordination of Cu(II) to the His in the active site. The negative peak on the Cys228 sulfur
and the positive peak adjacent to copper are consistent with the rotation of the residue. (C)
Crystal structure at 24h incubation with Cu(II), showing the thioeter bond and the Thr290 in
its stacking position. (Reprinted with permission from Ref. 636, copyright 2008 American
Chemical Society.)
Solomon et al. Page 373
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 111.
Spectral features of anaerobic Cu(II) loaded GO (406nm species). EPR from promptly made
preprocessed GO-Cu(II) (A black) and 4 h incubation (A blue at 100K and A red at 305K).
Absorption spectrum showing the formation of the 406 nm band (B). CD spectrum (C) and
rR spectrum (D) of the 406 nm LMCT.
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Figure 112.
Spectral features of Cu(II)-Y(•). Absorption, Circular Dichroism, EPR and resonance
Raman at 875nm.
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Figure 113.
Reaction mechanism for the aerobic copper(II) cofactor biogenesis. L has been reported to
be water or a negative counterion from the crystallization buffer (see 3.5.3)
Solomon et al. Page 376
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 114.
Reaction mechanism for the anaerobic copper(II) cofactor biogenesis
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Figure 115.
Reaction mechanism for the aerobic copper(I) cofactor biogenesis.
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Figure 116.
Methanotrophic bacteria metabolic pathway.
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Figure 117.
pMMO crystal structure. (a) Trimer viewed parallel to the membrane normal and (b)
perpendicular to the membrane normal. The three protomers are shown in dark purple,
magenta, and light pink. Helices are represented as cylinders and β strands are represented as
arrows. The soluble domain is represented by the β-barrels. (Reprinted with permission from
Macmillan Publishers Ltd: Nature Ref. 685, copyright 2005.)
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Figure 118.
The pMMO subunits. (a) Stereoview of a single protomer with pmoB shown in magenta,
pmoA shown in yellow, and pmoC shown in blue. Copper ions are shown as cyan spheres
(the arrow points to the binuclear copper site), and a zinc ion is shown as a grey sphere. (b)
The pmoB subunit viewed looking down the membrane normal. The N-terminal β-barrel is
in the middle. (c) The pmoA subunit, and (d) the pmoC subunit. (Reprinted with permission
from Macmillan Publishers Ltd: Nature Ref. 685, copyright 2005.)
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Figure 119.
The pMMO metal centers of the Bath enzyme. (a) Mononuclear copper center; (b) Binuclear
copper center; and (C) ‘zinc center’, which contains copper in the OB3b enzyme. Ligand
sets are color coded (Magenta (pmoB); Green (pmoC); and Blue (pmoA). (Reprinted with
permission from Ref. 657. Copyright 2007 American Chemical Society.)
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Figure 120.
Proposed location of ‘Site D’ in the X-ray crystal structure of the pMMO Bath enzyme.
(Reprinted with permission from Ref. 701. Copyright 2008 American Chemical Society.)
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Figure 121.
Structures of Methylocystis sp. strain M pMMO subunits. (A) One of the three protomers in
the trimer. The pmoB, pmoA, and pmoC subunits are shown in gray, blue, and purple,
respectively. Copper ions are shown in cyan and a zinc ion is shown in gray. The additional
helix is shown in yellow. (B) Overlay of the pmoA subunits from the Methylocystis sp.
strain M (blue) and the original M. capsulatus (Bath) (gray) structures. (C) Overlay of the
pmoC subunits from the Methylocystis sp. strain M (purple) and the original M. capsulatus
(Bath) structures. (Reprinted with permission from Ref. 703. Copyright 2011 American
Chemical Society.)
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Figure 122.
(Left) Unmodeled electron density located at the interface of the pmoB β-barrels. The 2Fo–
Fc density (contoured at 1σ) is colored light green and the Fo–Fc density colored yellow
(contoured at 3σ). A duroquinone molecule (HIC-up ID DQN) is superimposed on the
density. (Right) Surface representation of the pMMO protomer colored according to
electrostatic potential: red, −12 kT; white, 0 kT; blue, +12 kT. (Reprinted with permission
from Macmillan Publishers Ltd: Nature Ref. 685, copyright 2005.)
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Figure 123.
Structure of Cu(I) full length-mb.. (Reprinted with permission from Ref. 684. Copyright
2011 American Chemical Society.)
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Figure 124.
(Left) Q-band EPR spectra (2 K) of purified (upper) and membrane-bound (lower) pMMO.
(Reprinted with permission from Ref. 695, copyright 2003 National Academy of Sciences,
USA.) (Middle) Cu XANES spectra for pMMO from the Bath enzyme. (Right) Cu EXAFS
fitting analysis. (Panel A) Raw unfiltered EXAFS data and fits. (Panel B) Fourier transforms
and simulated fits. Empirical data are in black and fits are in gray. (Fit over a k range of 1–
12.85 Å−1.) (Reprinted with permission from Ref. 714. Copyright 2006 American Chemical
Society.)
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Figure 125.
(Left) X-Band EPR of purified M. trichosporium OB3b pMMO. (A) Experimental data; (B)
and (C) simulations of the major and minor components, respectively. (Middle) Copper
XANES spectrum of purified M. trichosporium OB3b pMMO (solid line indicates 8984
eV). (Right) Copper EXAFS fitting analysis for purified M. trichosporium OB3b pMMO.
(A) Raw unfiltered EXAFS data (Black) and simulations (Gray) for copper bound to
pMMO. (B) Fourier transforms of the raw EXAFS (Black) and the best-fit simulations
(Gray). (Reprinted with permission from Ref. 658. Copyright 2008 American Chemical
Society.)
Solomon et al. Page 388
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 126.
(Left) Copper EXAFS data and simulations for spmoB and spmoB variants. Raw k3-
weighted EXAFS data and phase-shifted Fourier transforms are shown for spmoB (A,B),
spmoB_H48N (C,D), and spmoB_H137,139A (E,F). Raw unfiltered data are shown in black
and best-fit simulations are shown in grey. χ, EXAFS region of the XAS spectrum; Δ,
apparent shift in Fourier transform displayed bond distance (by ~−0.5 Å) due to a phase shift
during calculation of the transform; k, photoelectron wavevector; R, metal-ligand bond
length. (Right) Normalized XANES spectra of spmoB (A), spmoB_H48N (B), and
spmoB_H137,139A (C). Vertical line is drawn at ~8984 eV. (Reprinted by permission from
Macmillan Publishers Ltd: Nature Ref. 659, copyright 2010.)
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Figure 127.
Absorption data for O2 and H2O2 binding in pMMO. (Left) H2O2 reacted with solubilized
pMMO from M. capsulatus (Bath) (Heme contaminant absorbs at 410 nm). Difference
absorption spectra for both H2O2 and O2 reacted with (Middle) spmoB and (Right) O2 with
spmoB and the spmoB_H48N, spmoB_H137,139A, and spmoB_H148N_137,139A variants.
All samples were anaerobically reduced before addition of oxidant. (Reprinted with
permission from Ref. 717. Copyright 2012 American Chemical Society.)
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Figure 128.
Catalytic activity of spmoB proteins. (a) Epoxidation activity measured as percentage of the
activity of as-isolated, membrane bound pMMO from the Bath enzyme. (b) Methane
oxidation activity measured as percentage of the activity of as-isolated, membrane bound
pMMO from the Bath enzyme. (Reprinted by permission from Macmillan Publishers Ltd:
Nature Ref. 659, copyright 2010.)
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Figure 129.
Two different mechanisms for H-atom abstraction from methane.
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Figure 130.
rR spectra of Cu-ZSM-5 + 16O2 and 18O2 (blue) using 457.9 nm excitation. Inset A:
Absorption spectrum of O2 activated Cu-ZSM-5. Inset B: 16,18O2 (green) and a 1:1
normalized sum of 16O2 and 18O2 (black). (Reprinted with permission from Ref. 39.)
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Figure 131.
Model of the active [Cu2O]2+ core in the 10-membered ring of the ZSM-5 lattice. (Reprinted
with permission from Ref. 39.)
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Figure 132.
DFT-calculated reactivity of the Cu(II)2O core with CH4. (A) Reaction coordinate of H-
atom abstraction from CH4 by Cu(II)2O. (B) SOMOs at the transition state. CH4 approach is
shown in the plane (Left) and below the plane of the figure (Right). (Reprinted with
permission from Ref. 39.)
Solomon et al. Page 395
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 133.
Diffuse reflectance UV-vis spectra of prereduced Cu-ZSM-5 (in He at 450 °C) during (A)
O2 treatment at RT (time interval between spectra is 10 s during the first 2 min, and then
every 50 s for 10 min) and (B) subsequent heating from 25 to 375 °C in He atmosphere
(temperature interval between spectra is 25 °C. (Reprinted with permission from Ref. 718.
Copyright 2010 American Chemical Society.)
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Figure 134.
(A) rR spectra (363.8 nm) of 16O2 (black) and 18O2 (blue) precursor formed at RT and (B)
rR spectra (457.9 nm) of the reactive site formed by heating the O2 precursor samples.
(Reprinted with permission from Ref. 718. Copyright 2010 American Chemical Society.)
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Figure 135.
Reactivity cycle for methane oxidation in Cu-ZSM-5. (Reprinted with permission from
Ref. 718. Copyright 2010 American Chemical Society.)
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Figure 136.
structural comparisons of multicopper oxidases. (A) 3-domain structure from Pyrobaculum
aerophilum (PDB: 3AW5). (B) 6-domain structure from Homo sapiens (PDB: 2J5W). (C) 2-
domain structure expressed in Escherichia coli (PDB: 2ZWN). Copper atoms depicted in
gold, oxygen atoms in red.
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Figure 137.
Water/O2 channels connecting the surface to the T2 and T3 Cu sites in T. versicolor laccase
(1GYC). Cu atoms depicted in gold, oxygen atoms representing water molecules in red.
Solomon et al. Page 400
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 138.
Type 1 Cu sites with Met (S to Cu 3.3A) (A) and Phe (B) in the axial coordination position
of CotA (2X88) and T. versicolor laccase (1GYC), respectively
Solomon et al. Page 401
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 139.
Coordination environments of the Type 1 Cu and substrate binding sites for (A) M.
albomyces laccase (3FU7) and ceruloplasmin (2J5W), respectively
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Figure 140.
Structural representation of the trinuclear cluster in the multicopper oxidases, depicting eight
1st sphere His in the HXH conformation. Also shown are the conserved carboxylate residues
D77 and D456 (numbering according to T. versicolor laccase (PDB: 1GYC))
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Figure 141.
Comparison of the TNC in reduced (red) and oxidized (blue) ascorbate oxidase
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Figure 142.
Spectroscopic features of the resting oxidized enzyme in RvL: (A) Electronic absorption and
(B) EPR.
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Figure 143.
Spectroscopic features of the trinuclear Cu site in Lc: (A) LT MCD and (B) RT CD of
oxidized T1Hg Lc. (Reprinted with permission from Ref. 922. Copyright 2001 John Wiley
and Sons Inc.)
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Figure 144.
Electronic structure of the resting trinuclear cluster. (From Ref. 921 – Reproduced by
permission of The Royal Society of Chemistry.)
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Figure 145.
(A) RT Abs (top) and LT MCD (bottom) spectra of azide titration at 2.5, 9.0 and 38 protein
equivalents (a,b, and c) of native RvLc. (Reprinted with permission from Ref. 884.) (B) LT
EPR spectra corresponding to the RT Abs and LT MCD samples. (Reprinted with
permission from Ref. 871. Copyright 1990 American Chemical Society.) (C) Optimized
structures of Niaz and Raz. (Reprinted with permission from Ref. 900, copyright 2007
National Academy of Sciences, USA.)
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Figure 146.
Fluoride binding to T1Hg Lc, showing the splitting of the parallel hyperfine structure into
doublets. Data-solid line, simulation-dotted line. Y-axis in units of Magnetic Field (Gauss).
(Reprinted with permission from Ref. 895. Copyright 2005 American Chemical Society.)
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Figure 147.
Decay of PI in T1Hg Lc. (A) decay of the RT absorption and (B) difference spectra of PI
with the spectrum of reduced T1Hg subtracted. (Reprinted with permission from Ref. 873.
Copyright 1996 American Chemical Society.)
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Figure 148.
IRMS and absorption of the decay of PI monitored under the same conditions. (Reprinted
with permission from Ref. 873. Copyright 1996 American Chemical Society.)
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Figure 149.
Comparison of (left) RT CD and (right) LT MCD of the oxidized resting state of T1Hg
laccase (dashed) and PI (blue). (Reprinted with permission from Ref. 922. Copyright 2001
John Wiley and Sons Inc.)
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Figure 150.
(A) Absorption spectra of the charge transfer region of oxy-Hc (black) and PI (red). (B) RT
Abs of the CT region of PI, with assignment of CT transitions indicated. (Reprinted with
permission from Ref. 906. Copyright 2007 American Chemical Society.)
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Figure 151.
Fourier transforms of the EXAFS data for PI (−), reduced (- -), oxidized (-_-) forms of T1Hg
Lc. (Reprinted with permission from Ref. 873. Copyright 1996 American Chemical Society.)
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Figure 152.
(A) Calculated geometric structures of PI without and with D94. The PI structure without
D94 (left) has both T3 Cu’s oxidized and the T2 Cu reduced while in the structure with D94
(right), the T3β and T2 are oxidized and the T3A is reduced. (B) Contours of the α- (based
on the T2 dx2-y2) and the β- (based on the T3 β dx2-y2) LUMOs of PI + D94. (Reprinted with
permission from Ref. 906. Copyright 2007 American Chemical Society.)
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Figure 153.
Stopped flow absorption spectra (top) and rapid freeze quench MCD spectra (A), Cu K-edge
XAS spectra (B), variable temperature, variable field behavior of the MCD spectra with
Brillouin function fits with different values (C), low temperature X-band EPR (D),
temperature dependence of the MCD spectra (E) and plot of temperature dependence of
MCD intensity at 25,000 cm−1 of NI. (From Ref.597–Reproduced by permission of The
Royal Society of Chemistry.)
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Figure 154.
Fourier Transformed EXAFS spectra of NI (A) and magnetostructural correlation of the Cu-
Cu distance (and angle) with exchange coupling constants (J) for OH bridged Cu(II) model
complexes (B). (Reprinted with permission from Ref. 909. Copyright 2002 American
Chemical Society.)
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Figure 155.
Energy levels of spin states in trinuclear Cu(II) species, with one, two, and three bridging
interactions, respectively. (From Ref. 921 – Reproduced by permission of The Royal Society
of Chemistry.)
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Figure 156.
Modeled LT MCD spectra of the ground and first excited state of NI (A), Coupling
coefficients of individual Cu’s in the ground and excited state wave functions (B), Estimated
bridging interactions between the three Cu(II)’s (C). (Reprinted with permission from
Ref. 909. Copyright 2002 American Chemical Society.)
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Figure 157.
Structures of the TrisOH (A) and μ3-oxo (B) model complexes. Mechanism for
antisymmetric exchange in TrisOH. (Reprinted with permission from Ref. 916. Copyright
2005 American Chemical Society.)
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Figure 158.
Single crystal LT EPR of TrisOH at angles from 0–60° spanning g-values from 2.3 to 1.2 of
the molecular z-axis with respect to the direction of the applied field. (Reprinted with
permission from Ref. 918. Copyright 2004 American Chemical Society.)
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Figure 159.
MCD spectra of the TrisOH model complex (A), and the μ3-oxo complex (B), Metal-based
SOC as observed in TrisOH (C), Ligand-based SOC as observed in μ3-oxo (D). (From
Ref. 921 – Reproduced by permission of The Royal Society of Chemistry.)
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Figure 160.
Spectroscopically derived calculated structure of NI where the μ3-oxo and μ2OH derive from
the 4-electron reduction of dioxygen. (Reprinted with permission from Ref. 906. Copyright
2007 American Chemical Society.)
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Figure 161.
Mechanism of O2 reduction to water by the multicopper oxidases. The catalytic cycle
comprise steps connected by the red arrows, with an additional facile intramolecular ET
from T1 to T2 Cu in-between step 1 and 2. Due to slow conversion, NI to resting oxidized
enzyme is not part of the catalytic cycle. (From Ref. 921 – Reproduced by permission of The
Royal Society of Chemistry.)
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Figure 162.
A. Cu K-edge XAS of deoxy Hc before and immediately after exposure to O2. B. Similar as
A, but with deoxy laccase. (From Ref. 921 – Reproduced by permission of The Royal
Society of Chemistry.)
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Figure 163.
Reaction coordinates for O2 binding in laccase. S=0 (obtained from broken symmetry
calculations) and S=1 energies are shown in filled and open symbols, respectively. Inset:
similar results for deoxy hemocyanin. (Reprinted with permission from Ref. 333.)
Solomon et al. Page 426
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 164.
Structures of deoxy hemocyanin and deoxy laccase emphasizing the backbone induced
constraints on the T3 Cu coordinating His residues. (Reprinted with permission from
Ref. 333.)
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Figure 165.
Active site structure with residue numbering according to the Fet3p sequence. (Reprinted
with permission from Ref. 907. Copyright 2010 American Chemical Society.)
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Figure 166.
Absorption spectra of reduced T1D WT (red) T1DH126Q (blue), and T1DH483Q (green),
immediately after exposure to O2. (Reprinted with permission from Ref. 907. Copyright 2010
American Chemical Society.)
Solomon et al. Page 429
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 167.
CD spectra of PI in T1D WT (red), T1DH126Q (blue) and band assignments (dotted).
(Reprinted with permission from Ref. 907. Copyright 2010 American Chemical Society.)
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Figure 168.
Morse Potential energy surfaces of reductive cleavage of peroxide in (A) 1e− and (B) 2e−
processes. (Reprinted with permission from Ref. 874. Copyright 2001 American Chemical
Society.)
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Figure 169.
PI decay rates as a function of pH of T1D WT (red), T1DD94E (blue), T1DE487D (green),
and T1DE487A (black). (Reprinted with permission from Ref. 889. Copyright 2007
American Chemical Society.)
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Figure 170.
Model for proton assisted reductive cleavage of the O-O bond in PI. (Reprinted with
permission from Ref. 889. Copyright 2007 American Chemical Society.)
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Figure 171.
Schematic of calculated structures in reduction of PI to NI. (Reprinted with permission from
Ref. 906. Copyright 2007 American Chemical Society.)
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Figure 172.
2 Dimentional energy surface plots of proton assisted- and unassisted pathways, as well as
intermediate pathways with concurrent elongation of the O-O bond and formation of the μ2-
O-H bond. Proton unassisted pathway goes through TS1 and proton assisted pathway
through TS2. (Reprinted with permission from Ref. 906. Copyright 2007 American Chemical
Society.)
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Figure 173.
Calculated spin densities of the three trinuclear cluster Cu’s in the conversion of PI to NI
with elongation of the O-O bond. (Reprinted with permission from Ref. 906. Copyright 2007
American Chemical Society.)
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Figure 174.
Schematic of the FMOs involved in O-O bond cleavage by the TNC. HOMO’s on T2/T3α
overlap with LUMO’s on O22−. The half occupied dx2-y2 helps stabilizing the energy of the
LUMO’s. (Reprinted with permission from Ref. 906. Copyright 2007 American Chemical
Society.)
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Figure 175.
(A) Model for decay of NI to resting oxidized enzyme, including two H+ transfer steps and
release of one water molecule. (B) Calculated relative energies of the last step in (A) for
NIH2O (red) and NIOH (blue). (Reprinted with permission from Ref. 900, copyright 2007
National Academy of Sciences, USA.)
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Figure 176.
Experimentally determined structures of the trinuclear clustes in the Native Intermediate
(left) and the resting state (right). (Reprinted with permission from Ref. 926 copyright 2013
American Chemical Society)
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Figure 177.
Schematic representation of subunit I/N showing the conserved redox centers common to all
Heme-copper oxidases. A) Electrons are transferred to the binuclear heme-CuB site via the
low-spin heme site (pink arrow). Proton transfer from the N-side of the membrane (grey
arrow) leads to the heme a3/CuB binuclear site to produce H2O from reduced O2 (red
arrows), and for pumping protons across the membrane (blue arrow). B) Dioxygen binding
site in HCO (structure of the fully reduced bovine CcO Protein Data Bank number 1v55998).
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Figure 178.
The minimal functional unit of Heme-copper Oxidases from the three families: types A, B
and C.
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Figure 179.
Structures of heme A, heme B and heme O. The numbering of the porphyrin carbons are
demonstrated in heme A.
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Figure 180.
Catalytic cycle of Heme-copper Oxidases. Species entering and leaving the binuclear site
(heme a3/CuB) are shown. Proton translocation/pumping is not shown here.
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Figure 181.
Proposed mechanism for the reaction of fully reduced CcO with O2. Curved arrows
represent species entering or leaving the binuclear site. Two additional electrons are needed
to generate the fully reduced site, R, from OH, not shown here. Block arrows represent
proton pumping. The references for the kinetic constants are given in the text.
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Figure 182.
Proposed mechanism for the reaction of mixed valence CcO with O2. PM to F and OH are
observed after injection of external electrons into CcO. Block arrows represent proton
pumping. The references for the kinetic constants are given in the text.
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Figure 183.
Proposed reaction scheme showing the two possible pathways for the reduction of the
oxidized pulsed form of the binuclear center in CcO. Block arrows represent proton
pumping that is absent when OH decays to O and gets reduced.
Solomon et al. Page 446
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 184.
Cytochrome c oxidase structure from bovine heart. (A) Overall structure where the 13
subunits are shown in different colors [subunit I (yellow), subunit II (green), subunit III
(red), subunit IV (dark blue)]. (B) Expanded view of the redox active metal centers.
CuA···Fea = 20.6 Å; CuA···Fea3 = 23.2 Å; Fea···Fea3 = 13.4 Å; CuB···Fea3 = 5.2 Å. Figure
generated from PDB ID 2Y691006 coordinates using VMD.
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Figure 185.
Structure of (left) ubiquinol oxidase from E. coli and (right) cytochrome c oxidase from P.
denitrificans parallel to the membrane. Subunits I,II, III and IV are shown in yellow/green,
green, blue and pink, respectively. Hemes b and o3 in subunit I are red and light blue,
respectively. The blue spheres in subunits I and II are the CuB and CuA (two Cu atoms)
centers, respectively. The dotted circle represents the location of the electron donating
substrates—ubiquinol at the posterior of ubiquinol oxidase within the membrane and
cytochrome c on the P-side of CcO. (Reprinted with permission from Macmillan Publishers
Ltd: Nature Structural Biology Ref. 991, copyright 2000)
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Figure 186.
Resting oxidized structure of CcO. Left) Fo-Fc difference electron density maps calculated
at 2.5 Å resolution. The datasets are depicted together with the structural model of heme a3
(red) and CuB (cyan). Right) Coordination geometries of the peroxide anion obtained from
structural refinement calculated at 2.1 Å resolution. The interatomic distances are given in
angstroms. Other distances and angles are Fea3-CuB = 4.87 Å; Nε2(H376)-Fea3-O1 = 168.5°;
Fea3-O1-O2 = 144.1° and O1-O2-CuB = 90.5°. (Figure reprinted with permission from
Ref. 1000.)
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Figure 187.
Structural comparison of the active site and key residues involved in proton pumping
between oxidized (PDB ID 2GSM1003) and reduced (PDB ID 2FYE1004) states of CcO from
R. sphaeroides. Reduced (solid), oxidized (transparent).
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Figure 188.
Schematic showing the crystallographic parameters of the (A, B) CO-, (C) NO-, and (D)
CN−-bound forms of the binuclear center of fully reduced CcO. Adapted from reference 999
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Figure 189.
Proposed ET pathways in bovine heart CcO based on pathways analysis. The Cys200 and
His204 CuA-to-heme a pathways are comparable in rate whereas the Cys196 pathway is
calculated to be two orders of magnitude less efficient. R438, R439 and Y440 belong to
subunit I: the remaining resides belong to subunit II. Figure generated from PDB ID
2Y691006 coordinates using VMD.
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Figure 190.
Residues forming a direct pathway between heme a and heme a3 centers. Figure generated
from PDB ID 1OCC989 coordinates using Chem3D.
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Figure 191.
A possible electron transfer pathway from the proposed ubiquinone binding site to heme b in
ubiquinol oxidase. (Reprited by permission from M Ref. Publishers Ltd: Nature Structural
Biology Ref. 991 copyright 2000)
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Figure 192.
Schematic drawing showing the residues invoked in the K (green) and D (pink) proton
pumping pathways. Figure generated from PDB ID 2Y691006 coordinates using VMD.
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Figure 193.
Schematic drawing showing the residues invoked in the K (green) and D (pink) proton
pumping pathways. Figure generated from PDB ID 2Y691006 coordinates using VMD.
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Figure 194.
Cu K-edge X-ray absorption edge spectra of oxidized (—) and reduced (- -) UbO; Inset:
Fourier transform of the Cu EXAFS. (Reprinted with permission from Ref. 1029. Copyright
1999 American Chemical Society.)
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Figure 195.
Resonance Raman spectra and difference spectra of the primary oxygen intermediate from
the reaction of fully reduced CcO with dioxygen. Reacion of fully reduced with A) 16O2,
B) 18O2, C) difference spectra showing the isotopic shift and D) difference spectra showing
isotopic shift of prmary intermediate in the reaction of oxygen with the mixed-valence
(Mixed Val) enzyme. Adapted from Reference1035 Proc Natl Acad Science USA
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Figure 196.
Resonance Raman spectrum (607 nm excitation) of a P state of bovine CcO.
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Figure 197.
ATR-FTIR difference spectrum of P. denitrificans cytochrome c oxidase state PM minus
state O. The feature at 1519 cm−1 is indicative of a tyrosyl radical.
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Figure 198.
Resonance Raman difference spectrum of the reaction of CcO with 16O2 and 18O2 at 520 μs
using 427 nm excitation that displays two oxygen isotope sensitive features, a νFe—O at
786 cm−1 and a δN—Fe—O at 355 cm−1, consistent with an Fe(IV)=O in state F. (Figure
reprinted with permission from Ref. 1035.)
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Figure 199.
Simplified consensus mechanism of the reductive cleavage of O2 by hemecopper oxidases.
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Figure 200.
Heme-copper models created by Collman and coworkers in which addition of dioxygen to
the reduced precursor generates a Fe(III)-superoxide intermediate which is competent for
inter- and intramolecular hydrogen atom abstraction to generate a phenoxy radical.
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Figure 201.
Addition of dicyclohexylimidazole to {[(F8)Fe]-O2-[Cu(AN)]}+ results in a distinct species
in which the imidazole coordinates the iron axially, and the geometry of the peroxide ligand
bridges changes from “side-on” to “end-on”. The spin of the heme also changes from high-
spin to low-spin upon coordination of the imidazole.
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Figure 202.
Schematic of the spin topology of the reductive cleavage of a putative peroxointeremdaite in
CcO to generate PM. A spin down electron originates from the Fe, and a spin up electron
originates from the crosslinked tyrosine to fill the σ* of the peroxide ligand. (Reprinted with
permission from Ref. 1075. Copyright 2011 American Chemical Society).
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Figure 203.
Overlay of the D-channel of wild-type (purple) and N131D (carbon atoms in yellow) variant
of P. denitrificans cytochrome oxidase. Hydrogen bonds between waters and channel
residues are shown in green (Ref 1093[Durr 2008]). E278 (E286 in R. Shpaeroides
numbering) is at the top of the channel and is found in two different orientations, “up” and
“down”.
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Figure 204.
The reduction of resting CcO (A) to generate fully reduced CcO (B) causes breaking of the
crosslinked tyrosine-porphryn farnesyl hydroxide hydrogen bond to break that is associated
with water entering the active site. (Reprinted with permission from Ref. 1004. Copyright
2009 American Chemical Society).
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Figure 205.
Illustration of the microscopic mechanism of proton pumping for the P → F proton pumping
step. The proton loading site is loaded in PM, PR, and F.
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Figure 206.
Comparison of trinuclear active site arrangements for the multicopper oxidases and Heme-
copper oxidases depicted in the NI and PM forms, respectively.
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Figure 207.
Enzymatic processes in fungi involving quercetin. A) Formation of quercetin from rutin by
rutinase and 2) 2,4-dioxygenation of quercetin catalyzed by quercetin 2,4-dioxygenase,
including ring and atom nomenclature for the quercetin ring.
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Figure 208.
Crystal structure of the A. japonicus quercetin 2,4-dioxygenase dimer. One monomer is
colored in blue and one in yellow, with different shades showing the two domains in each
monomer. Copper shown in green.
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Figure 209.
Structure of the mononuclear copper active site of A. japonicus quercetin 2,4-dioxygenase
from X-ray structures. A) Resting quercetin 2,4-dioxygenase site, Glu73-off conformation
(major form, 70%). B) Resting quercetin 2,4-dioxygenase site, Glu-on conformation (minor
form, 30%). C) quercetin 2,4-dioxygenase enzyme-substrate complex with quercetin. Dotted
lines represent hydrogen bonds.
Solomon et al. Page 472
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 210.
Absorption spectra of A. flavus quercetin 2,4-dioxygenase: A) resting enzyme at pH 6, B)
free quercetin, C) the ES complex of quercetin 2,4-dioxygenase with quercetin, and D) the
product spectrum after exposing the ES complex, C, to O2.
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Figure 211.
EPR spectra of different forms of quercetin 2,4-dioxygenase from A. japonicus. A) Resting
quercetin 2,4-dioxygenase at pH 6 (solid lines represent the major, tetrahedral form and
dashed lines represent the minor, 5 coordinate form). B) Resting quercetin 2,4-dioxygenase
at pH 10 (only the trigonal bipyramidal form contributes). C) quercetin 2,4-dioxygenase
enzyme-substrate complex with 1 eq. quercetin (2.5% DMSO). D) quercetin 2,4-
dioxygenase enzyme-product complex observed after exposure of (C) to air.
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Figure 212.
Proposed mechanism for the 2,4-dioxygenation of quercetin by 2,4-QD.
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Figure 213.
Alternative 2,4 dioxygenation routes observed in CuII flavonolate model complexes.
Solomon et al. Page 476
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 214.
Oxidation of amines to aldehydes catalyzed by amine oxidase.
Solomon et al. Page 477
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 215.
Amine oxidation catalyzed by TPQ-containing amine oxidases. A) Reductive half-reaction.
B) Oxidative half reaction of AO, including the proposed equilibrium between CuII-
aminoquinol and CuI-semiquinone forms of the amine-reduced site.
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Figure 216.
X-ray crystal structure of holo AGAO.
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Figure 217.
Active site structure of holo amine oxidase with TPQ in the active conformation (A) and
inactive conformation (B). Important second sphere residues pictured are Tyr284 (H-
bonding partner of TPQ), Asp298 (the active site base), and Tyr296 (lid for substrate access
channel).
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Figure 218.
X-ray snapshots of TPQ biogenesis. A) Apo Amine Oxidase. B) Anaerobic Cu-reconstituted
preprocessed Arthrobacter globiformis Amine Oxidase. C) DPQ intermediate trapped in the
crystal. D) TPQred on-Cu structure. E) Oxidized holo Arthrobacter globiformis Amine
Oxidase containing off-Cu TPQox.
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Figure 219.
Spectral features of processed (red, a) and preprocessed (black, b) Arthrobacter globiformis
Amine Oxidase. A) Room temperature absorption. B) Room temperature circular dichroism.
C) 77 K EPR spectra.
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Figure 220.
Crystal structures of tetrahedral phenolate-copper model complexes for active site of Amine
Oxidase. A) [Cu(OPh-F)(HB(3,5-i-Pr2Pz)3)] – L1. B) [Cu(OPh-F)(HB(3-tBu-5-i-Pr2Pz)3)] –
L3.
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Figure 221.
77K EPR spectra of [Cu(OPh-4-F)(L)]+ model complexes (top L1, bottom L3).
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Figure 222.
Low temperature absorption and MCD spectra of [Cu(OPh-4-F)(L)]+ model complexes (left
site L1, right side L3).
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Figure 223.
β LUMOs of [Cu(OPh-4-F)(L)]+ model complexes. A) L1, B) L3. (Reprinted with
permission from Ref. 1239. Copyright 2008 American Chemical Society.)
Solomon et al. Page 486
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 224.
Proposed mechanism for TPQ and LTQ biogenesis.
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Figure 225.
Orbital overlap of key frontier molecular orbitals showing the electron transfer process
during our proposed concerted mechanism for O2 attack on the [Cu(His)3(Tyr)]+ site in TPQ
biogenesis. Blue indicates orbitals involved in the transfer of a beta spin electron, red
indicates orbitals involved in the transfer of an alpha spin electron.
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Figure 226.
The nitrogen cycle.
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Figure 227.
The Type 1 and Type 2 sites of nitrite reductase with their ligands, showing the Cys-His
pathway.
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Figure 228.
The Type 2 site of copper nitrite reducatse with various ligands bound, including the key
second sphere residues Asp98 and His255. A) Resting T2 site with hydroxide ligand. B)
Nitrite bound oxidized T2 site. C) NO bound T2 site.
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Figure 229.
EPR spectra of significant nitrite coordinated T2 species. A) Nitrite coordinated T2 with T1
oxidized, pH 5.5, 77 K EPR. B) Nitrite coordinated T2 with T1 oxidized, pH 8.4, 77 K EPR.
C) Nitrite coordinated T2 with T1 reduced, pH 8.4, 77 K EPR.
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Figure 230.
EPR spectra of putative NO-bound CuNiR species and nitrite-bound CuNiR. A) Reported
CuII-NO− solution EPR spectrum, 77 K. B) Nitrite-bound T2 EPR spectrum, 77 K. C) CuI-
NO• EPR spectrum obtained upon freezing 30 s after addition of NO, 77 K.
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Figure 231.
Mechanism of nitrite reduction by Cu NiR, focused on the role of the T2 site.
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Figure 232.
Three possible geometries of HNO2 binding to the reduced T2 Cu site and the resulting
reactions. A) η2 bidentate, B) η1κN, and C) η1κO(H).
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Figure 233.
The increase in the specific activity of PnN2OR (blue) upon incubation with reduced methyl
viologen correlates with a decrease in the EPR spin intensity (red) of 1-hole CuZ*. Inset:
Intensity of the EPR spectra of 1-hole CuZ* decrease upon incubation with methyl viologen.
(Reprinted with permission from Ref. 1317. Copyright 2003 American Chemical Society.)
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Figure 234.
Protein structure of the N2OR homodimer (PdN2OR, 1.9 Å resolution) showing the head-to-
tail association of the two monomers and the positions of the CuA and CuZ sites. One
monomer is colored while the other is grey; copper is colored in green and sulfide in yellow.
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Figure 235.
The structure of CuA.
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Figure 236.
A comparison of the structures of CuZ from different N2OR crystal structures. A)
PdN2OR,1292 B) AcN2OR,1295 C) AcN2OR with iodide bound,1295 and D) anaerobically
purified PsN2OR.1296 Copper is colored in green; sulfide in yellow; iodine in purple; and
oxygen in red.
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Figure 237.
The structure of N2O bound at the CuZ site in a crystal of anaerobic PsN2OR. Distances to
CuZ and key residues labelled in Å.
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Figure 238.
DFT optimized ground state wavefunction (σu*) and low-lying excited state wavefunction
(πu) of CuA modeled as [Cu2(SCH3)(imz)2]+ (B3LYP/TZVP(Cu,S)/6-31G*). (Reprinted
with permission from Ref. 1335. Copyright 2003 American Chemical Society.)
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Figure 239.
Spectral features of CuA from the N2OR V variant of PsN2OR (lacking the CuZ cluster). A)
77 K EPR spectrum. B) Room temperature absorption spectrum. C) Low temperature MCD
spectrum.
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Figure 240.
Spectroscopic comparison of anaerobically and aerobically purified PsN2OR. A) Room
temperature absorption, low temperature MCD (7T, 5K), and low temperature EPR (77 K)
of anaerobically isolated N2OR in the fully oxidized state (black), ascorbate reduced state
(red) and dithionite-reduced state (blue). B) Room temperature absorption, low temperature
MCD (7T, 5K), and low temperature EPR (77 K) of aerobically isolated N2OR in the fully
oxidized state (black), ascorbate reduced state (red) and dithionite-reduced state (blue).
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Figure 241.
Copper K-edge X-ray absorption spectrum of N2OR, with fits predicted for a 3CuIICuI site
(dashed) and a CuII3CuI site (dotted).
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Figure 242.
A) 10 K absorption spectrum of 1-hole CuZ* from PnN2OR. B) MCD spectrum of 1-hole
CuZ* from PnN2OR (+7T, 5K).
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Figure 243.
Orientation of the S p orbitals in CuZ*. Selected MOs from a DFT calculation on an early
model of the CuZ* site (BP86 38%HF, 6-311G*/6-31G*). (Reprinted with permission from
Ref. 1330. Copyright 2002 American Chemical Society.)
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Figure 244.
Resonance Raman spectrum of 1-hole CuZ* with pH and H2O18 dependence. A) Resonance
raman spectrum of 1-hole CuZ* from PnN2OR at pH 7 (77 K, 629 nm excitation).1320 B)
Resonance raman spectrum at pH 10.5 (77 K, 629 nm excitation).1320 C) Excitation profiles
of the three resonance enhanced vibrations of 1-hole CuZ* profiled at pH 7, revealing three S
to Cu charge transfer transitions (5, 6, 7). D) Normal modes of the CuZ * core assigned by
normal coordinate analysis. (Reprinted with permission from Ref. 1330. Copyright 2002
American Chemical Society.)
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Figure 245.
EPR spectra of 1-hole CuZ* from PnN2OR. A) X-band EPR at pH 7 and 77 K (simulated
spectrum top, experimental bottom). B) Q-band EPR at pH 7 and 77 K (simulation top,
experimental bottom). (Reprinted with permission from Ref. 1320. Copyright 2007 American
Chemical Society.)
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Figure 246.
Lowest unoccupied molecular orbital of 1-hole CuZ*, labeled with Mulliken Atomic Spin
Density for core atoms (B3LYP/6-311++G** on Cu4SO/6-31G* on remaining atoms).
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Figure 247.
Proposed molecular mechanism for N2O reduction by CuZ* containing N2OR. MV
abbreviates methyl viologen.
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Figure 248.
Computationally predicted geometry and electronic structure of N2O binding to fully
reduced CuZ*. A) Optimized geometry of the lowest energy structure of N2O bound to 4CuI
CuZ* (BP86, 6-311G*). B) LUMO of the N2O complex. (Reprinted with permission from
Ref. 1339. Copyright 2006 American Chemical Society.)
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Figure 249.
Computational evaluation of sequential protonation and reduction steps to reduce 2-hole
oxo-bridged CuZ* to fully reduced aquo-CuZ* (B3LYP/6-311++G** on Cu4SL/6-31G*
otherwise).
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Figure 250.
(A) Reaction of cellulose chain opening by the polysaccharide monooxygenases, via H-atom
abstraction from the 1 position, as proposed by Phillips et al. (B) End-on bound superoxide
structure of PMO-2 from Neurospora crassa (pdb: 4EIR). Gold sphere: Cu, Red spheres:
oxygen. Second sphere residues Y168 and Q166 (<4Å from the Cu) are included
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Table 1
Effect of the Li (i =x,y,z) operator on the real d functions
L̂xdxy = −idxy L̂zdxz = idyz
L̂ydyz = idxy L̂zdyz = idxz
Lx̂dxy = idxz L̂ydxy = −idyz L̂zdxy = −2idx2−y2
L̂xdx2−y2 = −idyz Lŷdx2−y2 = −idxz L̂zdx2−y2 = 2idxy
L̂zdz2 = 0
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Table 3
Calculated Mulliken Spin Densities for Cu(II) in [CuCl4]2− D4h complex113
Method TZV*/6-31G* ECP(SDD)
HF 0.83 0.85
MP2 0.70 0.70
MP4 0.67 0.67
CCD 0.74 0.74
CISD 0.75 0.74
QCISD 0.60 0.58
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Table 4
Effect of second sphere interactions on the covalency of the Cu-S bond in blue Cu sites. Inclusion of protein
dipoles and H-bond interactions decreases the HF exchange needed in the hybrid functional.117
Model Functional Cu-spin SCys-spin
Experiment 0.41 d 0.38 p
33 atom BP86 0.27 0.61
B3LYP 0.33 0.57
B(38HF)P86 0.46 0.44
217 atom B3LYP 0.43 0.43
QM/MM (all protein) B3LYP 0.44 0.42
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Solomon et al. Page 518
Table 5
Crystal structure bond lengths and absolute difference with respect calculated bond length in DFT optimized
structures. All distances in Å.
Bond Lengths Crystal BP86 B3LYP B(38HF)P86
Cu-O(proximal) 1.927 0.113 0.079 0.027
Cu-O(terminal) 2.842 0.153 0.083 0.020
O-O 1.280 0.077 0.068 0.066
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Table 6
DFT calculation (6-311G* basis set) for hydrotris(3-tertbutyl-5-isopropyl-1-pyrazolyl)-borate CuO2. Ground
state geometries are all side-on bound superoxo-Cu(II). Energies relative to the lowest singlet state (kcal/mol)
after correction for spin contamination. Adapted from ref 121
Functional (2S+1) ΔE
BP86 1 0.00
BP86 3 1.23
B3LYP 1 0.00
B3LYP 3 −8.25
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Table 7
Oxygen affinities (P1/2) of hemocyanin at under physiological conditions.
Arthropod
Organism P1/2 (torr) pH T (° C) Samplea
Crab
    Atelecyclus rotundatus163 5.6 7.8 10 WB
    Birgus latro164 21 7.6 29 WB
    Bythograea thermydron160 3.0 to 5.3 7.7 2 to 20 S
    Callinectes sapidus165 1.4 to 15 7.5 to 7.9 5 to 25 WB
    Cancer borealis166 1.2 to 11 7.7 to 8.1 5 to 15 WB
    Cancer magister167 20 7.7 10 WB
    Cardisoma carnifex164 11 7.6 29 WB
    Coenobita brevimanus164 15 7.7 29 WB
    Corystes cassivelaunus168 3.1 to 4.5 7.8 to 7.9 10 WB
    Gecarcinus lateralis169 18 7.4 to 7.5 25 WB
    Goneplax rhomboids163 4.1 7.8 10 WB
    Holthuisana transversa170 2.6 to 12 7.4 15 to 35 WB
    Leptograpsus variegatus171 22 7.8 15 to 20 WB
    Libinia emarginata172 9 to 17 7.4 to 7.8 25 S
    Liocarcinus depurator163 11 8.1 10 WB
    Menippe mercenaria166 8.2 to 15 7.5 to 7.7 15 to 25 WB
    Pagurus bernhardus173 24 to 70 7.8 to 8.0 5 to 25 WB
    Ocypode quadrata172 7 to 11 7.9 to 8.1 25 S
Crayfish
    Astacus leptodactylus174 9.6 to 17 7.4 to 8.2 10 to 20 WB
    Orconectes rusticus175 7.0 to 8.4 7.7 to 7.9 15 WB
    Pacifastacus leniusculus 176 6.2 to 12 7.6 to 7.8 10 to 25 S
Isopod
    Glyptonotus antarcticus177 10 8.0 0 WB
Krill
    Meganyctiphanes norvegica178 18 to 50 7.9 5 to 10 WB
Lobster
    Galathea strigosa168 12 8.0 10 WB
    Jasus edwardsii179 29 7.6 20 S−
    Munida rugosa180 29 to 39 7.9 10 WB
    Munida sarsi180 50 7.9 10 WB
    Nephrops norvegicus168 11 7.9 10 WB
Shrimp
    Callianassa californiensis181 2.5 8.2 10 S
    Callianassa subterranean182 1.4 7.8 10 WB
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Arthropod
Organism P1/2 (torr) pH T (° C) Samplea
    Calocaris macandreae182 0.9 7.8 10 WB
    Gnathophausia ingens161 1.0 to 1.2 8.0 2 to 10 S
    Jaxea nocturna182 1.5 7.7 10 WB
    Macrobrachium rosenbergii183 6.7 to 35 7.5 to 7.7 22 to 32 WB
    Upogebia deltaura182 6.5 7.8 10 WB
    Upogebia stellate182 11 7.7 10 WB
Mollusc
Organism P1/2 (torr) pH T (° C) Samplea
Chiton
    Chiton tuberculatus184 24 7.3 25 WB
    Katherina tunicate184 23 7.4 25 WB
    Mopalia muscosa184 21 7.4 25 WB
Cuddlefish
    Sepia officinalis185,186 5.3 to 6.5 7.4 10 to 20 WB
Nautilus
    Nautilus pompilius187 17 7.5 18 WB
Octopus
    Octopus dofleini188,189 39 7.0 to 7.2 10 S
    Octopus vulgaris190 35 7.4 to 7.5 23 WB
Snail
    Buccinum undatum191 8.9 to 59 7.5 to 8.1 10 WB
    Busycon canaliculatum192 11 to 14 7.9 to 8.1 22 WB
    Fasciolaria tulipa193 7 7.7 to 7.9 25 WB
    Fusitrition oregonensis193 7 7.7 to 7.9 25 WB
    Haliotis iris194 3.9 7.0 15 WB
Squid
    Illex illecebrosus195,196 7.9 7.4 to 7.5 15 WB
    Loligo pealei195,196 7.9 to 13 7.2 to 7.5 15 WB
aWB (whole blood) or S (physiological saline solution)
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Table 10
Thermodynamic parameters for the T and R-states of several hemocyanins.
Organism ΔH
(kcal/mol)
ΔS
(cal mol−1 K−1)
Panulirus interruptus199
  T-Statea −10.6 −14.4
  R-Statea −6.9 2.4
Helix pomatia227
  T-State −15.4 −31.1
  R-State −11.5 −12.6
Levantina hierosolima228
  T-State 0.31 30.5
  R-State −0.75 −1.8
a
Thermodynamic parameters were calculated as described for Table 9.
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Table 11
Thermodynamic parameters for ligands that form side-on Cu2O2 complexes.
Ligand ΔH
(kcal/mol)
ΔS
(cal mol−1 K−1)
Binucleating
MeL66253 −7.7 −21
N3254 −20 −71
N4a,254 −20 to −14 −65 to −39
N5254 −19 −57
XYLb,254 −15 to −10 −47 to −42
Mononucleating
MeAN255 −28 −61
MePY2256 −21 −57
PYANb,257 −19 to −14 −50 to −34
aWith different coordinating ligands
b
In different solvents
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Table 11
Kinetic parameters for reversible O2 binding.
Organism Statea kon (µM−1 s−1) koff (s−1)
Panulirus interrputus199 R 30 to 44 13 to 80
Panulirus interrputus199 T 20 to 44 280 to 2750
Limulous polyphemus268 C 1.4 to 2.5 9 to 55
Buccinum undatum305 R 8.5 80
Helix pomatia303 R 3.8 10
Helix pomatia303 T 1.3 300
Lymnaea stagnalis203 C 25 to 31 44 to 188
a
R-state (R), T-state (T), or cooperative (C)
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Table 12
Atomic structures of arthropod and mollusc Hc.
species state resolution O2 affinity PDB code
Arthropod
  L. polyphemus306,309 deoxy-Hc 2.18 Å T-state 1LLA
oxy-Hc (hexameric) 2.40 Å T-state 1OXY
oxy-Hc (subunit II) 2.18 Å T-state 1NOL
  P. interruptus143 deoxy-Hc 3.20 Å none 1HCY
Mollusc
  E. dofleini157 oxy-Hc 2.30 Å unknown 1JS8
  R. thomasiana310 deoxy-Hc 3.30 Å unknown 1LNL
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Table 13
Selected geometric parameters from deoxy and oxy-Hc in Å.
deoxy-Hc
atomsa L. polyphemus309 P. interruptusb,143 R. thomasianab,310
NHis173-CuA 2.1 2.0 1.8
NHis177-CuA 2.0 2.1 2.7
NHis204-CuA 1.9 2.5 2.0
NHis324-CuB 2.2 2.0 2.0
NHis328-CuB 2.1 2.5 2.3
NHis364-CuB 1.9 2.3 2.1
CuA•••CuB 4.6 2.9 2.2
τ CuAc 0.2 1.0 0.8
τ CuBc 0.4 1.2 1.5
oxy-Hc
atomsa L. polyphemus306 E. dofleini157
NHis173-CuA 1.9 2.3
NHis177-CuA 2.0 2.2
NHis204-CuA 2.3 2.3
NHis324-CuB 2.0 2.2
NHis328-CuB 2.3 2.1
NHis364-CuB 1.9 2.1
CuA•••CuB 3.6 3.5
a
Residue numbering from L. polyphemus
bSubunit 1
c
The shortest distance from the Cu to the N,N,N plane.
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Table 16
Crystal structures of the coupled binuclear polyphenol oxidases.
Enzyme State Resolution PDB code
Plant CO
  I. batatas498 deoxy-CaOx 2.7 1BT2
met-CaOx (I) 2.7 1BT1
met-CaOx (II) 2.5 1BT3
PTU bound 2.7 1BUG
  V. vinifera499 met-CaOx 2.2 2P3X
Bacterial Ty
  S. castaneoglobisporus500 apo-Ty 2.02 1WX5
apo-Ty 1.20 1WXC
deoxy-Ty 1.37 2ZMZ
met-Ty (I) 1.33 2ZMX
met-Ty (II) 1.45 2ZMY
oxy-Ty 1.80 1WX2
  B. megaterium501 half apo-Ty 2.2 3NQ0
met-Ty (I) 2.0 3NM8
met-Ty (II) 2.3 3NTM
met-Ty (III) 2.2 3NPY
met-Ty + kojic 2.3 3NQ1
acid 2.3 3NQ5
met-Ty R209H
Fungal Ty
  A. bisporus502 met-Ty 2.30 2Y9W
met-Ty + tropolone 2.78 2Y9X
Insect Ty
  M. sexta503 met-Ty PPO1 1.97 3HHS
met-Ty PPO2 1.97 3HHS
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Table 17
Selected geometric parameters for deoxy and met tyrosinase and catechol oxidase.
deoxy-Ty and CaOx
Ty
Streptomycesa,500
CaOx
I. batatas498
CuA•••CuB 4.1 4.4
∠ CuA, O, CuB 136° 131°
τ CuAb 0.6 0.1
τ CuBb 0.6 0.3
PDB 2ZMZ 1BT2
met-CaOx
I. batatas
Met(I)c,498
I. batatas
Met(II)498
V. vinifera499
CuA•••CuB 3.0, 3.0 2.9 4.2
∠ CuA, O, CuB 104°, 105° f 104° 92°
PDB 1BT1 1BT3 2P3X
met-Ty
Streptomycesa
Met I500
Streptomycesa
Met II500
Bacillusd
Met Ic,501
CuA•••CuB 3.9 3.3 3.6, 3.6
∠ CuA, O, CuB 128° 92°, 107°f 116, 106°f
PDB 2ZMX 2ZMY 3NM8
Bacillusd
Met IIc,e,501
A. bisporusc,502
CuA•••CuB 3.2 4.4, 4.4
∠ CuA, O, CuB 106° 122°, 122° f
PDB 3NTM 2Y9W
atoms M. Sexta
PPO1503
M. Sexta
PPO2503
CuA•••CuB 4.5 4.9
∠ CuA, O, CuB --- 142°
PDB 3HHS 3HHS
aStreptomyces castaneoglobisporus.
b
The shortest distance from the Cu to the N,N,N plane.
c
Two unique molecules in the asymmetric cell.
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d
Bacillus megaterium
eOnly one subunit was fully loaded with Cu.
fContains two water derived ligands bridging the active site.
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Table 18
Representative Steady-State parameters for the non-coupled binuclear copper enzymes.
Enzyme (Substrate) kcat/s−1 Km/mM
PHM (hippuric acid)564,578,579 39.1 1.7
DβM (dopamine)580 12.7 0.49
TβM (tyramine)534 11.9 0.088
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Table 19
Primary Deuterium isotope effects on steady-state parameters
Enzyme (Substrate) D(Vmax) or
Dkcat
D(Vmax/Km)
substrate
PHM (hippuric acid)580,586 1.56 ~ 3.9
DβM (dopamine)587 1.00 ~ 3.7
TβM (tyramine)534 2.7 ~ 2.0
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Table 20
Dioxygen 18O isotope effects with primary proteo- and deterio- substrate.
Enzyme (Substrate) 18(V/K)H
(kcat/Km(O2))
18(V/K)D
(kcat/Km(O2))
PHM (hippuric acid)578 1.0173 1.0212
DβM (dopamine)587 1.0197 1.0256
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Table 21
Intrinsic isotope effects for the H-atom abstraction step.
Enzyme (Substrate) Dk (intrinsic)
Primary
Dk (intrinsic)
Secondary
PHM (hippuric acid)578 10.6 1.20
DβM (dopamine)580,592 10.9 1.19
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Table 22
Crystal structures of PHM.
Oxidation State Bound Ligand Resolution (Å) PDB ID Reference
Cu2+ NO2− 2.35 3MIB 601
Cu2+ N3− 2.42 3MIC 601
Cu2+ N3− 3.06 3MID 601
Cu2+ N3− 3.26 3MIE 601
Cu2+ CO 2.00 3MIF 601
Cu2+ NO2−a 2.70 3MIG
601
Cu2+ N3−a 2.74 3MIH
601
No CuM, Cu2+ 1.70 1YI9b 583
Cu2+ c 2.20 1YIP 583
Cu+ d 2.00 1YJK 583
No copper 2.40 1YJLb 583
Cu+ Substratee, dioxygen 1.85 1SDW 125
Cu2+ Substratef 2.10 1OPM 584
Cu+ d 2.10 3PHM 584
Cu2+ d 1.90 1PHM 538
Cu+ CO 2.15 3MLJg 601
Cu+ NO2− 3.10 3MLKg 601
Cu+ N3− 3.25 3MLLg 601
aSubstrate N-R-acetyl-3,5-diiodotyrosylglycine (Ac-DiI-YG, IYG) is present but showed not to bind to copper.
bWith mutation M314I.
c
Two solvent derived aquo ligands
dA solvent derived aquo ligand
eSubstrate N-acetyl-diiodotyrosyl-D-threonine (IYT)
fN-α-acetyl-3,5-diiodotyrosylglycine (IYG)
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Table 23
Structures and vibrational properties of Cu(II)-superoxo model complexes
Supporting
Ligand
Superoxide
Binding
Mode
ν(16O-16O)/cm−1
(Δ(18O)/cm−1)
ν(Cu-16O)/cm−1
(Δ(18O)/cm−1)
Refs.
TPA6'-NHPv η1 1130 (63) 482 (20) 606
TPANMe2 η1 1121 (63) 472 (20) 607
TrenMe,Bn η1 1120 (61) 474 (20) 608
TrenTMG η1 1120 (63) 435 (20) 123
Pyridyl-diazacycloocctane tridentate η1 1033 (65) 457 (15) 609
DPH3 η1 964 (55)* 610
Pyridyl diamido dianionic tridentate η1 1104(60) 611
Me6tren 1122(52) 612
HB(3-Ad-5-iPrpz)3 η2 1043 (59)* 613
HB(3-tBu-5-iPrpz)3 η2 1112 554 (20) 121
TACNPhOH η2 1120 (62) 450 (8), 422(5) 121
*
IR Data
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Table 24
Crystal structures for Galactose Oxidase and derivatives.
PDB ID Resolution/Å Enzyme Variant Reference
2VZ1 1.91 apo preprocessed GO 636
2VZ3 1.90 Bleached GO 636
2JKX 1.84 apo processed 642
2EIB 2.10 W290H variant 641
2EIC 2.80 W290F variant 641
2EID 2.20 W290G variant 641
2EIE 1.80 N3− coordinated to Cu(II) 641
1T2X 2.30 C383S variant643
1K3I 1.40 Precursor GO638
1GOF 1.70 First report of the thioether bond pH = 4.5 644
1GOG 1.90 First report of the thioether bond pH = 7.0 644
1GOH 2.20 Apo postprocessed 644
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Solomon et al. Page 544
Ta
bl
e 
25
Su
m
m
ar
y 
of
 D
FT
 st
ud
ie
s r
el
at
ed
 to
 se
ve
ra
l p
ut
at
iv
e 
Cu
x
O
y 
in
te
rm
ed
ia
te
 sp
ec
ie
s f
or
 m
et
ha
ne
 o
xi
da
tio
n 
in
 p
M
M
O
.
C
om
pl
ex
E a (k
ca
l/m
ol)
M
ec
ha
ni
sm
C
-H
(O
-H
)
Bo
nd
D
ist
an
ce
 (Å
)
i (c
m−
1 )
R
ef
er
en
ce
18
.8
H
-a
to
m
1.
32
1(1
.18
4)
14
45
59
8
44
.0
21
.0
Co
nc
er
te
d
Co
nc
er
te
d
1.
73
1(1
.01
4)
1.
63
1(1
.03
9)
70
3
79
9
71
9
72
0
14
.2
19
.1
40
.5
21
.7
H
-a
to
m
H
-a
to
m
Co
nc
er
te
d
H
-a
to
m
Co
nc
er
te
d
1.
39
6(1
.13
2)
1.
39
4(1
.14
4)
1.
38
2(1
.25
5)
1.
45
5(1
.11
3)
1.
38
4(1
.26
1)
12
26
12
98
14
87
10
52
14
88
71
9
72
0
72
1
72
1
72
1
9.
5
H
-a
to
m
1.
32
5(1
.17
6)
13
50
71
9
15
.0
Co
nc
er
te
d
1.
65
4(1
.09
5)
59
3
72
0
Chem Rev. Author manuscript; available in PMC 2015 April 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Solomon et al. Page 545
Table 26
Spectroscopically characterized Cux/O2 species. Adapted from Reference 39.
Cu/O2 species rR Vibrations (Δ18O2)
/ cm−1
O2-activated Cu-
ZSM-5
456 (8)
870 (40)
ν(Cu-O) = 606 (23)
ν(Cu-Cu) = 284 (0)
ν(O-O) = 763 (40)
ν(Cu-O) = 472 (20)
ν(O-O) = 1121 (63)
ν(Cu-O) = 554 (20)
ν(O-O) = 1043 (59)
ν(Cu -O) = 624 (17)
ν(O -O) = 843 (44)
ν(Cu-O) = 561 (26)
ν(O-O) = 832 (44)
ν(Cu-O) =322 (10)
ν(O-O) = 892 (52)
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Table 27
The two classes of multicopper oxidases.
Phenolic substrates (broad) Metal ion substrate (specific)
Laccases (plant, fungal, bacterial, insect) Ceruloplasmin/ Hephaestin
Ascorbate Oxidase CueO
Bilirubin Oxidase (including CotA) Fet3p
MnxG
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Table 28
Multicopper oxidase subgroups and their proposed functionalities.
Multicopper Oxidase subgroups Proposed Functionalities
Plant laccases wound healing738
lignin formation739
flavonoid oxidation740
cell wall formation741
Fungal laccases lignin degradation742
pathogenesis743
detoxification743
fungal development and morphogenesis743
Prokaryotic laccases melanin formation744,745
resistance against UV-light744,745
resistance against hydrogen peroxide744,745
Insect laccases cuticle formation746
Ascorbate Oxidase plant growth747
terminal oxidase in electron transport chain748
plant defense against insects749
hyperoxia prevention750
Bilirubin Oxidase lignin degradation751
Ferroxidases iron metabolism-including iron transport752
(Fet3p, ceruloplasmin) copper homeostasis753
Cuprous Oxidase (CueO) copper homeostasis754
antioxidant activity755
Manganese Oxidase manganese oxidation756
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Table 30
Decay rates and SKIE’s of T1D WT and variants in Fet3p
T1D T1DE487D T1DE487A T1DD94E
rate of PI decay
pH=5.0
1.8×10−3s−1 (1.6±0.1)×10−4s−1 (7.2±0.5)×10−5s−1 (3.7±0.4)×10−4s−1
rate of PI decay
pH=7.5
2.9×10−4s−1 (5.2±0.9)×10−5s−1 (8±1)×10−5s−1 (4±1)×10−5s−1
rate enhancement 6.2× 3.1× 1× 8.0×
SKIE@low pH 0.89 2.0 ~1 2.3
pH effect on resting T2 Cu yes Yes yes no
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Table 36
Various 2,4-QD substrates and steady-state kinetics parameters for 2,4-dioxygenation by P. olsonii 2,4-QD
(obtained with 20% DMSO assay content).1112
Substrate structure kcat (s−1) KM (µM) kcat/KM (M−1 s−1)
quercetin 167±3 19±1 8.8×106
kaempferol 467±17 13±2 3.6×107
galangin 33±5 20±4 1.7×106
fisetin 57±7 85±16 6.7×105
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Table 44
Bond lengths and angles for CuZ* for aerobically crystallized PdN2OR1327 and CuZ from anaerobically
crystallized PsN2OR.1296
CuZ*
PdN2OR1292
CuZ
PsN2OR1296
Resolution 1.6 Å 1.7 Å
Bond Lengths (Å) (Å)
CuI-CuIV 3.40 3.6
CuI-CuIII 3.39 3.0
CuII-CuIV 2.58 2.9
CuII-CuIII 2.58 2.6
CuIII-CuIV 3.04 3.4
CuI-S1 2.30 2.4
CuII-S1 2.24 1.9
CuIII-S1 2.28 2.1
CuIV-S1 2.36 2.4
CuI-O 2.62 -
CuIV-O 2.80 -
CuI-S2 - 2.5
CuIV-S2 - 2.3
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